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This thesis describes the application of vinylogous sulfonamides in a 
generalised synthetic protocol for the synthesis of indolizidine alkaloids, viz. 
monomorine I, 5-epi-monomorine I and the key precursor to indolizidine 209D. 
Chapter one puts the work into perspective with a review of the different 
classes of amphibian alkaloids, with specific emphasis on previous syntheses 
of indolizidine 209D and monomorine I. This is followed by a brief overview of 
previous synthetic strategies employed for alkaloid synthesis in the Wits 
laboratories and an introduction to vinylogous sulfonamides. Chapter 2 
concludes with our aims and proposed strategies for the project. 
 
The attempted total synthesis of (−)-indolizidine 209D is described in Chapter 3. 
The initial three steps to prepare t-butyl (3R)-3-{benzyl[(1R)-1-
phenylethyl]amino}nonanoate (274) proceeded well, but the fourth step, 
deprotecting the nitrogen, gave inconsistent results and hindered the 
completion of the synthesis. The free amine that we succeeded in isolating, t-
butyl (3R)-3-aminononanoate (275), reacted with chlorobutyryl chloride to give 
us lactam, t-butyl (3R)-3-(2-oxo-1-pyrrolidinyl)nonanoate (277) in addition to the 
unusual by-product N-(cyclopropanecarbonyl)cyclopropanecarboxamide (327). 
From the lactam (277) we successfully prepared the key intermediate, 
vinylogous sulfonamide t-butyl (3R)-3-{2-[(E)-(p-toluenesulfonyl)methylene-1-
pyrrolidinyl} nonanoate (280). The vinylogous sulfonamide effectively facilitated 
a high-yielding cyclisation reaction to produce the bicyclic hexahydroindolizine 
(282). Unfortunately the failing debenzylation reaction prevented the completion 
of the synthesis as no more material was available. 
 
The total syntheses of (±)-monomorine I and (±)-5-epi-monomorine I are 
described in Chapter 4. Notable intermediates include the enamide, ethyl 3-
[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293), which we prepared from a 
condensation reaction between the ketoester (292) and the racemic amine 
(291). The diastereoselective reduction of the enamide (293) was optimised to 
give ethyl 3-(2-butyl-5-oxo-1-pyrrolidinyl)butanoate (294) as a 1:5 mixture of 
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isomers. After thionation, the two isomers were separable, (295A) was the 
intermediate for (±)-monomorine I and (295B) the intermediate for (±)-5-epi-
monomorine I. Following the formation of the vinylogous sulfonamide, the key 
cyclisation step proceeded well for both the diastereomers to give the 
hexahydroindolizines (298A) and (298B). We obtained crystal structures of both 
hexahydroindolizines and were able to confirm the relative stereochemistry of 
the isomers. Defunctionalisation of the vinylogous sulfonamide included a 
stereoselective platinum-catalysed reduction of the alkene, followed by 
desulfonylation. Conditions were optimized and the synthesis was completed to 
give (±)-monomorine I in an overall yield of 3% and (±)-5-epi-monomorine I in 
an overall yield of 7%.  
 
Approaches towards the enantioselective synthesis were explored but, 
unfortunately, we experienced difficulties with the debenzylation reaction 
required to produce the chiral amine (291). In the process of trying to 
circumvent this problem a side route involving monobenzylated analogues was 
investigated. While the side route produced some interesting products, we were 
unable to direct the synthetic path back towards enantiopure monomorine I. 
 
The feasibility of extending this methodology to more complex alkaloids was 
briefly investigated. Initial experimentation involving allylated analogues of the 
ketoester (292) was investigated and was found to be incompatible with our 
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AN OVERVIEW OF AMPHIBIAN ALKALOIDS, AND REPORTED 
SYNTHESES OF INDOLIZIDINE 209D AND MONOMORINE I 
 
1.1 Definition, occurrence and classification of alkaloids 
 
In 1819 an apothecary from Halle gave the name “alkaloids” to the “alkali-like” 
compounds purified from plant extracts. These “alkaloids” proved to be very 
diverse in origin and structure. One of their few similarities is that they are all 
biosynthesized from amino acids.1 In the early days of alkaloid discovery, 
compounds such as coniine (1), morphine (2), nicotine (3) and the toxic 
molecule strychnine (4) from the seeds of the Strychnos plant were discovered. 
The poison used in the execution of Socrates, coniine, otherwise known as 
poison hemlock, was the first alkaloid to be synthesized by Ladenberg in 1886. 
The opium alkaloid morphine, whose name comes from Morpheus, the ancient 
Greek god of dreams, was first isolated in 1803, while its total synthesis only 
followed in 1952. Most alkaloids are toxic in large enough doses, but many, 




































The definition of alkaloids has evolved with time, but they are generally 
accepted as nitrogen-containing secondary metabolites that are limited in 
Nature. One useful definition is Pelletier’s “An alkaloid is a cyclic organic 
compound containing nitrogen in a negative oxidation state which is of limited 
distribution among living organisms”.3 This definition works for most alkaloids, 
but excludes the acyclic amines and amides. A more general and 
comprehensive definition is the recent IUPAC definition; “An alkaloid is a basic 
nitrogen containing compound (mostly heterocyclic) occurring mostly in the 
plant kingdom (but not excluding those from animal origin). Amino acids, 
peptides, nucleotides, nucleic acids, amino sugars and antibiotics are not 
normally regarded as alkaloids. By extension, certain neutral compounds 
biogenetically related to basic alkaloids are included”.4 
 
The first alkaloid isolated from an animal species was samandarine (6), isolated 
from the striking black and yellow European Fire Salamander in 1866.5 Today 
there are over ten thousand known alkaloids, widely exemplified in Nature. 
Initially, these secondary metabolites were named according to the organism 
from which they were isolated, ending in “-ine” to indicate they were amines.1, 2 
Then they were classified according to structural features. Nowadays, the type 
of ring system is a key feature of the classification. One such class of alkaloids 
is the indolizidines (7), which are bicyclic compounds, with fused 6- and 
5-membered rings and a bridgehead nitrogen. They are closely related to 
quinolizidines (8), which are analogous bicyclic structures with two fused 
6-membered rings sharing a bridgehead nitrogen (Figure 1.1).6 Indolizidines 
and quinolizidines form the structural basis for far more complicated fused 
polycyclic alkaloids and 25 to 30% of all known alkaloids incorporate either the 




Figure 1.1:  Indolizidine (7) and quinolizidine (8) structures with conventional 
numbering. 
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Indolizidines and quinolizidines occur widely in Nature, in bacteria, fungi, higher 
plants, invertebrates and vertebrates, both terrestrial and marine. A common 
ring system however, does not imply a common biogenetic pathway, and these 
apparent structural relationships are coincidental.7 
  
Alkaloids exhibit a wide range of biological activities. In plants they usually 
exhibit allelochemical properties, that is to say they act as deterrents to 
herbivores, micro-organisms and even to other plants. In animals, alkaloids 
generally appear to be a chemical defence against predators or as a defence 
against protozoans, fungi and bacteria. Even when they are not highly toxic, the 
alkaloids are bitter tasting and noxious to predators. Most of the indolizidine 
alkaloids affect the nerves or muscles of buccal tissue.8 Even so, many 
alkaloids have medicinal properties and have acted as scaffolds for drug 
development. 
 
Extensive review articles on alkaloids have been published, especially the 
amphibian  alkaloids and the “-izidine” alkaloids.9 - 19 From these reviews it is 
clear that while there is a lot of interest in the isolation and synthesis of 
alkaloids, biosynthetic elucidation is sparse, and considering the obvious 
biological activity, pharmacological and biochemical research is virtually non-
existent. The few alkaloids that have been well studied, such as  slaframine (9), 
swainsonine (10) and castanospermine (11), are good indicators of the 








1.2  Indolizidine alkaloids in Nature 
 
Amphibian skin contains an array of biologically active compounds, including 
biogenic amines, peptides, proteins, steroidal butadienolides, cardenolides and 
alkaloids. It has been shown that secretions from the granular skin glands can 
serve to protect amphibians from predators due to noxious effects on buccal 
tissue.8 Although the aposematic colouration of the frog skin warns predators of 
the toxins in the skin, to date there has been no correlation observed between 
the brightness of colouration, behaviour and toxicity in Dendrobates pumilio, a 
particularly varied and striking species of the frog.20  
 
Before we can discuss “amphibian” alkaloids, it is important to understand that 
although many of these alkaloids were originally extracted from frog skin, they 
have subsequently been found to occur in other organisms such as arthropods 
and plants. In many cases, the reason a given alkaloid was originally detected 
in frogs is due to the relatively high concentration of that alkaloid in the frog’s 
skin. These lipophilic alkaloids are extracted from the homogenized frog skins 
with methanol, followed by an acid/base partitioning.17 The alkaloids are then 
typically characterised by GCMS, HPLC, FTIR and NMR spectroscopy. 
Sometimes chemical transformations such as hydrogenations, acetylations, 
boronations, methylations etc. are employed to assist in the identification of key 
functional groups.17, 21 Flame ionization GC is used to quantitatively 
characterize mixtures of alkaloids.17, 21 As technology has advanced, we are 
now able to detect and characterise alkaloids that previously went undetected 
due to the microgram quantities isolated. 
 
As more “amphibian” alkaloids are detected in arthropods it has become 
increasingly obvious that there is a connection between them. In answer to this 
conundrum, John Daly proposed that the frogs in fact sequestered the alkaloids 
from arthropods through their diet. In 2000 a review by Daly et al.22 showed that 
of the five hundred alkaloids known in frogs, twenty-two of them were also 
found in arthropods. There were an additional twenty-two alkaloids which had 
been detected in arthropods that at the time had not been detected in frogs. 
Despite the large number of alkaloids that had still not been detected in the 
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supposed dietary source, this discovery prompted dietary studies on the frogs. 
One of the studies revealed that when frogs are raised in captivity on a fruit fly 
diet, i.e. in the absence of dietary alkaloids, no alkaloids are detected in their 
skin. A further study showed that when certain species of frog were fed fruit 
flies dusted with alkaloid-containing powder, they accumulated those specific 
alkaloids in their skin. It was also demonstrated that environmental 
manipulations such as light and stress did not trigger alkaloid production in 
these frogs.20 Another interesting observation from these studies indicated that 
while some frog species accumulate alkaloids with ease, other frog species 
cannot accumulate them at all, and that certain species accumulate certain 
alkaloids better than other species.20  
 
Of the eighty genera of frog that have been examined, only seven genera 
contained alkaloids.23 This reflects that only some species have the ability to 
transport and store the dietary alkaloids, thus it is a highly specialized and 
conserved biogenetic pathway. These alkaloids are so important to the frogs 
that they salvage skin alkaloids by ingesting their own shedded skin.8 While 
many species of frog reject several arthropods as a food source due to their 
bite and sting, certain frog species have evolved modified sodium channels that 
no longer respond to the toxins such as batrachotoxin (12),20 thus allowing 
them to eat the toxic arthropods. The dendrobatid frog species in particular 
have become known as the “ant specialists”, consuming toxic ants in higher 
proportions than they are present in the environment.23, 24 Because of this, 
many alkaloids were originally detected only in dendrobatid anurans and hence 
became known as the “Dendrobatid alkaloids”. These alkaloids have 
subsequently been isolated from three other anuran families, including ranid 
frogs of the genus Mantella.25 
 
In support of the dietary hypothesis, there is a large variation in alkaloid 
distribution within a particular species, but not within a given population. Thus 
there is a correlation between alkaloid distribution and environmental 
conditions/available food sources for a population.26 Importantly, early studies 
of alkaloid distribution in frog skin are fairly consistent with later studies for a 
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given population, allowing for the advancement of equipment and the superior 
detection of trace alkaloids.26  
 
In ants, the distribution of alkaloids is caste specific.23 For example, in certain 
Solenopsis species the queen ants contain the bicyclic indolizidines while the 
workers only contain the corresponding piperidines.23 This invited the 
postulation that the piperidines found in the workers could be the precursors for 
the biosynthesis of the indolizidines. The functional significance of alkaloids for 
arthropods is largely unknown; for example the queen ants do not defend the 
colony, so why would their venom contain these ‘deterrent’ bicyclic alkaloids? 
The possible biological function of these alkaloids could be to protect eggs from 
microbial infection or to use them as a sex attractant.23, 27 While there has been 
a study that indicated a possible taxonomic significance to the distribution of 
alkaloids in ants, the biosynthetic pathways to most of the alkaloids remain 
unknown. The pharmacological activity of these ant alkaloids still requires 
extensive investigation.23, 27 
 
The limited biological studies on amphibian alkaloids have investigated the 
interaction of these alkaloids with the binding sites on nicotinic acetylcholine 
receptor channel (AChR) complex from the Torpedo californica electric organ.28 
For indolizidines and gephyrotoxins (e.g. gephyrotoxin 287C) (13) the 
hydrophobic interaction of side chains seems to be especially important, with 
longer, saturated chains interacting more favourably as more potent non-
competitive blockers of the nicotinic receptor than shorter or unsaturated 
chains. The stereoconfiguration of these side-chains did not affect the results.28 
All the indolizidines and gephyrotoxins investigated acted as moderately active 
inhibitors. Presumably, artificially synthesized indolizidines with longer side 



















1.3  Major classes of “amphibian” alkaloids 
 
Originally two major groups of alkaloids were identified: The ones based on 
straight chains (class A) and the ones based on isoprene units (class B).25 This 
classification is no longer used, and instead there are now twenty structural 
classes of alkaloids in amphibians, with over eight-hundred “amphibian” 
alkaloids known to date.17 The conventional code given to any new alkaloids 
discovered consists of the nominal molecular weight and an identifying letter, 
both in bold face.17 Owing to the occurrence of mixtures of stereoisomers in 
Nature, sometimes the prefixes cis, trans, epi, or iso are given to discriminate 
between two isomers.a  
 
1.3.1 Steroidal alkaloids 
There are two classes of amphibian alkaloids that can be classified as steroidal 
alkaloids; samandarines (6 + 14) and batrachotoxins (12 + 15). Samandarines 
were first isolated from Salamandridae Salamandra, the European fire 
salamander.5 There is evidence that the salamanders synthesize samandarines 
from cholesterol. It forms the main component in parotid glands (20 mg/gland 
for the fire salamander, 5 mg/gland for the alpine salamander). Samandarine 
(6) is highly toxic, with an LD50 of 70 µg/mouse. This toxicity is likely due to 
potent local anaesthetic activity. Thus far nine structures that fit this class have 
been isolated.17 
                                                 
a For clarity when reading this thesis, boldface numbers will only be used to refer to 
structures, not when referring to alkaloids classified by the conventional code. 
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The second class of steroidal alkaloids are the batrachotoxins, isolated from 
Dendrobatidae Phyllobates in 1969. These are Western Colombian rain forest 
poison dart frogs. Only the three Colombian species of the five neotropical 
species of dendrobatid frogs (genus Phyllobates) have high levels of 
batrachotoxins and all of them have been used for poisoning blow darts. In 
contrast, the Central American species have very low levels of the toxins. 
Congeners of the batrachotoxins have been found in beetles of the species 
Melyridae Choresine and hence the beetles are the putative dietary source. The 
frogs that sequester the toxin have batrachotoxin resistant sodium channels 
and can therefore ingest the beetles with no ill effects. The batrachotoxins have 
also been found in the feathers and skin of passerine birds of Papua New 
Guinea. There have been no studies on the passerine birds to suggest 
biosynthesis or sequestering. There are three major alkaloids that fit into this 
class, and the most toxic frog, Phyllobates terribilis, has more than 1000 µg of 
batrachotoxin A (15) per frog skin, with a LD50 of 0.1 µg/mouse. P. bicolor and 
P. aurotaenia have 100 – 200 µg/skin. The mode of action of the toxin is by 
depolarisation of the nerve and muscle membranes by selective stabilization of 
sodium channels in an active, open form. These toxins have been widely used 




1.3.2 Monocyclic alkaloids 
There are two classes of monocyclic alkaloids, the pyrrolidines, for example, 
(16), and the piperidines, for example (17) and (18). Pyrrolidines were identified 
as major alkaloids in Dendrobates histrionicus in 1986. They have been known 
in myrmicine ant venom since 1970 and studies have shown that pyrrolidine 
197B (16) is sequestered poorly in an artificial environment. Ten pyrrolidines 
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have been identified to date, nine of which are trace alkaloids. There has been 
no toxicity data reported. They act as non-competitive blockers of nicotinic 
receptors.17 
 
2,6-Disubstituted piperidines were first reported in the skin extracts of South 
American dendrobatid frogs in 1986. Twenty piperidines have since been 
reported. They have been known to occur in the venom of certain myrmicine 
ants since 1971 and they are relatively rare in dendrobatids and mantellids, 
occurring only in trace amounts.29 Toxicity data has only been reported for the 
cis and trans piperidines from myrmicine ants – known as the solenopsins 253J 
(17 + 18) – which have proved toxic to mice and potent antifungals. They also 




1.3.3 Bicyclic alkaloids 
There are several classes of alkaloids that are classified as bicyclics: 
Histrionicotoxins, pumiliotoxins, decahydroquinolines, pyrrolizidines, 
indolizidines, quinolizidines, lehmizidines and epiquinamides.  
 
Histrionicotoxin 283A (19) was the first histrionicotoxin isolated from 
Dendrobates histrionicus, a South American, brightly coloured, extremely 
variable species of dendrobatid frog. The structure was first determined in 
1971, and to date sixteen amphibian alkaloids fit into this class. A New World 
myrmicine ant is the putative dietary source. These alkaloids have been 
isolated in all neotropical frogs, at the high levels of up to 200 µg/frog. They 
exhibit low toxicity (even 1000 µg was not lethal to a mouse), but they are 
noxious and bitter and therefore act as predator deterrents. Biologically they 
function as non-competitive blockers of nicotinic receptor channels.17 
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Pumiliotoxins were first isolated from Dendrobates pumilio in 1967. They were 
found as major alkaloids in this highly variable, brightly coloured, small 
Panamanian dendrobatid frog. The structures of pumiliotoxin A (20) and B (21) 
remained elusive until 1980, when X-ray crystallography revealed the structure 
of pumiliotoxin 251D (22); A and B were solved by analogy. Over thirty 
pumiliotoxins are known [with twenty of those being allopumiliotoxins (23)]. 
Many of the structures are tentative. These toxins are widely distributed in 
anurans from the neotropics, semi-temperate South America, Madagascar and 
Australia. They have been detected in formicine ants of two genera, as well as 
in oribatid mites – the putative dietary source for the ants.24 Dendrobatid 
anurans have the pumiliotoxin 7-hydroxylase enzyme that has been shown to 
convert the dietary pumiliotoxin enantioselectively into the highly toxic 
allopumiliotoxin. This is the only known example in amphibians of a 
metabolically altered sequestered alkaloid. These alkaloids are prevalent in 
fairly large quantities, up to 200 µg/frog. They exhibit high toxicity with an LD50 
of 50 µg/mouse for allopumiliotoxin and 7-fold less for pumiliotoxins. Biological 
studies have revealed marked cardiotonic activity by prolonging the open-time 
of voltage dependent sodium channels thereby triggering inositol triphosphate 
production in cardiac and neuronal preparations.17 
 
The first decahydroquinoline was originally isolated along with the pumiliotoxins 
in Dendrobates pumilio and mistakenly named pumiliotoxin C (24). The real 
structure of decahydroquinoline cis-195A (24) was determined in 1969 by X-ray 
crystallography. Fifty alkaloids now belong to the 2,5-decahydroquinoline class 
and they are commonly found in neotropical dendrobatids, and rarely found in 
mantellid and bufonid anurans. The putative dietary source is the myrmicine 
ants.22 These alkaloids occur in up to 50 µg/frog and exhibit low toxicity. The 
lethal dose for decahydroquinoline cis-195A is 250 µg/mouse. The mode of 


































Pyrrolizidines such as pyrrolizidine 223H (25) have been known to occur in 
myrmicine ants since 1980 and were first reported in anurans in 1993.21 There 
are about twenty-six alkaloids, including stereoisomers, in the 3,5-disubstituted 
pyrrolizidine class and both cis and trans isomers occur naturally. They are 
fairly common in trace amounts and myrmicine ants are definitely the dietary 
source.22 No toxicity data has been reported.17 
 
There are at least four classes of indolizidine alkaloids. The 3,5-disubstituted 
indolizidines were the first to be discovered in dendrobatid frogs. Indolizidine 
195B (26) was isolated in 1986 from dendrobatid anurans, and reported as the 
diastereomer of the 5Z,9Z alkaloid monomorine I (27), isolated from myrmicine 
ants in 1973.30 All four isomers (26 – 29) of monomorine I have been detected 
in anurans. In this class, at least thirty alkaloids, including stereoisomers, have 
been detected, and they occur randomly in dendrobatid, mantellid and bufonid 
anurans as minor or trace alkaloids. Myrmicine ants are undoubtedly the dietary 
source. Almost no toxicity data has been reported; the only tested 
3,5-disubstutituted indolizidine is indolizidine 239CD (30) with an LD50 of 
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The second class of indolizidines are the 5,8-disubstituted indolizidines, which 
were first described in 1987. This is the largest class of alkaloids in anuran 
skins with more than eighty examples, including stereoisomers. They are 
common in dendrobatid and mantellid frogs and uncommon in bufonids. In most 
cases they occur as minor or trace alkaloids. One example is indolizidine 209B 
(31). The dietary source is not clear, but these alkaloids are present in leaf-litter 
arthropods, so the most likely sources are ants and oribatid mites.24 There has 
been no toxicity data reported, but they are potent non-competitive blockers of 
nicotinic receptors.17 
 
A new major class of the amphibian indolizidine alkaloids has been proposed: 
The 6,7-dehydro-5,8-disubstituted indolizidines, for example indolizidine 207E 
(32). Thirty alkaloids in this class have already been identified, all of which are 
minor or trace alkaloids in dendrobatid, bufonid and mantellid skin extracts. The 
putative dietary source is the myrmicine ant. As yet no toxicity data or biological 
activity data has been reported.17 
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5,6,8-Trisubstituted indolizidines were first proposed in 1997, and already 
seventy alkaloids belonging to this class have been discovered. Most structures 
are still tentative. Indolizidine 249H (33), with a six carbon alkenyl chain, is the 
first and only example of a branched chain in the ‘-izidines’ from an anuran skin 
extract. Indolizidines 223A (34) and 231B (35) occur in quantities up to 
50 µg/frog, whereas the other alkaloids in this class occur as minor or trace 
alkaloids, hence the tentative structures. They are commonly found in mantellid 
species, but rarely found in bufonids. They have been detected in myrmicine 

























The structures proposed for the 5-monosubstituted indolizidines 167B (36) and 
209D (37) were both tentative, and they are the only members of this class. 
They have since been proved to be pyrrolizidines and renamed as 167F (38) 
and 209K (39). It remains unclear as to whether this class of alkaloids exists in 
Nature. If these alkaloids do exist, they occur as trace components only and as 

















There are two classes of quinolizidines, the 4,6-disubstituted quinolizidines and 
the 1,4-disubstituted quinolizidines. Of the 4,6-disubstituted quinolizidines there 
are only six examples, and five of these structures are tentative. Quinolizidine 
195C (40) is a minor or trace alkaloid in dendrobatid and mantellid frogs, and 
the others are rarely seen. Quinolizidine 195C is a major alkaloid in myrmicine 
ants, the confirmed dietary source. The frogs and ants both contain the same 
enantiomer of this alkaloid. No toxicity or biology has been reported.17 
 
The 1,4-disubstituted quinolizidines were first recognized in 1996 and since 
then twenty structures have been isolated. Most of these structures are 
tentative. Quinolizidine 217A (41), 231A (42), and 233A (43) are common in 
certain species of mantellid frogs (up to 50 µg/frog) and they are also seen in 
dendrobatids. The other quinolizidines occur as trace alkaloids and are rare in 
Nature. As yet, none have been identified from bufonid frogs. The dietary 
source was recently identified as oribatid mites.24 No toxicity data is available, 












[42] [43]  
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Lehmizidines are a new and exciting class of bicyclic alkaloids that occur only in 
one species of Colombian dendrobatid frogs, Dendrobates lehmanni. The 
structure of lehmizidine 275A (44) was finally established in 2001, and since 
then the structures of nine other lehmizidines have been tentatively assigned. 
They are all minor alkaloids and they only occur in this montane species of 
Western Colombia. The putative dietary source is the myrmicine ant and no 
toxicity or biological data are available.17 
 
The last class of the bicyclic alkaloids are the epiquinamides. Epiquinamide 
(45) was reported in 2003 as a trace alkaloid in the Ecuadorian dendrobatid 
frog Epipedobates tricolor. It is the only member of its class and it has only 
been detected in one extract of a dendrobatid frog. The dietary source is still 




1.3.4 Tricyclic alkaloids 
There are four classes of tricyclic alkaloids that have been found in frog skin 
extracts, namely gephyrotoxins, coccinelline tricyclics, cyclopentaquinolizidines 
and spiropyrrolizidines. The structure of gephyrotoxin 287C (46), isolated from 
Dendrobates histrionicus, was revealed in 1977 by X-ray crystallography. 
These alkaloids are rarely detected and occur as minor alkaloids. The putative 
dietary source is the myrmicine ant. They exhibit low toxicity with a lethal dose 
of greater than 500 µg/mouse and they act as non-competitive blockers of 
nicotinic receptors.17 
 
The coccinelline alkaloids have been known to occur in coccinellid beetles 
since 1971. They have been detected as a minor alkaloid in a Panamanian 
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dendrobatid frog. Coccinelline 205B (47), 261C (48) and 263G (49) are 
indolizidine tricyclics. The coccinelline alkaloids have been found in 
dendrobatid, mantellid and bufonid anurans as minor or trace alkaloids. 
Precoccinelline 193C (50) was recently reported in oribatid mites and is the 
presumed dietary source for the coccinellid beetles. There is no toxicity data 
available. The unnatural enantiomer of 205B (47) is a potent and selective 




Cyclopentaquinolizidines were discovered in the 1970s in a tiny Colombian 
dendrobatid frog, Minyobates bombetes. The structure was only reported in 
1992 and currently there are only ten alkaloids in this class, including 
cyclopentaquinolizidine 235H (51).17 
 
Spiropyrrolizidines have been detected in both mantellid and bufonid frogs but 
are rarely seen in dendrobatids. There are nine alkaloids in this class and they 
have also been detected in millipedes. The siphonotid millipede is the putative 
dietary source for spiropyrrolizidine 236 (52). No toxicity data is available, but 





1.3.5 Pyridine alkaloids 
Epibatidine (53) is the main pyridine alkaloid that has been detected in frogs. It 
acts as a potent analgesic and it only occurs in certain South American frogs of 
the genus Epipedobates. It is presumed to be sequestered through a plant to 
arthropod to frog food chain. It is highly toxic with a lethal dose of 
0.4 µg/mouse. Nicotine and other pyridine alkaloids found in plants have also 
been detected in anuran extracts.17 
 
1.3.6 Indole alkaloids 
Pseudophrynamines contain the indole skeleton and they were first detected in 
myobatrachid frogs in 1976 using an Ehrlich colour reaction for indoles. There 
are thirteen alkaloids in this class, including pseudophrynamine 258 (54), 
although some of the structures are tentative. These alkaloids are unique in that 
they are biosynthesized by the frogs and not sequestered through their diet. 
They have only been detected in myobatrachid frogs of the genus 







1.4 Indolizidines of interest in this project 
 
1.4.1.1 Introduction to indolizidine 209D 
The 5-monosubstituted indolizidine 209D (37) was the tentatively proposed 
structure of a natural product isolated from a dendrobatid frog and was one of 
the only two members of this class. It has since been shown that the real 
structure of this natural product is a pyrrolizidine and it has subsequently been 
renamed as 209K (39). It remains unclear as to whether this class of alkaloids 
does exist in Nature; however, indolizidine 209D has been the target alkaloid of 
many syntheses over the past thirty years and remains a popular choice for 











Indolizidine 209D became the first target molecule of this project as a previous 
student at the University of the Witwatersrand had already performed extensive 
research into its total synthesis.31 Repeating the experiments and optimising the 
reactions offered good experience with this type of chemistry and allowed for 
complete characterization of all the molecules in the synthesis for the purpose 
of publication.   
 
1.4.1.2 Previous syntheses of indolizidine 209D 
To date there have been at least twenty-five publications detailing the total 
synthesis of indolizidine 209D. Each of these publications uses a disconnection 
quite different from the one we chose to employ in our synthesis. Figure 1.2 
shows the key cyclisation disconnections used by other research groups. Table 
1.1 gives a detailed breakdown of which isomer was synthesized by which 















































Figure 1.2: Cyclisation disconnections used in previous syntheses of indolizidine 209D.  
 
Disconnection (+)-209D (−)-209D (±)-209D 
1 32 32 - 36 37, 38 
2 39, 40, (5-epi)-41 42  
3  43 44 
4  45  
5 46, 47 48 49 
6  50, 51 52 
OTHER  53 - 56 44, 57 
 
 
Table 1.1: Key disconnections in the synthesis of indolizidine 209D (literature 





The C8a –C1 disconnection approach 
Pohmakotr et al.49 used disconnection 5 (see Figure 1.2 and Table 1.1) to 
synthesize the indolizidine skeleton. Synthesis of the δ-lactam (56) was 
achieved in 60% yield by the Beckmann rearrangement of 
2-hexylcyclopentanone (55) using sodium hydroxide and tosyl chloride (see 
Scheme 1.1). This reaction gave an inseparable mixture of lactams (56) and 
(57) in a 4:1 ratio. This mixture was treated with 1-bromo-3-
phenylsulfonylpropane and sodium hydride to give sulfides (58) and (59) in 41% 
and 12% yield respectively. Sulfide (58) was separated from sulfide (59) and 
was oxidized in the presence of sodium periodate to give sulfoxide (60) in 87% 
yield. The key step in this synthesis was the cyclisation step which was 
promoted by deprotonating the α-position of the sulfoxide. This allowed ring 
closure onto the lactam carbonyl to give indolizidine (61). Due to the instability 
of (61) it was used without purification to give the reduced product (62) and its 
diastereomer (63) in 47% and 45% yield respectively, over the two steps. Initial 
desulfurization attempts using a sodium amalgam or Raney nickel proved 
unsuccessful, and finally the synthesis was completed by removing the 
sulfoxide group with nickel boride to give racemic indolizidine 209D (37) and its 
epimer in 80% and 86% yield respectively.  The total synthesis of racemic 209D 






Scheme 1.1: Total synthesis of indolizidine 209D by Pohmakotr and co-workers.49 
Reagents and conditions: i) a) NH2OH.HCl, EtOH; b) TsCl, NaOH, acetone, RT, 
overnight; ii) NaH, DMF, PhS(CH2)3Br, 0°C, to RT, overnight; iii) NaIO4, MeOH, H2O, 
0°C, to RT, overnight; iv) LiHMDS, THF, -78°C, to RT, overnight; v) NaBH4, MeOH, 










Yu et al.53 developed an efficient catalyst system that promotes cycloadditions 
between terminal alkyl alkynes and alkenyl isocyanates involving a carbonyl 
migration process. This technology was the key step in their synthesis of 
indolizidine 209D (37) (see Scheme 1.2). The [2+2+2] cycloaddition of an 
alkenyl isocyanate (64) and a terminal hexyl alkyne was attempted with various 
catalyst systems. The catalyst that gave the highest conversion and 
enantiomeric excess produced indolizidine (65) as the principal product in a 
yield of 66% and an ee of 91%. Vinylogous amide (65) readily underwent 
diastereoselective reduction in the presence of hydrogen and palladium to give 
compound (66) as a single diastereomer in 82% yield. The Barton-McCombie 
protocol for deoxygenation via (67) was employed to give (−)-indolizidine 209D 
(37) in 55% yield. Starting from the alkyne, the total synthesis was achieved in 
four steps with an overall yield of 30%. 
 
 
Scheme 1.2: Total synthesis of indolizidine 209D by Yu and co-workers.53 Reagents 
and conditions: i) 2.5 mol% [Rh(C2H4)2Cl]2, 5.0 mol% L-CH2OTIPS, PhMe, 110°C, 
12 hr.; ii) Pd-C, MeOH, H2, (1 atm.); iii) (imidazole)2CS, DMAP, neat, 50°C; iv) AIBN, 
Bu3SnH, PhMe, 100°C. 
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Pearson et al.54, 55 employed an approach that utilizes intramolecular Schmidt 
reactions of azides with carbocations (see Scheme 1.3). Starting from known 
β-ketoester (68) alkylation with chloropropyl iodide at the α-position, followed by 
azide formation and a second alkylation at the ketone with n-hexyl magnesium 
bromide and cerium chloride gave alcohol (69) in 30% yield over the three 
steps.  Alcohol (69) was dehydroxylated to generate a carbocation which 
rearranged rapidly by means of a 1,2 hydride shift to give a second carbocation 
that underwent intramolecular cyclisation onto the azide to  produce the 
spirocyclic aminodiazonium ion (70). Migration of the adjacent bonds formed 
iminium ions (71) and (72). Reaction with sodium borohydride produced 
indolizidine 209D in 24% [from (69)] and its structural isomer (73) in 36% yield 
[from (69)]. The total synthesis took five steps and produced indolizidine 209D 





Scheme 1.3: Total synthesis of indolizidine 209D by Pearson and co-workers.54 
Reagents and conditions: i) a) t-BuOK, Cl(CH2)3I; b) HBr, NaN3; c) n-hexyl MgBr, 
CeCl3, THF, 1 hr.; ii) TfOH, benzene; iii) NaBH4. 
 
Lee and Li55  started from S-proline ester (74) (see Scheme 1.4) which they 
protected with Cbz, followed by a borane reduction to the corresponding 
aldehyde and transformation to pyrrolidine acrylate (75) by a Horner-Emmons 
reaction in 65% yield for the three steps. Pyrrolidine (75) was hydrogenated and 
the ester was reduced with lithium aluminium hydride to give alcohol (76) in 
53% yield over the two steps. The alcohol (76) was treated with ethyl propiolate 
and brominated to give the key intermediate β-amino acrylate (77) in 73% yield 
over the two steps. The radical derived from the primary bromide of (77) 
underwent intramolecular conjugate addition to the β-amino acrylate to form the 
indolizidine skeleton as a single stereoisomer (78) in 86% yield. Reduction of 
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the ester (78) followed by activation of the resulting alcohol with a tosyl group 
gave indolizidine (79) in 91% yield over the two steps. The final step, 
homologation of the alkyl side chain with an appropriate dialkylcuprate, gave 
indolizidine 209D (37) in 99% yield. This route serves as a general route to 
5-monosubstituted indolizidine alkaloids and the use of a different 
dialkylcuprate in the final step gave access to indolizidine 167B as well. The 
total synthesis was achieved in eleven steps and produced indolizidine 209D in 
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Scheme 1.4: Total synthesis of indolizidine 209D by Lee and co-workers.55 Reagents 
and conditions: i) a) ClCO2Bn, NaOH; b) BH3.DMS, THF; c) Py.SO3, Et3N, DMSO, 
Ph3PCHCO2Et; ii) a) H2, Pd(OH)2, MeOH; b) LiAlH4, THF; iii) a) HCCCO2Et, p-TsCl, 
Et3N, CH2Cl2; b) LiBr, acetone; iv) Bu3SnH, AIBN, benzene, reflux, 5 hr.; v) a) LiAlH4, 
THF; b) p-TsCl, Et3N, CH2Cl2; vi) (C6H13)2CuLi, ether, 0°C. 
 
The synthetic strategy employed by Back and Nakajima56 is of particular 
interest to us as it utilizes vinylogous sulfonamides (see Chapter 2, Section 
2.2.2). Their synthesis relies on the coupling reaction of proline-derived 
chloroamine (80) and an alkynyl sulfone (81) (see Scheme 1.5). The acetylenic 
group is activated by the electron withdrawing sulfone allowing it to participate 
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in conjugate additions to give β-substituted vinyl sulfones (vinylogous 
sulfonamides). These can then be deprotonated at the α-position due to the 
anion stabilization of the sulfone and then reacted with electrophiles. The 
products can easily be desulfonylated by exposure to Birch reduction 
conditions. Chloroamine (80) was coupled with alkynyl sulfone (81) to give the 
vinylogous sulfonamide (82). In the presence of base (82) underwent 
intramolecular cyclisation to give indolizidine (83) in an efficient 94% yield over 
the two steps. Stereoselective reduction of the conjugated double bond 
followed by cleavage of the sulfone with sodium in ammonia gave indolizidine 




Scheme 1.5: Total synthesis of indolizidine 209D by Back and Nakajima.56 Reagents 
and conditions: i) THF, reflux; ii) LDA, THF, -78°C; iii) NaBH3CN, MeOH; iv) Na, NH3 
liq. 
 
This completes the brief overview of published syntheses of indolizidine 209D. 
Several of the additional publications follow analogous synthetic strategies to 
those detailed in section 1.4.2.2. Chapter 2 describes how our proposed 
synthesis differs from previously published syntheses and how we exploited 
novel methodology in an attempt to achieve the total synthesis of 209D. 
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1.4.2.1 Introduction to monomorine I 
The second target natural product of this project was monomorine I (27), and its 
total synthesis formed the bulk of the original research conducted during this 
project. Monomorine I (27) has frequently been used as a target molecule to 
illustrate the applicability of new synthetic methodology. It is the natural target 
molecule for any new methodology developed for the synthesis of 
3,5-disubstituted indolizidines as it is appropriately simple and has served as a 
target for many research groups. It thus allows for easy comparison between 
the different methods available. Monomorine I (27) was first detected in the 
pheromone trail of the myrmicine ant, Monomorium pharaonis, in 1973.  
Monomorine I was isolated from Monomorium pharaonis along with alkaloids 
monomorine II – VI (84 – 88), all in the scent trail mix (see Figure 1.3).30, 58 
Monomorene was also isolated and its structure was revealed as a bicyclic 
saturated hydrocarbon.58 Monomorine (27) was the first indolizidine derivative 
discovered in the animal kingdom.30, 59 It originates in the abdominal gland and 
is found both in the poison gland, the Dufour’s gland and in sting excretions.59 
Five years later, one of its diastereoisomers was discovered in a frog skin 
extract and became known as indolizidine 195B (26) after its molecular weight 
and chronology of discovery.17 Subsequently all four diastereomers of 3-butyl-5-


















Figure 1.3: Monomorine II – VI (84 – 88), isolated from the Monomorium pharaonis 
scent trail mix.  
 
The Pharaoh ant, Monomorium pharaonis is a tiny, red-brown ant that is 2 – 
3 mm in size and small enough to penetrate bandages and sterile packaging. 
Originally a tropical species, it has now become a domestic pest in non-tropical 
countries in both North America and Western Europe, and the ants are 
attracted to heated buildings, particularly hospitals, bakeries and 
households.29, 58 Their attraction to wound exudates, beds soiled with urine and 
baby slobber, combined with their ability to carry pathogenic bacteria causes 
them to transmit disease.29, 30, 58 Their well concealed nests and multi-queened 
colonies that thrive in small wall spaces have eluded most insecticides.60 There 
is a need to detect and control infestations at an early stage or it becomes 
almost impossible to route out the queens and the nests.60  
 
A famous infestation of the Biological Laboratories of Harvard University during 
the 1960s and 1970s was finally exterminated after discovering that the worker 
ants had carried radioactive chemicals from culture dishes to the surrounding 
walls (coincidently this inspired the science-fiction novel “Spirals” by William 
Patrick).60 Shortly thereafter the Dutch Ministry of Public Health and 
Environmental Hygiene commissioned research into trail pheromones as a 
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potential means to control the ant population.59 It had been noted that trail-
following behaviour was common in both the queens and the workers and it 
was hypothesized that the trail pheromones could be used to trap the ants and 
thus exterminate them.59 It was demonstrated that a crude hexane extract of 
homogenized ants could induce trail-following behaviour in the ants. 
Monomorine I (27) was one of the components in the ant-trail mix. Studies 
revealed that the trail following activity is both concentration dependent and 
synergistic.29 The term pheromone is no longer a valid term for a single 
molecule, as it is often refers to a mixture of compounds that creates the 
‘pheromone’ effect.59 This is definitely the case for monomorine I (27)  as the 
mutually synergizing mixtures of alkaloids are far more active than the 
individual compounds.29, 59, 61 Dual or multiple functions are suspected for most 
of these alkaloids, as sex attractants, insect repellents, trail markers, 
antimicrobials etc.58 The most active component of the trail pheromones is in 
fact faranal (89), a sesquiterpenoid also found in the Dufour’s gland, with as 




Monomorine I (27) seems to play a role both as a trail marker, a repellent and in 
allomone defence.59 It has been demonstrated as a repellent against ants when 
combined with 2,5-dialkylpyrrolidines.61 Interestingly, it is only the 5Z,9Z isomer 
of 3-butyl-5-methylindolizidine that has both attractant and arrestant (causing 
aggregation) activities in feeding studies with M. pharaonis.61 
 
Monomorine I (27) has three stereogenic centres, and therefore could exist as 
one of eight stereoisomers. The nitrogen atom is an sp3 hybridized centre, 
however the atomic inversion energy is easily overcome. In most indolizidines 
the trans-fused ring junction is dominant at equilibrium. Bohlmann determined 
that if two or more α hydrogen atoms were anti-periplanar to the lone pair on 
the nitrogen then bands would be observed in the infra-red spectrum in the 
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region of 2790 cm-1. Therefore the presence or absence of these bands could 
be used to determine the favoured ring junction configuration. In fact, a single 
hydrogen atom anti-periplanar to the nitrogen lone pair also gives a band in the 
IR spectra, but it is often obscured by methylene signals.4 In addition, the 
coupling constants and chemical shift in the 1H-NMR spectra could be used to 
determine the conformation of the molecule.4 
 
Initially the favoured chair conformer was expected for monomorine I, but the 
spectroscopic evidence accumulated accommodates the trans-fused boat 
conformer as illustrated in Figure 1.4. NMR spectral evidence supports this 
conformation as long-distance cis-coupling of the hydrogen atoms shown in 




Figure 1.4: The preferred, trans-fused boat conformation of monomorine I. 
 
The trans-fused indolizidine ring shows a single, weak, Bohlmann band due to 
the cis-relationship of H-5 and H-8a at approximately 2790 cm-1.2 This allows 
assignment of the relative configuration, but not the absolute configuration. The 
relative configuration of monomorine I (27) was elucidated by NMR spectral 
comparison of the natural compound to the four major diasteromers. The 
absolute configuration of monomorine I (27) has been established as 3R,5S,9S 
and that of indolizidine 195B (26) as 3S,5S,9S.4 Many differing stereoselective 
syntheses have been attempted with varying degrees of success. 
 
Structurally similar alkaloids to those found in the Pharaoh ant were discovered 
in dendrobatid frog species in 1986.3 Several of these 3,5-disubstituted 
indolizidine alkaloids are shown below (see Figure 1.5) (27 + 90 – 92). These 




Figure 1.5: Monomorine I (27) and structurally related indolizidines (90 – 92). 
 
1.4.2.2 Previous syntheses of monomorine I 
During the development of methodology for synthesizing monomorine I (27), all 
four diastereomers have been synthesized. As all four diastereomers are 
natural products all these syntheses have value and application in natural 
product chemistry. The many different synthetic routes have varying degrees of 
stereoselectivity and in the different syntheses, different enantiomers have 
been favoured as the final product. When comparing the approaches adopted 
by different research groups working on monomorine I and its diastereomers, 
and 3,5-disubstituted indolizidines in general, the key difference shows up in 
the cyclisation step (Figure 1.6 and Table 1.2), and although monomorine I has 
already been synthesised many times, the methodology envisaged in this 
project will provide a novel cyclisation strategy to 3,5-disubstituted indolizidines. 
 
The first successful synthesis of monomorine I was performed by Ritter et al.30 
in 1973. But it was only when Oliver and Sonnet64 synthesized all the 
diastereomers of monomorine I in 1974, making use of stereoselective 
reactions, that the relative stereochemistry of monomorine I was established. 
The first synthesis to give exclusively (+)-monomorine I was performed by 
Yamazaki and Kibayashi65 in 1988 and it incorporated disconnection 1 (see 
Figure 1.6) as the key disconnection. This was also the first disconnection that 
led to the successful synthesis of indolizidine 195B.7 Table 1.2 shows which 
disconnections from Figure 1.6 were used for the total synthesis of 



























































Figure 1.6: Cyclisation disconnections used in previous syntheses of monomorine I. 
 
Disconnection (+)-monomorine (−)-monomorine (±)-monomorine
1 65 - 76 77 64, 78 - 83 
2 73, 84 - 90 91, 92 93 - 101 
3  102 - 104 105 - 107 
4 108 - 110   
5   111 
6   112 
7   113 
8 114   
195B 19, 66, 84, 115, 116 117 - 120 101 
 
Table 1.2: Key disconnections in the synthesis of monomorine I (literature references 




Disconnection 1: The C5 - N disconnection approach  
Berry and Craig67 prepared (+)-monomorine I in eleven steps starting from 
chirally pure D-norleucine (see Scheme 1.6). A key feature of their synthesis 
was the highly stereoselective ring closure, via a 5-endo-trig cyclisation. 
Enantiopure aziridine (94) was prepared in two steps from D-norleucine via 
amino alcohol (93) and then exposed to anion ring opening by methyl phenyl 
sulfone at the less substituted carbon. The resulting amine was 
dephosphonylated and reprotected with a benzoyl group to give (95) in 58% 
yield over the three steps. Compound (95) was deprotonated with a strong base 
and condensed with hex-5-enal. The resulting alkoxy anion was trapped by 
acetylation to give (96) in 75% yield. Treatment of (96) with base resulted in a 
one-pot elimination of acetic acid and a 5-endo-trig cyclisation to give (97) in 
73% yield. Pyrrolidine (97) was formed as a single diastereomer as confirmed 
by X-ray diffraction. Reduction of the benzoyl group followed by a modified 
Wacker oxidation gave (98) in 66% yield. Debenzylation of pyrrolidine (98) 
resulted in spontaneous reductive amination to give indolizidine (99) as a single 
isomer. Desulfonylation using sodium naphthalenide gave the resulting 




Scheme 1.6: Total synthesis of monomorine I by Berry and Craig.67 Reagents and 
conditions: i) a) Ph2P(O)Cl (2.1 eq.), Et3N (3 eq.), THF, 0°C → RT, 12 hrs.; b) excess 
NaH, RT, 1 – 2 weeks; ii) PhSO2Me (1 eq.), BuLi (1 eq.) 3:1 THF-Me2N(CH2)2NMe2, 
-78°C → RT, 12 hrs.; iii) BF3.OEt2 (10 eq.) 1:1 CH2Cl2-MeOH, RT, 12 hrs.; iv) BzCl (1.2 
eq.), pyridine (1.1 eq.), CH2Cl2, RT, 12 hrs, work up with Me2N(CH2)3NH2; v) BuLi (2.1 
eq.) 3:1 THF-Me2N(CH2)2NMe2, -78°C, add hex-5-enal (1.3 eq.) -78°C, 40 min., then 
add Ac2O (5 eq.), -78°C → RT, 12 hrs.; vi) ButOK (2.1 eq.), ButOH (10 eq.), in THF, 
RT, 12 hrs.; vii) DIBAL-H (4 eq.), CH2Cl2, -78°C → RT, 2 hrs.; viii) Hg(OAc)2 (1.05 eq.), 
3:1 THF-H2O, PdCl2 (0.6 eq.), CuCl2 (3 eq.), RT, 1.5 hrs.; ix) 10% Pd-C, cyclohexa-1,4-
diene (15 eq.), MeOH, reflux, 4 hrs.; x) Na+C10H8- (3.5 eq.), THF, RT, 5 min. 
 
Riesinger, Bäckvall and co-worker70 employed a general approach to 
indolizidine alkaloids using an easily prepared, common chiral intermediate 
(103) in their synthesis of (+)-monomorine I (see Scheme 1.7). The 
stereochemistry was introduced either by using Sharpless epoxidation 
methodology on molecule (101) via (102) or by purchasing the commercially 
available chiral epoxide (100). Their key step was a novel Wittig coupling with a 
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ketone-protected phosphonium salt. Pyrrolidine (103) was subjected to a 
debenzylation to give (104) in 95% yield. Compound (104) was oxidized to the 
corresponding aldehyde (105), ready for the Wittig reaction. Wittig coupling 
gave (106) in 65% yield over the two steps. The double bond was reduced 
using platinum dioxide and the tosyl group was removed using dissolving metal 
conditions. Compounds (107) and (108) were obtained in 96% and 62% yields 
respectively. The final step was the cyclisation reaction which took place under 
acidic conditions to cleave the ketal and under one atmosphere of hydrogen 
pressure with activated palladium on carbon to reduce out the resulting imine 
and afford (+)-monomorine I (27) as it hydrochloride salt in 92% yield. The 




















































Scheme 1.7: Total synthesis of monomorine I by Riesinger and co-workers.70 
Reagents and conditions: i) Pd-C, H2, MeOH; ii) pyridine-SO3, DMSO, Et3N, CH2Cl2; 
iii) Br-Ph3P+(CH2)2C(OCH2C(CH3)2CH2O)CH3, ButOK, THF, -78°C; iv) PtO2, H2, EtOH; 
v) Na/NH3, EtOH, −78°C → RT; vi) 10% Pd-C, H2, HCl (1.0 M), MeOH. 
 
Yuguchi, Tokuda and Orito82 used a synthetic route with the novel feature of a 
one-pot, four component coupling reaction, palladium catalysed and mediated 
by an organozinc reagent under a carbon monoxide atmosphere (see Scheme 
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1.8). 1,4-Diketone (112) was prepared by this reaction from organozinc reagent 
(109) and the Michael acceptor (110) in 79% yield via intermediate (111). The 
diketone (112) was then subjected to a Paal-Knorr reaction with ammonium 
acetate to give pyrrole (113) in 99% yield. Catalytic hydrogenation of pyrrole 
(113) followed by a trimethylaluminium-mediated cyclisation gave indolizidine 
(114) in 80% yield over the two steps. The final steps introduced the methyl 
group via a Grignard reaction and mild reduction of the resulting alcohol with 
sodium borohydride. This gave racemic monomorine I (27) as a single 
diastereomer in 56% yield over the three steps. Thus monomorine I was 
synthesized in a total of eight steps with an overall yield of 35%. 
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Scheme 1.8: Total synthesis of monomorine I by Yuguchi and co-workers.82 Reagents 
and conditions: i) CO (1 atm.), Pd(PPh3)4, Me3SiCl, LiCl; ii) H3O+; iii) NH4OAc, EtOH;  








Disconnection 2: The C3 - N disconnection approach  
The presence of 2,6-disubstituted piperidines in ants together with the absence 
of the 2,5 dialkyl pyrrolidines suggests that the biogenetic pathway forms the 
6-membered ring prior to the 5-membered ring. Takahata and Momose84 chose 
to follow this “biomimetic” model (see Scheme 1.9). Starting with readily 
available enantiopure L-alanine, amine (115) was prepared. Intramolecular 
amidomercuration using mercury trifluoroacetate followed by sodium bromide 
gave piperidine (116). Oxidative demercuration with sodium borohydride gave a 
5.6:1 cis : trans mixture of piperidine alcohols (117) and (118). These 
diastereomers were separated by column chromatography to give the desired 
cis isomer in 56% yield from amine (115). Swern oxidation of the cis-piperidine 
alcohol (117) gave the aldehyde (119), which was the enantiomerically pure 
intermediate for the synthesis of several methyl substituted ant indolizidines. 
Chain homologation by Horner-Emmons reaction gave an (8:1) E:Z mixture of 
the unsaturated enone (120). Exposure of enone (120) to hydrogen in the 
presence of Pearlman’s catalyst reduced out the double bond, deprotected the 
nitrogen and allowed the subsequent cyclisation reaction to occur. Finally, the 
resulting iminium moiety was stereoselectively reduced to give the desired 
(+)-monomorine I (27) in 59% yield, along with its C-3 epimer (26) (indolizidine 








































Scheme 1.9: Total synthesis of monomorine I by Takahata and co-workers.84 Reagents 
and conditions: i) Hg(OCOCF3)2, CH3NO2; ii) NaBr, NaHCO3; iii) O2, NaBH4, DMF; 
iv) (COCl)2, DMSO, Et3N; v) (H3CO)2POCH2CO(CH2)3CH3, NaH, THF; vi) H2, Pd(OH)2, 
MeOH. 
 
Somfai et al.97 began their synthesis with the protection of alcohol (121) 
followed by epoxidation to give epoxide (122) in 88% yield over the two steps 
(see Scheme 1.10). The epoxide was then converted into aziridine (123) in 75% 
yield by reaction with sodium azide followed by treatment with 
triphenylphosphine. Aziridine (123) was alkylated with t-butyl bromoacetate 
under basic conditions to give compound (124) in 76% yield. The silyl group 
was removed under standard conditions to give a free alcohol which underwent 
Swern oxidation and Wittig olefination to give the key intermediate vinyl 
aziridine (125) in 60% yield over the three steps. The key step in this synthesis 
converted vinyl aziridine (125) into 2,6-disubstituted piperidine (126) via an aza-
[2-3]-Wittig rearrangement in the presence of lithium di-isopropylamide in an 
efficient 99% yield. This reaction gave exclusively the cis isomer.  
Hydrogenation of piperidine (126) using 5% palladium on carbon gave poor 
  40
yields, rather, 5% rhodium-on-carbon was employed to give (127) in an 
excellent 91% yield. Reduction of the t-butyl ester gave alcohol (128) in 93% 
yield. This was followed by a Swern oxidation and a Horner-Emmons reaction 
which gave enone (129), almost exclusively as the Z isomer, in a reasonable 
yield of 74%. The final step was reduction of the alkene followed by 
stereoselective cyclisation by reductive amination in the presence of 5% 
palladium on carbon. This gave racemic monomorine I (27) and racemic 
indolizidine 195B (26) in a 1.5:1 ratio in a combined yield of 73%. In total the 
synthesis took fourteen steps and gave an overall yield of 8% for 
















































Scheme 1.10: Total synthesis of monomorine I by Somfai and co-workers.97 Reagents 
and conditions: i) t-BuPh2SiCl, Et3N, DMAP, CH2Cl2; ii) m-CPBA, CH2Cl2; iii) NaN3, 
NH4Cl, MeOCH2CH2OH, H2O, reflux; iv) Ph3P, PhMe, reflux; v) t-butyl bromoacetate, 
K2CO3, 18-crown-6, CH3CN; vi) Bu4NF, THF, 0°C → RT; vii) DMSO, (COCl)2, Et3N, 
CH2Cl2, -78°C; viii) Ph3PCH3Br, KHMDS, THF, -20°C; ix) LDA, THF, -78°C; x) 5% 
Rh-C, H2, MeOH; xi) LiAlH4, THF; xii) DMSO, (COCl)2, Et3N, CH2Cl2, -78°C; 
xiii) (MeO)2POCH2COBu, LiCl, i-Pr2NEt, CH3CN; xiv) 5% Pd-C, H2, MeOH. 
  
Oliver and Sonnet64, 100 were one of the first research groups to synthesize 
monomorine I (see Scheme 1.11). Ritter et al.30 did perform an earlier 
synthesis, however, at the time they did not know which stereoisomer 
corresponded to the natural product. Oliver and Sonnet started with 2,6-lutidine 
(130), which was treated with n-butyllithium, followed by the addition of 
1,2-epoxyhexane to give alcohol (131) in 60% yield. Hydrogenation afforded 
both the cis and the trans piperidines (132) and (133) in a 1:1 ratio and a 
combined yield of 63%. These were separated using spinning band distillation. 
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Cyclisation of (132) using triphenylphosphine bromide followed by triethylamine 
gave 3-butyl-5-methyloctahydroindolizidines (26 – 27) in 85% yield and 
cyclisation of (133) gave (28 – 29) in 76% yield. Full interpretation of NMR, IR 
and MS data allowed assignment of the relative stereochemistry and 










































Scheme 1.11: Total synthesis of monomorine I by Oliver and Sonnet.64, 100 Reagents 
and conditions: i) a) BuLi; b) 1,2-epoxyhexane; ii) H2, PtO2; iii) a) Ph3P.Br2; b) Et3N. 
 
Disconnection 3: The C8 – C8a disconnection approach  
Jefford et al.105 employed a route that started with a straightforward Michael 
reaction between ethyl (E)-but-2-enoate (134) and 2-butylpyrrole (135) (see 
Scheme 1.12). The reaction yielded compound (136) in 69% yield, but did not 
run to completion as 20% of the pyrrole (135) was recovered. An Arndt-Eistert 
chain extension allowed preparation of the key intermediate diazoketone (137) 
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in 86% yield. Rhodium catalysed decomposition of (137) resulted in a 
regioselective cyclisation of the piperidine ring via (138) to give (139) in 88% 
yield. Compound (139) underwent catalytic reduction in the presence of Adams 
catalyst and hydrogen gas to give indolizidine (140) in 80% yield with all-cis 
geometry due to the stereoselective transfer of hydrogen from the platinum 
surface. Deoxygenation of (140) proved difficult, presumably as the hydroxyl 
group was in an equatorial position. Jefford et al.105 finally succeeded in 
removing the hydroxy group by following a procedure developed by Barton and 
McCombie: The alcohol was converted to an imidazolecarbothionate (141) in 
90% yield and then reduced by tributylstannane in toluene heated at reflux to 
give racemic monomorine I (27) in 70% yield. The total synthesis was 











































Scheme 1.12: Total synthesis of monomorine I by Jefford and co-workers.105 Reagents 
and conditions: i) KOH, CH3CN; ii) a) i-BuOCOCl, N-methylmorpholine; b) CH2N2, 
Et2O; iii) Rh2(OAc)4, CH2Cl2; iv) PtO2, EtOH, AcOH, H2 (20 bar); 
v) N,N-thiocarbonylimidazole, ClCH2CH2Cl; vi) Bu3SnH, toluene. 
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Disconnection 4: The C3 – N, C5 - N disconnection approach 
Randl and Blechert110 employed cross metathesis (CM) as the key step in the 
synthesis of (+)-monomorine I (see Scheme 1.13). The first coupling partner 
was prepared from the commercially available enantiopure starting material 
(R)-methyloxirane (142). This was converted to the corresponding alcohol by a 
Grignard reaction with vinylmagnesium bromide under regioselective copper-
catalysed conditions. The alcohol proved unstable and was immediately 
tosylated to give (143) in 65% yield.  Reaction with sodium azide gave azide 
(144) with inversion of stereochemistry. This proved a poor candidate for CM so 
the azide was reduced to the amine and protected with a benzoyloxycarbonyl 
(Cbz) group to afford the first coupling partner, compound (145). The other 
coupling partner was prepared via norbornene (145) which was prepared from 
a Stetter reaction of norbornene-2-carbaldehyde (146) with hept-1-en-3-one in 
85% yield. Flash pyrrolysis of (147) afforded the retro Diels-Alder product (148) 
in 81% yield. Alkenes (145) and (148) were coupled using the Grubbs-Hoveyda 
catalyst (149) to give the cyclisation precursor (150) in 89% yield. 
Hydrogenation of (150) with palladium on carbon reduced the alkene, 
deprotected the amine and caused double reductive amination to give 
(+)-monomorine I (27) in 75% yield. (−)-Indolizidine 195B (26) was isolated as a 
side product in 15% yield. Therefore the amination to create the pyrrole ring 
must have proceeded with a diastereoselectivity of 5:1. The synthesis was 





Scheme 1.13: Total synthesis of monomorine I by Randl and co-workers.105, 110 
Reagents and conditions: i) a) C2H3MgBr, Cu(COD)Cl (0.1 eq.), THF, -78°C → RT, 
12 hr.; b) TsCl, DMAP (0.1 eq.), CH2Cl2, 36 hr.; ii) NaN3, DMF, 40°C, 12 hr.; iii) a) 
LiAlH4, Et2O, 0°C → RT, 2 hr.; b) Cbz-Cl, K2CO3, THF, 12 hr.; iv) hept-1-en-3-one, 
3-benzyl-5-(2-hydroxyethyl)-4-methylthiazolium chloride (0.05 eq.), Et3N (0.5 eq.), 
65°C, 18 hr.; v) flash pyrrolysis, 500°C, 10 mbar; vi) Grubbs-Hoveyda (0.05 eq.), 
CH2Cl2, reflux, 4 hr.; vii) H2, Pd-C, MeOH, RT, 48 hr. 
 
Disconnection 5: The C1 - C8a disconnection approach  
By employing dissolving metal conditions, Grierson and Zeller111 went from 
2-butyl-10-cyano-5-oxa-1-azabicyclo[4.4.0]decane (151) to racemic 
monomorine I (27) in six steps (see Scheme 1.14). Firstly, the methyl group 
was introduced using methyl iodide and low temperatures to give the kinetic 
product (152) exclusively. The kinetic product was completely converted to the 
thermodynamic product (153) by heating it at reflux with catalytic zinc bromide. 
Dissolving metal conditions were employed to remove the cyano group and the 
product (154) was isolated in a 70% yield from the starting material (151). Ring 
opening of compound (154) was achieved using diethylcyanophosphate and 
zinc bromide and gave phosphonate (155) in 75% yield. Deprotonation using 
lithium diisopropylamine allowed stereoselective ring closure to give indolizidine 
(156) as a single diastereomer. To complete the synthesis the second cyano 
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group was removed using dissolving metal conditions and racemic monomorine 




Scheme 1.14: Total synthesis of monomorine I by Grierson and co-workers.111 
Reagents and conditions: i) s-BuLi, THF-HMPT, -78°C, CH3I; ii) ZnBr2, reflux; 
iii) Na/NH3 (liq.); iv) (EtO)2POCN, ZnBr2; v) LDA, THF, -20°C; vi) Na/NH3 (liq.). 
 
Using the same synthetic methodology, monomorine I was also obtained in a 
mere three steps with an overall yield of 4% (see Scheme 1.15). The first step 
employed methyl iodide and sodium in ammonia which gave a 1:4 mixture of 
the kinetic product (152) in 10% yield and the thermodynamic (154) product 
with the cyano group already removed in 40% yield. Ring opening of (154) 
using diethylcyanophosphate and zinc dibromide gave compound (155) in 75% 
yield. Lastly, the ring closure of (155) to monomorine I (27) was achieved 
directly by using potassium and 18-crown-6. However, there was a loss of 
stereoselectivity and the 8a-epimer (29) of monomorine I was isolated as the 





Scheme 1.15: Total synthesis of monomorine I by Grierson and co-workers.111 
Reagents and conditions: i) ICH3, Na/NH3 (liq.); ii) (EtO)2POCN, ZnBr2; iii) K, 
18-crown-6, THF. 
 
Disconnection 6: The C8a – N, C3 - N disconnection approach 
Castano and Echavarren112 formed both the piperidine and pyrrolidine ring in 
one step (see Scheme 1.16). 2-Methylpiperidine (157) was TROC protected in 
96% yield using Schotten-Baumann conditions and TROCCl. The protected 
piperidine (158) was oxidized to give imide (159) in 88% yield using sodium 
periodate and ruthenium trichloride according to the procedure developed by 
Sharpless and co-workers121 The imide (159) was hydrolysed by heating it at 
reflux in water and hence the carboxylic acid (160) was obtained in 89% yield. 
The carboxylic acid (160) was converted into the corresponding acid chloride 
and then coupled with a β-stannyl enone in the presence of palladium. The 
coupled product underwent a spontaneous reduction of the enone. This key 
step in the synthesis gave the desired diketone (161) in 45% yield in addition to 
the undesired product (162), produced by a reduction reaction by tributylstannyl 
chloride. The low yield of 45% was also attributed to the competitive re-
formation of the imide (159). Removal of the TROC protecting group from the 
diketone (161) allowed spontaneous cyclisation to form indolizidine (163). The 
optimum conditions for this reaction proved to be sonication in the presence of 
cadmium with acetic acid and dimethylformamide as the solvent, which gave 
(163) in a 96% yield. The final step was the reduction of the pyrrole ring of (163) 
  48
with rhodium on carbon in the presence of hydrogen. This gave racemic 
monomorine I (27) and two of its diastereomers (28 + 29) in a 2:2:1 ratio, and a 
combined yield of 60%. Several other hydrogenation conditions proved 
unsuccessful. Thus racemic monomorine I was synthesized in seven steps with 
an overall yield of 8%. 
 
 
Scheme 1.16: Total synthesis of monomorine I by Castano and co-workers.112 
Reagents and conditions: i) TROCCl, NaOH; ii) RuCl3 (cat.), NaIO4; iii) H2O, ∆; 
iv) a) SOCl2; b) E-Bu3SnCHCHCOBu, Pd(PPh3)4, dioxane, 100°C; v) Cd, HOAc-DMF, 
23°C; vi) H2, Rh-C, 25°C, EtOH. 
 
Disconnection 7: The C3, C5, C8a - N disconnection approach 
Mori, Hori and Sato113 developed a unusual route to monomorine I involving 
nitrogen fixation (see Scheme 1.17). The ketone (164) was prepared by the 
method of Shawe and Shiels.81 Ozonolysis of the ketone (164) followed by 
treatment with dimethyl sulfide gave the triketone (165) in 85% yield. The key 
step in the synthesis was coupling the triketone (165) with a titanium nitrogen 
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complex, formed by the reaction of titanium tetrachloride, lithium and 
trimethylsilyl chloride under dry air. This gave indolizidine (166) in 22% yield. 
The yield could be increased to 30% by using molecular nitrogen instead of dry 
air. Finally, the reduction of the pyrrole ring in the presence of rhodium on 
alumina and hydrogen atmosphere gave racemic monomorine I (27) in 32% 
yield, racemic indolizidine 195B (26) in 4% yield and the C-3, C-8a epimers (28 
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Scheme 1.17: Total synthesis of monomorine I by Mori and co-workers.113 Reagents 
and conditions: i) a) O3; b) Me2S; ii) Dry air, TiCl4, Li, TMSCl, THF; iii) Rh/Al2O3, EtOH, 
H2 (20 atm), 34 hr. 
 
Disconnection 8: The C2 - C3 disconnection approach 
Starting from benzoyl-protected D-glutamic acid (167), Lee and Chung114 
converted it into the corresponding oxazolidinone, which was reduced to the 
alcohol and brominated to give oxazolidinone (168) in 90% yield over three 
steps (see Scheme 1.18). Oxazolidinone (168) was reduced, the 
N-hydroxymethyl group was removed and the bromine was substituted for a 
phenyl selenide group to give selenide (169) in 81% yield over three steps. 
Prolonged treatment with base gave the cyclic carbamate, and subsequent 
reaction with ethyl propiolate gave β-amino acrylate (170) in 96% yield. Radical 
cyclisation formed the substituted piperidine ring in 80% yield as a 66:34 
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mixture of diastereomers. The major cis isomer (171) was converted into the 
selenide (172) via the alcohol and bromide in 83% yield. The carbamate ring 
was cleaved to give the diselenide product (173) in 91% yield. The nitrogen was 
realkylated with 1-pentyn-3-one to give (174) in 100% yield. The second radical 
cyclisation formed the indolizidine skeleton in 57% yield as a mixture of 
diastereomers (175). Formation of the corresponding dithioketals allowed 
separation of the two diastereomers (176 + 177) in 37% and 44% yield 
respectively. Removal of the dithioketal groups with Raney nickel in absolute 
ethanol gave (+)-monomorine I (27) and (+)-indolizidine 195B (26) in 71% and 
78% yield respectively. Although this was one of the longer syntheses (thirteen 
steps) it incorporated novel ring closures and effectively used radical 
cyclisations to give (+)-monomorine I in 6.3% overall yield and indolizidine 195B 














































































Scheme 1.18: Total synthesis of monomorine I by Lee and co-workers.114 Reagents 
and conditions: i) a) (CH2O)n, p-TsOH, PhMe; b) BH3.THF, 0°C; c) CBr4, PPh3, THF, 
0°C; ii) a) LiBH4, -78°C; b) KOMe, MeOH; c) (PhSe)2, NaBH4, EtOH, 0°C; iii) a) KOMe, 
MeOH-THF; b) HCCCO2Et, NMM, CH2Cl2; iv) Bu3SnH, AIBN, PhH; v) a) LiAlH4, -40°C; 
b) CBr4, PPh3, CH2Cl2; c) (PhSe)2, NaBH4, EtOH, 0°C; vi) PhSeSiMe3, ZnI2, PhMe; 
vii) HCCCOEt, CH2Cl2; viii) Bu3SnH, AIBN, PhH; ix) HSCH2CH2SH, BF3.OEt2, CH2Cl2, 
N2; x) Ra-Ni, EtOH.  
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This completes the general overview of the total syntheses of monomorine I. 
Chapter 2 details how our synthesis exploits novel methodology to achieve the 
total synthesis of both monomorine I and 5-epi-monomorine I. 
 
1.4.3.1 Introduction to tricyclic alkaloids 
Tricyclic alkaloids have been known to occur in coccinellid beetles since the 
early 1970s and more recently they have been detected in certain frog species. 
Due to their structural complexity there are far fewer reported total syntheses of 
the tricyclic alkaloids compared to the bicyclic alkaloids. The tricyclic alkaloids 
are rarely detected in Nature and occur in minor and trace amounts when they 
do. However, there was evidence of their potent biological activity which 
warrants further investigation. 
 
Certain of the tricyclic alkaloids show a structural relationship to the 
3,5-disubstituted indolizidines, as their tricyclic system formally incorporates a 
3,5-disubstituted indolizidine within the skeleton. This also means that they 
could potentially be accessed by closing the two side chains of the indolizidine 
to form the third ring. One possible method would be ring closing metathesis as 




Figure 1.7: Proposed synthetic connection between 3,5-disubstituted indolizidines 
(178) and tricyclic alkaloids (179). 
 
The structural relationship between these two classes of alkaloids drew our 
interest as it offered an additional area for extending this project.  The proposed 
RCM was an obvious choice for forming the third ring as our research group 




1.4.3.2 Previous synthesis of a tricyclic alkaloid 
The work of Smith III and Kim122 is a good example of exploiting the structural 
relationship between indolizidines and tricyclic alkaloids, and they have 
demonstrated the effectiveness of RCM in forming the tricyclic skeleton. 
Extending methodology developed for the synthesis of the 3,5-disubstituted 
indolizidine (−)-223AB (180), Smith III and Kim were able to synthesize 
(−)-coccinelline 205B (47).  
 
Coccinelline 205B (47) is one of the alkaloids isolated from the skin of a 












Smith III and Kim’s synthesis proceeds via a lynchpin coupling reaction 
between TBS dithiane, an epoxide and an aziridine (see Scheme 1.19). The 
umpolung electronics of the dithiane allow successive deprotonations and 
sequential alkylation with the epoxide and the aziridine electrophiles. The 
coupling between (181), (182) and (183) proceeded to give the dialkylated 
dithiane (184) in 53% yield, with 31% yield of the monoalkylated dithiane 
recovered. A one-pot removal of the two TBS groups and mesylation of the 
alcohols followed by removal of the tosyl group using a sodium amalgam 
allowed spontaneous cyclisation to form indolizidine (185) in 70% yield over the 
three steps. Indolizidine (185) was refluxed in an acidic acetone solution to 
remove the acetonide group and this gave the ketone (186) in 83% yield. The 
ketone (186) was transformed into the corresponding enol silyl ether to provide 
the second alkene for the intramolecular RCM reaction, which proceeded 
efficiently to give the tricyclic compound (187) in 81% yield over the two steps.   
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Some difficulty was experienced in obtaining the correct stereochemistry for the 
C-6 methyl group and Smith III et al.122 overcame this difficulty by proceeding 
via the methyl enol ether of ketone (187). Conversion of (187) to the methyl 
enol ether and hydrolysis to the aldehyde (188) produced the desired 
stereoselectively which can be accounted for by the proposed electrostatic 
repulsion of the hydronium ion and the ammonium ion – steric hindrance would 
have favoured the opposite stereoselectivity. The aldehyde (188) was reduced 
to the corresponding alcohol (189) in a yield of 74% from the ketone (187) over 
three steps. The alcohol was removed to give compound (190) in 83% yield. 
The dithiane was then removed to give (191) in 90% yield. The final steps in the 
synthesis follow a method developed by Toyooka et al.123 to give 
(−)-coccinelline 205B (47) in 64% yield. The overall yield for the (−)-coccinelline 




















































































Scheme 1.19: Total synthesis of coccinelline 205B by Smith III and co-workers.122 
Reagents and conditions: i) a) t-BuLi, Et2O, -78°C → -45°C, 1 hr.; b) (182), Et2O, -78°C 
→ -20°C, 2 hr.; c) (183), THF, -78°C to 0°C 2 hr.; ii) TBAF; iii) MsCl, Et3N, THF;  
iv) a) K2CO3, MeOH, 1 hr; b) 5% Na-Hg, Na2HPO4, 15 hr.; v) 2M HCl, acetone, reflux; 
vi) a) LHMDS, TMSCl, THF, -78°C; b) Grubbs II (0.1 eq.), benzene, 65°C, 15 hr.; 
vii) a) Ph3PCH2OMeCl, t-BuOK, THF, RT; b) 6M HCl/THF (1:1), 14 hr.; viii) NaBH4, 
MeOH, 0°C; ix) a) MsCl, Et3N, THF; b) LiHBEt3, THF, reflux; x)PhI(O2CCF3)2, TFA, 
CH3CN-H2O (1:1), RT; xi) a) Ph3PCH3Br, n-BuLi, THF; b) p-TsOH, benzene. 
 
Chapter 2 details how our project could be extended to provide a novel 
synthesis of the tricyclic skeleton. Due to time constraints our investigations into 
tricyclic alkaloids only extended as far as a model study. 
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CHAPTER 2 
BACKGROUND, AIMS AND SCOPE OF THIS PROJECT 
 
2.1  The “Wits Approach” to indolizidine alkaloids 
 
2.1.1 Introduction to the “Wits Approach” 
Alkaloid chemistry in the Backeberg Laboratories in the School of Chemistry at 
the University of the Witwatersrand has been very active over the past three 
decades with nine MSc students124 - 132 and seventeen PhD students31, 133 - 148 
having graduated during this time. Our approach to alkaloid synthesis relies 
largely on the use of enaminones e.g. (192) (see Figure 2.1), especially 
vinylogous urethanes and vinylogous amides. Alternatively they can be thought 
of as β-acylated enamines. We exploit these functionally rich moieties to 
develop generalized methodology, and our particular approach has come to be 




Figure 2.1: Generalised enaminone and corresponding cyclic enaminone. 
 
Invariably we use a secondary or tertiary amine that is part of a pyrrolidine 
(193) or piperidine ring with an exocyclic carbon-carbon double bond 
conjugated to an electron-withdrawing group. Their reactivity can be modulated 
by changing the electron-withdrawing group. In our group these serve as 
scaffolds for alkaloid synthesis, as they are easily incorporated into larger 
structures and offer opportunity for chemoselective, regioselective, 
diastereoselective and enantioselective control. This versatility is associated 




Figure 2.2: Reactive sites of the enaminone system. 
 
The enaminone group is resistant to mild hydrolysis and oxidation owing to the 
delocalization of charge through the vinyl substituent. In a vinylogous urethane, 
for example (R’ = OR), chemoselective reduction of esters present elsewhere in 
the molecule is possible, while leaving the vinylogous urethane untouched. 
 
2.1.2 Preparation of enaminones 
The earliest preparation of an exocyclic vinylogous urethane was by Lukeš150 
and dates from 1932. They used a Reformatsky reaction to react lactam (194) 
with ethyl bromoacetate (195) in the presence of magnesium to form the 











Scheme 2.1: Synthesis of an exocyclic vinylogous urethane by Lukeš and co-
workers.150 
 
One of the favourite methods of accessing enaminones in our laboratories 
involves reacting a thiolactam (197) with an α-halo carbonyl compound to form 
an α-thioiminium salt (198). The salt (198) is then treated with a mild base, and 
an episulfide (199) forms. In the presence of a sulfur scavenger the episulfide 
spontaneously collapses to form the exocyclic double bond and hence the 
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enaminone (200). This is known as the Eschenmoser sulfide contraction (see 
Scheme 2.2) after the researcher who developed it,151 and is one of the easier 
methods of accessing enaminones.  
 
 
Scheme 2.2: An example of the Eschenmoser sulfide contraction. 
 
A recent study on sulfide contraction reactions indicated that improved yields 
can be obtained through the addition of sodium iodide and the use of polar 
aprotic solvents such as acetonitrile or chloroform.152 
 
Another method frequently employed at Wits to access exocyclic vinylogous 
amides or urethanes also starts from a thiolactam (201).153 The thiolactam 
(201) is reacted with methyl iodide to form an α-thioiminium salt (202) which is 
then condensed with an anionic nucleophile (203) (e.g. a malonate) to give an 
intermediate acylated product (204). The acylated product (204) often 
spontaneously deacylates to form the enaminone (205) (see Scheme 2.3). If 
necessary, the deacylation reaction can be facilitated by heating the acylated 




Scheme 2.3: Formation of exocyclic vinylogous amides via a malonate condensation. 
 
Several other very specific routes to enaminones have also been used at Wits, 
but they will not be discussed since they were not used in the present project. 
For example, one such method, entailing a novel Reformatsky reaction with a 
thiolactam, is illustrated in Scheme 2.7. 
 
2.1.3 Enaminones in action at Wits 
At Wits we have used enaminone methodology to access pyrrolidines, 
indolizidines, quinolizidines, lehmizidines and perhydroindole alkaloids, 
pyrrolo[1,2-a]indoles and pyrrolo[1,2-a]quinolines. Most of these scaffolds 
exploit the nucleophilicity of the β-position of the enaminone (see Figure 2.2).  
 
Enaminones have been used at Wits as partners in acylative ring closure. One 
synthesis that utilized this methodology was the formal synthesis of ipalbidine 
(206). The aza-Michael addition of thiolactam (207) to the acceptor (208) gave 
the alkylated thiolactam (209). This compound underwent an Eschenmoser 
sulfide contraction with ethyl bromoacetate to form the exocyclic vinylogous 
urethane (210). Selective hydrolysis of the saturated ester followed by 
formation of a mixed anhydride facilitated the acylative ring closure of (210) by 
increasing the electrophilicity of the carbonyl group, hence allowing the weakly 
nucleophilic β-position of the enaminone to cyclise onto the anhydride to give 
the indolizidinone (211). Hydrolysis and decarboxylation of (211) followed by 
chemoselective reduction of the enaminone (212) gave (213), a known 
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Scheme 2.4: The formal synthesis of ipalbidine by Howard et al.155 Reagents and 
conditions: i) NaOH (cat.), THF; ii) BrCH2CO2Me, THF; iii) Ph3P, Et3N, MeCN; 
iv) NaOH, H2O, reflux; v) ClCO2Me, Bu4NI (cat.), THF; vi) KOH, H2O, reflux; vii) HCl, 
H2O, reflux; viii) LiAlH4, THF. 
 
The other popular cyclisation methodology used at Wits entails alkylative ring 
closure. A strategically placed alcohol, or a 3-hydroxypropyl substituted onto 
the pyrrolidine nitrogen, was converted into a better leaving group, such as an 
iodide, which allowed the weakly nucleophilic β-position of the enaminone to 
facilitate cyclisation. This approach was nicely demonstrated in the formal 
synthesis of (–)-indolizidine 209B (see Scheme 2.5).139, 156 Chiral amine (214) 
was added to the Michael acceptor (215) with subsequent debenzylation of the 
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amine in the presence of palladium-on-carbon to give the primary amine (216) 
in 68% yield over the two steps. Amine (216) was condensed with chlorobutyryl 
chloride and converted into the corresponding thiolactam (217) in 73% yield 
over the three steps. The thiolactam (217) then underwent an Eschenmoser 
sulfide contraction with ethyl bromoacetate to give the vinylogous urethane 
(218) in 94% yield. Chemoselective reduction of the saturated ester gave the 
alcohol (219) in 88% yield. Finally, alkylative ring closure proceeded in the 
presence of iodine, triphenylphosphine and imidazole to give the bicyclic 
product (220). Chemoselective and diastereoselective reduction of the 
enaminone and ester gave the alcohol (221) in 38% yield over two steps and 
completed the formal synthesis of (–)-indolizidine 209B (222). Following the 
synthesis of Holmes et al.157 the alcohol (221) was defunctionalized via the 
corresponding methanesulfonate and the total synthesis was completed.  
 
 
Scheme 2.5: The formal synthesis of (–)-indolizidine 209B (222) by Michael and 
Gravestock.139, 156 Reagents and conditions: i) BuLi, THF, -78°C; ii) H2, (7 atm.), 10% 
Pd-C, AcOH;  iii) Cl(CH2)3COCl NaHCO3, CHCl3, reflux; iv) KOBut, ButOH; 
v) Lawesson’s reagent, PhMe,  reflux; vi) a) BrCH2CO2Et, MeCN, RT; b) Ph3P, Et3N. 
MeCN, RT; vii) LiAlH4, THF, RT; viii) I2, imidazole, Ph3P, PhMe, 110°C; ix) H2, (1 atm.), 
PtO2, AcOH, RT; x) LiAlH4, THF, RT. 
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As shown in the preceding synthesis (Scheme 2.5), in order to use enaminone 
reactivity to assist with the enantioselective alkaloid synthesis, it was necessary 
to introduce at least one stereogenic centre prior to enaminone formation. 
Chiral auxiliaries should prove a useful tool in the introduction of stereogenic 
centres, but as yet appropriate chiral auxiliaries remain elusive. The successful 
stereoselective syntheses of indolizidines following the enaminone route have 
used β-amino acids, esters and lactones as homochiral building blocks. One of 
the successful routes uses methodology developed by Davies et al.158 to 
incorporate the correct stereochemistry. This methodology was successfully 
used to introduce chirality both in the synthesis of (−)-indolizidine 209B 
(Scheme 2.5) and (−)-indolizidine I67B (see Scheme 2.6). 
 
Starting from t-butyl bromoacetate (223) and triethyl phosphite, phosphonate 
(224) was prepared. The phosphonate (224) was then reacted in a Horner-
Wadsworth-Emmons reaction to give the Michael acceptor (225) in 63% yield 
over the two steps. The alkenoate (225) underwent a stereoselective aza-
Michael reaction with the dibenzylated chiral amine (214). After debenzylation 
with 10% palladium-on-carbon and hydrogen gas in acetic acid, the 
enantiomerically pure amine (226) was isolated in 52% yield over the two steps. 
This amine (226) was reacted with chlorobutyryl chloride and cyclised to form 
the lactam (227) in 56% yield. The lactam (227) was thionated in the presence 
of Lawesson’s reagent to give thiolactam (228) in 85% yield. The thiolactam 
underwent an Eschenmoser sulfide contraction reaction to give the enaminone 
(229) in 79% yield. The enaminone (229) was converted to the corresponding 
mixed anhydride via the carboxylic acid (230), and this facilitated acylative ring 
closure of the enaminone to give hexahydroindolizidinone (231) in 55% yield. 
Using standard transformations, defunctionalisation of the ester, enaminone 
and the resulting ketone proceeded via (232), (233) and (234) to give 
(−)-indolizidine 167B (36) in a total of fifteen steps and an overall yield of 1.5% 














































































Scheme 2.6: The total synthesis of (–)-indolizidine 167B (36) by Michael and 
Gravestock.159 Reagents and conditions: i) P(OEt)3, 110°C; ii) butanal, DBU, LiCl, 
MeCN, RT; iii) BuLi, THF, -78°C; iv) H2,, (7 atm.), 10% Pd-C, AcOH; v) Cl(CH2)3COCl, 
NaHCO3, CHCl3, RT; vi) KOBut, ButOH; vii) Lawesson’s reagent, toluene, reflux; 
viii) BrCH2CO2Et, MeCN, RT; ix) Ph3P, Et3N, MeCN, RT; x) Me3SiI, CCl4, RT; xi) Ac2O, 
MeCN, 50°C; xii) KOH, H2O, reflux, then HCl, reflux; xiii) LiAlH4, THF, RT; 




Enaminone cyclisations have also been used for the synthesis of 
aziridinomitosenes (see Scheme 2.7).160 In a model study, 2-bromoaniline was 
condensed with the protected D-erythronolactone (235), which was the source 
of chirality, to give the alcohol (236) in 89% yield. Mesylation of the alcohol 
(236) and subsequent ring closure gave the lactam (237) in 90% yield over two 
steps. Thionation of lactam (237) formed the thiolactam (238) in 90% yield. 
Initial attempts at the Eschenmoser sulfide contraction involving the N-aryl 
thiolactam (238) proceeded in very low yields, probably due to the decreased 
nucleophilicity of the sulfur atom owing to conjugation with the aromatic ring. 
This problem was overcome by using a novel zinc-mediated Reformatsky 
reaction with ethyl bromoacetate in the presence of catalytic iodine. This 
produced the vinylogous urethane (239) in 91% yield. The next step, the Heck 
cyclisation, was efficiently catalysed by palladium acetate and cyclisation onto 
the aromatic ring proceeded to give (240) in 99% yield. Deprotection of the 
alcohols gave the diol (241) which was reacted with thionyl chloride to give the 
cyclic sulfite ester (242) in 74% yield over the two steps. Reaction of the cyclic 
sulfite ester (242) with sodium azide regioselectively gave the azide (243) in 
92% yield and mesylation of the remaining hydroxy group gave (244) in 95% 
yield. Finally, the formation of the aziridine (245) completed the total synthesis 
in 60% yield. In total the synthesis took eleven steps and the overall yield was 
25%. This methodology was subsequently applied to the synthesis of a fully 




Scheme 2.7: The total synthesis of aziridinomitosene analogues (245) by Michael et 
al.160, 162 Reagents and conditions: i) 2-bromoaniline, EtMgBr, THF, -78°C; ii) MeSO2Cl, 
Et3N, CH2Cl2, 0°C, to RT; iii) NaH, THF, RT; iv) Lawesson’s reagent, PhMe, reflux; 
v) Zn (5 eq.), BrCH2CO2Et (3 eq.), I2 (0.2 eq.), THF, ultrasound, then add [238], THF, 
reflux; vi) Pd(OAc)2 (0.1 eq.), PPh3 (0.4 eq.), KOAc (7.5 eq.), Bu4NBr (2.5 eq.), 
DMF-MeCN-H2O (1:1:0.2), 100°C, 5 hr.; vii) TFA, THF-H2O (1:1), RT; viii) SOCl2, Et3N, 
CH2Cl2, -15°C; ix) NaN3, DMF, 55°C, then aq. H2SO4; x) MeSO2Cl, Et3N, CH2Cl2, 0°C, 
to RT; xi) P(OMe)3, THF, reflux, then NaH, RT. 
 
One final example from the Wits laboratories is the synthesis of tricyclic 
analogues of quinolone antibiotics (see Scheme 2.8).160 Starting from various 
N-aryl thiolactams (246) a modified Reformatsky reaction with diethyl 
bromomalonate gave the difunctionalised enaminones (247). Ring closure onto 
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the aromatic ring was catalyzed by polyphosphoric acid at elevated 
temperatures and gave the esters (248). The final step was the hydrolysis of 
































a) R1 = R4 = OMe, R2 = R3 = H
b) R1 = R2 = R3 = R4 = H
c) R1 = Me, R2 = R3 = R4 = H
d) R1 = R3 = R4 = H, R2 = Me
e) R1 = R2 = R4 = H, R3 = Me
f) R1 = R2 = R4 = H, R3 = OMe
g) R1 = R4 = H, R2-R3 = OCH2O
h) R1 = Br, R2 = R3 = R4 = H
i) R1 = R4 = H, R2 = R3 = F
 
 
Scheme 2.8: The synthesis of tricyclic analogues of quinolones (249) by Michael et 
al.160, 162 Reagents and conditions: i) BrCH(CO2Et)2 (4 eq.), Zn (4 eq.), I2 (0.2 eq.), THF, 
reflux; ii) PPA, 85-100°C; iii) NaOH, H2O, reflux, then HCl.  
 
Other research groups are also currently investigating new methodology 
pertaining to enaminones. One group in particular is that of Ma and co-
workers163, 164 who employ enaminones in the cyclisation step in the synthesis 
of indolizidine and quinolizidine alkaloids (see Scheme 2.9). They used a one-
pot process, mixing the alkene (250) and the amine (251) in the presence of 
potassium carbonate, to produce the allenyl enolate (252) or (253) in situ. The 
anion (252) or (253) spontaneously cyclised, alkylatively or acylatively, to give 
the corresponding bicyclic compound (254) or (255) respectively.  One example 
of an amphibian indolizidine synthesized via this route was indolizidine 223A 
  67























n = 0 or 1
Y = CO2Et
Y = Cl






















Scheme 2.9: The use of vinylogous urethanes in the synthesis of indolizidine and 
quinolizidine alkaloids by Ma and coworkers.163 
 
2.2  Vinylogous sulfonamides 
 
2.2.1  Preparation of vinylogous sulfonamides 
A particular type of “enaminone” analogue, namely the vinylogous sulfonamide, 
has recently emerged at Wits as an interesting enaminone variant. Its synthetic 
utility is due to the electron-withdrawing sulfone group, its ability to form 
α-sulfonyl anions, and its ready removal by hydrogenolytic, alkylative or 
oxidative cleavage once it has served its purpose. This allows for easy, high-
yielding ring closure and the formation of indolizidine products that do not bear 
substituents at C-8 (Figure 1.1).30 Vinylogous sulfonamides differ from the 
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classic enaminones in that the sulfone group does not participate in conjugation 
whereas the carbonyl group does.166 
 
The literature available on sulfone chemistry is abundant and vinylogous 
sulfonamides are currently receiving a lot of attention by various research 
groups. Kozerski et al.166 have performed extensive NMR studies on the three 
tautomeric forms of β-sulfonyl enamines viz. the E, Z and imine tautomers. As 
the energy difference between the imine and the enamine is very small these 
tautomers interchange rapidly at most temperatures by a proposed 
1,3-sigmatropic proton transfer.  
 
Arias et al.167 have developed a novel preparation of vinylogous sulfonamides 
by reacting α-lithiated alkyl sulfones with lactams of pyrrolidines and 
piperidines. Meanwhile, Brillon et al.168 have developed a novel preparation of 
difunctionalized enamines (256) by condensing 2-(phenylsulfonyl)acetonitrile 




2.2.2  Uses of vinylogous sulfonamides 
One of the principal research groups investigating the reactivity of vinylogous 
sulfonamides is that of Thomas Back.56 He has demonstrated the utility of his 
methodology in the synthesis of quinolones169, 170 piperidines, pyrrolidines, 
indolizidines and quinolizidines56 (see Figure 2.3). His research group primarily 
exploits acetylenic sulfones by deprotonating the α-position in order to facilitate 
ring closure in an alkylative manner, e.g. in the synthesis of indolizidines and 
quinolizidines (see Scheme 2.10) or an acylative manner. For example, in the 
synthesis of (−)-lasubine II (257)171 and pumiliotoxin C (24)172 (see Scheme 
2.11 and 2.12). He has reacted acetylenic sulfones with anilines in 
cycloaddition reactions, e.g. in the synthesis of quinolones I and II (258) (see 
Scheme 2.13). He also uses acetylenic sulfones as efficient dienophiles in 
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cycloaddition reactions, due to the electron-withdrawing effect of the sulfone. 
This research group’s expertise extends to include the reactivity of allenic 

























Figure 2.3: Natural products, (−)-Lasubine II (257), pumiliotoxin C (24) and quinolones I 








Scheme 2.10: Pyrrolidine (260) adds to the acetylenic sulfone (259) which facilitates 





























Scheme 2.11: Piperidine (263) adds to the acetylenic sulfone (262) which facilitates 








Scheme 2.12: Amine (266) adds to the acetylenic sulfone (265) which facilitates 






Scheme 2.13: Aniline (269) adds to the acetylenic sulfone (268) to form (270), the 
precursor to quinolones I and II.169, 170 
 
2.3 Aims and proposed strategies of this project 
 
2.3.1 (−)-Indolizidine 209D 
Ibrahim Yillah, a former PhD student in the Wits laboratories, endeavoured to 
use vinylogous sulfonamides in the “Wits approach” for the total synthesis of 
(−)-indolizidine 209D (37).31, 173 This indolizidine has since proved to be the 
incorrectly assigned structure of pyrrolizidine 209K (39) and as yet no 
5-monosubstituted alkaloids have been confirmed from amphibian origin. 
Although Yillah completed his PhD in 2002, some of the intermediate molecules 
in his synthesis were not reliably characterized, in particular, the optical rotation 
values obtained did not correspond to literature values for analogous 
compounds. The methodology employed in his synthesis aligns with the 
methodology chosen for the total synthesis of monomorine I and its 
diastereomers in this PhD project. In an attempt to familiarise ourselves with 
this chemistry, to obtain the full characterization information, verify his 
experimental data, and optimize some of his reactions, we undertook to repeat 
his total synthesis of (−)-indolizidine 209D (37). The work he reported in his 
PhD thesis is shown in Scheme 2.14. 
 
Starting from t-butyl bromoacetate (271), Horner-Wadsworth-Emmons 
methodology was utilized to transform phosphonate (272) into Michael acceptor 
(273) in 86% yield over two steps. Following the protocol developed by Davies 
et al.158 aza-Michael addition with a chiral dibenzylated amine (214) allowed for 
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the stereoselective formation of (274) in 99% yield. Debenzylation in the 
presence of palladium-on-carbon afforded amine (275) in 92% yield. The 
condensation of amine (275) with 4-chlorobutyryl chloride afforded amide (276) 
in 89% yield. In the presence of a strong base the amide (276) cyclised to form 
the lactam (277) in 73% yield. Thionation of the lactam (277) afforded the 
corresponding thiolactam (278) in 80% yield. The thiolactam (278) was 
condensed with 1-[(4-methylphenyl)sulfonyl]acetone (279) which spontaneously 
deacylated to give the vinylogous sulfonamide (280) in 77% yield. Reduction of 
the t-butyl ester proceeded to give the corresponding alcohol (281) in 94% 
yield. Alkylative cyclisation afforded the bicyclic molecule (282) in 83% yield. 
Finally, reduction of the double bond gave (283) in 56% yield, followed by 
reductive cleavage of the sulfone to give (−)-indolizidine 209D (37) in 72% yield. 
Overall the synthesis took twelve steps and gave (−)-indolizidine 209D (37) in 
9.9% yield. 
 
Unfortunately, the optical rotation for the final product did not conform to the 
reported data, thus casting doubt on either the purity of the product or on the 
stereochemical integrity of the sequence.  We chose to reattempt the total 
synthesis of (−)-indolizidine 209D in order to clarify the stereochemical integrity 
of this pathway, to optimize the route and to fully characterize the 
intermediates. This would provide us with ample opportunity to familiarise 
ourselves with the methodology and the laboratory techniques required to 
complete the synthesis of monomorine I and its diastereomers at a later stage. 
Repeating this synthesis in a systematic way would also ultimately allow for the 
publication of the total synthesis of (−)-indolizidine 209D. 
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Scheme 2.14: The total synthesis of (−)-indolizidine 209D (37) by Michael and Yillah.31 
Reagents and conditions: i) P(OEt)3, 100°C; ii) heptanal, NaH, Et2O, RT, 1 hr.; iii) BuLi, 
THF, -78°C; iv) H2 (7 atm.), 5% Pd-C, AcOH, 20 hr.; v) Cl(CH2)3COCl, NaHCO3, CHCl3, 
RT; vi) KOBut, ButOH; vii) P2S5,CHCl3, RT, 8 hr.; viii) MeI, THF, then (279), Et3N, 
CH2Cl2, 72 hr.; ix) LiAlH4, THF, 15 hr.; x) PPh3, imidazole, I2, CH3CN/toluene (2:1), 




2.3.2 Monomorine I and diastereomers 
Interest in the next target, monomorine I, at Wits started in the mid-90s when 
Penelope Cheesman undertook her Masters degree.128 She started to 
investigate the total synthesis of monomorine I, but unfortunately she failed to 
complete it. However, she did perform numerous investigations leading to 
several key precursors of monomorine I and thereby verified that the 
“enaminone route” was potentially viable. Shown below are the key steps she 
achieved, although she was unable to purify or fully characterize the final two 
products (see Scheme 2.15).128  
 
Starting from the racemic lactam (284), the carbonyl was thionated to give 
thiolactam (285) in 81% yield. Alkylation of the thiolactam (285) with ethyl 
crotonate proceeded to give (286) in a disappointing yield of 23% and as a 
mixture of diastereomers. Following the sulfide contraction and formation of the 
key intermediate, vinylogous urethane (287), the cyclisation reaction took place 
and separable diastereomers (288) were isolated in a 1:1 ratio. Unfortunately 
the following two steps, reduction of the enaminone and decarboxylation, were 
carried out on minimal material and not enough of the desired products were 
recovered to give conclusive characterization. There was however, 
spectroscopic evidence that compound (289) and indolizidinone (290) had been 
obtained. The final step in the synthesis, defunctionalisation of the keto group, 
















































Scheme 2.15: Progress towards the total synthesis of monomorine I by Cheesman and 
Michael.128 Reagents and conditions: i) P4S10, THF, Na2CO3; ii) NaH, THF, ethyl 
crotonate, 12 hr., then reflux for 5 hr.; iii) a) Ethyl bromoacetate, CH3CN, 0°C, 12 hr.; 
b) PPh3, Et3N, 2hr.; iv) a) NaOH, H2O, reflux; b) Ac2O, MeCN, 60°C; v) LiAlH4, THF, 
5 hr.; vi) a) KOH, reflux 2 hr;. b) HCl, reflux 1 hr. 
 
Although Cheesman was close to achieving the target, the mixture of 
diastereomers was a disadvantage, as was the need for a final 
defunctionalisation. We chose not to optimise this approach, but rather to 
investigate a new approach via vinylogous sulfonamides.  
 
In general, indolizidines are particularly appropriate target molecules for total 
synthesis when exploiting enaminone reactivity. By nucleophilic attack of the 
enaminone at an appropriately placed electrophilic centre on the R group, one 
can create the C-7/C-8 bond (see Figure 2.4). When comparing this ring 
closure to all previous syntheses of monomorine I it was clear that this 
approach was novel. Furthermore, different levels of stereoselectivity can be 















Figure 2.4: An enaminone for a potential C-7/C-8 ring closure to form an indolizidine. 
 
Once the double bond has been incorporated into the second ring, there is the 
opportunity for stereoselective reduction, potentially guided by the steric effects 
of the other ring substituents. This reduction would be diastereofacially 
selective, with the hydrogen atoms delivered to the less hindered face, and is 








Figure 2.5: Potentially diastereofacially selective reduction of the double bond. 
 
The aim of this second total synthesis was to exploit novel methodology in the 
synthesis of 3,5-disubstituted indolizidines and to incorporate the key 
intermediate vinylogous sulfonamide to expand the scope of the “Wits 
approach”.   
 
Our proposed synthetic route (see Scheme 2.16) begins with the preparation of 
the primary amine (291) and the bifunctional electrophile (292). The amine 
(291) and the keto-ester (292) should condense to give the lactam (293). 
Reduction of the exocyclic double bond to give (294) should offer an 
opportunity for diastereoselective control. Thionation of lactam (294) could 
proceed in the presence of phosphorus pentasulfide or Lawesson’s reagent to 
give thiolactam (295). The sulfone reagent (BrCH2SO2Ar) was not a suitable 
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substrate for Eschenmoser sulfide contraction, due to the limited reactivity of 
α-halosulfones towards nucleophilic substitution.174 Bordwell and Brannen174 
attribute this effect to the inductive and field effects of the sulfonyl oxygen 
atoms. Instead, an “activated” sulfone (279) has been selected which would 
allow deprotonation and condensation with the iminium salt of thiolactam (295) 
in a manner analogous to the synthesis of (−)-indolizidine 209D. The 
deacylation should proceed spontaneously. Reduction of ester (296) under 
standard conditions should give the corresponding alcohol (297), ready for 
alkylative ring closure to form the bicyclic skeleton (298). Finally, reduction of 
the double bond using hydrogen and palladium-on-carbon should allow 
diastereoselective control and provide only one diastereomer of (299). 
Desulfonylation under standard conditions should afford monomorine I (27), our 
target molecule. Should the diastereoselectivity favour one of the other isomers, 
the synthesis will still be that of a natural product (26, 28 or 29) and will still be 
complementary to the numerous reported syntheses in the literature (refer to 
Figure 1.6).  
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Scheme 2.16: Proposed synthetic route for the total synthesis of monomorine I and/or 
its isomers.  
 
To perform the enantioselective synthesis of monomorine I and/or its 
diastereomers, the methodology developed by Davies et al.158 will be 
incorporated into the preparation of amine (291) to provide the amine as a 
single enantiomer and hence continue the chiral synthesis with a single 
enantiomer rather than a racemate (see Chapter 3, section 3.2.2 for a more 
detailed discussion of Davies’ methodology and how it has been used in 








2.3.3 Accessing tricyclic alkaloids 
The tricyclic alkaloids are rarely detected in Nature and occur in minor and 
trace amounts when they do. However, there was evidence of their potent 
biological activity that warrants further investigation. Due to their structural 
complexity of tricyclic alkaloids, there are far fewer reported total syntheses of 
them compared to the bicyclic alkaloids. Very little work on accessing tricyclic 
alkaloids formally incorporating the indolizidine and quinolizidine systems has 
been done in the Wits laboratories. A fortuitous result from Howard, Orlek and 
co-workers134, 175 led to a hydrojulolidine derivative (305) during studies into the 
total synthesis of lupinine (see Scheme 2.21). Vinylogous urethane (300) was 
alkylated to form a mixture of chlorides (301) and (302). Following a Finkelstein 
reaction, compound (302) formed the iodide (303), which underwent alkylative 
cyclisation to form the tricyclic product (304). Reduction of the enamine gave 




Scheme 2.21: The fortuitous synthesis of a hydrojulolidine derivative (308) by Orlek 
and co-workers.134, 175 
 
As was mentioned at the end of Chapter 1, 3,5-disubstituted indolizidine 
alkaloids show a structural relationship to certain tricyclic alkaloids, as their 
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tricyclic system formally incorporates a 3,5-disubstituted indolizidine within the 




The basic tricyclic skeleton of these alkaloids could potentially be accessed by 
closing the two side chains of the 3,5 disubstituted indolizidine (178) to form the 
tricyclic system (179). One possible method would be ring closing metathesis 




Figure 2.6: Proposed synthetic connection between 3,5-disubstituted indolizidines 
(178) and tricyclic alkaloids (179). 
 
Our idea for forming tricyclic alkaloids via RCM was closely related to the 
method employed by Smith III and Kim (see Scheme 1.19).122 We hope to 
prepare the 3,5-disubstituted indolizidine (178) using the same methodology 
applied for synthesis of monomorine I and then use ring closing metathesis to 
form the final ring. Initially, our aim was to present a model study that would 
support this synthesis and thus prove its viability. If the model study proved 
successful then we could build the tricyclic scaffold of an alkaloid such as 205B. 
 
Holmes and co-workers176 have performed an extensive investigation of RCM 
using β-, γ- and δ-lactams (for example, see Scheme 2.22). They reacted 
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pyrrolidine (306) with allyl alcohol using Mitsunobu conditions and isolated the 
N-allyl derivative (307) in 95% yield. Using mild reducing conditions one of the 
carbonyls was reduced to give (308) in 51% yield. The second allyl group was 
introduced using trimethylallylsilane in the presence of boron triflouride etherate 
to give (309) in 81% yield. The metathesis reaction was catalysed by the 
Grubbs I catalyst and gave the bicyclic lactam (310) in 84% yield. They have 
successfully performed the final step in our proposed synthesis using the 
ruthenium alkylidene known as the Grubbs I catalyst, which is stable and 





















Scheme 2.22: Synthesis of bicyclic molecules from lactams using RCM by Holmes and 
co-workers.176 Reagents and conditions: i) CH2CHCH2OH, PPh3, DEAD, THF; ii) 
NaBH4, HCl, EtOH, -10°C; iii) CH2CHCH2SiMe3, BF3.OEt2, CH2Cl2; iv) 5 mol% Grubbs 
I, CH2Cl2. 
 
Our proposed model study was designed to determine if the initial reaction 
conditions in the synthesis of monomorine I would be mild enough to allow for 
the incorporation of alkene side-chains. We also wanted to explore the ease 
with which these alkene side-chains undergo RCM (see Scheme 2.23). Starting 
from the acyl chloride (311), a reaction with allylmagnesium bromide (312) 
should provide us with the allylketo-ester (313). Condensation of the keto-ester 
(313) with allylamine should proceed in an analogous manner to our proposed 
monomorine condensation reaction and allow access to lactam (314). By 
selecting a chemoselective reducing agent, for example a silane in 
trifluoroacetic acid, it should be possible to selectively reduce out the exocyclic 
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double bond and produce (309). Lactam (309) would be a promising candidate 
for RCM as the alkenes are terminal and the ring strain would be minimal. 
Cyclisation would produce the bicyclic product (310). 
 
 
Scheme 2.23: Proposed model synthesis for the RCM approach. 
 
In order to extend the model study to form the third ring of the desired targets, 
the allylamine would have to contain an ester side chain, which would ultimately 
be used to form the third ring (see Scheme 2.24). Lactam (315) should undergo 
RCM in an analogous manner to the model lactam (313) and following 
formation of the vinylogous sulfonamide should form the bicyclic structure 
(316). The bicyclic vinylogous sulfonamide (316) could be reacted in an 
analogous manner to the monomorine I synthesis, effecting ring closure to 
access the tricyclic compound (317). 
 
 
Scheme 2.24: Proposed synthesis for the formation of the tricyclic skeleton. 
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2.3.4 Summary of aims 
• To repeat Yillah’s synthesis of (−)-indolizidine 209D (37) while verifying 
the experimental procedures and fully characterizing all intermediates 
and (−)-indolizidine 209D (37), paying particular attention to the optical 
rotation values and hence prove the stereochemical integrity of this 
pathway. 
• To synthesize racemic monomorine I (27) and/or its diastereomers (26, 
28 + 29) using vinylogous sulfonamides for the key cyclisations. 
• To utilize Davies’ methodology for the enantioselective synthesis of 
monomorine I (27) and/or its diastereomers (26, 28 + 29). 
• To explore potential ways of accessing indolizidine-based tricyclic 











The chemistry employed by Ibrahim Yillah during his PhD in the 
enantioselective synthesis of (−)-indolizidine 209D (37)31 was analogous to our 
proposed novel synthesis of monomorine I (27). Unfortunately, the optical 
rotation Yillah obtained for  (−)-indolizidine 209D (37) did not conform to the 
reported data, thus casting doubt on either the purity of the product or on the 
stereochemical integrity of the sequence. Owing to the incomplete 
characterization of some of his intermediates and (−)-indolizidine 209D (37), 
and in particular, the poor correspondence of his reported optical rotation 
values with the literature, Yillah’s work remains unpublished.  
 
We chose to reattempt the total synthesis of (−)-indolizidine 209D (37) in order 
to clarify the stereochemical integrity of this pathway, to optimize the route, and 
to fully characterize the intermediates. This would also provide us with ample 
opportunity to familiarize ourselves with the methodology and with the 
laboratory techniques required in order to complete the synthesis of 
monomorine I (27) and/or its diastereomers at a later stage. Repeating this 
synthesis in a systematic way would also ultimately allow for the publication of 
the total synthesis of (−)-indolizidine 209D (37). 
 
The basic principle behind Yillah’s synthetic route was the use of the vinylogous 
sulfonamide to assist cyclisation in the formation of the indolizidine skeleton. 
Using standard transformations the appropriate vinylogous sulfonamide can be 
prepared which would in turn provide access to the bicyclic system via 
alkylative ring closure. Stereoselective reduction of the vinylogous sulfonamide 
and finally desulfonylation should afford (−)-indolizidine 209D (37). 
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In order to use vinylogous sulfonamides in a stereoselective synthesis, the first 
stereogenic centre must be introduced prior to the cyclisation reaction. Yillah 
chose to follow the methodology of Davies et al.158 to introduce the 
stereochemistry by using a chiral amine to direct the formation of the 
stereocentre. Their methodology incorporates the optically pure N-benzyl-N-
(1R)-1-phenylethylamine (214) as a chiral amine nucleophile. Not only was this 
type of reaction well documented, but it had already been successfully used in 
the total synthesis of indolizidines (−)-167B (see Scheme 2.6) and (−)-209B 
(see Scheme 2.5) by Gravestock in our laboratories at Wits.139 
 
The conjugate addition of the chiral amine to an alkenoate, or Michael acceptor, 
proceeded with a high degree of stereoselectivity, especially if the alkenoate 
contained a t-butyl ester group, provided that the alkenoate was a single 
geometric isomer. The standard literature procedure for producing exclusively 
the trans alkenoate was by means of a Horner-Wadsworth-Emmons variation of 
the Wittig reaction. This was where our synthesis started. 
 
3.2 Horner-Wadsworth-Emmons reaction; the Michael acceptor 
 
t-Butyl 2-(diethoxyphosphoryl)acetate (272), was prepared in quantitative yield 
starting from t-butyl bromoacetate (271) and heating at reflux with triethyl 
phosphite for twelve hours (see Scheme 3.1). The phosphonate structure was 
confirmed by 1H-NMR spectroscopy, which clearly showed a doublet at 2.88 
ppm which can be assigned to the methylene group adjacent to the carbonyl, 
coupling to the spin-active phosphorus atom with a 3JP-H of 21.5 Hz. The t-butyl 
signal at 1.48 ppm as well as the ethoxy signals at 4.17 and 1.35 ppm allowed 
conclusive assignment of the t-butyl 2-(diethoxyphosphoryl)acetate (272). The 







Scheme 3.1: Formation of the Michael acceptor. Reagents and conditions: i) P(OEt)3, 
110°C, 24 hr.; ii) NaH, heptanal, Et2O, RT, 1 hr. 
 
The next reaction, the Horner-Wadsworth-Emmons reaction, proceeded by 
reacting t-butyl 2-(diethoxyphosphoryl)acetate (272) with sodium hydride in 
diethyl ether at 0°C to produce the corresponding stabilized anion. Careful 
addition of freshly distilled heptanal in diethyl ether from a dropping funnel, 
followed by warming the mixture to ambient temperature and stirring for two 
hours, afforded t-butyl (E)-non-2-enoate (273) exclusively as the trans isomer in 
quantitative yield (see Scheme 3.1). The geometry of the double bond was 
confirmed by the trans vicinal coupling constant observed between the alkene 
hydrogens. The hydrogen in the α-position was observed at 5.73 ppm as a 
doublet of triplets (J 15.6 and 1.5 Hz) and the hydrogen in the β-position was 
observed at 6.86 ppm as a doublet of triplets (J 15.6 and 6.9 Hz). Large vicinal 
coupling constants between 12 and 18 Hz are characteristic of trans-alkenes 
(318). The corresponding cis-alkenes (319) give vicinal coupling constants 
between 8 and 12 Hz (see Figure 3.1).  None of the cis isomer was observed in 
the 1H-NMR or 13C NMR spectra. 
 
 
Figure 3.1: Characteristic coupling constants for trans and cis vicinal coupling in 
alkenes. 
  
The singlet observed at 1.48 ppm integrating for nine hydrogens, combined with 
the aliphatic signals between 2.16 and 0.88 ppm which integrated for thirteen 
hydrogens, confirm the presence of the t-butyl ester and the hexyl side chain 
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respectively. The 13C-NMR spectrum clearly indicates the ester carbonyl group 
at 166.1 ppm and the ester C-O group at 79.9 ppm. The characteristic alkene 
signals at 148.1 and 122.9 ppm confirm the presence of the alkene functional 
group. In addition, the FTIR spectrum confirmed the presence of an ester 
carbonyl group with the stretching absorption band at 1715 cm-1. Finally, mass 
spectroscopy failed to reveal a parent ion, however, there was a clear peak 
corresponding to the loss of the t-butoxy group at 139. 
 
3.3 Davies methodology: Conjugate addition reaction 
 
The next step was the conjugate addition reaction of the chiral amine (214) to 
our trans alkenoate (273) (see Scheme 3.2). This proceeded by the reaction of 
N-benzyl-N-(1R)-1-phenylethylamine (214) with n-butyllithium in 
tetrahydrofuran, cooled to −90°C in a liquid nitrogen/acetone bath, and stirred 
for thirty minutes to ensure complete deprotonation of the amine. The t-butyl 
(E)-non-2-enoate (273) was then added by means of a dropping funnel over 
forty-five minutes and the mixture was stirred for an additional four hours at 
−90°C before the reaction was quenched with saturated ammonium chloride 
solution. The product, t-butyl (3R)-3-{benzyl[(1R)-1-phenylethyl]amino} 
nonanoate (274), was isolated in yields as high as 82%. However, the reaction 
appeared to be extremely sensitive to the quality of the n-butyllithium and the 
ratio of n-butyllithium to the amine. The isolated yields decreased rapidly with 
older stock solutions of n-butyllithium, or when the ratio of n-butyllithium to 
amine was greater than 1:1. The product was stable at ambient temperature for 






Scheme 3.2: Conjugate addition reaction. Reagents and conditions: i) a) n-BuLi, THF, 
-90°C, 30 min.; b) (273), -90°C, 4 hr. 
 
Full characterization of the product confirmed its structure. Careful examination 
of the 13C-NMR spectrum revealed only one set of signals, indicating the 
presence of only one diastereomer. Another encouraging observation was the 
optical rotation value recorded for t-butyl (3R)-3-{benzyl[(1R)-1-
phenylethyl]amino}nonanoate (274), as this agreed favourably in sign and 
magnitude with similar compounds (see Table 3.1). The optical rotation 
obtained by Yillah was at least twice the magnitude of the analogous 






R-side chain Optical Rotation Concentration Solvent  
C3H7 [α]D30 +7.3 1.24 EtOH139 
C5H11 [α]D25 +5.1 1.07 EtOH139 
C6H13  (274) [α]D20 +4.5 1.00 CH2Cl2 
C6H13   (274) [α]D20 +13.8 1.38 CH2Cl231 
C7H15 [α]D25 +5.3 1.03 CHCl3177 
 
Table 3.1: Comparison of optical rotation data for analogous aminoesters. 
(Concentration measured in g/100 mL). 
  89
The 1H-NMR and 13C-NMR spectra were in close agreement with similar 
compounds reported in the literature. Table 3.2 shows selected 1H NMR and 
13C NMR spectral data for our conjugate adduct (274) with a hexyl side chain in 
comparison to the published pentyl and heptyl analogues. The spectra obtained 
by Yillah were virtually identical to the spectra we obtained and therefore are 
not shown in Table 3.2. Diastereotopic pairs of signals were observed for H-2 
and H-6 as they were the methylene groups nearest to the stereogenic centres. 











Signal R = C5H11 139 / ppm R = C6H13  (274) / ppm R = C7H15 177 / ppm 
H-2A 1.85 (dd, J 14.6, 7.8) 1.86 (dd, J 14.5, 9.2) 1.87 (dd, J 14.5, 9.2) 
H-2B 1.96 (dd, J 14.6, 3.6) 1.96 (dd, J 14.5, 3.7) 1.95 (dd, J 14.5, 3.8) 
H-3 3.40 – 3.28 (m) 3.35 – 3.24 (m) 3.30 (m) 
H-5 3.84 (q, J 7.0) 3.86 – 3.74 (m) 3.89 – 3.77 (m) 
H-6A 3.50 (d, J 15.0) 3.48 (d, J 15.0) 3.48 (d, J 15.0) 
H-6B 3.82 (d, J 15.2) 3.86 – 3.74 (m) 3.89 – 3.77 (m) 
H-7 1.35 (d, J 7.0) 1.32 (d, J 6.9) 1.33 (d, J 7.0) 
C-1 172.4 172.2 172.3 
C-2 37.7 37.9 38.0 
C-3 53.6 54.0 54.2 
C-4 35.8 33.5 33.6 
C-5 58.3 58.4 58.5 
C-6 50.1 50.1 50.2 
C-7 20.4 20.5 20.5 
 
Table 3.2: Comparison of selected NMR spectral data (in CDCl3) for analogous 
conjugate adducts. (J-values were measured in Hz). 
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The rationalization of the stereochemical outcome of this reaction has been well 
documented, and according to Davies and co-workers178 the basic principle 
behind it was a combination of steric and stereoelectronic effects. According to 
the proposed model, the lowest energy transition state (320) is when the lithium 
atom chelates to the carbonyl group of the ester and to the lone pair of 
electrons on the nitrogen (see Figure 3.2). The methyl group places steric strain 
on the amine, forcing it to assume a “butterfly” conformation, with the benzyl 
groups parallel to one another and pointing away from the alkene. The bulky 
ester group assists in positioning the amine with the methyl group on the 
opposite side. The chelation of the lithium locks the Michael acceptor in position 
and hence the nitrogen favours si-face addition. The methyl group controls the 













Figure 3.2: Rationalized stereochemical transition state (320) showing the nitrogen 
lone pair and the carbonyl oxygen chelating to the lithium atom.179 
 
According to Davies et al.,158 the use of a secondary amine is essential for the 
high diastereomeric excess. The use of the primary amine, 
α-methylbenzylamine, gave yields in the order of 20 – 30% and de’s of 0 – 4%. 
Low temperature, -78°C to -90°C, is also essential for maintaining de’s greater 
than 95%, while an increase in temperature to 15 °C can lead to a decrease in 
the de to around 66%.158 Finally, decreased diastereomeric excess values have 
been observed with the use of o-methoxybenzylamines due to the lithium 
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chelating to the methoxy group.158 Davies and co-workers have successfully 
demonstrated the use of this methodology in the asymmetric synthesis of 
Sedum alkaloids,180 β-amino acids,158 2-aryl-4-aminotetrahydroquinoline-3-
carboxylic acid derivatives,181 and β-pyridyl-β-amino acid derivatives182 to name 
but a few. 
 
3.4  Debenzylation reactions 
 
Yillah’s thesis indicated that stirring t-butyl (3R)-3-{benzyl[(1R)-1-
phenylethyl]amino}nonanoate (274) in acetic acid with 10% palladium on 
activated carbon under seven atmospheres of hydrogen pressure would 
remove both benzyl groups in excellent yields to give the primary amine (275) 




Scheme 3.3: Debenzylation reaction by Yillah.31 Reagents and conditions: i) H2 
(7 atm.), 10% Pd-C, AcOH, RT, 20 hr.  
 
We, however, discovered that the reaction conditions were much more delicate 
than expected and we frequently isolated either the mono-debenzylated 
species exclusively, or a mixture of mono- and fully debenzylated species. If 
mono-debenzylation took place the α-methylbenzyl group was always the 
benzyl group to remain. The same chemoselectivity has been noted by Davies 
and co-workers183, 184 when reducing (321) to (322) with the use of reagents 
such as ceric ammonium nitrate and by Yillah31 with the use of palladium black 





Scheme 3.4: Chemoselective reduction. Reagents and conditions: R = i-Pr, R’ = CH3 
i) CAN (2.1 eq.), MeCN-H2O (5:1), RT,  85% yield,184 or R = t-Bu, R’ = C6H13 i) Pd-
black, HCOOH-MeOH (1:20), RT, 12 hrs.31   
 
We obtained inconsistent results with regards to chemoselectivity (see Scheme 
3.5), and when the reactions were repeated under “the same” conditions 
different product mixtures were obtained. Upon closer examination, the 
chemoselectivity appeared to be dependent on which batch of catalyst was 
used for the reaction. Initially, in our case, using palladium catalysts already 
present in the laboratory, the fully debenzylated species (275) was prepared 
with a high degree of success. However, all the palladium catalysts purchased 
throughout the course of this project favoured the formation of the mono-
debenzylated species (323) and often little to none of the desired product (275) 
was obtained. 
 
The results for our debenzylation reactions varied from 99% yield to 0% yield 
(see Table 3.3). The 5% palladium on carbon was obtained on two different 
occasions from the local company, Palaborwa Mining Company (PMC). The 
first batch (2006) worked well, provided that the catalyst loading was 
quantitative, making it an expensive option. When the solvent system was 
altered to methanol and acetic acid (3:1) the product was isolated as the 
acetate salt. In this instance the salt was probably isolated due to incomplete 
removal of the acetic acid in vacuo prior to column chromatography. The 
second batch from PMC (2009), using quantitative catalyst loading, afforded 
53% of the mono-debenzylated species (323) and none of the desired product. 
The 10% palladium-on-carbon supplied by Fluka gave mixtures of the partially 
and fully debenzylated products, unless the catalyst loading was above 25%, in 
which case only the fully debenzylated species was obtained. The equivalent 
catalyst from Sigma-Aldrich gave low yields or none of the desired product, and 
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the equivalent catalyst from Alfa only ever produced the partially debenzylated 
product. Even Pearlman’s catalyst, activated palladium hydroxide on carbon, 
required a loading of 25% in order to fully debenzylate the product, and the 
yields were only moderate. When Pearlman’s catalyst was used in conjunction 
with ethanol, the only product isolated was t-butyl nonanoate, presumably 
formed from the reduction of the retro-Michael addition product, t-butyl (E)-non-
2-enoate (273). Unfortunately, platinum dioxide removed the benzyl groups, but 
went on to catalyse additional transformations and none of the desired product 




Scheme 3.5: Our observed chemoselectivity for the debenzylation of (274). Reagents 
and conditions: i) 5% Pd-C (PMC, 1.0 eq.), AcOH, H2 (7 atm.), RT; ii) 10% Pd-C 
(Sigma, 0.25 eq.), AcOH, H2 (7 atm.), RT; iii) 5% Pd-C (PMC, 0.25 eq.), AcOH/MeOH 









Supplier Catalyst Eq. Solvent (323) (275) (324) (325) 
PMC (’06) Pd-C 5% 1.0 AcOH 0% 99% 0% 0% 
PMC (’06) Pd-C 5% 0.25 AcOH/ 
MeOH (1:3) 
0% 0% 55% 0% 
PMC (‘06) Pd-C 5% 0.25 AcOH 0% 56% 0% 0% 
Fluka Pd-C 10% 0.10 AcOH 63% 36% 0% 0% 
Fluka Pd-C 10% 0.10 AcOH 46% 54% 0% 0% 
Fluka Pd-C 10% 0.25 AcOH 0% 100% 0% 0% 
Sigma Pd-C 10% 0.25 AcOH 0% 32% 0% 0% 
Sigma Pd-C 10% 0.25 AcOH 56% 0% 0% 0% 
Alfa Pd-C 10% 0.1 AcOH 42% 0% 0% 0% 
Alfa Pd-C 10% 0.2 EtOH 21% 0% 0% 0% 
Sigma Pd(OH)2-C 0.1 AcOH 30% 0% 0% 0% 
Sigma Pd(OH)2-C 0.25 AcOH 0% 61% 0% 0% 
PMC (‘09) Pd-C 5% 1.0 AcOH 53% 0% 0% 0% 
Sigma Pd(OH)2-C 0.20 EtOH 0% 0% 0% 53% 
 
Table 3.3: Effect of catalyst supplier, type, equivalents and solvent on debenzylation.  
 
When the free amine, t-butyl (3R)-3-aminononanoate (275), was isolated its 
optical rotation was [α]D20 -13.4 (c 0.98, CH2Cl2), which corresponds well in 
magnitude and sign to the value reported by Gravestock for t-butyl (3R)-3-
aminooctanoate [α]D26 -17.7 (c 1.19, EtOH). Yillah’s reported value for (275) 
was [α]D20 -23.4 (c 0.98, CH2Cl2) nearly twice our value. The 1H-NMR and 
13C-NMR spectra correspond reasonably well with those reported by Yillah, with 
the analogous compound synthesized by Gravestock and the one synthesized 
by Davies (see Table 3.4). The biggest discrepancy between them was in the 
position of the NH2 signal: For the hexyl analogue the NH2 signal occured at 
5.20 ppm, for the pentyl analogue the NH2 signal occured at 1.84 ppm and the 
heptyl analogue had no reported signal for the NH2 substituent. The most 
obvious evidence of the success of the reaction was the loss of the aromatic 
signals in the 1H-NMR and 13C-NMR spectra and the appearance of a weak but 




Signal R = C5H11 139 / ppm R = C6H13 (275) / ppm R = C7H15 177 / ppm 
NH2 1.84 (br, s) 5.20 (br, s) - 
H-2A 2.39 (dd, J 15.6, 4.2) 2.40 (dd, J 16.0, 4.2) 2.35 (dd, J 15.5, 4.0) 
H-2B 2.18 (dd, J 15.6, 8.7) 2.34 (dd, J 16.0, 7.8) 2.15 (dd, J 15.5, 8.0) 
H-3 3.21 – 3.09 (m) 3.29 – 3.18 (m) 3.10 (br, s) 
C-1 172.0 171.5 172.0 
C-2 43.6 41.7 43.9 
C-3 48.4 48.3 48.3 
C-4 37.3 35.9 37.5 
 
Table 3.4: Comparison of selected NMR spectral data (in CDCl3) for analogous primary 
amines. (J-values were measured in Hz). 
 
The acetate salt, (R)-1-tert-butoxy-1-oxononan-3-aminium acetate (324), was 
isolated as a creamy-white solid and was fully characterized. Its melting point 
was 69 - 73 °C and its optical rotation was [α]D20 -10.0 (c 1.00, CH2Cl2), with the 
same sign as the parent amine. The most significant difference between the 
free amine (275) and the salt (324) was the presence of a broad signal at 
7.17 ppm in the 1H-NMR corresponding to the NH3+ group. The acetate group 
was observed at 1.96 ppm. The 13C-NMR spectrum showed an additional 
carbonyl peak at 177.3 ppm corresponding to the acetate ion. 
 
The partially debenzylated species, t-butyl (3R)-3-[N-(1-phenylethyl)amino] 
nonanoate (323), was fully characterized and its optical rotation was 
[α]D20 +20.4 (c 0.91, CH2Cl2). Yillah’s optical rotation for the same molecule was 
significantly different in sign and magnitude, with a value of [α]D20 -38.3 (c 1.27, 
CH2Cl2). It was clear from the 1H-NMR spectrum that the α-methylbenzyl group 
was still present, as aromatic signals at 7.38 – 7.17 ppm integrating for five 
hydrogens were observed. The α-methyl group showed up as a doublet 
(J 6.5 Hz) at 1.33 ppm integrating for three hydrogens, and finally the benzylic 
CH was observed at 3.89 ppm as a quartet (J 6.5 Hz) integrating for one 
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hydrogen. The mono-debenzylated product (323) was recovered unchanged 
after reacting it with 10% palladium hydroxide on carbon in absolute ethanol 
under seven atmospheres of hydrogen pressure for three days. 
 
A second attempt at removing the remaining α-methylbenzyl group was with 
ceric ammonium nitrate. There are examples in the literature182 - 184 of removing 
one benzyl group, usually, but not exclusively, when the benzyl group has at 
least one methoxy substituent. t-Butyl (3R)-3-[N-(1-
phenylethyl)amino]nonanoate (323) and ceric ammonium nitrate were dissolved 
in acetonitrile/distilled water (1:5) and stirred at ambient temperature overnight. 
The crude material was extracted and purified by column chromatography to 
give back unreacted starting material. 
 
The final method we utilized for the attempted removal of both of the benzyl 
groups was to react t-butyl (3R)-3-{benzyl[(1R)-1-phenylethyl]amino}nonanoate 
(274) in methanol with eight equivalents of ammonium formate and 0.37 
equivalents of 10% palladium on carbon (purchased from Alfa) under nitrogen 
for three hours. The methanolic vapours proved extremely flammable in this 
particular reaction and the utmost care was required to prevent ignition.  Using 
this method the fully debenzylated t-butyl (3R)-3-aminononanoate (275) was 
isolated in 74% yield as a clear oil. Unfortunately, this result was not 
reproducible and a further four attempts produced the mono-debenzylated 
species (323) or the fully reduced t-butyl nonanoate (325) as the major product 











% Yield of isolated products Reaction 
(323) (275) (325) 
1 0% 74% 0% 
2 40% 30% 0% 
3 0% 12% 67% 
4 0% 12% 88% 
5 0% 10% 85% 
 
Table 3.5: Debenzylation reactions using ammonium formate and activated palladium. 
 
Another literature procedure,185 reported the use of formic acid to selectively 
remove the α-methylbenzyl group from a similar amine without hydrolysing the 
t-butyl ester. We attempted this reaction in the hope that if we could remove the 
α-methylbenzyl group using formic acid, then we should be able to remove the 
second benzyl group using palladium-on-carbon. After heating (274) at reflux in 
formic acid for three hours, the reaction was stopped, the formic acid was 
removed in vacuo, and the crude material was purified by column 
chromatography. The product isolated from the column was (3R)-3-
{benzyl[(1R)-1-phenylethyl]amino} nonanoic acid (326)  which was obtained in 




Scheme 3.6: Attempted debenzylation of (274). Reagents and Conditions: i) HCOOH, 
reflux, 3 hr. 
  
The carboxylic acid (326) was optically active, with an optical rotation of 
[α]D20 -26.9 (c 1.08, CH2Cl2). 1H-NMR and 13C-NMR spectra were largely similar 
to the spectra obtained for (274), with the exception of the loss of the t-butyl 
signals and the appearance of broad OH signal between 10 - 12 ppm. The 
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carbonyl signal shifted from 172.2 ppm to 164.2 ppm, within the characteristic 
region for a carboxylic acid. 
 
The unpredictability of these debenzylation reactions resulted in an excessive 
delay in the completion of the synthesis and thwarted several attempts to “push 
material through” to attempt later steps. 
 
3.5 Formation of the lactam and cyclopropane by-products 
 
With the primary amine in hand, the next step was the formation of the lactam 
ring by reacting the free amine with chlorobutyryl chloride over two steps (see 
Scheme 3.7). The reaction conditions, optimized by Yillah and Gravestock, 
involved reacting the amine with chlorobutyryl chloride in chloroform in the 
presence of sodium bicarbonate. Then, with or without purifying the 
intermediate amide, cyclisation was effected by the reaction of the amide with 






















Scheme 3.7: Formation of the lactam ring. Reagents and conditions: i) Cl(CH2)3COCl, 
NaHCO3, CHCl3, RT; ii) KOBut, ButOH. 
 
We proceeded by reacting t-butyl (3R)-3-aminononanoate (275) with 1.2 
equivalents of chlorobutyryl chloride and with 1.5 equivalents of sodium 
bicarbonate in chloroform at ambient temperature for twelve hours. For 
characterization purposes the intermediate amide, t-butyl (3R)-3-[N-(4-
chlorobutanoyl)amino]nonanoate (276), was purified and isolated as a 
odoriferous brown oil of low UV activity on TLC plates. The initial isolated yield 
was quantitative and thereafter the intermediate was not purified prior to the 
next step. Its optical rotation was [α]D20 +10.5 (c 1.00, CH2Cl2), slightly higher 
than the value reported by Gravestock for t-butyl (3R)-3-[N-(4-
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chlorobutanoyl)amino]octanoate, [α]D25 +6.6 (c 1.14, EtOH). Yillah’s reported 
optical rotation was [α]D20 -11.3 (c 1.25, CH2Cl2), differing in sign from the value 
we obtained.  
 
The 1H-NMR spectrum for (276) showed a broad NH peak at 6.22 ppm, 
characteristically deshielded by the carbonyl group to a downfield position. The 
NH peak appeared as a doublet (J 8.7 Hz) coupling to the adjacent hydrogen 
on C-3 (see Figure 3.3). H-3 appeared as a multiplet at 4.28 - 4.16 ppm 
integrating for one hydrogen atom. The other diagnostic signal was the 
methylene group adjacent to the chlorine atom, H-13, which appeared as a 
triplet at 3.61 ppm. The aliphatic signals and the t-butyl ester signals did not 




Figure 3.3: Numbering of amide (276) for assignment of spectroscopic data. 
 
FTIR spectroscopy diagnostically showed both a broad NH peak centred at 
3289 cm-1, and two carbonyl groups; the one for the ester appeared at 
1725 cm-1, and the one for the amide appeared at 1645 cm-1. 13C-NMR 
spectroscopy also showed the two carbonyl groups C-10 at 171.4 ppm and C-1 
at 171.2 ppm and the methylene group deshielded by the chlorine atom, C-13, 
at 44.4 ppm. Yillah’s reported spectra for (276) were in close agreement with 
the spectra we obtained. 
 
In the presence of freshly sublimed potassium t-butoxide and t-butanol the 
amide, t-butyl (3R)-3-[N-(4-chlorobutanoyl)amino]nonanoate (276), was 
deprotonated and cyclised to form the corresponding lactam, t-butyl (3R)-3-(2-
oxo-1-pyrrolidinyl)nonanoate (277). The t-butanol was used to prevent 
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exchange of the ester functionality, and the t-butoxide was used as it was 
previously found to be sufficiently basic to promote the cyclisation. Gravestock 
reported yields of 82% and 57% for t-butyl (3R)-3-(2-oxo-1-
pyrrolidinyl)octanoate,  and  t-butyl (3R)-3-(2-oxo-1-pyrrolidinyl)hexanoate  
respectively. Yillah reported a yield of 73%, whereas our highest yield for the 
formation of t-butyl (3R)-3-(2-oxo-1-pyrrolidinyl)nonanoate (277) was 49%. 
 
The lactam was optically active, [α]D20 +9.5 (c 1.00, CH2Cl2), with comparable 
magnitude and sign to Gravestock’s intermediate lactam t-butyl (3R)-3-(2-oxo-
1-pyrrolidinyl)octanoate which had an optical rotation of  [α]D24 +12.4 (c 1.29, 
EtOH). Yillah obtained an optical rotation of [α]D20 +18.6 (c 1.99, CH2Cl2), twice 
the magnitude that we obtained. 
 
The most significant changes in the 1H-NMR spectrum of (277), compared to 
(276), were the disappearance of the N-H peak, and the slight upfield shift of 
the H-13 signal. FTIR spectroscopy showed two carbonyl groups; the ester 
stretching vibration at 1724 cm-1 and the amide stretching vibration at 1686 cm-1 
as is characteristic for a lactam. The N-H band was no longer visible. Low 
resolution mass spectroscopy showed the parent ion at 297 as well as 
fragmentation corresponding to the loss of the t-butyl group at 241 and loss of 
the lactam group at 212.  
 
The 1H-NMR and 13C-NMR spectra correspond well with the analogous 
compounds synthesized by Gravestock (see Table 3.6). The observed geminal 
coupling constants for H-13AB were slightly larger in our lactam compared to 
those observed by Gravestock. Yillah reported the signals for H-13AB as 
doublets of triplets both with coupling constants of 9.6 and 7.1 Hz. All the other 
signals were virtually identical, except for the C-4 signals which deviated from 




Signal R = C3H7 / ppm R = C5H11 139 / ppm R = C6H13  (277) / ppm 
H-2 2.55 – 2.18 (m) 2.51 – 2.31 (m) 2.42 – 2.34 (m) 
H-3 4.51 – 4.39 (m) 4.52 – 4.33 (m) 4.53 – 4.36 (m) 
H-11 2.55 – 2.18 (m) 2.51 – 2.31 (m) 2.42 – 2.34 (m) 
H-12 1.99 (quin., J 7.5) 2.06 – 1.91(m) 1.99 (quin., J 7.6) 
H-13A 3.38 (dd, J 9.4, 6.9) 3.36 (dd, J 9.3, 6.9) 3.38 (dd, J 15.7, 7.1) 
H-13B 3.26 (dd, J 9.4, 6.9) 3.28 (dd, J 9.3, 6.9) 3.26 (dd, J 15.7, 7.9) 
C-1 170.3 170.1 170.2 
C-2 39.4 39.2 39.3 
C-3 48.5 48.6 48.8 
C-4 34.3 31.9 32.2 
C-10 174.9 174.6 174.8 
C-11 31.4 31.9 31.1 
C-12 18.3 18.1 18.3 
C-13 42.5 42.3 42.4 
 
Table 3.6: Comparison of selected NMR spectral data (in CDCl3) for homologous 
lactams. (J-values were measured in Hz). 
 
The reason for our poor yields seems to be the occurrence of a retro-Michael 
addition, as we managed to isolate t-butyl (E)-non-2-enoate (273) in several 
instances. Interestingly, in one instance, we also isolated 
N-(cyclopropanecarbonyl)cyclopropanecarboxamide (327). This result can be 
accounted for by the addition of two equivalents of chlorobutyryl chloride to the 
free amine (275), and subsequent cyclisation of the butyryl chloride groups by 
deprotonation of all three α-positions of the carbonyl groups (328) by the strong 





Scheme 3.8: Proposed mechanism for the formation of carboximide (327) –all three 
steps are shown in (328), as the sequence was unknown. Reagents and conditions: i) 
Cl(CH2)3COCl, NaHCO3, CHCl3, RT, 12 hr.; ii) KOBut, ButOH, RT, 72 hr. 
 
N-(Cyclopropanecarbonyl)cyclopropanecarboxamide (327) was isolated in 45% 
yield as white, crystalline needles of low solubility.  The X-ray diffraction crystal 
structure (see Figure 3.4) revealed the identity of the molecule and showed 
ordered packing dominated by hydrogen bonding. The symmetric imide packed 
in chains, typical of the trans-trans isomer, rather than the dimers 
characteristically displayed by the cis-trans isomer. These chains stack in a 
ladder-like arrangement (see Figure 3.5), with parallel layers at approximately 
90° to each other. The parallel chains were linked by hydrogen bonds between 
the carbonyl oxygens and the imide nitrogen. Van der Waals interactions 




Figure 3.4: The molecular structure of carboximide (327). Displacement ellipsoids are 




Figure 3.5: Crystal packing of carboximide (327), viewed along the c-axis.  
 
Owing to the symmetry of the molecule the 1H-NMR spectra shows four signals 
only. The imide signal occurs as a sharp singlet at 8.65 ppm, shifted heavily 
downfield due to the presence of two carbonyl groups. The CH signal was 
observed as a multiplet integrating for two hydrogens at 2.28 – 2.25 ppm, while 
the other two methylene signals were equivalent but diastereotopic and occur at 
1.14 – 1.11 ppm and 0.99 – 0.93 ppm, respectively, with each signal integrating 
for four hydrogens. There was one corresponding 13C-NMR spectral signal for 
the methylene groups which occured at 10.3 ppm. The signal at 175.3 ppm 
corresponds to the carbonyl and the signal at 15.0 ppm corresponds to the CH 
carbon. The FTIR spectrum showed the carboximide carbonyl at 1710 cm-1 and 
the NH stretching vibration as a broad signal at 3257 – 3161 cm-1.  
   
The discovery of this unusual side reaction led to an honours project by Caitlin 
Zipp, who undertook an alternative synthesis of N-(cyclopropanecarbonyl)cyclo 
propanecarboxamide (327) (see Scheme 3.9) and analogous symmetric and 
asymmetric carboximides.186, 187 Starting from the commercially available acid 
chloride (329), amide (330) was prepared in 63% yield. Amide (330) was then 
deprotenated with sodium hydride and reacted with one equivalent of the acid 
chloride (329) to produce the desired imide (327) in 7% yield. Interestingly, of 
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all the carboximides she synthesized, N-(cyclopropanecarbonyl)cyclopropane 





Scheme 3.9: The alternative synthesis of carboximide (327). Reagents and conditions: 
i) NH4OH (25% w/w), 12 hr.; ii) a) NaH, THF, b) (329), reflux, 12 hr. 
 
In view of the considerable quantities of the monobenzylated amine (323) which 
had accumulated during the numerous debenzylation attempts, we decided to 
investigate whether converting it into a tertiary amide would make it more 
susceptible to debenzylation. t-Butyl (3R)-3-[N-(1-phenylethyl)amino]nonanoate 
(323) was therefore heated at reflux in chloroform with chlorobutyryl chloride in 
the presence of sodium bicarbonate (see Scheme 3.10). After purification by 
column chromatography (R)-t-butyl 3-(4-chloro-N-(R)-1-phenylethyl) 
butanamido)nonanoate (331) was isolated in 11% yield, and starting material 
was recovered.  The low yields can be accounted for by the decreased 





Scheme 3.10: Formation of the tertiary amide (331). Reagents and conditions: 
i) Cl(CH2)3COCl, NaHCO3, CHCl3, RT. 
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Full characterization of compound (331) revealed that the α-methylbenzyl group 
was still present, as was the t-butyl ester and the hexyl side chain. In addition to 
these signals, the 1H-NMR spectrum showed signals at 4.34 ppm, 2.49 ppm 
and 2.39 – 2.20 ppm corresponding to the chlorobutyryl side chain; H-13, H-12 
and H-11, respectively (see Figure 3.6). The NH peak from the starting material 
was no longer present. The 13C-NMR spectrum showed four new carbon 
signals at 177.6 ppm (C-10), 68.4 ppm (C-13), 27.7 ppm (C-11) and 22.1 ppm 
(C-12), corresponding to the chlorobutyryl side chain. The other signals in the 





























Figure 3.6: Numbering of amide (331) for assignment of spectroscopic data. 
 
The FTIR spectrum showed both the ester and the amide carbonyl groups were 
present at 1728 cm-1 and 1605 cm-1, respectively. No NH stretching vibration 
was observed. The product was optically active as expected, with an optical 
rotation of [α]D20 +20.0 (c 1.00, CH2Cl2). 
 
We attempted to debenzylate the tertiary amide (331) by reacting it with 10% 
palladium on carbon in the presence of acetic acid and seven atmospheres of 
hydrogen, as the debenzylated product (276) could be recycled back into the 
synthesis. Unfortunately, only starting material was recovered and hence the 



















Scheme 3.11: Attempted debenzylation of (331). Reagents and conditions: i) H2 
(7 atm.), 10% Pd-C, AcOH, RT, 20 hr. 
 
We also attempted to debenzylate the tertiary amide (331) by reacting it with 
ceric ammonium nitrate in acetonitrile/water (1:5) at ambient temperature for 
twelve hours. After purification, t-butyl (3R)-3-[N-(1-phenylethyl)amino] 
nonanoate (323) was isolated in 100% yield. Clearly the chlorobutyryl side 
chain was more labile than the α-methylbenzyl group. 
 
To investigate if this benzylated species (331) would also undergo a retro-
Michael addition in the presence of a strong base, we reacted (R)-t-butyl 3-(4-
chloro-N-(R)-1-phenylethyl)butanamido)nonanoate (331) with potassium 
t-butoxide in the presence of t-butanol at ambient temperature for twelve hours 
(see Scheme 3.12). After purification, (R)-N-(1-phenylethyl)cyclopropane 
carboxamide (332) was isolated as a white crystalline solid in 56% yield with 




Scheme 3.12: Retro-Michael addition of (331). Reagents and conditions: i) KOBut, 
ButOH, RT, 12 hr. 
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The product (332) was characterized by 1H-NMR spectroscopy which showed 
the α-methylbenzyl group intact and the cyclopropane as three signals at 1.38 –
1.24 ppm for the CH group, and the diastereotopic signals at 0.97 – 0.86 ppm, 
and 0.74 – 0.61 ppm for the equivalent methylene groups. The NH signal 
appeared as a doublet (J 7.2 Hz) at 6.37 ppm, coupling to the adjacent CH 
group.  13C-NMR spectroscopy revealed the α-methylbenzyl group as before 
and the new amide peak at 172.7 ppm and the cyclopropane signals at 
21.8 ppm and 7.1 ppm.  FTIR spectroscopy showed the amide carbonyl 
stretching vibration at 1636 cm-1 and the NH band at 3330 cm-1. Optical rotation 
gave an exceptionally high value, with [α]D20 +130.4 (c 0.79, CH2Cl2). 
 
3.6 Thionation reactions 
 
Now that we had succesfully prepared the lactam, the next step in our synthesis 
was the functional group interconversion of the lactam (277) into the thiolactam 
(278). 
 
Thionation reactions can be chemoselective for lactams and amides even in the 
presence of esters or ketones.188 The conditions selected for the transformation 
from the lactam (277) to the corresponding thiolactam (278) employed these 
chemoselective conditions. Two different methods were used. The first method 
was a modified version of the Brillon procedure,189 as it was one of the most 
facile methods available for effecting thionation of lactams (see Scheme 3.13). 
The Brillon method uses sodium bicarbonate together with phosphorus 
pentasulfide in dry tetrahydrofuran stirred at ambient temperature for seventy-
two hours. In the modified version the sodium bicarbonate was omitted 
completely and chloroform was used as the solvent. Purification by column 
chromatography gave the thiolactam, t-butyl (3R)-3-(2-thioxo-1-





Scheme 3.13: Thionation reaction. Reagents and conditions: i) P2S5, CHCl3, RT, 8 hr.; 
OR i) Lawesson’s Reagent, CH2Cl2, RT, 72 hr. 
 
The moderate yield led us to investigate a second method, one that employed 
Lawesson’s reagent (332) as the thionating agent (see Figure 3.7). The lactam 
t-butyl (3R)-3-(2-oxo-1-pyrrolidinyl)nonanoate (277) was dissolved in 
dichloromethane together with Lawesson’s reagent (333) and stirred at ambient 
temperature for seventy-two hours. Following extraction and purification, the 
desired thiolactam (278) was obtained in 63% yield. Owing to the increased 





Figure 3.7: Lawesson’s reagent, used to thionate carbonyl groups. 
 
Another variation on the thionation reaction was the Curphey procedure, which 
used hexamethyldisiloxane as an additive in the presence of phosphorus 
pentasulfide.188 It has been shown that this improves the yields to values  
comparable to those obtained with Lawesson’s reagent.188 This version of the 
reaction was attempted, but unfortunately the isolated yield of the thiolactam 
(278) was 30%, far lower than the yields obtained using Lawesson’s reagent. 
 
There was a slight change in the optical rotation of the thiolactam (278) 
[α]D20 +7.4 (c 0.88, CH2Cl2) compared to the corresponding lactam (277) 
[α]D20 +9.5 (c 1.00, CH2Cl2). When our values were compared to those obtained 
by Gravestock for his thiolactams the value differed significantly in magnitude 
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but shared the same sign. For t-butyl (3R)-3-(2-thioxo-1-pyrrolidinyl)octanoate 
Gravestock obtained a value of [α]D30 +17.2 (c 0.90, EtOH), and for t-butyl (3R)-
3-(2-thioxo-1-pyrrolidinyl)hexanoate he obtained a value of [α]D30 +18.7 (c 1.39, 
EtOH). Yillah obtained an optical rotation of [α]D20 -9.8 (c 0.82, CH2Cl2) for 
(278), similar magnitude but opposite rotation to our value. 
 
On thionation, the key changes in the 1H-NMR spectrum were the shift of H-3 
from 4.4 to 5.4 ppm, of H-13AB from 3.4 and 3.3 ppm in the lactam (277) to 3.7 
and 3.6 ppm in the thiolactam (278) (see Figure 3.8). H-11 shifted from 2.4 to 
3.0 ppm and H-2A shifted from 2.4 to 2.6 ppm in the thiolactam. All other 
signals were approximately equivalent to the corresponding lactam signals. In 
the 13C-NMR spectrum, the most significant shift was that of C-10 which shifted 
from the amide region of 174.8 ppm to 201.7 ppm, an appropriate region for a 
thiocarbonyl group. C-3 also shifted downfield, from 48.8 to 53.3 ppm as did 




Figure 3.8: Numbering of thiolactam (278) for assignment of spectroscopic data. 
 
The FTIR spectrum showed the absence of the strong lactam carbonyl 
stretching vibration at 1686 cm-1 and instead the thiocarbonyl stretching 
vibration could be seen as a strong signal at 1310 cm-1. 
 
At this point Gravestock’s syntheses diverged along a synthetic path involving 
vinylogous urethanes, so our thiolactam was the final molecule for which we 
could compare the NMR data in a meaningful way. Table 3.7 highlights the key 
signals in the 1H-NMR and 13C-NMR spectra comparing t-butyl (3R)-3-(2-thioxo-
1-pyrrolidinyl)nonanoate (278), with t-butyl (3R)-3-(2-thioxo-1-pyrrolidinyl) 
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octanoate and t-butyl (3R)-3-(2-thioxo-1-pyrrolidinyl)hexanoate. The thiolactam 
we prepared shows almost identical 1H-NMR and 13C-NMR spectral data to 
those thiolactams prepared by Gravestock (see Table 3.7). The spectroscopic 















Signal R = C3H7 139 / ppm R = C5H11 139 / ppm R = C6H13  (278) / ppm
H-2 2.55 (dd, J 14.3, 6.1) 
2.44 (dd, J 14.2, 8.8) 
2.60 – 2.38 (m) 2.55 (dd, J 14.4, 6.0) 
2.43 (dd, J 14.4, 9.0) 
H-3 5.46 – 5.31 (m) 5.36 (quintet, J 7.5) 5.36 (quintet, J 7.5) 
H-11 3.00 (dt, J 7.8, 1.5) 3.04 – 2.96 (m) 3.00 (t, J 7.5) 
H-12 2.03 (quintet, J 7.5)  2.11 – 1.93 (m) 2.03 (quintet, J 7.5) 
H-13A 3.71 (dt, J 10.8, 7.2) 3.71 (dt, J 10.7, 7.2) 3.71 (dt, J 10.7, 7.5) 
H-13B 3.55 (dt, J 10.7, 7.2) 3.56 (dt, J 10.7, 7.1) 3.56 (dt, J 10.7, 7.5) 
C-1 169.6 169.5 169.5 
C-2 38.9 38.8 38.8 
C-3 53.1 53.3 53.3 
C-4 34.4 32.1 32.2 
C-10 201.9 201.7 201.7 
C-11 45.1 45.0 45.1 
C-12 20.0 20.0 20.0 
C-13 49.1 49.1 49.0 
 
Table 3.7: Comparison of selected NMR spectral data (in CDCl3) for analogous 







3.7  Formation of the vinylogous sulfonamide 
 
In order to form the vinylogous sulfonamide we needed to perform a modified 
Knoevenagel reaction between the thiolactam (278) and 
1-[(4-methylphenyl)sulfonyl]acetone (279). First we therefore had to prepare 
1-[(4-methylphenyl)sulfonyl]acetone (279).  
 
Following the method of Makosza and Golinski,190 sodium-p-toluenesulfinate 
(334) was dissolved in DMSO together with chloroacetone (335) and heated to 
90°C for four hours (see Scheme 3.14). Following extraction and purification by 
column chromatography, 1-[(4-methylphenyl)sulfonyl]acetone (279) was 





Scheme 3.14: Preparation of 1-[(4-methylphenyl)sulfonyl]acetone (279). Reagents and 
conditions: i) DMSO, 90°C, 4 hr. 
 
Full characterization of product (279) was in agreement with the literature 
values.190 The 1H-NMR spectrum revealed a 1,4-disubstituted aromatic ring 
showing two doublets each integrating for two hydrogens at 7.76 and 7.37 ppm, 
respectively. The aromatic methyl group occurred at 2.45 ppm, the methylene 
signal was at 4.15 ppm and the aliphatic methyl group was at 2.39 ppm, which 
is the typical region for a methyl adjacent to a carbonyl group. The 13C-NMR 
spectrum indicated the presence of a ketone at 196.6 ppm, as well as the 
characteristic aromatic signals at 145.9, 136.2, 130.4, and 128.6 ppm. The 
FTIR spectrum showed strong stretching bands at 1712 cm-1 and 1359 cm-1 for 
the ketone group and the sulfonyl group respectively. 
 
We employed two sets of conditions for the preparation of the vinylogous 
sulfonamide where we varied the base used to promote the reaction. The first 
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step in both methods was the formation of the methyl iodide salt (336) by 
reacting t-butyl (3R)-3-(2-thioxo-1-pyrrolidinyl)nonanoate (278) with methyl 
iodide in tetrahydrofuran under inert atmosphere and ambient temperature for 















































Scheme 3.15: Proposed mechanism for vinylogous sulfonamide formation and the 
base-catalysed deacylation. Reagents and conditions: i) a) MeI, THF, 72 hr.; b) (279), 
Et3N, CH2Cl2, RT, 96 hr. 
 
This reaction was performed under strictly anhydrous conditions and the flask 
was covered in tinfoil to protect the methyl iodide from exposure to light. Once 
the α-thioiminium salt formation was complete, as judged by TLC, the excess 
methyl iodide and the tetrahydrofuran were removed in vacuo and a premixed 
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solution of 1-[(4-methylphenyl)sulfonyl]acetone, triethylamine and 
dichloromethane was carefully added and the reaction was left stirring for a 
further 96 hours under inert conditions. Following purification by column 
chromatography two products were obtained: the acylated product t-butyl (3R)-
3-{2-[1-(p-toluenesulfonyl)-2-oxopropylidene]-1-pyrrolidinyl}nonanoate (337) in 
27% yield and the deacylated product, t-butyl (3R)-3-{2-[(E)-(p-
toluenesulfonyl)methylene-1-pyrrolidinyl} nonanoate (280), in 28% yield. 
Unreacted starting material was recovered as the lactam, t-butyl (3R)-3-(2-oxo-
1-pyrrolidinyl)nonanoate (277), in 25% yield, due to the hydrolysis of the 
α-thioiminium salt. The spontaneous in situ deacetylation in the presence of 
base can be accounted for by the mechanism shown in Scheme 3.15. 
 
In the second method, triethylamine was replaced by DBU (1,8-
diazabicyclo[5.4.0]undecene-7) and the desired product, t-butyl (3R)-3-{2-[(E)-
(p-toluenesulfonyl)methylene-1-pyrrolidinyl}nonanoate (280), was obtained in 
13% yield, while the acylated product, t-butyl (3R)-3-{2-[1-(p-toluenesulfonyl)-2-
oxopropylidene]-1-pyrrolidinyl}nonanoate (337), was obtained in 38% yield. 
Owing to the lower yields obtained in this variation, triethylamine was used for 
all subsequent reactions. In both methods the vinylogous sulfonamide (280) 
was obtained almost exclusively as the (E)-isomer – negligible amounts of the 
(Z)-isomer were observed in the 13C-NMR spectra. 
  
A recent study has shown that using sodium iodide as an additive during the 
formation of the thioiminium salt should decrease reaction times.152 In addition, 
the use of polar, aprotic solvents such as acetonitrile or chloroform increases 
the efficiency of the salt formation.152 However, when we attempted these 
conditions we experienced a reduction in yield. 
 
The optical rotations for t-butyl (3R)-3-{2-[(E)-(p-toluenesulfonyl)methylene-1-
pyrrolidinyl}nonanoate (280) and t-butyl (3R)-3-{2-[1-(p-toluenesulfonyl)-2-
oxopropylidene]-1-pyrrolidinyl}nonanoate (337) were [α]D20 +11.6 (c 0.69, 
CH2Cl2) and [α]D20 +44.0 (c 1.00, CH2Cl2), respectively. Yillah obtained optical 
rotations of [α]D20 -41.5 (c 0.27, CH2Cl2) and [α]D20 -59.5 (c 0.56, CH2Cl2) for 
  114
(280) and (337), respectively. These values were completely different in sign 
and magnitude to the values we obtained. 
 
Both products were fully characterized and conclusively revealed the 
incorporation of the tosyl group into the molecule, as well as the loss of the 
thiocarbonyl signals. Notably, a signal characteristic of an alkene was visible at 
5.00 ppm in the 1H-NMR spectrum for t-butyl (3R)-3-{2-[(E)-(p-
toluenesulfonyl)methylene-1-pyrrolidinyl}nonanoate (280). This signal was a 
singlet integrating for one hydrogen and corresponds to (H-14). The acylated 
product (337) did not have this signal, but it did contain an additional methyl 
group at 2.34 ppm and an additional carbonyl signal at 190.7 ppm in the 
13C-NMR spectrum.   
 
FTIR spectroscopy showed both an ester at 1724 cm-1, an alkene at 1569 cm-1, 
and a sulfonyl group at 1288 cm-1 for t-butyl (3R)-3-{2-[(E)-(p-
toluenesulfonyl)methylene-1-pyrrolidinyl}nonanoate (280). The acylated product 
(337) contained two carbonyl groups, 1727 cm-1 for the ester and 1687 cm-1 for 
the α-β unsaturated ketone, as well as the sulfonyl group at 1297 cm-1, and the 
alkene at 1616 cm-1.   
 
When comparing the key differences in the 1H-NMR and 13C-NMR spectra 
between the acylated and deacylated products (see Table 3.8) H-3 was 
identical, occurring at 3.93 ppm for both compounds, whereas H-2, H-11, H-12 
and H-13 were significantly shifted downfield in the acylated molecule owing to 
the electron withdrawing effect of the α,β-unsaturated ketone. The 13C-NMR 
spectrum showed significant differences for the alkene carbons, C-10 and C-14, 
which occur at 161.5 and 87.7 ppm for the deacylated product (280) and at 
174.9 and 103.7 ppm for the acylated product (337). Again this illustrates the 
increased deshielding due to the α,β-unsaturated system. C-2 and C-3 of the 
acylated product (337) were also shifted downfield, experiencing decreased 
electron density, whereas C-11 and C-12 were shifted upfield in the acylated 



















Signal (280) / ppm (280) 31 / ppm (337) / ppm (337) 31 / ppm 
H-2 1.78 (dd, J 14.7)  3.36 – 3.23 (m) 2.95 (dd, J 15.2)  
2.48 – 2.40 (m) 
3.64 – 6.54 (m) 
H-3 3.93 – 3.58 (m) 3.86 (q, J 7.9) 3.94 (tt, J 8.7) 3.96 (q, J 7.5) 
H-11 2.90 (t, J 7.7) 3.00 (t, J 7.1) 3.40 (dt, J 15.3)  
3.03 (dt, J 15.3) 
2.90 (td, J 7.6) 
H-12 1.45 – 1.32 (m) 2.46 – 2.39 (m) 2.12 – 1.83 (m) 1.44 – 1.50 (m) 
H-13 3.18 (dt, J 16.1)  
3.18 (dt, J 16.1) 
2.46 – 2.39 (m) 3.66 – 3.49 (m) 3.64 – 3.54 (m) 
H-14 5.00 (s) 5.07 (s) - - 
C-1 169.8 169.75 169.7 174.80 
C-2 32.1 46.27 36.9 37.95 
C-3 52.2 48.84 58.5 49.16 
C-4 31.6 31.59 32.3 36.98 
C-10 161.5 161.55 174.9 169.78 
C-11 39.0 38.99 37.8 32.34 
C-12 26.1 32.08 20.1 31.52 
C-13 47.0 52.25 49.1 58.53 
C-14 87.9 87.83 103.7 103.88 
C-22 - - 190.7 190.89 
 
Table 3.8: Comparison of selected NMR spectral data (in CDCl3) for vinylogous 







3.8 Attempted deacetylation reactions 
 
We attempted two acid-catalyzed deacetylation reactions on t-butyl (3R)-3-{2-
[1-(p-toluenesulfonyl)-2-oxopropylidene]-1-pyrrolidinyl}nonanoate (337), the first  
heated (337) at reflux in neat trifluoroacetic acid for twelve hours, and the other 
heated at reflux in toluene and trifluoroacetic acid for five hours, while 
monitoring by TLC. Neither method produced any of the desired product, even 
the t-butyl ester survived the harsh reaction conditions.  Analysis of the 1H-NMR 
spectrum indicated some sort of decomposition, with the loss of the tosyl group. 
These two procedures were modified from the work of Ban and co-workers;154 
please refer to the literature for the proposed mechanism of the acid-catalysed 
deacetylation. 
 
Owing to the unsuccessful deacetylation reaction, the product could not be 
recycled back into the synthetic sequence and this unfortunately meant a 
serious reduction in overall yield. 
 
3.9 Reduction to the alcohol 
 
In the next step, the t-butyl ester group of t-butyl (3R)-3-{2-[(E)-(p-
toluenesulfonyl)methylene-1-pyrrolidinyl}nonanoate (280) was reduced to the 
corresponding alcohol, t-butyl (3R)-3-{2-[(E)-(p-toluenesulfonyl)methylene-1-
pyrrolidinyl}nonan-1-ol (281), under standard reduction conditions using lithium 
aluminium hydride in tetrahydrofuran at ambient temperature for twelve hours 
(see Scheme 3.16). After purification by column chromatography, the alcohol 






Scheme 3.16: Reduction of the ester (280) to the alcohol (281). Reagents and 
conditions: i) LiAlH4, THF, RT, 15 hr. 
 
Full characterization revealed the disappearance of the t-butyl group and the 
appearance of the hydroxy group. The 1H-NMR spectrum showed a broad new 
peak at 2.17 ppm corresponding to the OH and an additional methylene signal 
was observed at 3.20 ppm as a triplet (J 6.7) corresponding to H-1 (see Figure 
3.9). The 13C-NMR spectrum showed the absence of the t-butyl peaks at 
81 ppm and 28 ppm, and the loss of the ester carbonyl at 170 ppm. C-1 was 
observed as a new signal at 45.9 ppm, deshielded by the adjacent hydroxy 
group. For the 1H-NMR spectrum, Yillah did not report an O-H signal, he 
reported H-1 at 3.55 – 3.51 ppm (0.30 ppm higher than our value) and H-3 at 
3.55 – 3.51, whereas we observed H-3 at 3.75 – 3.62 ppm. The values Yillah 



























Figure 3.9: Numbering of alcohol (281) for assignment of spectroscopic data. 
 
FTIR spectroscopy revealed a broad stretching vibration at 3474 cm-1 
corresponding to the O-H bond and the ester carbonyl stretching vibration was 
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no longer observed.  The alcohol had significant optical activity, [α]D20 -25.0 
(c 0.30, CH2Cl2), which was opposite in sign compared to the preceding ester. 
Yillah obtained an optical rotation of [α]D20 -5.3 (c 1.25, CH2Cl2) for the same 
molecule. High resolution mass spectrometry showed the parent ion of (281) 
with a mass of 379.2176, in close agreement with the calculated value of 
379.2181. 
 
3.10 Cyclisation reaction 
 
The next step in the synthesis was the key step, the novel cyclisation reaction. 
This reaction makes use of the vinylogous sulfonamide’s nucleophilicity to 
facilitate intramolecular ring closure. The alcohol (281) was first converted into 
an iodide (338), which was a better leaving group, using Appel-type reaction 
conditions;191 triphenylphosphine, iodine and imidazole, a mild organic base 
(see Scheme 3.17). The alcohol (281) was heated at reflux in toluene together 
with the triphenylphosphine, iodine and imidazole and once the intermediate 
iodide (338) was formed the vinylogous sulfonamide spontaneously facilitated 
cyclisation. Following work-up and purification, the bicyclic product, (5R)-5-
hexyl-1,2,3,5,6,7-hexahydro-8-indolizinyl 4-methylphenyl sulfone (282), was 
isolated in 96% yield as a pale yellow oil that discoloured to blue in the 































Scheme 3.17: Mechanism for the key cyclisation reaction. Reagents and conditions: 
i) PPh3, imidazole, I2, toluene, reflux, 6 hr. 
 
Yillah employed slightly different reaction conditions, using acetonitrile/toluene 
(2:1) as the solvent. He isolated the desired product in 83% yield. His reported 
spectra were in close agreement with the spectra we obtained. 
 
The bicyclic product, (5R)-5-hexyl-1,2,3,5,6,7-hexahydro-8-indolizinyl 
4-methylphenyl sulfone (282), retained its optical activity, although again the 
sign changed from the negative value obtained for the alcohol (281) to 
[α]D20 +9.4 (c 0.85, CH2Cl2). Yillah reported the optical rotation of (282) as 
[α]D20 +31.0 (c 0.36, CH2Cl2). The most significant change in the 1H-NMR 
spectrum was the loss of the alkene proton at 5.09 ppm and the disappearance 


















Signal (281) / ppm (282) / ppm 
H-1 3.08 – 2.96 (m) 
2.97 – 2.84 (m) 
3.13 (t, J 7.2) 
H-2 1.86 (quintet, J 7.4) 1.91(quintet, J 7.2) 
H-3 3.62 – 3.44 (m) 3.19 (t, J 7.1) 
H-5 3.75 – 3.62 (m) 3.49 (quintet, J 6.9) 
H-6 1.71 (q, J 6.7) 1.80 – 1.51 (m) 
H-7 3.20 (t, J 6.7) 1.80 – 1.51 (m) 
H-8 5.09 (s) - 
C-1 31.4 32.1 
C-2 20.8 29.3 
C-3 59.0 51.2 
C-5 51.6 53.9 
C-6 34.7 31.4 
C-7 45.9 31.7 
C-8 86.2 92.4 
C-8a 162.6 155.1 
 
Table 3.9: Comparison of selected NMR spectral data (in CDCl3) for alcohol and 
bicyclic products. (J-values measured in Hz). 
 
The 13C-NMR spectrum showed several significant changes, most notably C-8 
and C-8a shift from 86.2 and 162.6 ppm to 92.4 and 155.1 ppm, respectively. 
This was because of the change in electronic environment due to the inductive 
effect of the closed ring system.  
 
FTIR spectroscopy revealed the loss of the O-H stretching vibration as no band 
was visible in the region of 3000 – 3500 cm-1 characteristic of this bond. The 
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spectrum showed alkene stretching vibrations at 1593 cm-1, sulfonyl stretching 
vibrations at 1291 cm-1, and aliphatic stretching vibrations. High resolution mass 
spectrometry gave a molecular ion at 361.2071, in very close agreement with 




Unfortunately, the final two steps in the synthesis were never attempted (see 
Scheme 3.18). Although the preceding step was successful, not enough of the 




Scheme 3.18: Final two steps in the synthesis; reduction and desulfonylation. 
Reagents and conditions: i) H2 (7 atm.), PtO2, MeOH; ii) Na(Hg), Na2HPO4. 
 
Although the plan was to go back to the beginning of the synthesis and push 
material through the initial steps so that the final two steps could be optimized 
and completed, the debenzylation reaction repeatedly failed to remove both 
benzyl groups. After numerous attempts at removing both benzyl groups the 
conclusion was reached that the palladium catalysts currently available were 
not sufficiently active to perform the reaction. It was most frustrating to be 
thwarted by a reaction which initially worked exceptionally well; we have 
however, come to accept that with the current difficulties experienced with the 
debenzylation reaction it has become necessary to explore alternative 
reactions. There are other chiral amines that could be used in place of N-
benzyl-N-(1R)-1-phenylethylamine (214), which can be removed under different 
reaction conditions. For example, the dimethoxy equivalent can be cleaved 
under oxidative conditions by ceric ammonium nitrate. 
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Although the total synthesis was not completed, the synthesis was thoroughly 
explored, we did gain enough experience with this type of chemistry to continue 
with the racemic synthesis of monomorine I and it isomers, and the optical 
rotation results that were obtained have values that align well with the 
analogous compounds synthesized by Gravestock. It was clear that many of 
the optical rotations recorded by Yillah did not correspond in sign or magnitude 
to those obtained by Gravestock and Davies for similar compounds. Full 
characterization of all the intermediate compounds was obtained and the 
reaction conditions were altered to improve the efficiency of the reactions. 
Novel side reactions were identified and explored and alternative debenzylation 






THE TOTAL SYNTHESIS OF MONOMORINE I AND  
5-epi-MONOMORINE I  
 
4.1  Introduction  
 
Once the synthesis of (−)-indolizidine 209D was well underway (barring 
unforeseen difficulties), the completion of the synthesis was imminent, we 
began investigations into the total synthesis of monomorine I and/or its 
diastereomers. Initially the synthesis of the racemic alkaloid was investigated, 
as the use of a chiral auxiliary made the enantioselective route more expensive 
to execute. For conciseness, however, results pertaining to the racemic and 
enantioselective alternatives are presented in parallel throughout this chapter. 
 
For convenience, a pictorial summary of the strategy to be followed is repeated 




Scheme 2.16: Proposed synthetic route for the total synthesis of monomorine I and/or 
its isomers.  
 
4.2  Preparation of the ketoester and amine precursor 
 
4.2.1 Preparation of the ketoester 
Our desired starting material, the ketoester ethyl 4-oxooctanoate (292), was a 
known compound and a review of the literature revealed many different 
strategies for preparing (292) and analogous 1,4-ketoesters. Four of the 
dominant strategies are outlined in Figure 4.1. Strategy A192 - 194 executes a 
three step synthesis from the cheap and readily available starting material ethyl 
acetoacetate (339). Strategy B uses methodology developed by Stetter et al.,195 
- 197 and involves an ionic reaction between ethyl acrylate (340) and 
valeraldehyde (341), catalysed by a thiazolium-based catalyst. The conditions 
for this reaction were fairly sensitive and a syringe-pump was required for the 
addition of the ethyl acrylate in order to prevent unwanted side reactions. 
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Strategy C198 - 204 was a Grignard reaction, starting with the fairly expensive 
ethyl 4-chloro-4-oxobutyrate (342). Great care must be taken to ensure that 
only single addition occurs. There were several additives and catalysts 
available to help prevent multiple additions, but ultimately it was low 
temperatures and short reaction times that minimized the unwanted by-
products. The advantage of strategy C was that it was a one-step synthesis. 
Strategy D205 started from the cheap and readily available succinic anhydride 
(343) and involved two standard transformations to get to the desired ketoester 
(292).  
 
Because ethyl 4-oxooctanoate (292) was the starting point for our proposed 
synthesis of monomorine I, we needed to prepare it in large quantities and high 
yields.  All four strategies were investigated in order to find the most efficient 



























Figure 4.1: Four general routes to ketoester (292). 
  
Strategy A192 
Strategy A was a three-step synthesis starting from the cheap and readily 
available starting material ethyl acetoacetate (339). The first step was the 
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formation of the stabilized secondary enolate, followed by the addition of 
valeroyl chloride to form ethyl 2-acetyl-3-oxoheptanoate (344). The second step 
was the deacetylation to form ethyl 3-oxoheptanoate (345) (see Scheme 4.1), 
and the final transformation was a CH2 insertion reaction to give the desired 




Scheme 4.1: Strategy A, first approach. Reagents and conditions: i) NaH, THF, 
valeroyl chloride, RT, 12 hr.; ii) a) NH3 (gas), Et2O, 90 min. b) HCl; iii) Et2Zn, CH2Cl2, 
CH2I2, 0 °C − RT, 30 min. 
 
For the first step, ethyl acetoacetate (339) was carefully added to a cooled 
solution of sodium hydride in tetrahydrofuran. For a 180 mmol scale, a large 
flask (1 litre), vigorous stirring, and a low molarity of ethyl acetoacetate (0.40 M) 
were required in order to prevent a clumpy emulsion from forming. After the 
addition was complete, the solution was bright yellow in colour. Valeroyl 
chloride was added dropwise and the solution gradually turned opaque. The 
reaction was allowed to warm to ambient temperature and was quenched with 
distilled water twelve hours later. After extraction and purification by column 
chromatography, the desired product, ethyl 2-acetyl-3-oxoheptanoate (344), 
was isolated in 92% yield as a clear yellow oil. Presumably (344) was found 
entirely as the enol form, as only one set of spectral signals was observed. 
Characterization by 1H-NMR spectroscopy revealed that the enol hydrogen had 
shifted downfield to an astounding 17.80 ppm due to the combined effect of the 
hydrogen-bonded carbonyl groups. 13C-NMR spectroscopy showed three 
carbonyl groups at 167.2 ppm, 195.6 ppm and 198.8 ppm. The latter two 
signals were both in an appropriate region for ketone carbonyls but presumably 
the two enol tautomers were in equilibrium, giving the enol carbons ketone-like 
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character (see Figure 4.2). The signal for the central carbon, C-2, appeared at 
108.6 ppm. FTIR spectroscopy clearly indicated the presence of three carbonyl 
stretching vibrations at 1762 cm-1, 1710 cm-1 and 1670 cm-1 and no signal was 
observed for the enol OH. This may have been owing to excessive broadening 
of the O-H signal, because of hydrogen-bonding and the equilibrium, or 



















Figure 4.2: Two of the enol tautomers of (344). 
 
For the second step, ethyl 2-acetyl-3-oxoheptanoate (344) was dissolved in dry 
diethyl ether and ammonia gas was bubbled through the solution for 
approximately ninety minutes. This was followed by an acidic work up with 
dilute hydrochloric acid, followed by extraction of the product into ethyl acetate. 
According to the literature,194 the acetyl group should selectively cleave, leaving 
ethyl 3-oxoheptanoate. After purification by column chromatography, we found 
that the major product was in fact ethyl acetoacetate (339) (84% yield) and the 
desired compound, ethyl 3-oxoheptanoate (345), was the minor product (16% 
yield). Clearly the reaction was favouring the removal of the wrong acyl group, 
opposite of what was observed in the literature.194 The 1H-NMR spectrum 
showed H-2 as a singlet, moderately shifted to 3.43 ppm, and only two carbonyl 
signals were observed by 13C-NMR spectroscopy at 202.9 ppm and 167.2 ppm 
in the characteristic regions for a ketone and an ester carbonyl respectively. 
FTIR spectroscopy confirmed the presence of only two carbonyl stretching 
vibrations at 1741 cm-1 and 1715 cm-1. 
 
Owing to the low yield of ethyl 3-oxoheptanoate (345) (16%) an alternative 
method was attempted. This method206 also made use of ethyl acetoacetate 
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(339) as a starting material and then employed a double deprotonation reaction 
prior to the addition of chloropropane. Firstly, sodium hydride was used to 
deprotonate the more acidic position, the methylene adjacent to both carbonyls, 
as the sodium cation could chelate to both the resulting enolate and the 
carbonyl group. Then, n-butyllithium was carefully added and the terminal 
methylene, adjacent to the ketone, was deprotonated. The lithium could not 
chelate to the carbonyl as the sodium had already blocked the position. 
Chloropropane was carefully added and, theoretically, only the terminal 
carbanion should react with it. The reaction was quenched with distilled water 
and after extraction and purification by column chromatography, ethyl 
3-oxoheptanoate (345) was isolated in 8% yield as a clear oil with a pleasant, 
fruity odour. The low yield was attributed to the inferior quality of the 
n-butyllithium reagent available at the time. The reaction was neither repeated 
nor optimized, since alternative approaches were already proving more 




Scheme 4.2: Strategy A, second approach. Reagents and conditions: i) a) NaH, THF; 
b) n-BuLi; c) chloropropane; ii) Et2Zn, CH2Cl2, CH2I2, 0°C − RT, 30 min. 
 
Having prepared some of the ethyl 3-oxoheptanoate (345), it was possible to 
attempt the exciting CH2 insertion reaction. The literature method193 we chose 
to follow used neat diethylzinc to perform this transformation. Due to the highly 
pyrophoric nature of the reagent, great care was taken to ensure dry and 
oxygen-free conditions for the reaction. Dry dichloromethane and diethylzinc 
were mixed in a flask under nitrogen and diiodomethane was carefully added. 
Exothermic bubbling commenced, after which the solution was cooled to 0°C. 
Ethyl 3-oxoheptanoate (345) was rapidly added and the reaction was left for a 
further thirty minutes. The reaction was quenched with ammonium chloride 
solution and the organic material was extracted into ethyl acetate. Following 
purification by column chromatography, the desired product ethyl 
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4-oxooctanoate (292), was isolated in 62% yield as a clear oil. Although the 
reaction was successful and fun to execute, the empty syringe invariably ignited 
after the addition of diethylzinc was complete and hence the reaction was most 
definitely not suitable for scale-up. 
 
Ethyl 4-oxooctanoate (292) was fully characterized and all spectroscopic data 
was in agreement with the literature.195, 207 In the 1H-NMR spectrum, the ethyl 
group was observed at 4.13 ppm and 1.25 ppm as a quartet and triplet, 
respectively. The three methylene groups, H-2, H-3 and H-5 (see Figure 4.3), 
were observed at 2.72 ppm, 2.62 – 2.45 ppm and 2.45 ppm, downfield due to 
deshielding by the adjacent carbonyls. 13C-NMR spectroscopy showed the 
ketone, C-4, at 209.5 ppm, and the ester, C-1, at 173.2 ppm, within the 
















Figure 4.3: Numbering of ester (292) for assignment of spectroscopic data. 
 
Strategy A gave ethyl 4-oxooctanoate in 9% overall yield (see Scheme 4.1) 
over three steps, via ethyl 2-acetyl-3-oxoheptanoate (344). The two step 
variation of strategy A gave ethyl 4-oxooctanoate in 5% overall yield (see 
Scheme 4.2). This was not the most economic and efficient route for preparing 
our starting material. 
  
Strategy B195 - 197 
This method used the Stetter reaction, a one step ionic reaction, involving ethyl 
acrylate (340) and valeraldehyde (341) (see Scheme 4.3). The thiazolium-
based catalyst, 3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazolium chloride, 
ethyl acrylate, triethylamine and dioxane were mixed together under inert 
conditions at ambient temperature. A mixture of valeraldehyde and a second 
portion of ethyl acrylate were added over ten hours using a syringe pump. The 
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reaction was stopped and the product was extracted into ethyl acetate and 
rinsed with dilute hydrochloric acid, sodium bicarbonate solution and distilled 
water.  After purification by column chromatography, the desired product, ethyl 
4-oxooctanoate (292), was isolated in a low yield of 16% and showed 
contamination by diethyl succinate. The low yield was attributed to the 
evaporation of the ethyl acrylate during the reaction as well as the sensitive 




Scheme 4.3: Strategy B, the Stetter reaction. Reagents and conditions: i) Thiazolium 
cat., (340), Et3N, dioxane; b) (340), (341), 10 hr., RT. 
 
The Stetter reaction was attempted several times further, but the yield did not 
improve. The physical set up of the system contributed significantly to the 
evaporation of the ethyl acrylate during the reaction and the decision was made 




This method involves a standard organometallic reaction involving addition of 
either a cuprate198, 199 or an organolithium reagent to an acyl chloride (see 
Scheme 4.4).198, 200 - 204 The challenge of this reaction was controlling the single 
addition of the organometallic nucleophile by varying the temperature, time, and 
catalyst. Initially the reaction was attempted using a cuprate. Di-n-butylcopper 
lithium was prepared in situ by reacting copper iodide with n-butyllithium at 
-90°C for one hour. Ethyl 4-chloro-4-oxobutyrate (342) was added to the 
cuprate solution and the reaction mixture was warmed to ambient temperature 
and left stirring for a further twelve hours. Following work-up and purification by 
column chromatography, the desired product, ethyl 4-oxooctanoate (292), was 
isolated in 80% yield. On closer examination of the 1H-NMR spectrum, it 
became apparent that the sample was heavily contaminated with diethyl 
succinate (346), (approximately 30% of the sample), which eluted with an 
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identical Rf value in all the solvent systems tested. Diethyl succinate and ethyl 
4-oxooctanoate do however differ in boiling points,  with the former being 105°C 
and the latter 125°C at 15 torr and therefore could be separated by distillation if 
the scale of the reaction allowed it. For these reasons this reaction was 




Scheme 4.4: Strategy C, organometallic reaction. Reagents and conditions: i) a) CuI, 
n-BuLi, THF, -90°C, 1 hr.; b) (342), RT, 12 hr. 56%. ii) n-BuMgCl, bis-
(N,N-dimethylaminoethyl)ether, THF, -90°C, 2.5 hr., 21%; iii) a) Bu3P, THF, -29°C, 
25 min.; b) n-BuMgCl, 10 min., 93%; iv) n-BuMgCl, Fe(acac)3, THF, 0°C, 10 min. 
100%. 
 
The second method200 - 202 uses the Grignard reagent, n-butylmagnesium 
chloride, premixed with the additive bis-(N,N-dimethylaminoethyl)ether, which 
reportedly coordinates to the magnesium to form a tridentate ligand and 
reduces the formation of by-products during the reaction.  This mixture was 
added to a solution of ethyl 4-chloro-4-oxobutanoate (342) in tetrahydrofuran at 
–90°C. After twenty minutes TLC indicated no formation of product and the 
reaction mixture was warmed to ambient temperature and stirred for an 
additional two hours. After work up and purification by column chromatography, 
ethyl 4-oxooctanoate (292) was isolated in a low yield of 21%. 
 
After reviewing the literature again,203, 204 tri-n-butylphosphine emerged as a 
potential additive for Grignard reactions to ketoesters. Ethyl 4-chloro-4-
oxobutanoate (342) was dissolved in tetrahydrofuran and cooled to –29°C in a 
xylene/liquid nitrogen slurry. Tri-n-butylphosphine was carefully added and the 
solution was stirred for twenty-five minutes. The n-butylmagnesium bromide 
solution was quickly added and the reaction was left stirring for ten minutes 
before it was quenched with dilute hydrochloric acid. Following extraction and 
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purification by column chromatography, ethyl 4-oxooctanoate (292) was 
isolated in 93% yield. This result seemed to indicate that short reaction times 
were of paramount importance in achieving high yields for this reaction. One of 
the reactions we had previously attempted using iron(III) acetoacetate as a 
catalyst had repeatedly given us yields in the region of 40 - 60%. Inspired by 
the high yield obtained with the tri-n-butylphosphine we set about repeating the 
Grignard reaction catalysed by the iron(III) acetoacetate.198 Ethyl 4-chloro-4-
oxobutanoate (342) was dissolved in tetrahydrofuran together with catalytic 
amounts of iron(III) acetoacetate. The solution was cooled to 0°C and then n-
butylmagnesium bromide solution was added dropwise from a dropping funnel. 
After ten minutes the addition was complete and the reaction was immediately 
quenched with dilute hydrochloric acid. The product was extracted into ethyl 
acetate and purified by column chromatography to give ethyl 4-oxooctanoate 
(292) in quantitative yield.  
 
Strategy D 
Strategy D starts with the readily available succinic anhydride (343) and also 
involves the addition of a cuprate199 or organolithium reagent,198 followed by 
esterification (see Scheme 4.5). First we attempted the Grignard reaction. 
n-Butylmagnesium bromide was prepared in situ by reacting bromobutane with 
magnesium turnings in dry tetrahydrofuran for one hour at 0°C under nitrogen. 
The Grignard reagent was slowly added to a solution of succinic anhydride 
(343) and a catalytic amount of iron(III) acetoacetate in tetrahydrofuran at 
ambient temperature. After an hour the reaction was quenched with a dilute 
hydrochloric acid solution and the product was extracted into diethyl ether. 
Following purification by column chromatography, 4-oxooctanoic acid (347) was 
isolated in 25% yield as a white crystalline solid. 5,5-Dibutyldihydro-2(3H)-





Scheme 4.5: Strategy D, organometallic reaction with succinic anhydride. Reagents 
and conditions: i) n-BuMgCl, Fe(acac)3, THF, RT, 1 hr. 25%; ii) a) CuI, n-BuLi, THF, 
-90°C, 1 hr.; b) (343), RT, 3 hr., 34%;  iii) EtOH, H2SO4 (cat.), RT, 3 hr. 100%. 
 
4-Oxooctanoic acid (347) was fully characterized and showed the characteristic 
broad O-H signal at 12 – 10 ppm in the 1H-NMR spectrum. 13C-NMR 
spectroscopy showed the acid carbonyl signal at 179.1 ppm and the FTIR 
spectrum showed the broad O-H stretching vibration at 3550 – 3350 cm-1. The 
by-product, 5,5-dibutyldihyro-2(3H)-furanone, gave a simple 1H-NMR spectrum 
due to the symmetry of the molecule. The lactone signals appeared as triplets 
at 2.57 ppm and 2.02 ppm, and the butyl chain signals were observed at 1.66 – 
1.57 ppm, 1.40 – 1.26 ppm and 0.92 ppm. Only eight signals were observed in 
the 13C-NMR spectrum. FTIR spectroscopy showed a stretching vibration at 
1772 cm-1, characteristic of a lactone carbonyl group. 
  
Secondly we attempted the addition of di-n-butylcopper lithium to succinic 
anhydride (343) in tetrahydrofuran. The reaction mixture was stirred at ambient 
temperature for three hours and was then quenched with a saturated 
ammonium chloride solution. The crude product was extracted into diethyl 
ether, the solvent removed in vacuo, and the crude product was esterified 
directly by reacting it with acidified absolute ethanol for three hours at ambient 
temperature.205 Following work up and purification, ethyl 4-oxooctanoate (292) 
was obtained in 34% yield over the two steps. 
  
The iron (III) acetoacetate catalysed Grignard reaction used in strategy C198 
was clearly the most economic and efficient method for preparing the ketoester 
(292). It required only one step, ten minutes reaction time, relatively little 
solvent, 3% catalyst loading, and boasted a quantitative yield with no 
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contamination by by-products, provided that the reaction time was carefully 
monitored. 
 
4.2.2 Preparation of the racemic amine  
During the initial trouble-shooting phase in the development and optimization of 
the synthetic pathway, we wanted an inexpensive method to prepare the 
racemic amine, ethyl 3-aminobutyrate (291). One of the literature methods208 - 
210 for preparing β-amino esters was by reacting a β-ketoester with an ammonia 
source and reducing out the resulting imine or its enamine tautomer. We also 
intended to use methodology developed by Davies and co-workers,158 
incorporating a chiral auxiliary, to access the equivalent enantiopure amine. A 
comparable racemic pathway can be emulated using dibenzylamine for the 
aza-Michael reaction. These two potential pathways for accessing the racemic 























Scheme 4.6: Two potential pathways for accessing racemic amine (291). Reagents 
and conditions: i) NH4CH3CO2, AcOH, reflux, 4 hr.; ii) NaBH4, AcOH; 
iii) a) dibenzylamine, n-BuLi, THF, -90°C, 30 min.;  b) (350), 2 hr.; iv) Pd/C, H2 (7 atm.), 
AcOH, 72 hr. 
 
When preparing the racemic amine, the nature of the side-chain of the ester 
group was inconsequential, as it would be reduced to the alcohol later in the 
synthesis. We therefore chose to attempt the method with the β-ketoester on 
both ethyl acetoacetate (339) (see Scheme 4.6) and on t-butyl acetoacetate 
(352) (see Scheme 4.7). First, ethyl acetoacetate was dissolved in benzene in a 
flask connected to a Dean-Stark apparatus. Acetic acid and ammonium acetate 
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were then added and the solution was heated at reflux for four hours. After 
cooling, the solvent was removed in vacuo and the residual oil was washed with 
sodium carbonate and extracted into ethyl acetate. The enamine, (Z)-ethyl 3-
aminobut-2-enoate (349A), was isolated by vacuum distillation in 91% yield as 
a low melting solid (28 – 30°C). The 1H-NMR spectrum indicated the product 
(349A) was in equilibrium with its imine tautomer (349B) in a 3:1 ratio 
respectively.  
 
The most significant peaks in the 1H-NMR spectrum included the NH2 signal, a 
broad singlet at 8.5 – 7.5 ppm, and the enamine H-2 signal at 4.52 ppm (see 
Figure 4.4). The only signal which displayed different chemical shifts for the two 
tautomers was the methyl group, H-4; in (349A) the signal was at 1.90 ppm and 
for (349B) the signal shifted to 1.66 ppm. The 13C-NMR spectrum showed 
doubling up of all the peaks for the tautomers. C-3 appeared at 159.9 ppm for 
the enamine, and 200.6 ppm for the imine. C-2 appeared at 83.1 ppm for the 




Figure 4.4: Numbering of tautomers (349A) and (349B) of amine for assignment of 
spectroscopic data. 
 
The identical procedure was carried out with t-butyl acetoacetate (352). (Z)-t-
Butyl 3-aminobut-2-enoate (353) was isolated by vacuum distillation in 89% 




Scheme 4.7: Potential pathway for accessing racemic amine (354). Reagents and 
conditions: i) NH4CH3CO2, AcOH, reflux, 4 hr.; ii) NaBH4, AcOH. 
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With the increased molecular weight, the melting point of the t-butyl 
3-aminobut-2-enoate (35 – 37°C) was slightly higher than that of the ethyl 
equivalent. The 1H-NMR spectrum showed the NH2 signal at 8.5 – 7.5 ppm as a 
broad singlet, and the H-2 singlet at 4.46 ppm (see Figure 4.5). None of the 




Figure 4.5: Numbering of amine (353) for assignment of spectroscopic data.  
 
Both of the enamines were subjected to various reducing conditions210 with 
sodium borohydride, sodium triacetoxyborohydride or platinum dioxide in the 
presence of hydrogen. After purification by column chromatography, none of 
the desired product was isolated under any of the conditions mentioned. 
Presumably, the failure to isolate the desired product was due to the high 
volatility and water solubility of the free amines (291) and (354) rather than the 
reaction conditions. No starting material was recovered from these reductions. 
 
Owing to the limited success of these initial attempts at preparing the racemic 
amine, we decided to move on to model the enantioselective method (see 
Scheme 4.8).158 Dibenzylamine was dissolved in tetrahydrofuran under inert 
conditions and the solution was cooled to −90°C in an acetone/liquid nitrogen 
slurry. n-Butyllithium was carefully added by syringe and the reaction mixture 
turned from clear to deep red. The mixture was allowed to stir for thirty minutes 
at −90ºC before a solution of ethyl crotonate in tetrahydrofuran was added from 
a dropping funnel over forty minutes. After a further two hours, the reaction was 
quenched and the crude product was extracted. Following purification by 
column chromatography, ethyl 3-(dibenzylamino)butanoate (351) was isolated 
in 74% yield as a clear and pungent oil (see Figure 4.6). The two benzyl groups 
were identified in the 1H-NMR spectrum at 7.65 ppm, 7.60 ppm and 7.53 ppm 
for the aromatic signals and the benzylic protons (H-5A and H-5B) were 
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observed as diastereotopic signals at 3.97 ppm and 3.78 ppm, respectively. 
The alkene signals associated with ethyl crotonate were absent. H-3 occurred 
as a multiplet at 3.70 – 3.58 ppm, and H-2 was diastereotopic, occurring at 2.96 
and 2.59 ppm as two double doublets with a geminal coupling constant of 13.9 
Hz. 13C-NMR spectroscopy showed a characteristic ester signal at 172.7 ppm, 
four signals in the aromatic region, an ethyl ester signal at 60.7 ppm, and 
















Figure 4.6: Numbering of dibenzylamine (351) for assignment of spectroscopic data.  
 
Ethyl 3-(dibenzylamino)butanoate (351) was subjected to standard 
debenzylation conditions (see Scheme 4.8).158 It was dissolved in absolute 
ethanol together with a catalytic amount of hydrochloric acid and activated 10% 
palladium on carbon and placed in an hydrogenator under seven atmospheres 
of hydrogen pressure for seventy-two hours. After filtration through Celite® the 
partially debenzylated product, ethyl 3-(benzylamino)butanoate (355), was 




Scheme 4.8: Preparation of the racemic amine (291). Reagents and conditions; 
i) a) dibenzylamine, n-BuLi, THF, -90°C, 30 min.; b) (350), 3 hr.; ii) Various conditions 
(see Table 4.1). 
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The second debenzylation method we attempted was also in the hydrogenator, 
but this time acetic acid was used as the solvent.211 After filtration through 
Celite®, the crude product was purified by column chromatography. 
Unfortunately, most of the desired product, ethyl 3-aminobutanoate (291), 
remained fixed to the silica gel and was isolated in a mere 24% yield.  
 
Two other variations of the debenzylation were attempted. One used neat 
ethanol as a solvent, but neither of the products was isolated. The other used a 
hydrogen balloon and acidic ethanol for the reaction. The balloon pressure was 
approximately one atmosphere and in this instance both products were isolated 
in 15% yield (see Table 4.1). 
  
Pressure Catalyst Eq. (w/w) Solvent (355) (291) 
7.5 atm. Pd-C 10% 0.48 AcOH 0% 24% 
7.5 atm. Pd-C 10% 0.48 EtOH 0% 0% 
≈ 1 atm. Pd-C 10% 0.48 EtOH/HCl 
(15:1) 
15% 15% 




Table 4.1: Yields for debenzylations where the product was purified by column 
chromatography, resulting in reduced yields. 
 
It became clear that using 10% palladium on carbon and acetic acid as the 
solvent was a viable method for preparing amine (291), provided that we did not 
isolate or purify the amine, but rather used it directly in the next reaction. After 
the reaction had gone to completion the palladium was removed by filtering the 
reaction mixture through Celite®, which was rinsed thoroughly with 
dichloromethane, and the dichloromethane was removed in vacuo. The residual 
acetic acid was not removed in vacuo, as the higher temperatures required 
would result in further loss of the volatile product. The crude mixture was not 
purified by column chromatography, as that also led to reduced yields. The 




Both the free amine (291) and the monobenzylated amine (355) were 
characterized by 1H-NMR spectroscopy (see Figure 4.7). The free amine 
showed the ethyl group as a quartet at 4.15 ppm and a triplet at 1.27 ppm. The 
NH2 signal appeared at 1.71 ppm as a broad singlet. The H-3 signal appeared 
as a multiplet at 3.42 – 3.34 ppm, and the H-2 group was diastereotopic, 
showing two double doublets at 2.41 and 2.29 ppm, with a geminal coupling of 
15.6 Hz. For the monobenzylated amine in addition to the same signals there 
were aromatic signals present at 7.40 – 7.21 ppm and a diastereotopic benzylic 
signal for H-5 at 3.84 and 3.76 ppm, both appearing as doublets with a geminal 











[291]   
 
Figure 4.7: Numbering of amine (291) and benzylamine (355) for assignment of 
spectroscopic data. 
 
Now that the preparation of the racemic amine via our enantioselective model 
had proved viable and an inexpensive alternative remained elusive, we ceased 
to prepare the racemic amine. Instead we purchased it from Sigma-Aldrich as a 
90% pure racemic mixture, which was both expensive and unstable, requiring 
storage at −18°C.  
  
4.2.3 Davies’ methodology: enantiopure amine158  
The only difference between the synthesis of enantiopure ethyl (3R)-3-
aminobutanoate (356) and our model racemic synthesis was a methyl group at 
the benzylic position of the dibenzylamine. The stereochemistry of this methyl 
group was principal in directing the formation of the new stereogenic centre 
(see Chapter 3, Section 3.3 for a full explanation of the stereocontrol). 
 
The chiral amine, benzyl[(1R)-1-phenylethyl]amine (214), was dissolved in 
tetrahydrofuran and the solution was cooled to −90ºC (see Scheme 4.9). 
n-Butyllithium was added by syringe and the reaction turned from clear to deep 
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red. The mixture was stirred for thirty minutes to allow complete formation of the 
lithium amide and a solution of ethyl crotonate (350) in tetrahydrofuran was 
then added from a dropping funnel over forty minutes. After an additional two 
hours the reaction was quenched with an ammonium chloride solution and the 
product was extracted into dichloromethane. After column chromatography, the 
product, ethyl (3R)-3-{benzyl[(1R)-1-phenylethyl]amino}butanoate (356), was 




Scheme 4.9: Preparation of the enantiopure amine (291). Reagents and conditions; 
i) a) benzyl[(1R)-1-phenylethyl]amine, n-BuLi, THF, -90°C, 30 min.; b) (350), 2 hr.; 
ii) Pd/C, H2 (7 atm), AcOH, RT, 72 hr. 
 
The dibenzylated product (356) was optically active, with an optical rotation of 
[α]D20 +7.6 (c 1.06, CH2Cl2). 1H-NMR spectroscopy showed the presence of two 
benzyl groups with aromatic signals between 7.42 ppm and 7.17 ppm 
integrating for ten hydrogen atoms. The benzylic CH2 appeared as a 
diastereotopic signal at 3.71 ppm and at 3.69 ppm, both as doublets with 
geminal coupling of 14.7 Hz. The benzylic CH appeared as a quartet at 
3.92 ppm coupling to the methyl group with a coupling constant of 7.0 Hz. H-3 
appeared as a multiplet at 3.50 – 3.40 ppm, and H-2 displayed diasterotopic 
splitting to give signals at 2.36 ppm and 2.10 ppm. Importantly, no doubling up 
of signals was observed in the 13C-NMR spectrum, indicating the presence of 
only one diastereomer. FTIR spectroscopy showed aromatic stretching 
vibrations at 3062 cm-1 and 3027 cm-1 and the ester carbonyl at 1732 cm-1. 
 
The next step was the removal of the benzyl groups to expose the amine 
functionality (see Scheme 4.9). This proved to be non-trivial. The first method 
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we attempted was a debenzylation in the hydrogenator using acetic acid as the 
solvent and 10% palladium on carbon as the catalyst.211, 212 After purification by 
column chromatography the desired free amine (291) was isolated in 35% yield 
and the monobenzylated species, ethyl (3R)-3-{[(1R)-1-phenylethyl]amino} 
butanoate (357), was isolated in 26% yield. 
 
We also attempted using the reputably better debenzylation catalyst, 
Pearlman’s catalyst (palladium hydroxide on carbon), in absolute ethanol, but 
isolated a fluffy, white, polymeric compound and none of the desired amine 
(see Table 4.2). 
 
Pressure Catalyst Eq. (w/w) Solvent (357) (291) polymer 
7.5 atm. Pd/C 10% 0.45 AcOH 26% 35% 0% 
7.5 atm. Pd-(OH)2/C 0.20 EtOH 0% 0% 100% 
7.5 atm. Pd-(OH)2/C 0.10 EtOH 0% 0% 100% 
 
Table 4.2: Yields for debenzylations where the product was purified by column 
chromatography, resulting in reduced yields. 
 
Owing to the difficulties in purifying the amine (291) we ceased attempting to 
isolate it. Using 10% palladium on carbon and acetic acid as the solvent was a 
reasonably viable method for preparing amine (291) and as the next reaction 
required acetic acid as well (see Section 4.3.1), we filtered the reaction mixture 
through Celite® to remove the palladium, rinsed thoroughly with 
dichloromethane, and removed the solvent in vacuo. The crude product, 
together with the residual acetic acid, was immediately used in the next 
reaction. The yields over the two steps were generally between 30 – 50% and 
the reaction results were fairly consistent for the first two and a half years of the 
project. It was only in the last year and a half, when the focus of the project 
turned to the enantioselective synthesis that the same reaction conditions failed 
to produce any of the fully debenzylated amine (291) and consistently yielded 
the monobenzylated amine (357). The sudden shift in results led us to the 
conclusion that the batch of palladium catalyst was of paramount importance. 
Although we continued to attempt the debenzylation with 5% and 10% 
palladium on carbon from at least four different suppliers (Aldrich, Fluka, Alfa 
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and PMC), varying the ratio (0.10 equivalents – 1.0 equivalents), the solvent 
(acetic acid, ethanol and methanol), the hydrogen pressure (1 atmosphere – 
8 atmospheres), and the reaction length (12 hours – 120 hours) the reaction 
failed to produce the fully debenzylated amine (291), and we finally had to 
admit defeat. We did not attempt to vary the temperature of the reaction as the 
hydrogenator was not equiped for high temperatures. 
 
Another debenzylation method we attempted on ethyl (3R)-3-{benzyl[(1R)-1-
phenylethyl]amino}butanoate (356) was with ammonium formate and palladium 
on carbon (0.37 eq.) in methanol. The reaction was left at ambient temperature 
for three and a half hours until no more starting material was observed by TLC. 
Following extraction and purification by column chromatography, the 
monobenzylated product (357) was isolated in 69% yield. None of the desired 
fully debenzylated product was obtained. 
 
We also attempted to remove the second benzyl group from (357) by reacting it 
with Pearlman’s catalyst, acetic acid and seven atmospheres of hydrogen 
pressure. The α-methylbenzyl group could not be removed, only starting 
material was recovered. 
 
There are examples in the literature of the complete debenzylation of (356) to 
give (291) by Fenwick and Davies211 and by Li et al.212 Li et al. observed that in 
the presence of Pearlman’s catalyst, ethanol and four atmospheres of hydrogen 
pressure for 48 hours, amine (356) underwent complete debenzylation to give 
(291) in 89% yield (see Scheme 4.10). They also claimed that in the presence 
of 10% palladium on carbon (0.125 w/w), ethanol, 5% hydrochloric acid, and 
one atmosphere of hydrogen pressure for an hour, amine (356) underwent 
monodebenzylation to give (357) in 94% yield.212 This chemoselectivity in the 
presence of acid was the opposite to the chemoselectivity reported by Fenwick 





Scheme 4.10: Debenzylation by Li et al.212 Reagents and conditions: i) H2 (4 atm.), 
20% Pd(OH)2/C, EtOH, RT, 48 hr.; ii) H2 (1 atm.), 10% Pd/C, EtOH/HCl, RT, 1 hr. 
 
Cimarelli and Palmieri213 cleaved an α-methyl benzyl group from a β-amino 
ester (358) (see Scheme 4.11) using acidified methanol and Pearlman’s 
catalyst (67 mg/mmol) to give the primary amine (359), displaying none of the 

















Scheme 4.11: Debenzylation by Cimarelli and Palmieri.209 Reagents and conditions: 
i) Pd(OH)2/C (67 mg/mmol), MeOH-H2O-AcOH (20:2:05), H2 (3 atm.), RT, 12 hr. 
 
Fleck et al.214 have also reported the synthesis of (291) from (356). They 
required 80% (w/w) Pearlman’s catalyst in methanol under thirty psi of 
hydrogen pressure to remove both benzyl groups from (356). Interestingly, they 
were also the first group, using chiral lithium amides, to detect the by-product 
(360) in the aza-Michael addition (see Figure 4.8). The by-product (360) forms 
when excess of the lithium amide was present in the reaction mixture and it 
added to the ester as well as the α,β-unsaturated system.214  We never 












Figure 4.8: Reported by-product (360) of the aza-Michael addition reaction.214 
 
In another publication, Davies et al.158 reported the debenzylation reaction for 
amines analogous to amine (291) (see Scheme 4.12). For an ethyl analogue 
(361) of amine (356) Davies et al.158 reported complete debenzylation to give 
(362) in 95% yield in the presence of palladium on carbon, methanol and five 
atmospheres of hydrogen pressure. For the methyl analogue (363) they 
reported complete debenzylation in the presence of Pearlman’s catalyst, 
ethanol and five atmospheres of hydrogen pressure. Interestingly, their yield for 
the methyl analogue (364) using Pearlman’s catalyst was 68%, whereas their 
yield for the equivalent ethyl analogue (366) using palladium on carbon in acetic 
acid was 90%.158 Clearly, the methyl group plays a role in reducing the 


































Scheme 4.12: Debenzylations by Davies et al.158 Reagents and conditions: i) Pd/C, 
H2 (5 atm.), MeOH; ii) R=Me a) Pd(OH)2/C, H2 (5 atm.), EtOH; R=Et b) Pd/C, 
H2 (5 atm.), AcOH. 
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In a recent publication by Davies et al.,180 the preparation of cyclic β-amino 
acids required a large amount of Pearlman’s catalyst (50% w/w) to remove 
α-methyl benzyl groups from various cyclic β-amino esters (e.g. 367) to give the 
corresponding secondary amine (e.g. 368) (see Scheme 4.13 for an example). 





Scheme 4.13: Recent debenzylation by Davies et al.180, 181 Reagents and conditions: 
i) H2 (5 atm.), Pd(OH)2/C (50% w/w), EtOAc, RT, 12 hr. 
 
Another method for removing benzyl groups was with the reagent ceric 
ammonium nitrate (CAN). CAN was usually used for removing para-
methoxybenzyl groups, but there was literature evidence of CAN cleaving 
unsubstituted benzyl groups from tertiary amines. Davies and co-workers184 
successfully used CAN in acetonitrile and water to monodebenzylate (369) to 
give (370) in 54 – 90% yield depending on the R-group, and to 
monodebenzylate (372) to give (373) (see Scheme 4.14).182 CAN was unable to 
debenzylate the secondary amines (e.g. 370) to give primary amines (371). 
 
Formic acid displays the opposite chemoselectivity and has been used to 
selectively cleave α-methylbenzyl groups. For example (374) was selectively 
debenzylated to give (375) (see Scheme 4.14).185 Our limited success with the 
formic acid debenzylation during the attempted synthesis of (−)-indolizidine 
209D dissuaded us from attempting it on (356). Other methods in the literature 
include using dissolving metal conditions such as lithium and ammonia in 






































Scheme 4.14: Chemoselective debenzylation by Davies and co-workers.184, 185 
Reagents and conditions: i) CAN (2.1 eq.), MeCN-H2O (5:1), RT; ii) a) HCOOH, 50°C; 
b) SOCl2, MeOH. 
 
We confirmed what Davies and co-workers184 reported and selectively cleaved 
an unsubstituted benzyl group from the tertiary amines (351) by reacting it for 
twelve hours with CAN. After work-up and purification, monobenzylated (355) 
was isolated in 81% yield.  
 
The amine that we did successfully isolate was fully characterized and 
Table 4.3 compares the key 1H-NMR and 13C-NMR spectroscopic signals and 





   
Signal (356) / ppm (357) / ppm (291) / ppm 
N-H - 2.07 (s) 1.71 (s) 
H-2 2.36 (dd, J 14.1) 
2.10 (dd, J 14.1) 
2.60 (dd, J 15.4) 
2.43 (dd, J 15.4) 
2.41 (dd, J 15.6) 
2.29 (dd,  J 15.6) 
H-3 3.50 – 3.40 (m) 3.10 (m) 3.38 (m) 
H-4 1.14 (d, J 6.7) 1.12 (d, J 6.5) 1.13 (d, J 6.4) 
H-5 4.03 – 3.95 (q, J 7.0) 4.03 (q, J 6.7) - 
H-6 1.35 (d, J 7.0) 1.44 (d, J 6.7) - 
H-11 3.71 (d, J 14.7) 
3.69 (d, J 14.7) 
- - 
C-1 172.8  177.0 172.4 
C-2 40.2 40.7 44.3  
C-3 50.5 48.7 44.1 
C-4 14.5 21.3 23.6 
C-5 60.5 56.2 - 
C-6 18.3  24.3 - 
C-11 50.0  - - 
[α]D20 +7.6 (c 1.06, CH2Cl2) +23.0 (c 1.65, CH2Cl2) +37.0 (c 1.20, 
CH2Cl2) 
 
Table 4.3: Comparison of selected NMR spectral data (in CDCl3) for tertiary, secondary 
and primary amines (356), (357) and (291). (J-values were measured in Hz). 
 
Interestingly, the chemical shifts and coupling constants for H-2, H-3, and H-4 
were extremely similar in all three compounds; however, C-2, C-3, and C-4 
have fairly different chemical shifts. The chemical shifts for C-2 and C-4 
increased as the benzyl groups were removed and the chemical shift for C-3 
decreased as the nitrogen lost the inductive effect of the benzyl groups. The 
optical rotation values for (356), (357) and (291) were compared with the 
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available literature values. For ethyl (3R)-3-{benzyl[(1R)-1-phenylethyl]amino} 
butanoate (356) we measured [α]D20 +7.6 (c 1.06, CH2Cl2), which compared 
favourably with the literature value of [α]D25 +4.9 (c 1.0, CHCl3), and compared 
well with the values reported for analogous aminoesters, which range from 
[α]D30 +7.3 to [α]D20 +4.5 (refer to Table 3.1 in Chapter 3).218 For ethyl (3R)-3-
{[(1R)-1-phenylethyl]amino}butanoate (357) we measured [α]D20 +23.0 (c 1.65, 
CH2Cl2) which was slightly lower than the reported value, [α]D25 +31.1 (c 1.0, 
CHCl3),218 but compared favourably with the measured value for the analogous 
aminoester (323), [α]D20 +20.4 (c 0.91, CH2Cl2). For ethyl (3R)-aminobutanoate 
(291) we measured [α]D20 +37.0 (c 1.20, CH2Cl2), which did not compare well 
with either of values reported in the literature [α]D20-7.5 (1.00, CH3OH)219 and 
[α]D20-10.6 (1.00 CH3OH),220 nor did it compare well to the value we measured 
for analogous amine, t-butyl (3R)-3-aminononanoate (275), [α]D20 -13.4 (c 0.98, 
CH2Cl2). Unfortunately, owing to the volatile nature of the amine, we were 
unable to repeat the optical rotation measurement. 
 
Although there are some inconsistencies in the literature with regards to 
chemoselectivity, there are still many publications reporting successful 
debenzylation reactions using Davies methodology. Unfortunately, our system 
has ceased to work and a new approach will have to be examined in the future. 
 
4.3  Preparation of N,5-disubstituted pyrrolidin-2-ones 
 
Now that the two precursors, ketoester (292) and amine (291), had been 
synthesized, the next objective was to condense them to give the key pyrrolidin-
2-one (293). Relevant results will be described in this section.  
 
4.3.1 Condensation reactions 
The first condensation reaction we tried was the two step method to form (377) 
demonstrated by Penny Cheesman128, 221 (see Scheme 4.15). Starting with 
4-oxooctanoic acid (347), we converted it into the corresponding acid chloride 
by stirring with oxalyl chloride for two hours at ambient temperature. The acid 
chloride (376) was then reacted with racemic ethyl 3-aminobutanoate (291) and 
triethylamine in dichloromethane for fourteen hours. Following purification by 
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column chromatography, ethyl 3-[(4-oxooctanoyl)amino]butanoate (377) was 
































Scheme 4.15: Proposed synthesis of lactam (293) by Cheesman.128 Reagents and 
conditions: i) oxalyl chloride, RT, 2 hr.; ii) (291), Et3N, CH2Cl2; iii) TFA. 
 
Before trying the ring closure, the ethyl 3-[(4-oxooctanoyl)amino]butanoate 
(377) was placed in an NMR tube with catalytic trifluoroacetic acid, in order to 
investigate whether the open chain form (377) was in equilibrium with the 
cyclised form (378). 1H-NMR spectral data were collected at frequent intervals 
and after twenty-four hours tiny peaks started appearing in the spectra at 
5.00 ppm, 2.05 ppm and 1.45 ppm, indicating the presence of the cyclised 
structure (378). These peaks had an intensity of approximately 5% of the open-
chain form. After a week no further increase in the intensity of these 1H-NMR 
spectral signals was observed.  
 
In order to drive the equilibrium forward the ethyl 3-[(4-
oxooctanoyl)amino]butanoate (377) was heated at reflux in toluene with five 
equivalents of acetic acid for seventy-two hours while the reaction was 
monitored by TLC. After three days the reaction was stopped; 100% conversion 
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had occurred and the cyclised, dehydrated product, ethyl 3-[(2E)-2-butylidene-
5-oxopyrrolidinyl]butanoate (293), was isolated in quantitative yield, exclusively 
as the E-isomer. 
 
The first product, ethyl 3-[(4-oxooctanoyl)amino]butanoate (377) was fully 
characterized and the N-H signal appeared as a doublet at 6.18 ppm, coupling 
to adjacent H-3 (see Figure 4.9). H-3 appeared as a multiplet at 4.28 – 4.21 
ppm, and H-2, H-6, H-7 and H-9 showed up as multiplets in the region 2.68 – 
2.31 ppm. The ethyl and butyl chains were also evident. The 13C-NMR 
spectrum had one ketone and two ester/amide carbonyls at 209.1 ppm, 
170.6 ppm and 170.1 ppm, respectively, and four signals at 41.5 ppm, 
41.1 ppm, 39.2 ppm and 36.6 ppm in the appropriate region for methylene 
carbons adjacent to carbonyl groups. The FTIR spectrum showed a broad band 
at 3306 cm-1 corresponding to the NH stretching vibration, and three carbonyl 
groups at 1731 cm-1, 1707 cm-1 and 1640 cm-1 corresponding to the ester, 
ketone and amide, respectively. The 1H-NMR and 13C-NMR spectra were fully 




Figure 4.9: Numbering of amide (377) for assignment of spectroscopic data. 
 
Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) was characterized 
by 1H-NMR spectroscopy and showed distinct differences from the ring-open 
form (377). The key difference was the appearance of the alkene signal at 
4.77 ppm, corresponding to H-4 (see Figure 4.10). The signal corresponding to 
H-10 was a multiplet at 4.45-4.37 ppm and the adjacent diastereotopic protons 
H-11 appeared as two double doublets at 3.04 ppm and 2.81 ppm. The 
13C-NMR spectrum showed only two carbonyl signals at 175.7 ppm and 
171.4 ppm, indicating the absence of the ketone. An enamine was clearly 
present, with signals at 138.7 ppm and 101.0 ppm and C-6 and C-7 had shifted 
upfield to 29.2 ppm and 21.6 ppm. FTIR spectroscopy also showed the 
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presence of only two carbonyl groups; the ester and the amide at 1735 cm-1 




















Figure 4.10: Numbering of lactam (293) for assignment of spectroscopic data. 
 
In order to ascertain whether the alkene was exocyclic or endocyclic, both a 
COSY and a NOESY experiment were performed. These experiments showed 
short range and long range coupling between hydrogen atoms. C-H correlation 
experiments were also performed to assist with assignment (see Figure 4.11). 
Highlighted with coloured arrows are two examples: In blue, C-4 correlates to 
































Figure 4.11: C-H correlation experiment (in CDCl3) for lactam (293). 
 
It was clear from the 13C-NMR spectrum that the product was a single 
geometric isomer, as no doubling up of signals was observed. The next 
experiment we performed was a selective NOE irradiation, in order to establish 
whether the geometry of the double bond was E or Z. When irradiating H-4 at 
4.77 ppm, H-9 and H-11 showed a positive response, while H-6 and H-7 
showed no response. This indicated that the product was exclusively the E 
isomer, as H-4 was on the same side of the double bond as H-9 and H-11. 
 
Although Penny Cheesman’s proposed route to ethyl 3-[(2E)-2-butylidene-5-
oxopyrrolidinyl]butanoate (293) was successful,128, 221 we wondered whether the 
product could not be accessed directly by heating ethyl 4-oxooctanoate (292) 
with ethyl 3-aminobutyrate (291) to reflux in toluene. Our initial attempt proved 
successful and after seventy-two hours of heating to reflux in toluene we 
isolated ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) in 52% 
yield.222 For this first attempt, the ethyl 3-aminobutyrate was the crude material 
from the debenzylation reaction. When the reaction was repeated with the 
commercially available ethyl 3-aminobutyrate the yield dropped to an 
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unsatisfactory 21%. This led us to the fortuitous discovery that the acetic acid 
contaminating the crude amine was catalyzing the reaction. 
 
The reaction was attempted with catalytic p-toluenesulfonic acid which gave the 
product in 50% yield. After several investigations, both in the microwave 
reactor, and with various proportions of the reagents, it was found that five 
equivalents of acetic acid, two equivalents of the ester, and one equivalent of 
the amine heated at reflux for a minimum of seventy-two hours gave the 
optimum yield of 87%. The reaction was set-up in with a Dean-Stark apparatus, 
which assisted in removing water from the reaction flask and helped to drive the 
reaction forward. Our suggested mechanism for the acid-catalysed reaction is 



































Scheme 4.16: Suggested mechanism for the formation of (293). Reagents and 
conditions: i) AcOH, toluene, reflux, 72 hr. 
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When the reaction was repeated using the enantiopure amine, ethyl (3R)-
aminobutanoate (291), the optically active product, ethyl (3R)-[(2E)-2-
butylidene-5-oxopyrrolidinyl]butanoate (293), was isolated in 46% yield with an 
optical rotation of [α]D20 -10.0 (c 1.20, CH2Cl2). All other characterization was 
identical to the racemate. 
 
In our system, the presence of exclusively the E-isomer opened up possibilities 
for the stereoselective reduction of the alkene using a chiral reducing agent. In 
many instances it is the mixture of geometric isomers that prevents the use of 
chiral reducing agents, as they are only selective if exclusively one geometric 
isomer is present. We did not pursue this option as chiral reducing agents were 
prohibitively expensive and we wanted to complete the synthesis of both 
diastereomers as both intermediates should lead to natural products. 
  
4.3.2 Attempted enzymatic resolution 
At this stage, the opportunity to explore enzymatic resolution emerged. The 
principle behind enzymatic resolution is that the enzyme selectively catalyzes 
the reaction with one enantiomer only, leaving the other enantiomer untouched. 
There was literature precedent223 - 225 that CAL B (Candida antarctica lipase B) 
selectively catalyses the acylation of ethyl (3R)-aminobutyrate and not the 
reaction with ethyl (3S)-aminobutyrate. This would allow us to access the 
(+)-isomer of monomorine I and its diastereomers, the opposite of our current 
route. This also offers a cost effective way to resolve a racemate into its 
individual isomers. Working with enzymes requires special attention to the 
reaction conditions, as high temperatures can denature the enzyme and the 
effective pH range was limited.223 Only certain solvents are compatible with the 
enzymatic reaction and often the reaction mixture was heterogeneous.223  
 
The biochemistry department of the CSIR (Council for Scientific and Industrial 
Research) offered us their expertise and the use of their laboratories and 
enzymes in order to attempt this reaction. The reaction itself was straight 
forward (see Scheme 4.17), CAL B and ethyl 3-aminobutyrate (291) were 
mixed in ethyl butanoate for twenty-five hours at ambient temperature. The 
enzyme was removed by filtration through a sintered glass funnel and the 
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Scheme 4.17: Enzymatic resolution of racemic (291). Reagents and conditions: i) CAL 
B, ethyl butanoate, RT, 25 hr. ii) (292), AcOH, toluene, reflux, 72 hr. 
 
In order to avoid difficulties with the volatility of the amine and the complications 
associated with column chromatography, Gedey et al.224 reacted the crude 
mixture with acetic anhydride, thus converting any remaining amine (291) into 
the corresponding amide which was easier to purify. The reaction ee’s were 
calculated using the amide (379). Our synthesis was not compatible with this 
method of isolation, as the free amine was necessary for subsequent reactions 
(see Scheme 4.17).  
 
Instead, we chose to react the crude mixture of ethyl butanoate, ethyl 
(3S)-aminobutyrate (291) and ethyl (3R)-butyramidobutanoate (379) together 
with ethyl 4-oxooctanoate (292) in the condensation reaction (see Scheme 
4.17) and hence isolate the stable product (293). The various products were 
separated by column chromatography and (293) was isolated in 33% yield over 
the two steps. The optical rotation of (293) was measured as [α]D20 +1.0 (c 1.00, 
CH2Cl2). This was a rather disappointing value, because although the positive 
sign indicates an excess of the S-enantiomer, the magnitude was a mere 10% 
of the magnitude of the R-enantiomer which gives the reaction an enantiomeric 
excess of only 10% (see Figure 4.12).b HPLC on a chiral column was ideally 
required to calculate ee’s accurately, but optimizing the HPLC conditions did 
not seem warranted in view of the low optical activity. This poor result was 
attributed to the incomplete resolution of the racemate, owing to short reaction 
                                                 
b Enantiomeric excess was calculated based on the formula: ee = ([α]obs/[α]max)  x 100 
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times or inactive enzymes. Owing to lack of experience with this type of 
reaction, and as the S-enantiomer of the chiral amine, benzyl[(1S)-1-
phenylethyl]amine, was also commercially available we chose not to optimize 




Figure 4.12: The configuration for both enantiomers of lactam (293). 
 
4.3.3 Diastereoselective reduction and optimization   
The next step in the synthesis was the first real opportunity for 
diastereoselectivity. The reduction of the exocyclic double bond introduces the 
second stereogenic centre into the molecule; and theoretically, the first 
stereogenic centre should offer a platform for stereoselectivity, even with achiral 
reagents.  
 
For the first reduction we attempted, ethyl 3-[(2E)-2-butylidene-5-
oxopyrrolidinyl]butanoate (293) was reacted with catalytic palladium on carbon 
in absolute ethanol under seven atmospheres of hydrogen pressure.226 After 
purification, ethyl 3-(2-butyl-5-oxo-1-pyrrolidinyl)butanoate (294) was isolated 
as an inseparable mixture of diastereomers in a ratio of 2:3 in quantitative yield 
(see Scheme 4.18). The minor isomer, (the ‘cis‘ isomer), has been designated 
isomer A  (294A) and the major isomer, (the ‘trans‘ isomer), has been 
designated isomer B (294B).c The isomer ratio was determined by the relative 
                                                 
c The  terms ‘cis’ and ‘trans’ refer to the relative stereochemistry of the methyl and the 
butyl chains in the bicyclic products (298), (299) and the target compounds (26 – 29). 
Although, technically they are meaningless in the monocyclic products (294), (295), 
(296) and (297), they have been used in this thesis to distinguish the two 
diastereomeric pathways.  
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integration in the 1H-NMR spectrum of the hydrogen atoms at the two 
stereogenic centres, H-5 and H-10 (see Figure 4.13). The identification of the 




Scheme 4.18: Diastereoselective reduction of (293). Reagents and conditions: 
i) Various conditions (see Table 4.4). 
 
The limited stereoselectivity with the palladium catalyzed reduction was owing 
to the free rotation around the N-C bond, which prevents the methyl group from 



















Figure 4.13: Numbering of lactam (294) for assignment of spectroscopic data. 
 
Initially, prompted by the expense of the palladium, we decided to try a 
reduction with triethylsilane and titanium tetrachloride in dichloromethane.215 
The general protocol for the reaction was as follows: Ethyl 3-[(2E)-2-butylidene-
5-oxopyrrolidinyl]butanoate (293) was dissolved in freshly distilled 
dichloromethane and cooled to −90ºC. Titanium tetrachloride was added and 
the reaction mixture was stirred for five minutes. Triethylsilane was then added 
by syringe and the reaction was allowed to warm to ambient temperature and 
react for forty-eight hours. The reaction was quenched with a saturated 
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ammonium chloride solution and the product was extracted into 
dichloromethane. Purification by column chromatography gave ethyl 3-(2-butyl-
5-oxo-1-pyrrolidinyl)butanoate (294) as an inseparable mixture of 
diastereomers in 84% yield. Surprisingly, the ratio of isomers was 1:4, again 
favouring isomer B (294B). This increase in stereocontrol indicated that the 
reagents used were having an effect on the stereoelectronics or the steric 
hindrance experienced by the hydrogen source.  
 
Our first hypothesis for the observed stereocontrol was that the oxophilic 
titanium tetrachloride must be coordinating to the lactam carbonyl and the ester 
carbonyl and limiting the free rotation of the N-C bond. By coordinating to the 
ester and the lactam, the free rotation of the side chain was blocked and the 
stereocontrol increased. In order to examine this hypothesis a series of different 
protic and Lewis acids was employed to catalyze the reaction under identical 
conditions. Trifluoroacetic acid, aluminium trichloride, boron trifluoride etherate, 
tin tetrachloride and zirconium tetrachloride were all tested. All of them showed 
lower selectivity than the titanium tetrachloride (see Table 4.4), but all of them 
favoured isomer B (294B).  
 
Catalyst H-Source Ratio (A:B) Yield 
Pd-C 10% a H2 2:3 100% 
TFA b Et3SiH 2:3 94% 
AlCl3 b Et3SiH 3:4 100% 
BF3.Et2O b Et3SiH 4:5 90% 
SnCl4 b Et3SiH 2:3 80% 
TiCl4 b Et3SiH 1:4 84% 
ZrCl4 b Et3SiH 3:4 79% 
TiCl4 c Ph3SiH 1:5 85% 
Ti(OPri)4 b Et3SiH - 0% 
La(F3CSO3)3 b Et3SiH - 0% 
 
Table 4.4: Attempted diastereoselective reductions of (293). a) 50% (w/w) Pd-C 10%, 
H2 (7 atm.), EtOH, RT, 72 hr.; b) Lewis acid, Et3SiH, CH2Cl2, -90°C, 2 hr., increased to 
RT, 72 hr.; c) Lewis acid, Ph3SiH, CH2Cl2, -90°C, 2 hr. increased to RT, 72 hr. 
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Our second hypothesis was that the titanium tetrachloride was more effective 
than the other Lewis acids as it has a higher affinity for oxygen. Lanthanum has 
a higher affinity for oxygen than titanium, so we attempted the reaction using 
lanthanum trifluoromethanesulfonate. Interestingly, none of the desired product 
was isolated, but 85% yield of the open chain amide, ethyl 3-[(4-
oxooctanoyl)amino]butanoate (377) was isolated. 
 
Still presuming stereocontrol based on steric hindrance, we attempted two 
further reactions, one using titanium isopropoxide as a bulky Lewis acid, and 
the other using triphenylsilane as a bulky hydrogen source in place of 
triethylsilane. The titanium isopropoxide failed to catalyze the reaction and 
starting material was recovered. The triphenylsilane, however, improved the 
stereoselectivity to a ratio of 1:5.  
 
Pleased with the level of stereocontrol we had achieved in the absence of 
expensive chiral reagents, we ceased exploring physical reactions and turned 
our attention to explaining the observed results. The increased stereoselectivity 
observed with the bulky hydrogen source indicates steric hindrance as a major 
contributor. However, later in the synthesis (see Section 4.4.5) we were able to 
separate and characterize more advanced intermediates, convert them back 
into the lactams (294A) and (294B), and thus retrospectively assign the relative 
configuration of these lactams. The favoured diastereomer (294B) was 
confirmed as the trans isomer (R,R or S,S). This means that the hydrogen was 
added from the same face that the methyl group was “blocking”. 
  
A search of the Cambridge Structural Database (CSD Version 5.30, May 
2009)227 for all compounds containing titanium coordinated to two carbonyl 
oxygen atoms, and at least two chlorine atoms resulted in forty hits, with the 
coordination geometry around the titanium atom being octahedral in all cases. It 
seemed reasonable to assume a similar coordination with our molecule. 
Several attempts were made to model a potential transition state using 
Hyperchem228 that could explain the observed stereocontrol. Upon closer 
examination of a local energy minimum conformation it became apparent that 
with the titanium coordinating to both the ester and the amide it forms an eight-
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membered ring. This eight-membered ring puckers, pushing the methyl group 
out of the plane. The molecular dynamic / simulated annealing experiments 
were only performed on the R-enantiomer, as the S-enantiomer would mirror 
the result and hence favour the same selectivity. 
 
After repeating the molecular dynamic / simulated annealing ten times, two 
energy conformers were identified for the R-enantiomer (293). The first 
conformer was slightly lower in energy than the second conformer 
(2.4 kcal/mol) and of the ten simulated annealing experiments, eight of them 
produced the first conformer and two of them produced the second conformer. 
In the first conformer, the methyl group was forced down, opening up the top 
face for attack by the hydrogen (see Figure 4.14). When the hydrogen added 
the butyl group was pushed down and the new stereogenic centre formed with 




Figure 4.14: Two views of R-enantiomer (293) first low energy conformer coordinated 
to titanium tetrachloride, methyl group pointing down: addition from top face. 
 
In the second case, the low energy conformer produced by Hyperchem228 failed 
to provide us with a satisfactory steric-hindrance model. In the second low 
energy conformer for the R-enantiomer (293), the methyl group was forced up, 
pointing away from the alkene entirely (see Figure 4.15). In the conformer 
shown below neither face is particularly hindered and therefore the hydrogen 
could add from the top or the bottom to form either diastereomer. As yet the 





Figure 4.15: Two views of R-enantiomer (293) second low energy conformer 
coordinated to titanium tetrachloride, methyl group pointing up: addition from either 
face. 
 
Initially, the diasteromers were fully characterized as a mixture, however, later 
in the synthesis (see Section 4.4.5) we were able to separate and characterize 
more advanced intermediates, convert them back into the lactams (294A) and 
(294B), and thus a pure sample of each isomer was obtained and fully 
characterized.  The reduction of the alkene was indicated by the absence of the 
1H-NMR spectroscopic signal at 5.00 ppm. H-10 and H-5 were shifted downfield 
due to the nitrogen, and appeared as multiplets (refer to Figure 4.13). For the 
cis isomer they appeared at 3.97 – 3.94 ppm and 3.68 – 3.63 ppm, 
respectively, and for the trans isomer they appeared at 4.20 – 4.10 ppm and 
3.61 – 3.55 ppm, respectively. H-11, H-6 and H-7 all displayed diastereotopic 
splitting for the cis isomer, however, for the trans isomer H-11 appeared as a 
doublet, while H-6 and H-7 exhibited diastereotopic splitting. The 13C-NMR 
spectrum had no alkene signals, but did have an additional signal present at 
60.0 ppm for the cis isomer and 58.1 ppm for the trans isomer, corresponding 
to C-5. C-10 appeared at 46.8 ppm and 46.1 ppm for the cis and trans isomers 
respectively. FTIR spectroscopy showed two carbonyl signals, one at 1731 cm-1 
and one at 1679 cm-1, corresponding to the ester and amide, respectively.  
 
COSY (see Figure 4.16) and HSQC experiments were conducted to allow 
definitive assignment of all the signals. Figure 4.14 shows two short range 
interactions for (294A): The first interaction is shown in blue, H-13 couples to 
H-14, the second interaction is shown in red, H-10 couples to H-9, and the 





















Figure 4.16: COSY experiment (in CDCl3) for lactam (294A). 
 
We were able to repeat the reduction with the enantiopure ethyl (3R)-[(2E)-2-
butylidene-5-oxopyrrolidinyl]butanoate (293) and chose to use the palladium 
catalysed reduction, as it provided quantitative yield and both of the 
diastereomers, and hence could be used for the total synthesis of both 
monomorine I and its diastereomer. No optical rotation was recorded for the 
product as it was an inseparable mixture of diastereomers. All other 
characterization was identical to the racemate.  
 
4.4  Preparation and cyclisation of the vinylogous sulfonamide  
 
Now that we had successfully prepared the lactam (294), our synthetic strategy 
converged with the pathway used in the attempted synthesis of (−)-indolizidine 
209D. The next task was to prepare the vinylogous sulfonamide and form the 




4.4.1 Thionation reaction and separation of diastereomers 
The thionation reaction followed standard literature conditions229 using 
Lawesson’s reagent. Although commercial Lawesson’s reagent was more 
expensive than the phosphorus pentasulfide, it could conveniently be prepared 
from phosphorus pentasulfide and anisole. This reaction, while odoriferous, was 
relatively easy to execute and an ample supply of Lawesson’s reagent was 
available. A diastereomeric mixture of ethyl 3-(2-butyl-5-oxo-1-
pyrrolidinyl)butanoate (294) and Lawesson’s reagent were stirred in dry 
dichloromethane at ambient temperature under a nitrogen atmosphere for 
ninety-six hours (see Scheme 4.19). The solvent was removed in vacuo and the 
organic residue was purified by column chromatography to give ethyl 3-(2-butyl-
5-thioxo-1-pyrrolidinyl)butanoate (295) in 98% yield as a mixture of 
diastereomers with an identical ratio to the starting material (i.e. 2:3 favouring 













Scheme 4.19: Thionation of lactam (294) to form separable thiolactam diastereomers. 
Reagent and conditions: i) Lawesson’s reagent, CH2Cl2, RT, 72 hr. 
 
The Rf values on silica gel TLC plates for isomer A and isomer B showed a 
maximum difference in a 10% ethyl acetate-hexane solution: Isomer A ran with 
an Rf of 0.25 and isomer B ran with an Rf of 0.22. While at least 80% of the 
collected fractions contained both isomers, repeated and exhaustive column 
chromatography allowed partial separation of the diastereomers. Sufficient 
racemic material was available to separate enough material to continue the 
synthesis separately with each racemic diastereomer. Without more precious 
enantiomerically pure intermediate (295), there was, unfortunately, insufficient 
material to allow for exhaustive chromatography, and the enantiopure 
diastereomers were used as a mixture for all subsequent steps. 
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 The racemic isomers were characterized separately. The most significant 
spectroscopic changes from the lactam (294) to the thiolactam (295) were the 
chemical shifts of H-5 and H-10, and the C-8 shift from the carbonyl region at 
174 ppm to the thiocarbonyl region of 200 ppm (see Figure 4.17). The individual 
isomers differed significantly in the chemical shift of H-5 and H-10. For the cis 
isomer H-5 appeared as a multiplet at 4.11-4.02 ppm and H-10 at 4.80 – 
4.72 ppm, while the trans isomer H-5 possessed a broader multiplet 4.11 – 3.95 














OEtO[295]    
 
Figure 4.17: Numbering of thiolactam (295) for assignment of spectroscopic data. 
 
Table 4.5 shows a list of the significant 1H-NMR and 13C-NMR spectroscopic 
signals in each isomer and the corresponding signals in (278), the thiolactam 
isolated during the attempted synthesis of (−)-indolizidine 209D. With the 
exception of H-5, the observed signals for (278) were almost identical to those 











Signal  (295A) / ppm  (295B) / ppm (278) / ppm 
H-4 1.90 – 1.60 (m) 1.85 – 1.68 (m) - 
H-5 4.11 – 4.02 (m) 4.11 – 3.95 (m) 3.71 (dt, J 10.7, 7.5) 
3.56 (dt, J 10.7, 7.5) 
H-6 2.25 – 2.04 (m) 
1.90 – 1.60 (m) 
2.20 – 2.04 (m) 
1.58 – 1.46 (m) 
2.03 (quintet, J 7.5) 
H-7 3.10 – 2.85 (m) 3.10 – 2.85 (m) 3.00 (t, J 7.5) 
H-9 1.52 (d, J 7.1) 1.41 (d, J 7.0) 1.64 – 1.55 (m) 
H-10 4.80 – 4.72 (m) 5.30 – 5.10 (m)   5.36 (quintet, J 7.5) 
H-11 3.53 (dd, J 6.3, 16.2) 
2.48 (dd, J 8.0, 16.2) 
2.79 (dq, J 7.5, 15.5) 2.55 (dd, J 14.4, 6.0) 
2.43 (dd, J 14.4, 9.0) 
C-4 33.7  34.2  - 
C-5 67.7  65.5  49.0 
C-6 26.1  26.4  20.0 
C-7 45.1  44.4  45.1 
C-8 200.9  201.9 201.7 
C-9 17.5  18.9  32.2 
C-10 51.3 51.0  53.3 
C-11 38.3  38.8  38.8 
C-12 171.6  170.9  169.5 
 
Table 4.5: Comparison of selected NMR spectral data (in CDCl3) for thiolactam (295A), 
(295B), (278). (J-values were measured in Hz). 
 
For the three 13C-NMR spectra, the signals for C-7, C-8, C-10, C-11, and C-12 
were virtually identical, while those for C-5, C-6, and C-9 differed significantly. 
The chemical shifts for C-5 were 67.7 ppm, 65.5 ppm and 49.0 ppm, for (295A), 
(295B) and (278), respectively. This highlights the deshielding effect of the butyl 
chain on C-5, and although these compounds were very similar, it clearly 
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indicated a difference in electronic structure between these three compounds 
which could have resulted in different degrees of reactivity in subsequent 
reactions. The same effect was seen for C-6, which has chemical shifts of 
26.1 ppm, 26.4 ppm and 20.0 ppm for (295A), (295B) and (278), respectively. 
Interestingly, the effects of the methyl group versus the hexyl chain on the 
chemical shift of C-10 were almost identical.  C-10 occurs at 51.3 ppm, 
51.0 ppm and 53.3 ppm for (295A), (295B) and (278), respectively, with only a 
slight increase in the deshielding effect for the hexyl chain.   
 
In the literature the examples of lactam thionations were in the absence of an 
exocyclic alkene. Although our lactam (293) contained an exocyclic alkene, we 
wondered whether our reaction sequence was flexible and decided to attempt 
the thionation reaction on (293) directly, as (380) would offer different levels of 












Scheme 4.20: Proposed thionation of (293). Reagent and conditions: i) Lawesson’s 
reagent, CH2Cl2, RT, 72 hr. 
 
Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) was dissolved in 
distilled dichloromethane at ambient temperature under a nitrogen atmosphere. 
Lawesson’s reagent was added, and the reaction was left stirring at ambient 
temperature for ninety-six hours. The solvent was removed in vacuo and the 
crude residue was purified by column chromatography. None of the desired 
thiolactam (380) was isolated. However, two other interesting products were 
isolated, ethyl 3-(2-butyl-1H-pyrrol-1-yl)butanoate (381) in 25% yield, and ethyl 




Scheme 4.21: Thionation of (293) produced two unexpected pyrroles (381) and (382). 
Reagent and conditions: i) Lawesson’s reagent, CH2Cl2, RT, 72 hr. 
 
The thiolactam (380) must have formed and the exocyclic alkene 
spontaneously rearranged, favouring the stabilization of the aromatic pyrrole 
system in (382). The desulfurisation of (382) to form (381) was less easy to 
explain. Although this particular reaction had no further application in our 
synthesis, it does offer a novel way of preparing substituted pyrroles and would 
be an interesting reaction to investigate further in the future.  
 
Both products were characterized and showed the pyrrole signals in the 
1H-NMR spectrum at 6.62 ppm, 6.10 ppm, and 5.84 ppm for (381) and at 
6.28 ppm and 5.73 ppm for (382). The 13C-NMR spectral signals for the pyrrole 
ring were at 133.0 ppm, 115.2 ppm, 107.5 ppm, and 105.0 ppm for (381) and at 
134.4 ppm, 131.9 ppm, 111.4 ppm, and 104.1 ppm for (382). 
 
4.4.2 Condensation of thiolactam with β-ketosulfone 
In order to form the vinylogous sulfonamide, we needed to perform a modified 
Knoevenagel reaction between the thiolactam (295) and 1-[(4-
methylphenyl)sulfonyl]acetone (279). The preparation of 1-[(4-
methylphenyl)sulfonyl]acetone (279) is described in section 3.7 in Chapter 3.190  
 
We prepared the vinylogous sulfonamide (296) by reacting the thiolactam (295) 
with excess methyl iodide in tetrahydrofuran under an inert atmosphere.173 After 
twenty-four hours the starting material was no longer visible by TLC and the 
α-thioiminium salt (383) could be seen on the baseline. In this instance, the 
α-thioiminium salt did not precipitate from solution, but remained as a thick 
yellow oil. After the solvent and excess methyl iodide was removed in vacuo, a 
premixed solution of triethylamine and 1-[(4-methylphenyl)sulfonyl]acetone 
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(279) in dichloromethane were added to the α-thioiminium salt (383). The new 
reaction mixture was stirred for ninety-six hours at ambient temperature and 
was monitored by TLC. When the reaction had gone to completion, it was 
quenched with distilled water. The organic products were extracted into 
dichloromethane and purified by column chromatography. In our first attempt, 
none of the desired product was obtained, only the hydrolysis product of the 
α-thioiminium salt, ethyl 3-(2-butyl-5-oxo-1-pyrrolidinyl)butanoate (294) was 
isolated in 81% yield (see Scheme 4.23). This indicated that the conditions 
used were not completely water-free.  
 
The reaction was repeated under strictly anhydrous conditions and two 
products were isolated, ethyl 3-((E)-2-butyl-5-(2-oxo-1-
tosylpropylidene)pyrrolidin-1-yl)butanoate  (384) in 45% yield, and the desired 
product, ethyl 3-((5E)-2-butyl-5-{[4-methylphenyl)sulfonyl]methylene} 
pyrrolidinyl)butanoate (296), in 25% yield (see Scheme 4.23). This mixture of 
acylated (296) and deacylated (295) vinylogous sulfonamides was expected, as 
a similar result was obtained during the attempted total synthesis of (−)-
indolizidine 209D (see Section 3.7). Two further variations of this synthesis 
were attempted; they followed the same general protocol, but employed a 
different solvent and/or base for the second part of the reaction (see Table 4.6). 
The method with the highest combined yield used triethylamine and 
dichloromethane and hence this was the method used for the individual 


































Scheme 4.23: The formation of the α-thioiminium salt (383) and the two possible 
pathways, hydrolysis back to (294) or reaction with (279) to form (384). Reagents and 
conditions: i) MeI, THF, 48 hr.; ii) H2O; iii) (279), Et3N, CH2Cl2, RT, 96 hr.; iv) TFA, 
reflux, 30 min. 
 
Base/Solvent Isomer (296)  (384)  
Et3N/ CH2Cl2 A and B 25% 45% 
Et3N/ CH2Cl2 A 37% 37% 
Et3N/ CH2Cl2 B 23% 30% 
K2CO3/ DMF A and B 39% 0% 
DBU/ CH2Cl2 A and B 49% 0% 
 
Table 4.6: Comparison of yields for vinylogous sulfonamides (296) and (384) under 
reaction conditions at ambient temperature. 
 
Both the acylated diastereomers (384A) and (384B), and the deacylated 
diastereomers (296A) and (296B) were fully characterised. The key 1H-NMR 
and 13C-NMR spectroscopic signals for both isomers and both products are 
summarized in Table 4.7.  
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Signal (296A) cis (296B) trans (384A) cis (384B) trans 
H-4 1.95 – 1.82 (m) 2.00 – 1.79 (m) 1.80 – 1.63 (m)  
1.40 – 1.23 (m) 
1.79 – 1.63 (m) 
1.50 – 1.20 (m) 
H-5 3.73 – 3.68 (m) 3.68 – 3.62 (m) 4.25 – 4.10 (m) 4.22 – 4.15 (m) 
H-6 1.70 – 1.62 (m) 
1.62 – 1.51 (m) 
1.72 – 1.65 (m) 
1.59 – 1.51 (m) 
3.41 (dd) 
2.55 – 2.42 (m) 
2.78 (d) 
2.28 – 2.10 (m) 
H-7 2.92 – 2.80 (m) 
2.45 – 2.31 (m) 
2.68 – 2.52 (m) 3.76 (m)  
2.74 (dt) 
3.96 – 3.86 (m) 
2.73 – 2.55 (m) 
H-9 1.32 (d, J 6.9) 1.32 (d, J 6.9) 1.39 (d, J 7.2) 1.54 (d, J 6.7) 
H-10 3.98 – 3.91 (m) 4.05 – 3.90 (m) 4.03 (m) 4.38 – 4.31 (m) 
H-11 3.11 – 3.01 (m)  
2.92 – 2.80 (m) 
3.12 – 3.02 (m) 
2.88 – 2.75 (m) 
2.10 – 1.95 (m) 
1.80 – 1.63 (m) 
2.10 – 1.95 (m) 
1.79 – 1.63 (m) 
H-15 4.99 (s) 4.98 (s) - - 
H-22 - - 2.34 (s) 2.30 (s) 
C-5 62.5  61.4 55.7  60.3  
C-6 25.7  26.2 38.0  40.7 
C-7 38.2  38.6 35.0  38.6 
C-8 159.7 160.4  170.4 169.5  
C-9 17.5  18.0  27.5  18.5  
C-10 48.3  48.3  62.8  56.6 
C-11 33.8  34.1 25.4  24.7  
C-12 170.7  170.3 174.4  174.5 
C-15 87.4  87.4 104.4  104.9 
C-21 - - 189.9 189.3 
C-22 - - 22.3 21.2  
 
Table 4.7: Comparison of selected NMR spectral data (in CDCl3) for vinylogous 
sulfonamides. (Chemical shifts are reported in ppm. J-values were measured in Hz). 
 
  171
When comparing the two products (296) and (384), the most notable difference 
in the 1H-NMR spectra was the presence of the enamine signal (H-15) at 
4.99 ppm in (296), and the presence of the methyl signal (H-22) at 2.34 ppm in 
(384). The 13C-NMR spectra also differ significantly; C-21 and C-22 occurred at 
189.9 ppm and 22.3 ppm in the acylated product (384) and were absent in the 
deacylated product (296). The alkene signals C-8 and C-15 occurred at 
159.7 ppm and 87.4 ppm in the deacylated product (296), and at 170.4 and 
107.4 ppm in the acylated product (384), illustrating the electron withdrawing 
effect of the conjugation to the acyl group. H-5, H-6 and H-7 were also affected 
by the delocalization of charge in the acylated product (384) and were 
significantly deshielded compared to the deacylated molecule (296). H-11 was 
more deshielded in the deacylated product (296) than the acylated product 
(384). A similar trend was observed  in the 13C-NMR spectra, C-6 and C-10 
were more deshielded in the acylated product (384), while C-11 was more 
deshielded in the deacylated product (296). 
 
When comparing the diastereomers, the spectroscopic signals of greatest 
interest were the signals near the stereogenic centres, viz. C-5, C-6, C-9, and 
C-10. In the deacylated product (296), the spectra for each isomer were 
virtually indistinguishable. In the acylated product (384), the isomers were 
significantly different. For (384A), C-5, C-6, and C-7 occur at 55.7 ppm, 
38.0 ppm, and 35.0 ppm, whereas for (384B), the corresponding signals occur 
at 60.3 ppm, 40.7 ppm and 38.6 ppm, consistently 3 - 4 ppm further downfield. 
C-9 and C-10 show the reverse trend; in (384A) they occur at 27.5 ppm and 
62.8 ppm, respectively, whereas in (384B) they occur at 18.5 ppm and 
56.6 ppm, 6 - 9 ppm further upfield. 
 
The FTIR spectrum for the deacylated product (296) showed a single carbonyl 
group at 1731 cm-1 corresponding to the ester, whereas the acylated product 
(384) showed two carbonyl groups at 1731 cm-1 and 1680 cm-1, confirming the 





4.4.3 Deacetylation reactions154 
In order to maximize the overall yield, the acylated product (384) had to be 
deacetylated and cycled back into the synthesis as (296). We attempted two 
methods for deacetylating (384). The first method involved heating (384) to 
reflux in acetic acid and toluene, and the second method employed heating 
(384) to reflux in neat trifluoroacetic acid. Both methods were successful (see 
Table 4.8). Interestingly, in both methods, the ester did not hydrolyse but 
remained unaffected by the acidic conditions. This was an unexpected but 
extremely useful result, as it meant the product (296) could be cycled straight 
back into the main synthesis without any additional transformations (e.g. 
reducing the carboxylic acid to the corresponding alcohol or esterifying the 
carboxylic acid). 
 
Of the two sets of conditions employed, heating (384) to reflux in neat 
trifluoroacetic acid for thirty minutes proved to be more effective than heating to 
reflux in acetic acid and toluene for fourteen hours. The 1H-NMR spectrum of 
the additional material isolated by column chromatography from these reactions 
indicated that the prolonged heating to reflux led to decomposition of the 
vinylogous sulfonamide, as there were no longer aromatic peaks present in the 
spectra. The by-products were never fully identified. These two procedures 
were modified from the work of Ban and co-workers,154 please refer to the 
literature for the proposed mechanism of the acid-catalysed deacetylation. 
 
Conditions Isomer Yield of (296)  
AcOH, toluene, reflux 14 hr. A and B 45% 
TFA, reflux, 30 min. A 67% 
TFA, reflux, 30 min. B 54% 
 
Table 4.8: Deacetylation of (384), conditions and yields. 
 
4.4.4 Reduction of the ester 
Textbook conditions1, 173 were used to convert the ethyl ester into the 
corresponding alcohol. Ethyl 3-((5E)-2-butyl-5-{[(4-methylphenyl)sulfonyl] 
methylene}pyrrolidinyl) butanoate (296) was dissolved in tetrahydrofuran under 
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a nitrogen atmosphere. Lithium aluminium hydride was then added and the 
reaction mixture was left to stir at ambient temperature for twelve hours (see 
Scheme 4.25). Distilled water was added to quench the reaction and the 
solution was filtered through Celite® to remove residual lithium salts. Purification 
by column chromatography produced the desired product, 3-((5E)-2-butyl-5-
{[(4-methylphenyl)sulfonyl] methylene}pyrrolidinyl)-1-butanol (297), in 92% yield 
as a clear oil. When the reaction was repeated with single diastereomers, the 




Scheme 4.25: Reduction of the ethyl ester (296) to the corresponding alcohol (297). 
Reagents and conditions: i) LiAlH4, THF, RT, 15 hr. 
 
Both diastereomers of the alcohol (297) were fully characterized. Significantly, 
the 1H-NMR spectral signals at 4.09 ppm and 1.15 ppm, and the 13C-NMR 
spectral signals at 60.7 ppm and 14.0 ppm corresponding to the ethyl ester 
were absent from the spectra. The ester carbonyl group was absent from the 
FTIR spectrum, and a characteristic OH stretching vibration was observed in 
the region of 3481 cm-1.  
 
Table 4.9 shows the key signals for isomer (297A) (R,S and S,R) and isomer 
(297B) (R,R and S,S). The 1H-NMR spectra were virtually the same, with slight 
shifts observed in some of the signals. Notably, the signal for H-13 was 
observed at 5.07 ppm for the cis isomer (297A) and at 4.95 ppm for the trans 
isomer (297B). The 13C-NMR spectra showed slight variation in the chemical 
shifts of C-5, C-8, C-9, C-10, and C-11. This was expected as these were the 





    
Signal (297A) / ppm (297B) / ppm 
H-4 2.02 – 1.53 (m) 1.96 – 1.53 (m) 
H-5 3.74 – 3.60 (m) 3.72 – 3.58 (m) 
H-6 2.02 – 1.53 (m) 1.96 – 1.53 (m) 
H-7 3.04 (ddd) 
2.82 (dt) 
3.15 – 3.03 (m) 
2.81 – 2.69 (m) 
H-9 1.31 – 1.16 (m) 1.35 – 1.08 (m) 
H-10 3.74 – 3.60 (m) 3.72 – 3.58 (m) 
H-11 2.02 – 1.53 (m) 1.96 – 1.53 (m) 
H-12 3.74 – 3.60 (m) 3.72 – 3.58 (m) 
H-13 5.07(s) 4.95 (s) 
C-4 27.7 27.7 
C-5 60.3 61.3 
C-6 29.9 29.7 
C-7 33.9 34.0 
C-8 160.4 160.9 
C-9 17.2 18.1 
C-10 48.5 48.1 
C-11 36.6 36.1 
C-12 59.2 59.4 
C-13 86.1 86.2 
 
Table 4.9: Comparison of selected NMR spectral data (in CDCl3) for diastereomers of 
alcohol (297).  
 
4.4.5 Cyclisation reaction139, 230 
The next step was the key step, the ring closure to form the bicyclic skeleton. 
As illustrated in the attempted total synthesis of (−)-indolizidine 209D, this 
reaction makes use of the vinylogous sulfonamide’s nucleophilicity to facilitate 
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intramolecular ring closure. The initial investigations into this reaction were 
performed on the diastereomeric mixture of the alcohol (297). The alcohol (297) 
was heated at reflux in toluene together with triphenylphosphine, iodine, and 
imidazole. Once the intermediate iodide had formed, the vinylogous 




Scheme 4.26: Formation of the bicyclic skeleton facilitated by the vinylogous 
sulfonamide. Reagent and conditions: i) PPh3, imidazole, I2, toluene, reflux, 3 hr. 
 
The first attempt at this reaction yielded starting material, but the subsequent 
attempt, using completely dry and inert conditions, yielded the diastereomeric 
mixture of the bicyclic product, 3-butyl-5-methyl-8-[(4-methylphenyl)sulfonyl]-
1,2,3,5,6,7-hexahydroindolizine (298), in 85% yield as a sticky, pale-pink oil. 
These conditions were repeated using single diastereomers and for the cis 
isomer (R,S and S,R)  a yield of 78% was obtained whereas the trans isomer 
(R,R and S,S) yielded a less satisfactory 67%. The ring closure for the trans 
isomer (R,R and S,S)  was repeated and the yield did not improve. The reason 
for the lower yield may be owing to steric interference of the butyl group. 
 
Following slow evaporation from ethyl acetate and hexane, several tiny pink 
crystals of each of the diastereomers were isolated. These crystals were 
successfully characterized by X-ray diffraction and the crystal structure of each 
diastereomer was obtained.  This was an extremely exciting result, as it finally 
allowed for conclusive assignment of the relative stereochemistry of the two 
diastereomers. Diastereomer A, the minor diastereomer, showed a cis 
arrangement (R,S and S,R) of the butyl and methyl groups (see Figure 4.18), 
whereas isomer B, the major diastereomer, showed a trans arrangement (R,R 





Figure 4.18: The molecular structure of the cis isomer (R,S and S,R) of vinylogous 









Figure 4.19: The molecular structure of the trans isomer (R,R and S,S) of vinylogous 
sulfonamide (298B). Displacement ellipsoids are drawn at the 50% probability level.   
 
In addition to X-ray diffraction, both isomers were fully characterized. Loss of 
the hydroxy-group was evident from the FTIR spectrum, which lacked the O-H 
stretching vibration, as well as from HRMS, which produced parent ions of 
347.1917 and 347.1921 for the cis isomer (298A) and trans isomer (298B), 
respectively. Both of these values agree well with the calculated value of 
347.1919. 1H-NMR spectroscopy showed the disappearance of the H-8 signal 
at 5 ppm, and both  the 1H-NMR and 13C-NMR spectra showed significant 
changes in their chemical shifts for the signals corresponding to H-7, H-6, H-5, 
and C-8, C-7, C-6, and C-5, respectively.  
 
Table 4.10 lists the key 1H-NMR and 13C-NMR spectroscopy signals for both 
isomers (298A) and (298B), and compares them with the bicyclic vinylogous 
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sulfonamide (282) formed during the attempted total synthesis of 
(−)-indolizidine 209D. As expected, the signals which displayed the greatest 
variation were the ones corresponding to C-3 and C-5, the substitution points. 
For the cis isomer (298A) they occur at 48.0 ppm and 64.6 ppm, respectively. 
For the trans isomer (298B) they occur at 45.5 ppm and 60.1 ppm, respectively, 
and for the monosubstituted (282) they occur at 51.2 ppm and 53.9 ppm, 
respectively. The n-butyl chain donated electron density, shifting the C-3 signal 
for (298A) and (298B) upfield relative to (282), whereas the effect of the hexyl 
group of (282) shifts C-5 further upfield relative to C-5 for (298A) and (298B), 
which have a methyl group attached to C-5. C-8 and C-8a were virtually 
identical for all three compounds. Notably, the signal corresponding to C-1 
occurred at 32.1 ppm in (282), but at 18.5 ppm and 17.1 ppm in (298A) and 
(298B).  For the 1H-NMR spectra, most of the signals were overlapping 
multiplets in the region of 3.50 – 1.00 ppm. Diastereotopic splitting was clearly 
observed in (298A) for H-1, H-2, H-6 and H-7, whereas in (298B) only H-2 and 
H-10 showed clear diastereotopic splitting. Compound (282) did not show clear 
diastereotopic splitting, however, it may have been obscured by the overlapping 
of signals.  
 
The bicyclic vinylogous sulfonamide isomers (298A) and (298B), had 
significantly different melting points; the cis isomer (298A) had a melting point 














Signal (298A) / ppm (298B) / ppm (282) / ppm 
H-1 2.47 – 2.40 (m) 
2.30 – 2.19 (m) 
2.36 – 2.29 (m) 3.13 (t, J 7.2) 
H-2 2.11 – 2.00 (m) 
1.68 – 1.50 (m) 
2.04 – 1.96 (m) 
1.72 – 1.53 (m) 
1.91(quin., J 7.2) 
H-3 3.50 – 3.42 (m) 3.50 – 3.45 (m) 3.19 (t, J 7.1) 
H-5 3.43 – 3.34 (m) 3.50 – 3.45 (m) 3.49 (quin., J 6.9) 
H-6 1.85 – 1.75 (m) 
1.47 – 1.18 (m) 
1.72 – 1.53 (m) 1.80 – 1.51 (m) 
H-7 3.27 – 3.17 (m) 
2.93 (dt, 17.4, 8.1) 
3.11 – 3.01 (m) 1.80 – 1.51 (m) 
H-9 1.06 (d, J 6.6) 1.05 (d, J 6.6) 1.38 – 1.25 (m) 
H-10 1.15 – 1.08 (m) 1.72 – 1.53 (m) 
1.37 – 1.21 (m) 
- 
C-1 18.5 17.1  32.1 
C-2 27.5 27.3  29.3 
C-3 48.0 45.5  51.2 
C-5 64.6 60.1  53.9 
C-6 34.7  31.7 31.4 
C-7 29.7 30.1 31.7 
C-8 91.8  91.9 92.4 
C-8a 154.8  155.2 155.1 
C-9 21.2 21.4  25.6 
C10 27.0 26.9  - 
 
Table 4.10: Comparison of selected NMR spectral data (in CDCl3) for bicyclic 





4.5  Completion of the synthesis 
 
Now that the bicyclic skeleton was formed, all that remained to do was the 
defunctionalization of the vinylogous sulfonamide. During the attempted total 
synthesis of (−)-indolizidine 209D, this was as far as we were able to proceed 
owing to lack of material. This meant the next two steps were optimized and 
investigated specifically for monomorine I and its isomers. 
 
4.5.1 Reduction of the vinylogous sulfonamide  
The next step, the reduction of the vinylogous sulfonamide (see Scheme 4.27), 
offered us a second opportunity for stereocontrol, as the bicyclic structure 
constrains free rotation. Using a platinum-catalysed reduction, we assumed that 




Scheme 4.27: Reduction of the vinylogous sulfonamide (298) to give indolizidine (299). 
Reagents and conditions: i) H2 (7 atm.), PtO2, MeOH, 12 hr. 
 
The reduction was performed using platinum dioxide (Adams’ catalyst) together 
with 3-butyl-5-methyl-8-[(4-methylphenyl)sulfonyl]-1,2,3,5,6,7-hexahydro 
indolizine (298) in acetic acid under seven atmospheres of hydrogen 
pressure.31  When the reaction was performed using the diastereomeric 
mixture, a yield of 84% for 3-butyl-5-methyl-8-[(4-methylphenyl)sulfonyl] 
octahydroindolizine (299) was obtained.  When the reaction was repeated with 
pure cis isomer (298A), a yield of 88% for (299A) was obtained, and when it 
was repeated with pure trans isomer (298B), a 72% yield of (299B) was 
obtained (see Figure 4.20). The orientation of H-8a was not explicitly proved, 




The second method we attempted for the reduction of the double bond was 
using sodium borohydride in methanol at ambient temperature for four hours.171 
Following extraction and purification by column chromatography, the desired 





Figure 4.20: Dominant relative stereochemistry of all four stereogenic centres for both 
isomers. 
 
Both isomers were fully characterized. The key spectroscopic changes 
compared to the preceding compounds were the appearance of H-8 and H-8a 
in the 1H-NMR spectra, and the significant shift of C-8a and C-8 from 
154.8 ppm and 91.8 ppm to 67.1 ppm and 59.5 ppm in the cis isomer (299A) 
and from 155.2 ppm and 91.9 ppm to 62.9 ppm and 47.0 ppm in the trans 
isomer (299B). The two isomers had virtually identical 1H-NMR spectra, both 
with overlapping multiplets in the region of 0.80 – 3.50 ppm (see Table 4.11).  
 
For the cis isomer, (299A), H-8 was visible as a triplet, coupling to H-7 only, 
whereas in the trans isomer, (299B), H-8 appeared as a multiplet, coupling to 
H-7 and H-8a. H-8a appeared at 2.58 – 2.48 ppm for the cis isomer (299A) and 
at 3.49 – 3.02 ppm for the trans isomer (299B). The 13C-NMR spectra for both 
isomers were largely the same, with the major differences occurring at the four 
stereogenic centres, C-3, C-5, C-8a, and C-8. For the cis isomer (299A), these 
signals were at 63.4 ppm, 61.6 ppm, 59.5 ppm, and 67.1 ppm, whereas for the 
trans isomer (299B), these signals were at 60.2 ppm, 56.5 ppm, 47.0 ppm, and 
62.9 ppm, respectively, with all four of the signals significantly upfield of the cis 
counterpart, indicative of the different stereoelectronics in each system.   
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Signal  (299A) / ppm  (299B) / ppm 
H-1 1.82 – 1.15 (m) 1.52 – 1.02 (m) 
H-2 1.82 – 1.15 (m) 1.52 – 1.02 (m) 
H-3 2.62 (m) 2.67 – 2.54 (m) 
H-5 3.33 (m) 3.49 – 3.02 (m) 
H-6 2.25 – 2.13 (m) 1.80 – 1.65 (m) 
H-7 2.25 – 2.13 (m) 2.07 – 1.98 (m) 
H-8 3.03 (t, J 7.5) 3.49 – 3.02 (m) 
H-8a 2.58 – 2.48 (m) 3.49 – 3.02 (m) 
H-9 0.91 (d, J 7.5) 0.99 – 0.81 (m) 
H-10 1.82 – 1.15 (m) 1.52 – 1.02 (m) 
C-1 29.0 28.5 
C-2 28.7 28.0  
C-3 63.4  60.2  
C-5 61.6  56.5 
C-6 39.2  33.0  
C-7 30.5  29.7  
C-8 59.5  47.0  
C-8a 67.1  62.9  
C-9 21.6  20.7 
C-10 27.7  27.8  
 
Table 4.11: Comparison of selected NMR spectral data (in CDCl3) for indolizidine 
isomers. (J-values were measured in Hz). 
 
During this stereoselective hydrogenation, the two unconstrained groups were 
the butyl chain, and the tolyl group. In an attempt to understand the 
stereoselective reduction of (298A) and (298B), the crystal structures of both 
were imported into Hyperchem,228 and various torsion angles involving the butyl 
chain were manually altered, such that the butyl chain was positioned above 
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the plane of the ring (see Figure 4.21 and 4.22). These conformations illustrate 
how the butyl group may have hindered the reduction of the double bond from 
the top face of the ring in both diastereomers. 
 
For (298A), the cis isomer, the modelled conformer (see Figure 4.21) clearly 
showed the top face of the molecule was sterically hindered by both the methyl 
and the butyl group. In the conformation shown, the tolyl group also contributes 
to blocking the top face. However, free rotation of the tolyl group around the 




Figure 4.21: Possible conformation for (298A), indicating the sterically hindered top 
face from two different views. 
 
Using Hyperchem,228 the following model was obtained for (298B), the trans 
isomer (see Figure 4.22), and in this case, the stereocontrol was not quite as 
complete. In the conformation shown, the methyl group and the butyl group 
blocked opposite faces, and the tolyl group, with free rotation, could block either 
face. The butyl chain, with more degrees of freedom than the methyl, appears 
to play a greater role in steric hindrance and blocked the top face, while the 
methyl group hardly blocked the bottom face at all. The overall stereochemical 




Figure 4.22: Possible conformation for (298B), indicating the sterically hindered top 
face from two different views. 
 
4.5.2 Desulfonylation reaction 
4.5.2.1 Methods of desulfonylation  
Sulfones have been extensively used in natural product synthesis and the 
sulfone group is usually cleaved off after it has performed its function. Standard 
literature desulfonylation include reduction desulfonylation, alkylative 
desulfonylation and oxidative desulfonylation.231 The method we were most 
interested in was reductive desulfonylation. One of the methods in the literature 
used magnesium dissolved in ethanol or methanol. This method was devised 
by Carpino and co-workers232 and used by Chakraborty and Simpkins who 





Scheme 4.28: Reductive desulfonylation by Chakraborty and Simpkins.233 Reagents 
and conditions: i) Mg, EtOH, 2-5 hr. 
 
For the final step in the total synthesis of (−)-indolizidine 209D, Yillah31 used  
the desulfonylation conditions of Trost,234 or Carretero and Dominguez;235 
which made use of a sodium amalgam reduction. This reaction was carried out 
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Scheme 4.29: Reductive desulfonylation by Yillah and Michael.31 Reagents and 
conditions: i) Na/Hg (6%), Na2HPO4,, 3 – 15 hr. 
 
The preferred desulfonylation method of Thomas Back’s research group56, 236 
was under Birch reduction condition, using sodium in liquid ammonia. As 
illustrated in his total synthesis of monomorine I, this reaction was effective 











[387] [37]  
 
Scheme 4.30: Reductive desulfonylation by Back and Nakajima.56 Reagents and 
conditions: i) Na, NH3 liq. 
 
Craig and Berry67 made use of a sodium naphthalenide solution to reductively 
cleave the sulfone group.67 These harsh conditions cleave the sulfone group 
within minutes at ambient temperature to give the indolizidine in moderate yield 






Scheme 4.31: Reductive desulfonylation by Craig and Berry.67 Reagents and 
conditions: i) Na+C10H8- (3.5 eq.), THF, RT, 5 min. 
 
4.5.2.2 Desulfonylation  
The final step in the synthesis, reductive desulfonylation (see Scheme 4.32), 
took several attempts and different methods before it was successfully 
achieved. Initially, the method reported by Yillah31, 234 was attempted. A sodium 
amalgam was freshly prepared and added to a mixture of 3-butyl-5-methyl-8-
[(4-methylphenyl)sulfonyl]octahydroindolizine (299) and sodium hydrogen 
phosphate in methanol. This method was attempted several times and 
repeatedly starting material was recovered, even when the temperature and 




Scheme 4.32: Desulfonylation of (299A) to give monomorine I (27). Reagents and 
conditions: i) Na/Hg (6%), Na2HPO4,, 3 – 15 hr.; ii) Mg, EtOH, 2 – 5 hr.; iii) Na+C10H8- 
(15 eq.), THF, RT, 15 min. 
  
The second method we attempted was that of Chakraborty and Simpkins,233 
reacting (299) with magnesium turnings in methanol at 50°C for three hours. 
When the reaction had gone to completion, as monitored by TLC, the crude 
product was purified by column chromatography and a diastereomeric mixture 
of monomorine I, 5-epi-monomorine I, and indolizidine 195B was isolated in a 
combined yield of 60%. Owing to the limited amount of material isolated, the 
diastereomers could not be separated, and isomers were characterized as a 
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mixture by 13C-NMR spectroscopy only (the 1H-NMR spectrum had completely 
overlapping signals between 0.80 ppm and 3.50 ppm and the individual isomers 
could not be distinguished). Fortunately, 13C-NMR spectrum has been reported 
in the literature for all the isomers of monomorine I, thus making the 
indentification of the various alternative isomers possible. 
 
The third method we attempted was that of Craig and Berry,67 using sodium 
naphthalenide in tetrahydrofuran for reductive desulfonylation. Following the 
exact conditions of Craig and Berry, a pure sample of the cis isomer of 3-butyl-
5-methyl-8-[(4-methylphenyl)sulfonyl]octahydroindolizine (299A) was mixed 
with three and a half equivalents of sodium naphthalenide for five minutes 
before the reaction was quenched and the product was purified by column 
chromatography. Racemic monomorine I was isolated as a pale oil in 23% yield 
based on consumed starting material. The reaction was repeated with the ratio 
of sodium naphthalenide to (299A) increased to 15:1, and the reaction time 
increased to fifteen minutes. After purification by column chromatography on 
silica gel through a Pasteur pipette, monomorine I was isolated in 73% yield. 
 
The same method was used with the trans isomer (299B), using a 1:8 ratio of 
3-butyl-5-methyl-8-[(4-methylphenyl)sulfonyl]octahydroindolizine (299B) to 
sodium naphthalenide, and reacting at ambient temperature for fifteen minutes. 
Following purification by column chromatography through a Pasteur pipette, the 
5-epi-monomorine I was isolated in 71% yield as a pale oil that discoloured to 
turquoise over time. The final mixed fraction collected from the column showed 
some starting material, 5-epi-monomorine I and evidence of indolizidine 195B in 
the 13C-NMR spectrum, however, the quantities were insufficient for full 
characterization. The presence of indolizidine 195B together with 5-epi-
monomorine I was in agreement with the model proposed in Figure 4.19, which 
suggested the stereocontrol in the reduction of the double bond was not as 
complete as with the cis isomer, as the methyl and butyl groups blocked 
opposite faces of the molecule.  
 
The spectroscopic characterization of both monomorine I (see Figure 4.23) 
corresponded well to the literature values.93, 100, 103 Table 4.12 tabulates the 
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spectroscopic data we obtained for racemic monomorine I in comparison to 
those reported by Artis,103 Royer93 and Sonnet.100 Our spectral data were 
virtually indistinguishable to those obtained by Artis et al.103 and differred by at 
most 0.1 ppm from those obtained by Royer et al.93 The spectral data obtained 
by Sonnet et al.100 differred from ours by up to 1.1 ppm, viz. the signal 
corresponding to C-3, reported at 61.8 ppm by Sonnet in contrast to the 
62.90 ppm we observed. However, Sonnet’s data were the oldest in the 
literature (1975) and were obtained on a less sensitive instrument. 
 
 
Figure 4.23: The 13C-NMR spectrum (in CDCl3) that we obtained for monomorine I. 
 
Owing to the volatility of the molecule, high resolution mass spectrometry, 
under standard EI conditions, produced no parent ion; however, the milder 
method of chemical ionisation (APCI) gave a low resolution parent ion at 
195.37, which compares reasonably with the calculated value of 195.1987. 
FTIR spectroscopy showed the presence of a Bohlmann band237 at 2860 cm-1, 






Signal (27) Artis et al.103 Royer et al.93 Sonnet et al.100 
C-1 30.91 30.90 31.1 31.8 
C-2 29.76 29.76 29.8 29.7 
C-3 62.90 62.91 63.0 61.8 
C-5 60.26 60.27 60.3 59.7 
C-6 35.84 35.83 36.1 36.4 
C-7 24.91 24.90 25.1 25.3 
C-8 30.34 30.33 30.5 30.9 
C-8a 67.17 67.16 67.3 67.6 
CH3 22.86 22.90 22.9 22.9 
CH2 39.73 39.73 39.8 39.8 
CH2 29.40 29.42 29.4 28.7 
CH2 22.90 22.90 23.0 23.2 
CH3 14.16 14.17 14.2 14.3 
 
Table 4.12: Comparison of spectroscopic data (in CDCl3) for monomorine I (27) with 
literature data. (All chemical shifts were measured in ppm). 
 
Table 4.13 displays the spectroscopic data we obtained for 5-epi-monomorine I  
(see Figure 4.24) compared to those obtained by Artis et al.,103 and by Sonnet 
et al.100  Our spectral data were in close agreement with those obtained by 
Artis,103 differing by up to 0.16 ppm. The spectral data obtained by Sonnet et 
al.100 again had one signal that differred by 0.90 ppm, the signal for C-6, 














Signal (28) Artis et al.103 Sonnet et al.100 
C-1 32.34 32.44 33.2 
C-2 31.46 31.58 32.0 
C-3 55.49 55.39 55.4 
C-5 47.38 47.33 47.2 
C-6 32.21 32.37 33.1 
C-7 19.26 19.31 19.8 
C-8 29.12 29.25 30.1 
C-8a 59.21 59.13 58.7 
CH3 7.60 7.53 7.4 
CH2 28.82 28.80 28.44 
CH2 28.12 28.19 28.36 
CH2 23.08 23.10 23.5 
CH3 14.09 14.09 14.3 
 
Table 4.13: Comparison of spectroscopic data (in CDCl3) for 5-epi-monomorine I (28) 
with literature data. (All chemical shifts were measured in ppm). 
 
 
Despite the volatility of the molecule, high resolution mass spectrometry 
produced a parent ion at 195.1976 which compares well with the calculated 
value of 195.1987. FTIR spectroscopy for 5-epi-monomorine I also had a 
Bohlmann band237 at 2859 cm-1, as expected, indicating at least one hydrogen 









Figure 4.24: The 13C-NMR spectrum (CDCl3) that we obtained for 5-epi-monomorine I. 
 
Table 4.14 displays the spectroscopic data we obtained for indolizidine 195B 
compared to those obtained by Artis et al.,103 Takahata et al.84 and by Sonnet et 
al.100 The only spectral evidence of indolizidine 195B (26) was obtained in a 
mixed sample of monomorine I, 5-epi-monomorine I and indolizidine 195B. The 
13C-NMR spectrum was carefully examined, and by comparison to the literature 
we were able to discern the presence of all three diastereomers. We never 
succeeded in characterizing a pure sample of indolizidine 195B. Our spectral 
data were in close agreement with those obtained by Artis,103 differing by up to 
0.25 ppm. The spectral data obtained by Sonnet et al.100 had one signal that 
differred significantly from those obtained by Artis et al.,103 Takahata et al.84 and 
by us; the value Sonnet et al.100 obtained for C-3 was 56.6 ppm, which differred 
from ours by 2.3 ppm. The other signals obtained by Sonnet et al.100 agreed 




     
Signal (26) Artis et al.103 Takahata et al.84 Sonnet et al.100 
C-1 32.39 32.39 32.28 33.0 
C-2 26.33 26.32 26.32 26.8 
C-3 58.92 58.80 58.92 56.6 
C-5 51.91 52.00 52.09 51.8 
C-6 34.58 34.52 34.44 35.3 
C-7 24.73 24.72 24.71 24.9 
C-8 30.05 30.02 29.98 30.6 
C-8a 58.71 58.96 59.00 58.9 
CH3 20.46 20.45 20.39 20.9 
CH2 24.84 24.89 24.97 25.2 
CH2 29.27 29.18 29.14 29.6 
CH2 23.11 23.03 23.01 23.3 
CH3 14.19 14.24 14.20 14.3 
 
Table 4.14: Comparison of spectroscopic data (in CDCl3) for indolizidine 195B (26) with 
literature data. (All chemical shifts were measured in ppm). 
 
Thus the total synthesis of racemic monomorine I and 5-epi-monomorine I was 
successfully completed using new methodology involving a vinylogous 
sulfonamide-assisted cyclisation. Key to this synthesis were the two steps 
which contain a high degree of stereocontrol, the reduction of the exocyclic 
alkene, and the reduction of the vinylogous sulfonamide. 
 
4.6 Alternative approach via monobenzylated intermediates 
 
When the debenzylation reaction of the chiral amine (see Section 4.2.3) ceased 
to remove both benzyl groups, we accumulated a fair amount of the 
monodebenzylated amine (357). Owing partly to the need to circumvent the 
failing debenzylation reaction and partly to the fortuitous reaction described in 
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Section 4.6.1, we investigated a side-route to enantiopure monomorine I and its 
isomers, making using of monobenzylated intermediates. 
 
4.6.1  Condensation reaction 
Owing to the volatility of the free amine (291) subsequent to debenzylation, the 
amine was usually used directly in the condensation reaction without further 
purification. During the condensation reaction, a partially debenzylated amine 
(357) was accidentally reacted with the ketoester (292) and a novel product 
was isolated in 47% yield over the two steps (388) (see Scheme 4.33). Upon 
closer examination it became apparent that a retro-Michael addition had 
occurred, with the loss of ethyl crotonate (see Scheme 4.34) and the 
condensation reaction had taken place between (R)-α-methylbenzylamine and 



















Scheme 4.33: Condensation reaction between (357) and (292). Reagents and 
conditions: i) AcOH, toluene, reflux, 72 hr. 
 
Although this benzylated lactam (388) was not our intended product, it contains 
striking similarities to the desired lactam (293), and provided that the benzyl 
group could be removed at a later stage this could be an alternative route for 
the synthesis of indolizidine alkaloids.  
 
In order to prove the hypothesized retro-Michael addition, we condensed the 
ketoester (292) directly with (R)-α-methylbenzylamine by heating to reflux in 
toluene and acetic acid for seventy-two hours. Following purification, (R,E)-5-
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butylidene-1-(1-phenylethyl)pyrrolidin-2-one (388) was isolated in quantitative 




Scheme 4.34: Proposed mechanism for the acid catalyzed retro-Michael addition. 
Reagents and conditions: AcOH, toluene, reflux, 72 hr. 
 
The product (388) was optically active, with an optical rotation of [α]D20 +43.1 
(c 1.30, CH2Cl2). It was characterized by 1H-NMR and 13C-NMR spectroscopy 
and, analogous to the lactam (293), it was isolated exclusively as the E-isomer. 
The 1H-NMR and 13C-NMR spectra clearly showed the presence of the α-
methyl benzyl group with signals at 7.28 - 7.24 ppm integrating for five 
hydrogens, and a benzylic signal at 5.65 ppm integrating for one hydrogen (see 
Figure 4.25). The signal at 5.65 ppm was split into a quartet with a J value of 
7.2 Hz, coupling to a doublet at 1.71 ppm which integrated for three hydrogens. 


















Figure 4.25: Numbering of lactam (388) for assignment of spectroscopic data. 
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The 13C-NMR spectrum showed the enamine carbons at 136.6 ppm and 
104.0 ppm (C-5 and C-4) as well as the lactam carbonyl (C-8) at 175.7 ppm. 
Signals corresponding to the propyl chain and the benzyl group were also 
present, as were C-6 and C-7. FTIR spectroscopy confirmed the presence of 
the lactam with a stretching vibration at 1666 cm-1, and low resolution mass 
spectroscopy showed a fragmentation pattern consistent with the assigned 
structure. High resolution mass spectrometry was not performed as the parent 
ion at 243 coincided with the reference peak used during the experimentation. 
 
4.6.2 Stereoselective reduction  
The next step was the stereoselective reduction of the exocyclic alkene (see 
Scheme 4.35). This reduction was analogous to the stereoselective reduction of 
lactam (293), but instead of the ethyl ester group, there was now a bulkier 
benzyl group. According to the proposed stereocontrol, the carbonyl of the ester 
could coordinate to the titanium tetrachloride (see Figure 4.14 and Figure 4.15), 
hence restricting free rotation and creating a face bias. However, the benzyl 
group of (388) does not coordinate to titanium and hence the selectivity should 




Scheme 4.35: Diastereoselective reduction of (388) to form lactam (389). Reagents 
and conditions: i) Various conditions (see Table 4.15). 
 
Three different reducing conditions were employed. The first was a palladium-
catalysed reduction in the presence of acetic acid and hydrogen under 
pressure, the second was with titanium tetrachloride and triethylsilane, and the 
third made use of titanium tetrachloride and the bulky hydrogen source, 
triphenylsilane (see Table 4.15). Interestingly, the greatest stereoselectivity was 
observed for the palladium-catalysed reduction, with a ratio of 7:1 for the 
diastereomers. The triethylsilane reduction was moderately stereoselective, 
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with a ratio of 3:1, and the triphenylsilane reduction was not selective at all, 
giving a 1:1 ratio of the isomers. This trend was exactly the opposite of what 
was observed with the reduction of lactam (293) (refer to Table 4.3), which 
supported the theory that the titanium must have coordinated to the ester 
carbonyl in order to facilitate the steric hindrance.  
 
Catalyst H-Source Ratio (A:B)  Yield 
Pd-C 10%  H2 7:1 89% 
TiCl4  Et3SiH 3:1 68% 
TiCl4  Ph3SiH 1:1 100% 
 
Table 4.15: Diastereoselective reductions of (388). a) 10% (w/w) Pd-C 10%, H2 
(7 atm.), AcOH, RT, 72 hr.; b) Lewis acid, Et3SiH, CH2Cl2, -90°C, 2 hr., increased to 
RT, 72 hr.; c) Lewis acid, Ph3SiH, CH2Cl2, -90°C, 2 hr. increased to RT, 72 hr. 
 
The outcome of the palladium-catalysed hydrogenation was slightly harder to 
explain. With lactam (293) the selectivity was 2:3, favouring the trans isomer 
(R,R or S,S). With lactam (388) the selectivity was 7:1, but as the benzyl group 
could freely rotate, there should not have been more steric hindrance on one 
face than the other. Unfortunately, owing to the nature of the lactam we were 
unable to form salts or grow crystals, and as a result the absolute 
stereochemistry of the major isomer remains unknown. Not knowing which 
diastereomer was favoured made it difficult to rationalize or model a scenario 
that could explain the observed outcome. The one big difference between the 
palladium-catalysed reduction of (293) and of (388) was the solvent; compound 
(388) was reduced in the presence of acetic acid rather than absolute ethanol. 
The acid may have encouraged imine formation and altered the puckering of 
the lactam ring. Alternatively, the acid may have stabilized different 
conformations of (388) which had greater steric hindrance than the 
conformation found in absolute ethanol. 
 
At this stage in the synthesis the diastereomers (389A) and (389B) were not 
separable, however we did successfully separate them at a later stage, and by 
hydrolysis back to the lactam, we were able to characterize each isomer 
individually. Both of them showed optical activity, isomer A (389A), the major 
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isomer, had an optical rotation of [α]D20 +15.7 (c 1.15, CH2Cl2), while isomer B 
(389B), the minor isomer, had a high optical rotation value of [α]D20 +131.6 
(c 0.98, CH2Cl2). 
 
In contrast to the preceding compound (388), the alkene signal at 4.39 ppm 
was no longer present and a new multiplet corresponding to H-5 was seen at 
3.73-3.67 ppm for isomer A (389A) and at 3.26-3.18 ppm for isomer B (389B) 
(see Figure 4.26). The signal corresponding to H-4 shifted upfield to the 
aliphatic region while the signals for H-6 and H-7 showed diastereotopic 
splitting. The 13C-NMR spectra for both isomers showed the absence of the 
enamine carbons and C-5 and C-4 were observed at 56.9 ppm and 33.9 ppm 
for isomer A (389A) and at 57.2 ppm and 34.7 ppm for isomer B (389B). FTIR 
spectroscopy indicated the presence of a lactam carbonyl at 1681 cm-1 and 
1674 cm-1 for (389A) and (389B) respectively, and HRMS produced a 


















Figure 4.26: Numbering of lactam (389) for assignment of spectroscopic data. 
 
4.6.3 Thionation reaction and separation of diastereomers  
Following an analogous pattern to the monomorine I synthesis, thionation of 
lactam (389) should allow separation of the diastereomers. Two different sets of 
thionation conditions were attempted. The first thionation used phosphorus 
pentasulfide in dichloromethane stirring at ambient temperature for seventy-two 
hours. Following extraction and purification by column chromatography, the 
desired thiolactam (390) was isolated in 66% yield. During the second 
thionation, the lactam (389) was reacted with hexamethyldisiloxane, 
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phosphorus pentasulfide and dichloromethane at ambient temperature for 
seventy-two hours.188 Following purification, the desired product was isolated in 
quantitative yield. As expected, the isomers could be separated by careful 




Scheme 4.36: Thionation of lactam (389) to form (390). Reagents and conditions: 
i) P2S5, HMDO, CHCl3, RT, 8 hr.  
 
Both isomers had unusually high optical rotation values, with isomer A (390A), 
the minor isomer, having an optical rotation of [α]D20 + 226.7 (c 0.75, CH2Cl2) 
and isomer B (390B), the major isomer, having an optical rotation of 
[α]D20 +383.6 (c 1.22, CH2Cl2).  
 
The key change in the 13C-NMR spectra for the thiolactam isomers in 
comparison to their precursor lactams was the shift of the carbonyl carbon (C-8) 
from 175.2 ppm and 175.0 ppm for (390A) and (390B), respectively, to the 
thiocarbonyl region of 201.8 ppm for both isomers. FTIR spectroscopy also 
showed the C-S stretching vibration at 1447 cm-1 and 1450 cm-1 for (390A) and 
(390B), respectively. When comparing the two isomers, their 1H-NMR spectra 
were fairly different (see Table 4.16). Notably, the quartet corresponding for H-
10 occurs at 6.30 ppm for (390A) and at 6.55 ppm for (390B). H-5 followed the 
same trend, occurring at 3.51 – 3.47 ppm for (390A) and at 4.05 – 3.99 ppm for 
(390B). Both isomers displayed greater diastereotopic splitting for H-6 than for 
H-7, due to the closer proximity to the stereogenic centre at C-5. Looking at the 
differences in their 13C-NMR spectra, (390A) had C-5 at 64.4 ppm and C-10 at 
55.6 ppm, whereas (390B) had C-5 at 63.8 ppm and C-10 at 53.7 ppm.  
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Signal (390A) / ppm (390B) / ppm 
H-4 1.67 – 0.96 (m) 1.05 – 0.77 (m) 
H-5 3.51 – 3.47 (m) 4.05 – 3.99 (m) 
H-6 2.02 – 1.88 (m)  
1.67 – 0.96 (m) 
2.18 – 2.05 (m) 
1.78 – 1.69 (m) 
H-7 3.12 – 3.00 (m) 3.16 – 2.95 (m) 
H-9 1.70 (d, J 7.2) 1.66 (d, J 7.2) 
H-10 6.30 (q, J 7.2) 6.55 (q, J 7.2) 
C-4 33.5  33.2  
C-5 64.4 63.8  
C-6 29.7 27.3  
C-7 43.7  43.6  
C-8 201.8 201.8 
C-9 16.4  15.1  
C-10 55.6  53.7  
 
Table 4.16: Comparison of selected NMR spectral data (in CDCl3) for thiolactam 
isomers (390A) and (390B). (J-values were measured in Hz). 
 
4.6.4 Preparation of the vinylogous sulfonamide  
At this stage none of the monobenzylated intermediates (388), (389), and (390) 
had shown any sign of solidifying to allow us to obtain crystal structures and 
conclusive evidence as to which diastereomer was favoured. We had hoped 
that the formation of the vinylogous sulfonamide would finally allow for strong 
enough intermolecular forces such as additional π-π stacking to aid 
crystallization of at least one of the isomers.  
 
In two separate reactions, each isomer of (R)-5-butyl-1-(1-
phenylethyl)pyrrolidine-2-thione (390) was dissolved in dichloromethane 
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together with sodium iodide and methyl iodide and stirred at ambient 
temperature for forty-eight hours to allow for complete salt formation.188 The 
solvent was removed and a premixed solution of triethylamine, 1-[(4-
methylphenyl)sulfonyl]acetone (279) and dichloromethane were added to the α-
thioiminium salt and left to react for a further ninety-six hours. Following work 
up and purification, the major product from both reactions was (R)-5-butyl-1-(1-
phenylethyl)pyrrolidin-2-one (389), the hydrolysis product of the salt. In the case 
of isomer A, a small amount of (R,E)-2-butyl-1-(1-phenylethyl)-5-
(tosylmethylene)pyrrolidine (391) and (E)-1-(5-butyl-1-((R)-1-phenylethyl) 
pyrrolidin-2-ylidene)-1-tosylpropan-2-one (392) was obtained as a mixture in 
10% yield (see Scheme 4.37). The low yield of the desired product may be due 
to the presence of moisture during the reaction or due to low reactivity of the 
substrate due to the bulkiness of the benzyl group. The product that was 




Scheme 4.37: Formation of vinylogous sulfonamides (391) and (392). Reagents and 
conditions: i) a) MeI, THF, 48 hr.; b) (279), Et3N, CH2Cl2, RT, 96 hr. 
 
Although the isolated product was a mixture of the acylated (392) and 
deacylated (391) vinylogous sulfonamides, use of a COSY spectrum made it 
possible to distinguish key signals from the two compounds and to assign them. 
Of particular importance was the presence of the vinyl signal at 4.89 ppm for 
(391) and the presence of additional methyl singlet at 2.40 ppm for (392).  
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When the NMR spectral data for (391) and (392) were compared with the 
spectral data for the analogous vinylogous sulfonamides (296A) and (384A) 
there were some strong correlations (see Table 4.17). The signals 
corresponding to H-4, H-5 and H-6 were further upfield in (391) and (392) 
compared with the corresponding signals in (296A) and (384A), while H-9 and 
H-10 for (391) and (392) were downfield shifted compared to (296A) and 
(384A) owing to the electron-withdrawing effect of the phenyl substituent. The 
signal corresponding to H-7 in both (391) and (392) matched well in chemical 
shift, but did not show the pronounced diastereotopic splitting of (296A) and 
(384A), respectively. The key signals were almost identical, with H-15 of (391) 
corresponding well with H-15 of (296A) and H-22 of (392) corresponding well 

































































Signal (296A) / ppm (391) / ppm (384A) / ppm (392) / ppm 
H-4  1.95 – 1.82 (m) 1.75 – 1.04 (m) 1.80 – 1.63 (m)  
1.40 – 1.23 (m) 
1.75 – 1.04 (m)
H-5 3.73 – 3.68 (m) 3.40 – 3.32 (m) 4.25 – 4.10 (m) 3.51 (tt, J 8.9, 
2.8) 
H-6 1.70 – 1.62 (m) 
1.62 – 1.51 (m) 
2.07 – 1.81 (m) 3.41 (dd) 
2.55 – 2.42 (m) 
2.07 – 1.81 (m)
H-7 2.92 – 2.80 (m) 
2.45 – 2.31 (m) 
2.89 – 2.78 (m) 3.76 (m)  
2.74  (dt) 
3.16 – 3.01 (m)
H-9 1.32 (d, J 6.9) 1.61 (d, J 7.1) 1.39 (d, J 7.2) 1.70 (d, J 7.2) 
H-10 3.98 – 3.91 (m) 4.72 (q, J 7.1) 4.03 (m) 6.31 (q, J 7.2) 
H-11 3.11 – 3.01 (m)  
2.92 – 2.80 (m) 
- 2.10 – 1.95 (m) 
1.80 – 1.63 (m) 
- 
H-15 4.99 (s) 4.89 (s) - - 
H-22 - - 2.34 (s) 2.40 (s) 
  
Table 4.17: Comparison of selected NMR spectral data (in CDCl3) for vinylogous 
sulfonamides. (J-values were measured in Hz). 
 
4.6.5 Attempted debenzylations  
The synthetic pathway of the monobenzylated species (see Scheme 4.38 for 
the overall summary of the route) would only be useful in the synthesis of 
indolizidine alkaloids if the N-benzyl group could be removed at some stage in 
the synthesis. We attempted to debenzylate at three different stages: from the 
enamide (388), from the lactam (389), and from the thiolactam (390) (see 





Scheme 4.38: Synthetic pathway via monobenzylated intermediates. Reagents and 
conditions: i) AcOH, toluene, reflux, 72 hr.; ii) 50% (w/w) Pd-C 10%, H2 (7 atm.), EtOH, 
RT, 72 hr.; OR TiCl4, Ph3SiH, CH2Cl2, -90°C, 2 hr. increased to RT, 72 hr.; iii) P2S5, 
HMDO, CHCl3, RT, 8 hr.; iv)  a) MeI, THF, 48 hr.; b) (279), Et3N, CH2Cl2, RT, 96 hr. 
 
The first attempted debenzylation reacted the lactam (389) with 50% 
Pearlman’s catalyst in acetic acid under five atmospheres of hydrogen pressure 
for ninety-six hours. Following work-up and purification, only starting material 
was recovered in 85% yield.  
 
The second attempted debenzylation was performed on the thiolactam (390), 
together with Pearlman’s catalyst and acetic acid, under seven atmospheres of 
hydrogen pressure for seventy-two hours. Following work-up and purification, 





























Scheme 4.39: Attempted debenzylation reactions. Reagents and conditions: i) Pd/C 
(10%), NH4HCO2, MeOH, RT, 3 hr.; ii) Pd(OH)2/C, H2 (5 atm.), AcOH, 96 hr.; iii) CAN 
(4 eq.), MeCN-H2O (5:1), RT, 12 hr. 
 
The third attempt was an ammonium formate reduction of the enamide (388), 
using methanol, ammonium formate and 10% palladium on carbon. The 
solution was stirred for three hours and then filtered through Celite® and the 
residue was purified by column chromatography. Again only starting material 
was recovered in 65% yield.  
 
The final two attempted debenzylations used ceric ammonium nitrate, as there 
was literature evidence that debenzylations of lactams was possible.216, 217 The 
standard procedure involved dissolving four equivalents of ceric ammonium 
nitrate in acetonitrile and water (1:5 ratio) and stirring at ambient temperature 
for twelve hours. This procedure was followed using lactam (389) and only 
starting material was recovered in 100% yield. When this procedure was used 
on the thiolactam (390), starting material was recovered in 61% yield, and the 
remaining material hydrolysed to reform lactam (389) in 39% yield. 
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From these five failed attempts, it became apparent that removing the benzyl 
group was not a trivial matter.  Unfortunately, this meant that it was impossible 
to cycle the material back into the synthesis of enantiopure monomorine I and 
5-epi-monomorine I.  Although we strongly suspect that this route favours the 
cis isomer (R,S) rather than the trans isomer (R,R), we were unable to obtain 
crystals of any of the intermediates and it remains speculation. If this route were 
optimised and debenzylation achieved, it could offer greater overall yields of 




The syntheses of (±)-monomorine I and (±)-5-epi-monomorine I were both 
successful. From where the synthetic path diverged, the key intermediates 
(295A) and (295B), respectively, the overall yield for monomorine I was 24% 
and for 5-epi-monomorine I the yield was 12%. The yield for the key 
intermediates (295A) and (295B), from ethyl 4-chloro-4-oxobutyrate, were 
dependent on which diastereoselective reduction was performed. Using the 
palladium-catalysed reduction, (295A) and (295B) were synthesized with an 
overall yield of 34% and 51%, respectively, and using the titanium tetrachloride 
and triphenylsilane reduction (295A) and (295B) were synthesized with an 
overall yield of 12% and 60%, respectively. Hence the utility of vinylogous 
sulfonamides in accessing 3,5-disubstituted indolizidine alkaloids was 
successfully demonstrated. Unfortunately, the synthesis of enantiopure 
monomorine I and 5-epi-monomorine I never reached completion as the 
debenzylation reactions repeatedly failed to give the desired result. Clearly our 
method of introducing the first chiral centre needs to be carefully re-examined 
and a new route determined. Frustratingly, the initial attempts at debenzylating 
the chiral amine were successful and only the latter attempts failed to work. 
After thorough investigation of this problem we can only conclude that the 
commercially available palladium catalysts were not of the same quality as the 




A MODEL STUDY FOR APPLYING RING-CLOSING 
METATHESIS IN THE SYNTHESIS OF INDOLIZIDINE-BASED 
ALKALOIDS 
 
5.1 Introduction  
 
Certain tricyclic alkaloids, for example coccinelline 205B (47), show a structural 
relationship to the 3,5-disubstituted indolizidines, as their tricyclic system 
formally incorporates a 3,5-disubstituted indolizidine within the skeleton (see 
Figure 5.1). The structural relationship between these two classes of alkaloids 
drew our interest as it offered an additional area for extending this PhD project. 
Ring-closing metathesis (RCM) was an obvious choice for forming the third ring 
as our research group has some experience with RCM reactions238, 239 and 














Figure 5.1: Structural relationship between 3,5-disubstituted indolizidine alkaloids 
(shown in blue) and the tricyclic alkaloid (47). 
 
We proposed a model study to explore the use of RCM in an analogous 
condensation reaction to the one we used during the total synthesis of 
monomorine I (see Scheme 4.16). Our proposed model study (see Scheme 
5.1) was designed to determine if the initial reaction conditions in the synthesis 
of monomorine I would be mild enough to allow for the incorporation of alkene 

























Scheme 5.1: Proposed model synthesis for the RCM approach. Reagents and 
conditions:  i) Fe(acac)3, THF, 0°C, 10 min.;  ii) AcOH, toluene, reflux, 72 hr.; iii) TiCl4, 
Ph3SiH, CH2Cl2, -90°C, 2 hr., increased to RT, 72 hr. iv) 5 mol% Grubbs II, toluene. 
  
Holmes and co-workers176 have performed an extensive investigation of RCM 
using β-, γ- and δ-lactams. They have successfully performed the final step in 
our proposed synthesis using the ruthenium alkylidene known as Grubbs I to 




Scheme 5.2: Synthesis of bicyclic molecules from lactams using RCM by Holmes and 
co-workers.176 Reagents and conditions: i) 5 mol% Grubbs I, CH2Cl2. 
 
In order to extend the proposed model study to form the tricyclic system, the 
allylamine would have to contain an ester side chain, which would ultimately be 





Scheme 5.3: Proposed synthesis for the formation of the tricyclic skeleton. Reagents 
and conditions: i) 5 mol% Grubbs II, toluene; ii) Lawesson’s reagent,CH2Cl2, RT, 72 
hr.; iii) a) MeI, THF, 48 hr.; b) (279), Et3N, CH2Cl2, RT, 96 hr.; iv) TFA, reflux, 30 min.; 
v) LiAlH4, THF, RT, 15 hr.; vi) PPh3, imidazole, I2, toluene, reflux, 3 hr. 
 
5.2  Preparation of allylic ketoesters 
 
Our first challenge was to synthesize ketoester (313) which proved to be non-
trivial. The first method we attempted was the proposed Grignard reaction 
between ethyl 4-chloro-4-oxobutyrate (311) and allylmagnesium bromide (312), 
using iron(III) acetoacetate as a catalyst (see Scheme 5.4), which was 
analogous to our first step in the synthesis of monomorine I (see Section 4.2.1). 
Despite maintaining the reaction at –10°C and quenching it with dilute 
hydrochloric acid after a mere seven minutes, double addition of the 
allylmagnesium bromide occurred and ethyl 4-allyl-4-hydroxyhept-6-enoate 


















Scheme 5.4: Grignard reaction between (311) and (312) resulted in the di-addition 
product (394). Reagents and conditions:  i) Fe(acac)3, THF, -10°C, 7 min. 
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The alcohol (394) was characterized by 1H-NMR spectroscopy and showed the 
alkene signals at 5.84 ppm integrating for two hydrogens and at 5.18 – 5.07 
ppm integrating for four hydrogens. The ethyl ester signals were at 4.16 ppm 
and 1.26 ppm and the OH showed as a singlet at 1.56 ppm. The 13C-NMR 
spectrum confirmed the presence of the ester with a signal at 172.1 ppm and 
the alkene with signals at 133.5 ppm and 118.6 ppm, respectively. The carbon 
adjacent to the hydroxyl group was observed at 73.7 ppm. FTIR spectroscopy 
confirmed the presence of the ester and the alcohol functionalities with signals 
at 1716 cm-1 and at 3090 cm-1. 
 
This result confirmed that the increased reactivity of the allylmagnesium 
bromide compared to the butylmagnesium bromide used in the synthesis of 
monomorine I, meant an alternative method had to be employed. A variety of 
methods were attempted, all with limited success: Firstly, we tried substituting 
iron(III) acetoacetate by tributylphosphine, or we used allylzinc bromide instead 
of allylmagnesium bromide,240 or allyl(chloro)dimethylsilane. We also attempted 
going via the less reactive aldehyde instead of the acid chloride. All methods 
resulted either in multiple additions of the allyl group or more complex products 
that were not identified. Finally, we tried using a stannane nucleophile. 
 
Ethyl 4-chloro-4-oxobutyrate (311) was reacted with allyl tri-n-butyl tin (395) 
together with Wilkinson’s catalyst in dichloromethane in a sealed tube at 65°C 
for five hours (see Scheme 5.5). The solvent was removed in vacuo and the 
crude material was purified by column chromatography to give ethyl 4-oxohept-





Scheme 5.5: Organometallic reaction for the formation of allylketoester (313). 
Reagents and conditions:  i) Wilkinson’s cat., CH2Cl2, 65°C, 5 hr. 
 
  209
Ethyl 4-oxohept-6-enoate (313) was characterized by 1H-NMR spectroscopy 
which revealed a terminal alkene at 5.98 – 5.88 ppm integrating for one 
hydrogen and at 5.16 ppm, integrating for two hydrogens. The 13C-NMR 
spectrum showed the ketone carbonyl at 206.4 ppm, the ester carbonyl at 
172.4 ppm and the alkene at 130.2 ppm and 118.7 ppm. 
 
Despite the high toxicity of the allyl tri-n-butyl tin, this was a pleasing result and 
we set about repeating it. The reaction was set up as before, and after five 
hours at 65°C, the reaction was left stirring at ambient temperature for twelve 
hours (see Scheme 5.6). The solvent was removed in vacuo and the crude oil 
was rinsed with acetonitrile and hexane to remove the residual tin. The 
acetonitrile fraction was rinsed a further two times, and the solvent was then 
removed in vacuo. The crude material was purified by column chromatography 
to give ethyl (5E)-4-oxohept-5-enoate (396) in 65% yield as a mixture of 




Scheme 5.6: Organometallic reaction for the formation of allylketoester (396). 
Reagents and conditions:  i) Wilkinson’s cat., CH2Cl2, 65°C, 5 hr., then cooled to RT, 
12 hr. 
 
It was clear from the NMR spectra that the alkene was no longer terminal and 
had shifted to the internal position in conjugation with the carbonyl; in the 1H-
NMR spectrum the alkene signals occurred at 6.90 ppm and 6.16 ppm as a 
doublet of quartets and a doublet, both integrating for only one hydrogen. The 
adjacent methyl group had two signals, a doublet at 1.91 ppm for the trans 
isomer and a doublet at 1.54 ppm for the cis isomer. The 13C-NMR spectrum 
confirmed the presence of both cis and trans isomers, as most of the signals 
were duplicated.  
 
This result was disappointing, as the double bond had clearly shifted to a more 
stable position after over-exposure to Wilkinson’s catalyst, despite the relatively 
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mild conditions. At a later stage we discovered that (313) spontaneously 
isomerizes to (396) after standing at ambient temperature for several days. 
   
5.3  Attempted condensation reactions 
 
More of ethyl 4-oxohept-6-enoate (313) was prepared, being careful not to let it 
react for too long or stand in the presence of Wilkinson’s catalyst. Immediately 
after purification (313) was set up to react with allylamine in toluene and acetic 
acid heated at reflux (see Scheme 5.7). Unfortunately, the conditions were too 
harsh and (313) isomerised to (396) prior to reacting with the amine. The amine 
appeared to react with the Michael acceptor rather than the ketone, and 
although the product of the reaction was not fully characterized, it was clear 
from the spectroscopic results that the ester and the ketone were still present, 



















Scheme 5.7: Attempted condensation reaction with (313) and allylamine. Reagents 
and conditions: i) AcOH, toluene, reflux, 72 hr. 
 
In order to confirm that the problem with the condensation reaction was due to 
the allylketoester (313), and not the allylamine, we attempted a condensation 
reaction between allylamine and ethyl 4-oxooctanoate (292) under our standard 
conditions: toluene and acetic acid heated at reflux for seventy-two hours. The 
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condensation reaction worked perfectly and (5E)-1-allyl-5-butylidenepyrrolidin-




Scheme 5.8: Condensation reaction between ketoester (292) and allylamine. Reagents 
and conditions: i) AcOH, toluene, reflux, 72 hr. 
 
(5E)-1-Allyl-5-butylidenepyrrolidin-2-one (398) was fully characterized and, 
analogous to earlier condensation reactions, (398) was isolated as a single 
geometric isomer (see Figure 5.2). The key 1H-NMR spectral signals include 
the terminal alkene signals, H-10 and H-11 at 5.78 – 5.65 ppm and 5.17 – 
5.12 ppm, respectively, the internal alkene signal, H-4, at 4.66 ppm, and 
H-9 which occurred at 4.09 ppm as a doublet. The 13C-NMR spectrum had one 
carbonyl signal at 175.1 ppm and four alkene signals at 138.7 ppm, 131.8 ppm, 
116.7 ppm and 101.3 ppm. The HRMS produced a parent ion at 179.1325, in 













Figure 5.2: Numbering of lactam (398) for assignment of spectroscopic data. 
 
Inspired by the successful condensation with allylamine, we decided to see if 
bicyclic structures could be formed by RCM using the exocyclic alkene that 
forms during the condensation. (5E)-1-Allyl-5-butylidenepyrrolidin-2-one (398) 
presented us with a poor candidate for RCM, as the ring strain involved in 
forming a four-membered ring would probably interfere with the metathesis. We 
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purchased butenylamine hydrochloride in order to prepare the analogous RCM 
precursor (399), which would be more suitable for RCM as it could form a five-
membered ring.d Butenylamine hydrochloride was thus condensed with 
ketoester (292) under our standard conditions; toluene and acetic acid heated 
at reflux for seventy-two hours (see Scheme 5.9). After purification by column 
chromatography, (5E)-1-but-3-enyl-5-butylidenepyrrolidin-2-one (399) was 
isolated as a yellow oil in 45% yield. The use of the readily available 












Scheme 5.9: Condensation reaction between ketoester (292) and butenylamine. 
Reagents and conditions: i) AcOH, toluene, reflux, 72 hr. 
 
(5E)-1-But-3-enyl-5-butylidenepyrrolidin-2-one (399) was characterized by NMR 
spectroscopy (see Figure 5.3). Again, the key signals in the 1H-NMR spectrum 
were for the internal and the terminal alkenes; H-11 at 5.85 – 5.71 ppm, H-12 at 
5.10 – 5.02 ppm and H-4 at 4.65 ppm. In contrast to (398), there was an 




Figure 5.3: Numbering of lactam (399) for assignment of spectroscopic data. 
                                                 
d Pentenylamine hydrochloride would be a better precursor, as the condensation 
product could undergo RCM to form an indolizidine skeleton. However, it was 
prohibitively expensive for a purely speculative investigation. 
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Table 5.1 compares the three condensation products (389), (399) and (293) 
which had virtually indistinguishable signals for the lactam and butyl side-chain 
(H-3, H-4, H-6, H-7, C-4, C-5, C-6, C-7 and C-8). The nitrogen side chains 




Signal  (398) / ppm  (399) / ppm (293) / ppm 
H-3 1.98 (q, J 7.2) 2.00 (q, J 7.2) 2.00 (q, J 7.3) 
H-4 4.66 (t, J 7.2) 4.65 (t, J 7.2) 4.77 (t, J 7.4) 
H-6 2.74-2.44 (m) 2.60 (t, J 7.2) 2.58 (t, J 8.0) 
H-7 2.74-2.44 (m) 2.50 – 2.44 (m) 2.42 ( t, J 8.0) 
H-9 4.09 (d, J 5.1) 3.53 (t, J 7.2) 4.45 – 4.37 (m) 
H-10 5.78 – 5.65 (m) 2.33 – 2.26 (m) 3.04 (dd, J 7.4, 15.7) 
2.81 (dd, J 7.3, 15.7) 
H-11 5.17 – 5.12 (m) 5.85 – 5.71 (m) - 
C-4 101.3 100.6 101.0 
C-5 138.7 139.0 138.7 
C-6 21.2 21.3 21.6 
C-7 28.7 28.9 29.2 
C-8 175.1 175.4 175.7 
C-9 42.1 39.0 45.2 
C-10 131.8 30.8 37.6 
C-11 116.7 134.9 171.4 
 
Table 5.1: Comparison of NMR spectral data (in CDCl3) for enamides (398), (399) and 





5.4  Ring-closing metathesis reactions 
 
RCM reactions are traditionally catalysed by Grubbs I, 1st generation catalyst or 
by Grubbs II, 2nd generation catalyst (see Figure 5.4). We chose to use Grubbs 





Figure 5.4: Grubbs I and Grubbs II. 
 
The two compounds we had prepared (398) and (399) were not the ideal 
candidates for RCM due to the internal alkene and potential ring strain. In spite 
of this, we decided to attempt RCM, as (398) and (399) were easy to prepare. 
We initially attempted the RCM in toluene at ambient temperature in the 
presence of Grubbs II. TLC indicated that no reaction was occurring and so we 
heated the solution to reflux for twelve hours (see Scheme 5.10). After 
purification by column chromatography none of the desired product (400) was 
obtained. However, a small amount of the starting material had isomerised to 
give us (E)-5-butylidene1-(prop-1-enyl)pyrrolidin-2-one (401) in 11% yield. No 














Scheme 5.10: Attempted RCM reaction on (398). Reagents and conditions: i) 5 mol% 
Grubbs II, toluene, reflux, 12 hr. 
 
(E)-5-Butylidene1-(prop-1-enyl)pyrrolidin-2-one (401) was fully characterized, 
and the spectroscopic data obtained were largely similar to the precursor (398). 
The key difference was the terminal alkene signal at 5.78 – 5.65 ppm and 5.17 
– 5.12 ppm was absent and instead an alkene signal integrating for two 
hydrogens was present at 6.09 – 5.96 ppm. The adjacent methyl group was 
observed as a doublet at 1.81 ppm integrating for three hydrogens. 
Interestingly, only one geometric isomer was observed. The 13C-NMR spectrum 
had four alkene signals at 139.2 ppm, 122.4 ppm, 121.3 ppm and 102.7 ppm.  
 
The butenyl alkene (399) was a marginally better candidate for RCM, as it 
would form a pyrrolizinone (402), with less ring strain than (401). However, 
internal alkenes, which are not as susceptible to RCM as terminal alkenes, 




Scheme 5.11: Attempted RCM reaction of (399). Reagents and conditions: i) 5 mol% 
Grubbs II, toluene, reflux, 12 hr. 
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The reaction was attempted twice; once in toluene at ambient temperature for 
five days, from which only starting material was recovered, and once in a 
toluene solution heated at reflux for twelve hours, which decomposed all the 
starting material. 
 
5.5  Conclusion 
 
These results were extremely disappointing, as clearly the proposed model 
study (see Scheme 5.1) proved to be an invalid synthetic pathway. The work of 
Holmes and co-workers,176 Kim and co-workers242 and Smith III et al.122 has 
already shown the potential of RCM in the synthesis of bicyclic and tricyclic 
nitrogenous compounds, but in order to incorporate this methodology into our 
current synthetic strategy we would need to modify the allylketoester (313) into 
a more stable precursor that can withstand the condensation reaction (see 
Figure 5.5). The simplest modification would be to change the allyl chain into a 
terminal butenyl chain which would be less susceptible to isomerisation. The 
second major consideration would be to revise the synthetic route for accessing 
lactam (315) and hence extend the vinylogous sulfonamide methodology to 
include tricyclic alkaloids. Time did not allow for further investigations into this 

















SUMMARY, FUTURE PROSPECTS, AND CONCLUSION  
 
6.1  Summary 
 
6.1.1 Attempted total synthesis of (−)-indolizidine 209D 
Our first aim at the start of this project was to repeat Yillah’s synthesis of 
(−)-indolizidine 209D,31 while verifying the experimental procedures and fully 
characterizing all intermediates as well as (−)-indolizidine 209D, particularly the 
optical rotation values. We succeeded in completing the first ten steps of the 
total synthesis (see Scheme 6.1), and obtained optical rotation values that 
correspond reasonably in sign and magnitude to the data obtained for the 
homologous synthesis by Gravestock139, 230 (see Table 6.1). Our data do, 




(c ≈ 1.0, CH2Cl2) 
Our data 
(R= C6H13)  
(c ≈ 1.0, CH2Cl2) 
Gravestock230  
(R= C5H11) 
(c ≈ 1.0, EtOH) 
(274) [α]D20 +13.8 [α]D20 +4.5  [α]D25 +5.1 
(275) [α]D20 -23.4 [α]D20 -13.4  [α]D26 -17.7 
(276) [α]D20 -11.3 [α]D20 +10.5  [α]D25 +6.6 
(277) [α]D20 +18.6  [α]D20 +9.5  [α]D24 +12.4 
(278) [α]D20 -9.8 [α]D20 +7.4  [α]D30 +17.2 
(280) [α]D20 -41.5 [α]D20 +11.6  - 
(281) [α]D20 -5.3 [α]D20 -25.0 - 
(282) [α]D20 +31.0 [α]D20 +9.4  - 
 
Table 6.1: Comparison of optical rotation data. ‘R’ refers to the alkyl side chain for 





























































































Scheme 6.1: The attempted total synthesis of (−)-indolizidine 209D. Reagents and 
conditions: i) P(OEt)3, 110°C, 24 hr.; ii) NaH, heptanal, Et2O, RT, 1 hr.; iii) a) (214), 
n-BuLi, THF, -90°C, 30 min.; b) (273), -90°C, 4 hr.; iv) H2 (7 atm.), 5% Pd-C (1.0 eq.), 
AcOH, 48 hr.; v) Cl(CH2)3COCl, NaHCO3, CHCl3, RT, 12 hr.; vi) KOBut, ButOH, RT, 
72 hr.; vii) Lawesson’s reagent,CH2Cl2, RT, 72 hr.; viii) a) MeI, THF, 72 hr.; b) (279), 
Et3N, CH2Cl2, RT, 96 hr.; ix) LiAlH4, THF, RT, 15 hr.; x) PPh3, imidazole, I2, toluene, 
reflux, 6 hr. xi) H2 (7 atm.), PtO2, MeOH;  xii) Na(Hg), Na2HPO4. 
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Our yields for the first ten steps in the synthesis compared favourably with 
those obtained by Yillah, with the exception of steps (iv), (vi) and (viii) (see 
Scheme 6.1). For steps (vi), and (viii), the low yield we observed in both cases 
was due to the formation of by-products that could not be cycled back into the 
synthesis. Step (iv), the debenzylation step, initially worked excellently (99% 
yield), but then it ceased to fully debenzylate (274), with the monodebenzylated 
product frequently isolated. This continuous failure of this reaction prevented us 
from making enough of the amine (275) to complete the synthesis. The problem 
was investigated and several alternative methods were attempted, but to no 
avail.  
 
In conclusion, we successfully completed ten out of the twelve steps in the 
synthesis of (−)-indolizidine 209D (37). We obtained optical rotation data that 
align well with similar molecules, we isolated several novel side-products, and 
most importantly, we gained sufficient experience with the methodology to 
continue with the synthesis of monomorine I and its isomers. 
 
6.1.2  Total synthesis of (±)-monomorine I 
Our second aim was to synthesize racemic monomorine I and/or its 
diastereomers using vinylogous sulfonamides for the key cyclisations. Basically, 
we wanted to extend the methodology used in the attempted synthesis of the 
5-monosubstituted indolizidine 209D (37) to include 3,5-disubstituted 
indolizidines such as monomorine I (27). The alkyl side-chain at the 3-position 
had to be introduced prior to the formation of the lactam ring, hence this 
synthesis only corresponds with the synthesis of indolizidine 209D after the 
formation of the lactam (294). Starting from achiral material, the first four steps 
in the synthesis were the basis for the synthesis of both monomorine I and its’ 
isomer 5-epi-monomorine I (see Scheme 6.2).  
 
Step (iii) was our first opportunity for stereocontrol, and by exploiting the 
functionality present we were able to adjust the stereoselectivity from (2:3) to 
(1:5), in both instances favouring the trans-isomer that was the precursor of 5-
epi-monomorine I. After the thionation reaction (step iv), the key intermediate 
diastereomers (295A) and (295B) were separated by column chromatography. 
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The overall yield for the monomorine I precursor, the cis-isomer (295A), was 


































Scheme 6.2: The synthesis of monomorine I precursor (295A). Reagents and 
conditions: i) n-BuMgCl, Fe(acac)3, THF, 0°C, 10 min.; ii) AcOH, toluene, reflux, 64 hr.; 
iii) 50% (w/w) Pd-C 10%, H2 (7 atm.), EtOH, RT, 72 hr.;  OR TiCl4, Ph3SiH, CH2Cl2, 
-90°C, 2 hr. increased to RT, 72 hr.; iv) Lawesson’s reagent,CH2Cl2, RT, 72 hr. 
 
Once the diastereomers (295A) and (295B) were separated, the synthesis of 
monomorine I was carried out independently of the 5-epi-monomorine I 
synthesis. Scheme 6.3 shows the total synthesis of racemic monomorine I from 
(295A). In general, all the yields for the cis-isomer were higher than for the 
trans-isomer, and the stereoselective reduction (step v) had greater 
stereocontrol than the equivalent step for the trans-isomer. (±)-Monomorine I 
was isolated as a single isomer, in 24% yield (from 295A). The spectroscopic 
data obtained compared well to the literature. Hence, monomorine I was 
synthesized via a novel ring closure in a reasonable number of steps and with 







































Scheme 6.3: The synthesis of (±)-monomorine I. Reagents and conditions: i) a) MeI, 
THF, 48 hr.; b) (279), Et3N, CH2Cl2, RT, 96 hr.; ii) TFA, reflux, 30 min.; iii) LiAlH4, THF, 
RT, 15 hr.; iv) PPh3, imidazole, I2, toluene, reflux, 3 hr. v) H2 (7 atm.), PtO2, MeOH; 
vi) Na+C10H8- (15 eq.), THF, RT, 15 min. 
 
6.1.3  Total synthesis of (±)-5-epi-monomorine I 
The route we pioneered to lactam (294) provided us with a synthetic pathway to 
both monomorine I and 5-epi-monomorine I (see Scheme 6.2), and to our 
delight, not only could we manipulate the diastereoselectivity, but we could also 
separate the thiolactam isomers by column chromatography. The overall yield, 
from ethyl 4-chloro-4-oxooctanoate, for the trans-isomer (295B) was between 
51-60%, depending on the conditions employed for the diastereoselective step 
(iii) (see Scheme 6.2). Once the diastereomers (295A) and (295B) were 
separated, the synthesis of 5-epi-monomorine I was carried out independently 
(see Scheme 6.4). In general, all the yields for the trans-isomer were lower than 
for the cis-isomer. In some of the steps the reason for the lower yield may be 
due to steric interference of the butyl group. The reduction (step v) had lower 
stereoselectivity than for the cis-isomer, and trace amounts of a third 
diastereomer, indolizidine 195B, were also detected after the final 
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desulfonylation (step vi). (±)-5-epi-Monomorine I was isolated in 12% yield (from 







































Scheme 6.4: The synthesis of (±)-5-epi-monomorine I. Reagents and conditions: 
i) a) MeI, THF, 48 hr.; b) (279), Et3N, CH2Cl2, RT, 96 hr.; ii) TFA, reflux, 30 min.; 
iii) LiAlH4, THF, RT, 15 hr.; iv) PPh3, imidazole, I2, toluene, reflux, 3 hr. v) H2 (7 atm.), 
PtO2, MeOH; vi) Na+C10H8- (8 eq.), THF, RT,15 min. 
 
6.1.4 Attempted enantioselective synthesis 
Our third aim for this project was to incorporate Davies’ methodology158 into our 
strategy, and hence complete the enantioselective synthesis of monomorine I 
and/or its diastereomers. Although the literature precedent was great,158, 180 - 182, 
184 and Davies’ methodology has been used in similar syntheses in the Wits 
laboratories,156 we were unable to achieve this aim. Analogous to the problems 
we experiences with the synthesis of indolizidine 209D, the benzylated amine 
(356) initially underwent complete debenzylation but later attempts at the 
reaction ceased to produce any of the desired amine (291). Instead we isolated 
the monobenzylated species (357) (see Scheme 6.5). After investigating 
several variations of the palladium-catalysed debenzylation, we concluded that 
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Scheme 6.5: Preparation of the enantiopure amine (291). Reagents and conditions; 
 i) a) benzyl[(1R)-1-phenylethyl]amine, n-BuLi, THF, -90°C, 30 min.; b) (350), 2 hr., 
95%; ii) Pd/C, H2 (7 atm), AcOH, 72 hr. 
 
We were able to prepare enough of the amine (291) to attempt the synthesis of 
enantiopure (−)-monomorine I and (−)-5-epi-monomorine I. However, there was 
insufficient material to allow for the separation of the diastereomers (295A) and 
(295B), and as a result no optical rotation values were measured.    
 
6.1.5  Benzylated analogues 
While we were still investigating the debenzylation reaction, we accidentally 
condensed the monobenzylated amine (357) with the keto-ester (292). This led 
us to the fortuitous discovery of the enamide (388) which was remarkably 
similar to the compound we were trying to synthesize (293). We decided to 
explore the same synthetic methodology on the “benzylated analogues” (see 
Scheme 6.6) in the hope that the benzyl group could be removed at a later 
stage, and the material cycled back into the synthesis of the enantiopure 
indolizidines. The condensation reaction using (R)-α-methylbenzylamine rather 
than (357) gave superior yields and provided us with a shorter and more 
convenient method for introducing the chiral centre.  
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Scheme 6.6: The synthesis of monobenzylated analogues. Reagents and conditions: 
i) AcOH, toluene, reflux, 72 hr.; ii) 50% (w/w) Pd-C 10%, H2 (7 atm.), EtOH, RT, 72 hr.;  
OR TiCl4, Ph3SiH, CH2Cl2, -90°C, 2 hr. increased to RT, 72 hr.; iii) P2S5, HMDO, CHCl3, 
RT, 8 hr.; iv)  a) MeI, THF, 48 hr.; b) (279), Et3N, CH2Cl2, RT, 96 hr. 
 
Analogous to the monomorine I synthesis, the reduction at step (ii) was 
diastereoselective, with the highest selectivity being a 1:7 ratio of isomers. The 
thionation step (iii) also allowed separation of the isomers by column 
chromatography. We were only able to attempt step (iv) once, and unfortunately 
most of the material hydrolysed to the lactam (389), due to moisture present in 
the reaction. The product that was recovered was a mixture of (392) and (391) 
in 10% combined yield.   
 
For compounds (388), (389) and (390) we did attempt to remove the benzyl 
group using Pearlman’s catalyst with hydrogen, ammonium formate with 
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palladium on carbon, or ceric ammonium nitrate. No debenzylation was 
observed under any of the conditions we employed.  
 
The synthetic pathway for the monobenzylated analogues warrants further 
investigation as it had a higher degree of diastereoselectivity, higher yields, and 
fewer steps than the original pathway for the synthesis of (−)-monomorine I. 
 
6.1.6  Model study for ring-closing metathesis  
Our final aim for this project was to explore potential ways of accessing 
indolizidine-based tricyclic systems using model systems and ring-closing 
metathesis. We were hoping to extend our methodology to include more 
complex alkaloid systems such as the tricyclic alkaloid 205B, which 
incorporates the 3,5-disubstituted indolizidine skeleton into its structure.  
 
The results we obtained were extremely disappointing. We finally succeeded in 
preparing the allylketoester (313) when the alkene isomerised to the conjugated 
internal position, giving an intermediate that acts as a Michael-acceptor when 
heated with the allylamine. Clearly, the proposed model study (see Scheme 
6.7) proved to be an invalid synthetic pathway. The work of Holmes and co-
workers,176 Kim and co-workers,242 and Smith III et al.122 has already shown the 
potential of RCM in the synthesis of bicyclic and tricyclic nitrogenous 
compounds, but in order to incorporate this methodology into our current 
synthetic strategy, we would need to modify the allylketoester (313) into a more 
stable precursor that can withstand the condensation reaction. The simplest 
modification would be to change the allyl chain into a terminal butenyl chain 
which would not be as susceptible to isomerisation. Time did not allow for 
























Scheme 6.7: Proposed model synthesis for the RCM approach. Reagents and 
conditions:  i) Fe(acac)3, THF, 0°C, 10 min.;  ii) AcOH, toluene, reflux, 72 hr.; iii) TiCl4, 
Ph3SiH, CH2Cl2, -90°C, 2 hr., increased to RT, 72 hr. iv) 5 mol% Grubbs II, toluene. 
 
6.2 Future prospects 
 
6.2.1  A new chiral auxiliary 
The biggest difficulty faced during this project was the introduction of the chiral 
centre using Davies’ methodology, and in order to complete the total synthesis 
of (−)-indolizidine 209D, (−)-monomorine I and (−)-5-epi-monomorine I, it is 
mandatory that this hurdle is overcome.  The next few pages offer alternative 
methods for introducing the amine enantioselectively to the generic alkenoate 
(403), and then removing the chiral auxiliary to give the aminoester (406).  
 
Davies et al.211 have recently developed a novel chiral amine, 
(α-methylbenzyl)allylamine, which extended the scope of their strategy to 
include functional groups such as alkenes. The most important feature of this 
chiral amine is that it can be completely deprotected without using 
hydrogenation conditions (see Scheme 6.8). The allyl group can be selectively 
cleaved from compound (404), using Wilkinson’s catalyst, and the α-
methylbenzyl group can be selectively cleaved from compound (405) using 
dissolving metal conditions. The reported yields for a range of alkyl and alkenyl 
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Scheme 6.8: Aza-Michael addition by Davies et al.211 Reagents and conditions: 
i) (S)-(α-methylbenzyl)allylamine, n-BuLi, THF, -78°C; ii) (PPh3)3RhCl; iii) Na/NH3. 
 
 
Enders et al.243 developed a method for introducing the amino-group via TMS-
SAMP, (S)-(−)-2-methoxymethyl-1-trimethylsilylaminopyrrolidine (see Scheme 
6.9). This method avoids the use of palladium-catalysed hydrogenation. 
Compound (407) was deprotected in two steps; treatment with silica followed by 
a Raney-nickel reduction. The Scheme below has been demonstrated for a 




Scheme 6.9: Aza-Michael addition by Enders et al.243 Reagents and conditions: 
i) TMS-SAMP, n-BuLi, THF, -78°C; ii) a) SiO2, EtOAc; b) Raney-Ni/H2. 
 
Davies and co-workers182, 183, 184 have also worked with another chiral amine, 
(R)-N-benzyl-N-α-methyl-4-methoxybenzylamine, which has slightly different 
chemical properties than N-benzyl-N-(1R)-1-phenylethylamine (214), the chiral 
amine we used during this project. The presence of the methoxy group makes 
the amine more susceptible to oxidative cleavage when reagents such as ceric 
ammonium nitrate (CAN) and 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) are 
used.183, 184 Scheme 6.10 illustrates the chemoselective debenzylation of 
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compound (408), followed by removal of the 4-methoxybenzyl group from (409). 
Davies and co-workers182 obtained ee’s of 97%, whereas Zhang and co-
workers,244 who used formic acid to remove the 4-methoxybenzyl group, 





Scheme 6.10: Aza-Michael addition by Davies and co-workers182, 184 Reagents and 
conditions:  i) (R)-N-benzyl-N-α-methyl-4-methoxybenzylamine, n-BuLi, THF, -78°C; ii) 
CAN (2.1 eq.) MeCN: H2O (1:5), RT; iii) CAN (4.0 eq.), MeCN : H2O (1:5), RT; OR iii) 
HCO2H, Et3SiH. 
 
Another method of introducing the stereogenic centre is to use a chiral ester to 
direct the aza-Michael addition. d’Angelo and co-workers245 have successfully 
demonstrated this method (see Scheme 6.11) with de’s for compound (411) 
greater than 99% when R was a methyl group. The one disadvantage of this 


















Scheme 6.11: Aza-Michael addition by d’Angelo and co-workers245 Reagents and 
conditions:  i) Ph2CHNH2, 14 - 15 bar. 
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6.2.2  Extending the reach of the Wits methodology  
Having successfully completed the synthesis of two 3,5-dialkylated indolizidine 
alkaloids, we wish to apply our methodology to a broader range of alkaloids 
within this family. Additional 3,5-disubstituted ant and amphibian alkaloids are 
shown in Figure 6.2. Some of them differ from monomorine I only in the length 
of the alkyl substituents [compounds (90), (91) and (92)], while others contain 
alkenes or hydroxy-groups [compounds (88), (412), (413), (414), (415) and 
(30)]. We have already glimpsed the difficulties that can be encountered when 
incorporating an alkene into the side-chain, and incorporating an alcohol would 





























Figure 6.2: A range of ant and amphibian 3,5-disubstituted indolizidines. 
 
The basic synthetic strategy would be the same, (see Figure 6.3). Lactam (416) 
would be accessed from a condensation reaction between ketoester (417) and 
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amine (418). The ketoester could be prepared from acid chloride (311) using a 
Grignard reaction, and the amine could be accessed via an aza-Michael 
addition reaction with the alkenoate (419). Various parameters would need to 
be changed and optimized, especially for the targets with functionalized side-
chains. The hydroxy-groups would need to be protected to prevent interference 
with the cyclisation reaction, and the reduction reactions would have to be 



























Figure 6.3: Retrosynthetic scheme of the pyrrolidinone intermediate.  
 
6.2.3  Partnering up with ring-closing metathesis  
On closer examination of our brief explorations into RCM, it is clear that the 
positioning of the alkene groups is critical for the success of the synthetic 
strategy. The work of Holmes and co-workers,176 Kim and co-workers,242 and 
Smith III et al.122 has already demonstrated the potential of RCM in the 
synthesis of bicyclic and tricyclic nitrogenous compounds. However, in all three 
cases, both alkene groups are terminal, and neither alkene is positioned where 
it can isomerise into conjugation.  
 
Therefore, in order to incorporate this methodology into our current synthetic 
strategy, we would need to modify the allylketoester (313) into a more stable 
precursor that can withstand the condensation reaction (see Figure 6.4). The 
simplest modification would be to change the allyl chain into a butenyl chain 





Figure 6.4: Allylketoester (313) and the modified analogue (405). 
 
Our original idea was to develop a route to access lactam (315) and hence 
apply RCM to form the bicyclic system (316) (see Scheme 6.12). Then the 
vinylogous sulfonamide methodology could be used to extend it to a tricyclic 
system (317). Future workers will need to revise the synthetic route for 
accessing lactam (315), avoiding condition such as toluene and acetic acid 















In conclusion, the use of vinylogous sulfonamides as the key intermediate for 
forming the bicyclic skeleton of indolizidine alkaloids, (−)-indolizidine 209D, 
(±)-monomorine I and (±)-5-epi-monomorine I was proven a successful 
strategy. Unfortunately, the method of introducing the chiral centre presented 
us with problems we were unable to overcome. We did, however, explore 
additional side routes to try and circumvent the problem, and in the process 
uncovered interesting by-products, not to mention red herrings! Our attempt to 
extend the methodology to tricyclic systems was not successful, although it did 
pave the way for future workers to investigate the use of RCM in conjunction 




EXPERIMENTAL PROCEDURES RELATING TO CHAPTER 3 
 
7.1 General experimental procedures  
 
7.1.1 Purification of solvents and reagents 
Solvents used for chromatographic purposes were distilled before use by 
means of conventional distillation procedures. Unless otherwise stated, 
solvents used for reaction purposes were dried over an appropriate drying 
agent and then distilled under nitrogen gas. Tetrahydrofuran (THF) and diethyl 
ether (Et2O) were distilled from sodium wire using benzophenone as an 
indicator. Toluene was distilled from sodium lumps. Dichloromethane (CH2Cl2), 
dimethylformamide (DMF) and acetonitrile (MeCN) were distilled from calcium 
hydride. Potassium t-butoxide was resublimed under vacuum immediately prior 
to use. n-Butyllithium was titrated immediately prior to use, using the titration 
method outlined by Krasovskiy and Knochel.246 
 
7.1.2 Chromatography 
Separation of compounds by column chromatography was performed using 
Merck or Fluka silica-gel (particle size 0.063-0.200 mm). Rf values quoted are 
for thin layer chromatography (TLC) which was performed using Merck silica-
gel 60 F254 or on Fluka silica-gel 60 F254 coated on aluminium sheets. 
Compounds on the TLC plates were viewed under UV light, or by staining the 
plates with basic potassium permanganate, bromocresol green, iodine or 
Dragendorff’s reagent as appropriate.  
 
7.1.3 Spectroscopic and physical data 
1H NMR spectra were recorded either on a Bruker AVANCE 300 spectrometer 
or on a Bruker DRX-400 spectrometer at the indicated frequency. Chemical 
shifts are reported on the δ scale relative to tetramethylsilane as an internal 
standard. The chemical shifts are reported as follows: Value (number of 
hydrogens, description of signal, coupling constant(s) in Hz where applicable, 
and assignment). Abbreviations used include: s (singlet), d (doublet), t (triplet), 
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q (quartet) and m (multiplet). Diastereotopic hydrogens are differentiated with 
the suffix A and B. COSY spectra were routinely run to enable more complete 
assignment of the signals. 
  
13C NMR spectra were recorded either on a Bruker AVANCE 300 spectrometer 
or on a Bruker DRX-400 spectrometer at frequencies of 75 MHz or 100 MHz 
respectively. Chemical shifts are reported on the δ scale relative to the central 
signal of deuterated chloroform, taken as 77.00 ppm. DEPT and C-H spectra 
were routinely run to enable more complete assignments of the signals. 
 
Infra-red spectra were recorded on a Bruker Tensor 27 Fourier Transform 
spectrometer with diamond ATR attachment. Abbreviations used in describing 
the signals are: s (strong), m (medium), w (weak), br (broad). Assignments are 
only indicated for key signals. 
 
Optical rotations were obtained on a Jasco DIP-370 Digital Polarimeter. The 
reported values each represent an average of consistent measurements. The 
concentration of the sample is given in g / 100 mL of solvent. 
 
Melting points were recorded using a JM 626 melting-point apparatus with 
microscope and a digital thermometer. 
 
High-resolution mass spectra (ESI/EI) were recorded either on a VG70 MS 
(Mass spectrum CC Pyramid data system), a VG70 SEQ (VG 11-205J or Mar II 
data system), or on a DFS High Resolution Magnetic Sector mass 
spectrometer. 
 
Crystallographic information was obtained using intensity data collected on a 
Bruker SMART 1K CCD area detector diffractometer with graphite 
monochromated Mo Kα radiation (50 kV, 30 mA). The collection method 
involved ω-scans of width 0.3°. Data reduction was carried out using the 
programme SAINT+.247 The crystal structure was solved by direct methods 
using SHELXTL248 and WINGX.249 Non-hydrogen atoms were first refined 
isotropically followed by anisotropic refinement by full matrix least-squares 
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calculations based on F2 using SHELXTL.248 Hydrogen atoms were first located 
in the difference map, then positioned geometrically and allowed to ride on their 
respective parent atoms. Diagrams were generated using SHELXTL248 and 
PLATON.250 Crystal structures were grown using Mercury 1.4.251 
 
All molecular dynamic/simulated annealing calculations (MD/SA) were 
performed using Hyperchem,228 together with the Generalised Amber Force 
Field (GAFF)252, 253 parameters. Where parameters were not available (i.e. 
parameters involving titanium), new, crude ones were developed. A typical 
MD/SA simulation designed to discover stable conformations, began by an 
initial heating phase of 5 ps from 0 K to 1200 K. The run phase was then varied 
between 0 ps and 18 ps at 1200 K. This was subsequently followed by a 
cooling phase from 1200 K to 0 K over 50 ps. At this point the molecule was 
subjected to a full energy minimisation. 
 
7.1.4 Additional general procedures and terminology 
Evaporation in vacuo refers to the removal of solvent under reduced pressure 
at 40 - 50°C on a rotary evaporator.  
 
Hydrogenations were set up in a Büchiglasuster picoclave “Parr Hydrogenator” 
with a built in stirrer and a maximum pressure of 10 bar. 
 
Dean-Stark apparatus refers to a U-shaped glass apparatus which allows 
solvent heated at reflux to collect and separate by density in the side arm 
before flowing back into the flask, hence aiding the removal of a dense solvent 
such as H2O from the reaction. We prepared a modified Dean-Stark apparatus 
whereby the solution heats to reflux and passes through a catchment area of 
molecular sieves before returning to the round bottom flask.  
 
7.1.5 Nomenclature and compound numbering 
The compounds prepared during this project are named in the following 
experimental sections according to systematic nomenclature. However, the 
numbering system used in the diagrams of the compounds is one adopted for 
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convenience and to allow easier comparison between NMR assignments and 
does not reflect the systematic numbering of these compounds. 
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7.2 Towards the total synthesis of enantiopure (−)-indolizidine 209D 
 
7.2.1 Horner-Wadsworth-Emmons reaction 
7.2.1.1 Preparation of t-butyl 2-(diethoxyphosphoryl)acetate (272) 
Triethyl phosphite (4.7 mL, 28 mmol) was added to t-butyl bromoacetate (3.7 
mL, 25 mmol) in a RBF fitted with a condenser, under a nitrogen atmosphere. 
The mixture was heated at reflux at 110°C for 24 hours until starting material 
could not be detected by TLC analysis. The reaction was cooled and the crude 
product was rinsed with distilled H2O (25 mL) and extracted into EtOAc (2 × 25 
mL). The combined organic extracts were dried with sodium sulfate and filtered. 
The solvent was removed in vacuo and the crude product was purified by 
column chromatography (30% EtOAc/hexane) to give t-butyl 2-
(diethoxyphosphoryl)acetate (272) (6.31 g) as a clear oil in quantitative yield. 













Rf 0.10 (30% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 4.17 (4H, dq, JP-H 14.3, J 7.1, H-3), 2.88 (2H, d, 
JP-H  21.5, H-2), 1.48 (9H, s, H-6), 1.35 (6H, t, J 7.1, H-4). 
 
13C (75 MHz, CDCl3) δC /ppm 164.6 (d, JP-C 6.3, C-1), 81.7 (C-5), 62.2 (d, JP-C 
6.2, C-3), 35.4 (d, JP-C 133.2, C-2), 27.2 (C-6), 16.1 (d, JP-C 6.3, C-4). 
 
31P (121 MHz, CDCl3) δP /ppm 321.4 (P). 
νmax. / cm-1: 2981 (m, C-H), 2934 (m, C-H), 1725 (s, C=O), 1394 (m), 1368 (m), 
1286 (s, P=O), 1255 (s, P=O), 1164 (m), 1113 (m), 1029 (s), 959 (s), 829 (w). 
 
m/z: 197 (36%), 179 (100), 151 (53), 123 (41), 81 (9), 57 (40).  
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7.2.1.2 t-Butyl (E)-2-nonenoate (273) 
An oven-dried, 100 mL RBF was charged with sodium hydride (60% in oil, 1.50 
g, 37.5 mmol) and pre-distilled Et2O (60 mL), under an atmosphere of nitrogen 
gas. The resulting suspension was cooled to 0°C in an ice bath and t-butyl 2-
(diethoxyphosphoryl)acetate (272) (6.31 g, 25.0 mmol) was added dropwise 
over 10 minutes. Heptanal (3.8 mL, 28 mmol) in Et2O (15 mL) was added by 
dropping funnel over 15 minutes. The ice bath was removed and the mixture 
was stirred at ambient temperature for an additional hour. The reaction was 
quenched by the addition of saturated ammonium chloride solution (20 mL) and 
then extracted into Et2O (3 × 50 mL). The combined organic extracts were dried 
with sodium sulfate and filtered. The solvent was evaporated in vacuo and the 
crude product was purified using column chromatography (2% - 5% 
EtOAc/hexane) to give t-butyl (E)-2-nonenoate (273) (5.31 g, 100% yield) as a 




Rf 0.72 (5% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 6.86 (1H, dt, J 15.6, 6.9, H-3), 5.73 (1H, dt, J 
15.6, 1.5, H-2), 2.20-2.12 (2H, m, H-4), 1.48 (9H, s, H-11), 1.36-1.23 (8H, m, 
H-5, H-6, H-7, H-8), 0.88 (3H, t, J 6.7, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 166.1 (C-1), 148.1 (C-3), 122.9 (C-2), 79.9 
(C-10), 32.0 (C-4), 31.7 (C-5), 28.8 (C-6), 28.1 (C-11), 28.0 (C-7), 22.5 (C-8), 
14.0 (C-9). 
 
νmax. / cm-1: 2957 (m, C-H), 2927 (m, C-H), 2857 (m, C-H), 1715 (s, C=O), 1653 
(m, C=C), 1457 (m), 1367 (m), 1152 (s), 1124 (s), 978 (m), 851 (w). 
 
m/z: 157 (36%), 139 (16), 115 (100), 97 (88), 70 (57), 55 (82). 
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7.2.2 Conjugate addition reaction 
7.2.2.1 t-Butyl (3R)-3-{benzyl[(1R)-1-phenylethyl]amino}nonanoate (274) 
N-Benzyl-N-(1R)-1-phenylethylamine (5.97 g, 28.3 mmol) was mixed with pre-
distilled THF (100 mL) in an oven dried RBF under a nitrogen atmosphere and 
the mixture was cooled to -90°C in a liquid nitrogen/acetone bath. Freshly 
titrated n-butyllithium in hexane (1.2 M, 26 mmol) was carefully added and the 
mixture was stirred for 30 minutes. A pronounced colour change from clear to 
deep red was observed as the n-butyllithium was added and the red colour 
remained throughout stirring. t-Butyl (E)-2-nonenoate (273) (5.00 g, 23.5 
mmol) was mixed with THF (20 mL) and added over a period of 30 minutes by 
means of a dropping funnel. The reaction was kept at -90°C for a further 4 
hours, and during this time the colour of the mixture lightened. The reaction was 
quenched by the addition of saturated ammonium chloride solution (20 mL). 
The THF was removed in vacuo and the product was extracted into EtOAc (3 × 
50 mL), dried with sodium sulfate and filtered. The solvent was removed in 
vacuo and the resulting crude yellow oil was purified by column 
chromatography (5% EtOAc/hexane) to give t-butyl (3R)-3-{benzyl[(1R)-1-

























Rf 0.63 (10% EtOAc/hexane), [α]D20 +4.5 (c 1.00, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.47-7.17 (10H, m, Ar-H), 3.86-3.74 (2H, m, 
H-12, H-14A), 3.48 (1H, d, J 15.0, H-14B), 3.35-3.24 (1H, m, H-3), 1.96 (1H, dd, 
J 14.5, 3.7, H-2A), 1.86 (1H, dd, J 14.5, 9.2, H-2B), 1.61-1.15 (10H, m, H-4, 
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H-5, H-6, H-7, H-8), 1.39 (9H, s, H-11), 1.32 (3H, d, J 6.9, H-13), 0.88 (3H, t, J 
6.7, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 172.2 (C-1), 143.2 (C-15/15`), 142.1 (C-15/15`), 
128.2 (C-16/16`), 128.1 (C-16/16`), 128.0 (C-17/17`), 127.9 (C-17/17`), 126.8 
(C-18/18`), 126.5 (C-18/18`), 79.8 (C-10), 58.4 (C-12), 54.0 (C-3), 50.1 (C-14), 
37.9 (C-2), 33.5 (C-4), 31.9 (C-5), 29.3 (C-6), 28.1 (C-11), 26.9 (C-7), 22.7 
(C-8), 20.5 (C-13), 14.1 (C-9). 
 
νmax. / cm-1: 2929 (m, C-H), 2857 (m, C-H), 1726 (s, C=O), 1455 (m), 1368 (m), 
1146 (s), 956 (w), 848 (w), 702 (s). 
 
m/z: 423 (1%, M), 408 (2), 352 (4), 338 (32), 308 (30), 282 (22), 250 (10), 204 
(28), 178 (64), 146 (26), 105 (100), 91 (89). Found 423.3131, C28H41O2N 
requires 423.3137. 
 
7.2.3 Debenzylation reactions 
7.2.3.1 t-Butyl (3R)-3-[N-(1-phenylethyl)amino]nonanoate (323) and t-butyl 
(3R)-3-aminononanoate (275) 
Method A 
10% Palladium on carbon (80 mg, 0.10 eq.) was added to a mixture of t-butyl 
(3R)-3-{benzyl[(1R)-1-phenylethyl]amino}nonanoate (274) (0.80 g, 1.9 
mmol) dissolved in AcOH (5 mL). The resulting suspension was set up under 7 
atmospheres of hydrogen pressure in a hydrogenator and stirred at ambient 
temperature for 48 hours. The solution was then filtered through Celite® and 
rinsed with CH2Cl2 (150 mL) in order to remove the residual catalyst. The 
CH2Cl2 was removed in vacuo and the AcOH was removed using toluene as an 
azeotrope. The crude yellow oil was purified by column chromatography (10% 
EtOAc/hexane - 10% MeOH/EtOAc) to give t-butyl (3R)-3-aminononanoate 
(275) (204 mg, 46% yield) and t-butyl (3R)-3-[N-(1-




















Rf 0.56 (20% EtOAc/hexane), [α]D20 +20.4 (c 0.91, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.38-7.17 (5H, m, H-15, H-16, H-17), 3.89 (1H, q, 
J 6.5, H-12), 2.76-2.68 (1H, m, H-3), 2.66-2.50 (1H, s, N-H), 2.37 (1H, dd, J 
14.4, 5.9, H-2A), 2.26 (1H, dd, J 14.4, 4.4, H-2B), 1.45 (9H, s, H-11), 1.33 (3H, 
d, J 6.5, H-13), 1.30-1.09 (10H, m, H-4, H-5, H-6, H-7, H-8), 0.85 (3H, t, J 6.8, 
H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 171.8 (C-1), 145.9 (C-14), 128.3 (C-15/16), 126.8 
(C-17), 126.7 (C-15/16), 80.2 (C-10), 55.1 (C-12), 52.2 (C-3), 39.6 (C-2), 35.1 
(C-4), 31.7 (C-5), 29.2 (C-6) , 28.1 (C-11), 25.7 (C-7), 24.7 (C-8), 22.5 (C-13), 
14.0 (C-9). 
 
νmax. / cm-1: 3194 (w, br, N-H), 2957 (m, C-H), 2926 (m, C-H), 2856 (m, C-H), 
1724 (s, C=O), 1666 (w), 1454 (m), 1366 (m), 1150 (s), 953 (w), 843 (w), 700 
(s).  
 
m/z: 333 (1%, M), 318 (3), 262 (16), 248 (11), 218 (18), 192 (46), 172 (7), 120 






Rf 0.33 (100% EtOAc), [α]D20 -13.4 (c 0.98, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 5.20 (2H, s, N-H), 3.29-3.18 (1H, m, H-3), 2.40 
(1H, dd, J 16.0, 4.2, H-2A), 2.34 (1H, dd, J 16.0, 7.8, H-2B), 1.46 (9H, s, H-11), 
1.46-1.21 (10H, m, H-4, H-5, H-6, H-7, H-8), 0.88 (3H, t, J 6.4, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 171.5 (C-1), 80.9 (C-10), 48.3 (C-3), 41.7 (C-2), 
35.9 (C-4), 31.6 (C-5), 29.1 (C-6), 28.1 (C-11), 25.7 (C-7), 22.5 (C-8), 14.0 
(C-9). 
 
νmax. / cm-1: 3420 (br, N-H), 2957 (m, C-H), 2928 (m, C-H), 2858 (m, C-H), 1727 
(s, C=O), 1558 (s), 1393 (m), 1368 (m), 1150 (s), 948 (w), 842 (w). 
 
m/z: 229 (1%, M), 172 (14), 144 (7), 114 (43), 88 (100), 56 (53). Found 
229.2036, C13H27O2N requires 229.2042. 
 
Method B 
5% Palladium on carbon (400 mg, 1.0 eq.) was added to a mixture of t-butyl 
(3R)-3-{benzyl[(1R)-1-phenylethyl]amino}nonanoate (274) (0.40 g, 
0.95 mmol) dissolved in AcOH (3 mL). The resulting suspension was set up 
under 7 atmosphere of hydrogen pressure in a hydrogenator and stirred at 
ambient temperature for 48 hours. The solution was then filtered through 
Celite® and rinsed with CH2Cl2 (150 mL) in order to remove the residual 
catalyst. The CH2Cl2 was removed in vacuo and the AcOH was removed using 
toluene as an azeotrope. The crude yellow oil was purified by column 
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chromatography (10% EtOAc/hexane -10% MeOH/EtOAc) to give t-butyl (3R)-
3-aminononanoate (275) (215 mg, 99% yield) as a pale yellow, gummy oil.e 
 
Method C 
5% Palladium on carbon (2.17 g, 0.25 eq.) was added to a mixture of t-butyl 
(3R)-3-{benzyl[(1R)-1-phenylethyl]amino}nonanoate (274) (8.66 g, 
20.5 mmol) dissolved in AcOH (5 mL) and MeOH (15 mL). The resulting 
suspension was set up under 5 atmospheres of hydrogen pressure in a 
hydrogenator and stirred at ambient temperature for 96 hours. The solution was 
then filtered through Celite® and rinsed with CH2Cl2 (150 mL) in order to remove 
the residual catalyst. The CH2Cl2 was removed in vacuo and the AcOH was 
removed using toluene as an azeotrope. The crude oil was purified by column 
chromatography (10% EtOAc/hexane - 10% MeOH/EtOAc) to give (R)-1-t-




M.p. 69 -73 °C 
 
Rf  0.06 (50% EtOAc/hexane),  [α]D20 -10.0 (c 1.00, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.17 (3H, s, N-H), 3.34-3.14 (1H, m, H-3), 
2.48-2.44 (2H, m, H-2), 1.96 (3H, s, H-13), 1.66-1.50 (2H, m, H-4), 1.45 (9H, s, 
H-11), 1.38-1.23 (8H, m, H-5, H-6, H-7, H-8), 0.88 (3H, t, J 6.5, H-9). 
 
                                                 
eThe yields for partially and fully debenzylated products were extremely variable and a 




13C (75 MHz, CDCl3) δC /ppm 177.3 (C-12), 171.2 (C-1), 81.3 (C-10), 48.2 
(C-3), 39.8 (C-2), 34.6 (C-4), 31.6 (C-5), 29.1 (C-6), 28.0 (C-11), 25.6 (C-7), 
23.3 (C-13), 22.5 (C-8), 14.0 (C-9). 
 
νmax. / cm-1: 3500-2800 (br, N-H), 2957 (m, C-H), 2930 (m, C-H), 2860 (m, C-H), 
1731 (s, C=O), 1560 (s), 1395 (s), 1369 (m), 1231 (m), 1157 (s), 949 (w), 843 
(w), 650 (w). 
 
Method D 
A 100 mL RBF was charged with MeOH (15 mL) and t-butyl (3R)-3-
{benzyl[(1R)-1-phenylethyl]amino}nonanoate (274) (500 mg, 1.18 mmol). 
Ammonium formate (596 mg, 9.45 mmols) was added and the solution was 
stirred under a nitrogen atmosphere until the solution was homogenous. 10% 
Palladium on carbon (185 mg, 0.37 eq.) was carefully stirred into the mixture 
(the methanolic vapours readily ignited if the system was not properly flushed 
with nitrogen). The reaction was left at ambient temperature for 3 hours until 
TLC indicated that all the starting material was consumed. The mixture was 
filtered through Celite® and rinsed with MeOH (2 × 20 mL) to remove the 
catalyst. The solvent was removed in vacuo and the residue was rinsed with 
sodium hydroxide solution (1.0 M, 8 mL) and extracted into CH2Cl2 (2 × 20 mL). 
The combined organic extracts were dried with sodium sulfate and the solvent 
was removed in vacuo. Purification of the crude oil by column chromatography 
(5% - 100% EtOAc/hexane) gave t-butyl (3R)-3-aminononanoate (275) 
(200 mg, 74% yield) as a clear oil.f  
 
Method E 
10 - 20% Palladium hydroxide on carbon (2.00 g, 0.25 eq.) was added to a 
mixture of t-butyl (3R)-3-{benzyl[(1R)-1-phenylethyl]amino}nonanoate (274) 
(8.00 g, 18.9 mmol) dissolved in absolute EtOH (30 mL). The resulting 
suspension was set up under 7 atmosphere of hydrogen pressure in a 
hydrogenator and stirred at ambient temperature for 48 hours. The solution was 
then filtered through Celite® and rinsed with CH2Cl2 (150 mL) in order to remove 
                                                 
f Unfortunately this reaction was not reproducible; see Chapter 3 for a detailed 
discussion. 
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the residual catalyst. The solvent was removed in vacuo and the crude yellow 
oil was purified by column chromatography (5% - 100% EtOAc/hexane) to give 
t-butyl nonanoate (325) (2.12 g, 53% yield) as a clear oil. 
 
Method F 
t-Butyl (3R)-3-{benzyl[(1R)-1-phenylethyl]amino}nonanoate (274) (500 mg, 
1.18 mmol) was dissolved in formic acid (5 mL) and was heated at reflux for 3 
hours. The reaction mixture was cooled, the formic acid removed in vacuo, and 
the crude residue purified by column chromatography (20% - 100% 
EtOAc/hexane) to give (3R)-3-{benzyl[(1R)-1-phenylethyl]amino}nonanoic 























Rf 0.49 (50% EtOAc/hexane), [α]D20 -26.9 (c 1.08, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 11.2-10.8 (1H, s, O-H), 7.33-7.24 (10H, m, Ar-H), 
4.16 (1H, q, J 7.2, H-10), 3.92 (1H, d, J 14.0, H-12A), 3.84 (1H, d, J 14.0, 
H-12B), 3.41-3.34 (1H, m, H-3), 2.37 (1H, dd, J 16.8, 4.8, H-2A), 2.07 (1H, dd, J 
16.8, 10.8, H-2B), 1.70-1.62 (1H, m, H-4A), 1.57 (3H, d, J 6.9, H-11), 1.41-1.12 
(9H, m, H-4B, H-5, H-6, H-7, H-8), 0.88 (3H, t, J 7.2, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 174.2 (C-1), 139.3 (C-13/C-13’), 135.8 
(C-13/C-13’), 129.2, 128.8, 128.7, 128.4, 128.2, 128.0 (C-14, C-14’, C-15, 
C-15’, C-16, C-16’), 60.3 (C-10), 56.8 (C-3), 49.5 (C-12), 35.0 (C-2), 31.5 (C-4), 
30.4 (C-5), 29.2 (C-6), 26.7 (C-7), 22.5 (C-8), 17.8 (C-11), 13.9 (C-9) 
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νmax. / cm-1: 2955 (m, C-H), 2928 (m, C-H), 2856 (m, C-H), 1716 (s, C=O), 1492 
(s), 1396 (m), 1375 (m), 1273 (m), 1207 (m), 749 (m), 700 (s). 
 
m/z: no parent ion, 352 (5%), 308 (16), 282 (27), 250 (17), 204 (18), 178 (42), 
146 (40), 105 (100).  C24H33O2N requires 367.2511. 
 
Method G 
t-Butyl (3R)-3-[N-(1-phenylethyl)amino]nonanoate (323) (0.30 g, 0.90 
mmols) was dissolved in absolute ethanol (3 mL)  with palladium hydroxide (10 
- 20%, 30 mg, 0.10 eq.). The reaction was set up under 7 atmospheres of 
hydrogen pressure in the hydrogenator at ambient temperature for 72 hours. 
The reaction mixture was filtered through Celite® to remove the catalyst, and 
was rinsed with CH2Cl2 (150 mL). The solvent was removed in vacuo and then 
the crude product was dried under high vacuum for 20 minutes. 1H-NMR 
spectra of the crude material indicated 100% recovery of starting material and 
that no debenzylation had occurred. 
 
Method H 
t-Butyl (3R)-3-[N-(1-phenylethyl)amino]nonanoate (323) (0.50 g, 1.5 mmol) 
and ceric ammonium nitrate (3.29 g, 6.00 mmol) were dissolved in MeCN/H2O 
(1:5, 12 mL) and stirred at ambient temperature for 12 hours. The reaction was 
quenched with saturated sodium bicarbonate solution (10 mL) and filtered 
through cotton wool. The product was extracted into CH2Cl2 (4 × 20 mL) and 
dried with sodium sulfate. The solvent was removed in vacuo and the crude 
product was purified by column chromatography (5% - 50% EtOAc/hexane) to 
give back starting material t-butyl (3R)-3-[N-(1-phenylethyl)amino]nonanoate 
(323) (250 mg, 50%  recovery). 
 
7.2.4 Formation of the lactam and cyclopropane by-products 
7.2.4.1 t-Butyl (3R)-3-[N-(4-chlorobutanoyl)amino]nonanoate (276) 
In an oven dried flask, t-butyl (3R)-3-aminononanoate (275) (0.22 mg, 
0.94 mmol) was dissolved in CHCl3 (2 mL) followed by the addition of sodium 
bicarbonate (0.12 g, 1.4 mmol) and 10 minutes of stirring. Chlorobutyryl 
chloride (126 µl, 1.1 mmol) was then added and the reaction was left stirring at 
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ambient temperature for 12 hours. The mixture was filtered to remove residual 
solids and was rinsed thoroughly with CH2Cl2 (2 × 20 mL). The solvent was 
removed in vacuo and the crude material was purified by column 
chromatography (10% - 50% EtOAc/hexane). The product, t-butyl (3R)-3-[N-
(4-chlorobutanoyl)amino]nonanoate (276), was only UV-active at high 
concentrations and was recovered as a odoriferous, pale brown oil in 




Rf 0.63 (20% EtOAc/hexane), [α]D20 +10.5 (c 1.00, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 6.22 (1H, d, J 8.7, N-H), 4.28-4.16 (1H, m, H-3), 
3.61 (2H, t, J 6.6, H-13), 2.54 (1H, t, J 7.2, H-11A), 2.46-2.30 (1H, m, H-11B), 
2.39-2.32 (2H, m, H-2), 2.16-2.01 (2H, m, H-12), 1.45 (9H, s, H-15), 1.47-1.10 
(10H, m, H-4, H-5, H-6, H-7, H-8), 0.87 (3H, t, J 6.5, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 171.4 (C-10), 171.2 (C-1), 81.2 (C-14), 46.2 
(C-3), 44.4 (C-13), 39.6 (C-2), 34.1 (C-4), 33.4 (C-11), 30.8 (C-5), 29.0 (C-6), 
28.2 (C-12), 28.0 (C-15), 26.0 (C-7), 22.5 (C-8), 14.0 (C-9). 
 
νmax. / cm-1: 3289 (br, N-H), 2928 (m, C-H), 2857 (m, C-H), 1725 (s, OC=O), 
1645 (s, NC=O), 1545 (m), 1367 (m), 1256 (m), 1153 (s), 947 (w). 
 
m/z: 333 (2%, M), 277 (25), 260 (21), 224 (26), 192 (56), 172 (77), 156 (96), 





7.2.4.2 t-Butyl (3R)-3-(2-oxo-1-pyrrolidinyl)nonanoate (277) 
Potassium t-butoxide was carefully sublimed and t-butanol was pre-distilled. 
t-Butyl (3R)-3-[N-(4-chlorobutanoyl)amino]nonanoate (276) (1.96 g, 
5.90 mmol) was dissolved in t-butanol (10 mL) and the potassium t-butoxide 
(1.32 g, 11.7 mmol) was carefully added to the solution under a nitrogen 
atmosphere. The mixture was left to stir at ambient temperature for 72 hours 
and was quenched by the careful addition of AcOH (5 mL). The solution was 
rinsed with distilled H2O (20 mL) and extracted into CH2Cl2 (5 × 20 mL). The 
combined organic extracts were dried with sodium sulfate, filtered, and the 
solvent removed in vacuo. The crude oil was purified by column 
chromatography (30% EtOAc/hexane) to give N-(cyclopropanecarbonyl) 
cyclopropane carboxamide  (327) (400 mg, 45% yield), t-butyl (E)-2-
nonenoate (273) (290 mg, 23%) and the desired product t-butyl (3R)-3-(2-




Rf 0.23 (30% EtOAc/hexane), [α]D20 +9.5 (c 1.00, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 4.53-4.36 (1H, m, H-3), 3.38 (1H, dd, J 15.7, 7.1, 
H-13A), 3.26 (1H, dd, J 15.7, 7.9, H-13B), 2.42-2.34 (4H, m, H-11, H-2), 1.99 
(2H, quintet, J 7.6, H-12), 1.48-1.39 (2H, m, H-4), 1.42 (9H, s, H-15), 1.35-1.15 
(10H, m, H-4, H-5, H-6, H-7, H-8), 0.87 (3H, t, J 6.5, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 174.8 (C-10), 170.2 (C-1), 80.7 (C-14), 48.8 
(C-3), 42.4 (C-13), 39.3 (C-2), 32.2 (C-4), 31.4 (C-5), 31.1 (C-11), 28.9 (C-6), 
27.8 (C-15), 26.0 (C-7), 22.5 (C-8), 18.3 (C-12), 14.0 (C-9). 
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νmax. / cm-1: 2926 (m, C-H), 2857 (m, C-H), 1724 (s, OC=O), 1686 (s, NC=O), 
1422 (m), 1367 (m), 1267 (m), 1220 (m), 1150 (s), 953 (w), 843 (w). 
 
m/z: 297 (2%, M), 241 (43), 224 (27), 212 (7), 182 (100), 156 (56), 138 (22), 




1H (300 MHz, CDCl3) δΗ /ppm 8.65 (1H, s, N-H), 2.28-2.25 (2H, m, H-2), 
1.14-1.11 (4H, m, H-3/H-4), 0.99-0.93 (4H, m, H-3/H-4).  
 
13C (75 MHz, CDCl3) δC /ppm 175.3 (C-1), 15.0 (C-2), 10.3 (C-3, C-4). 
 
νmax. / cm-1: 3257-3161 (br, N-H), 2923 (m, C-H), 2853 (m, C-H), 1710 (m, 
C=O), 1519 (m), 1461 (m), 1379 (s), 1212 (s), 1168 (s), 1111 (s), 1061 (s), 
1035 (m), 943 (s). 
 
7.2.4.3 (R)-t-Butyl 3-(4-chloro-N-(R)-1-phenylethyl)butanamido)nonanoate 
(331)  
A 10 mL RBF was charged with t-butyl (3R)-3-[N-(1-phenylethyl)amino] 
nonanoate (323) (500 mg, 1.5 mmols) and sodium bicarbonate (0.22 g, 
2.6 mmols) in dry CHCl3 (8 mL). Chlorobutyryl chloride (0.32 g, 2.2 mmols) was 
added by syringe and the mixture was heated at reflux for 12 hours. The solid 
sodium bicarbonate was filtered off and the residue was rinsed with CH2Cl2 
(20 mL). The solvent was removed in vacuo and the crude mixture was purified 
by column chromatography (5% - 50% EtOAc/hexane). The product, (R)-t-butyl 
3-(4-chloro-N-(R)-1-phenylethyl)butanamido)nonanoate (331) (70 mg, 11% 




























Rf  0.47 10% (EtOAc/hexane) [α]D20 +20.0 (c 1.00, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.36-7.18 (5H, m, H-19, H-20, H-21), 4.34 (2H, t, 
J 7.1, H-13), 3.89 (1H, q, J 6.6, H-16), 2.71 (1H, quintet, J 5.7, H-3), 2.49 (2H, t, 
J 8.0, H-11), 2.39-2.20 (4H, m, H-2, H-12), 1.39 (9H, s, H-15), 1.24 (3H, d, J 
6.6, H-17), 1.35-1.18 (10H, m, H-4, H-5, H-6, H-7, H-8), 0.90 (3H, t, J 7.5, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 177.6 (C-10), 171.8 (C-1), 145.9 (C-18), 128.2 
(C-19), 126.7 (C-21), 126.6 (C-20), 80.1 (C-14), 68.4 (C-13), 54.9 (C-16), 52.1 
(C-3), 39.5 (C-2), 35.1 (C-4), 31.7 (C-5), 29.1 (C-6), 28.0 (C-15), 27.7 (C-11), 
25.7 (C-7), 24.7 (C-17), 22.5 (C-8), 22.1 (C-12), 14.0 (C-9). 
 
νmax. / cm-1: 2960 (m, C-H), 2929 (m, C-H), 2859 (m, C-H), 1728 (s, OC=O), 
1605 (w, NC=O), 1456 (m), 1369 (m), 1259 (m), 1156 (s), 764 (w), 703 (m). 
 
7.2.4.4 Attempted debenzylation reaction 
Method A 
(R)-t-Butyl 3-(4-chloro-N-(R)-1-phenylethyl)butanamido)nonanoate (331) 
(50 mg, 0.11 mmol) was dissolved in AcOH (10 mL). Palladium hydroxide (10 - 
20%, 40 mg, 0.80 eq.) was added and the reaction was set up under 
7.5 atmospheres of hydrogen pressure in the hydrogenator. The reaction was 
stirred at ambient temperature for 48 hours. The catalyst was removed by 
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filtration through Celite® and the product was thoroughly rinsed with acetone 
(50 mL). The solvent was removed in vacuo and the crude material was purified 
by column chromatography (10% - 50% EtOAc/hexane). None of the desired 
product was isolated. 
 
Method B 
(R)-t-Butyl 3-(4-chloro-N-(R)-1-phenylethyl)butanamido)nonanoate (331), 
(100 mg, 0.22 mmol) and ceric ammonium nitrate (482 mg, 0.880 mmol) were 
dissolved in MeCN/H2O (1:5, 6 mL) and stirred at ambient temperature for 12 
hours. The reaction was quenched with saturated sodium bicarbonate solution 
(10 mL) and filtered through cotton wool. The product was extracted into CH2Cl2 
(3 × 15 mL) and dried with sodium sulfate. The solvent was removed in vacuo 
and the crude product was purified by column chromatography (20% - 50% 
EtOAc/hexane) to give t-butyl (3R)-3-[N-(1-phenylethyl)amino]nonanoate 
(323) (73 mg, 100% yield). 
 
7.2.4.5 (R)-N-(1-Phenylethyl)cyclopropanecarboxamide (332) 
(R)-t-Butyl 3-(4-chloro-N-(R)-1-phenylethyl)butanamido)nonanoate (331), 
(500 mg, 1.5 mmol) was dissolved in t-butanol (10 mL). Freshly sublimed 
potassium t-butoxide (337 mg, 3.00 mmol) was carefully added and the reaction 
was stirred for 72 hours at ambient temperature. The reaction was quenched by 
the careful addition of AcOH (5 mL). The solution was rinsed with distilled H2O 
(20 mL) and extracted into CH2Cl2 (5 × 20 mL). The combined organic extracts 
were dried with sodium sulfate, filtered, and the solvent removed in vacuo. The 
crude oil was purified by column chromatography (30% EtOAc/hexane) to give 
(R)-N-(1-phenylethyl)cyclopropanecarboxamide (332) (171 mg, 56% yield) 
















M.p. 82 -84 °C 
 
Rf  0.63 (50% EtOAc/hexane), [α]D20 +130.4 (c 0.79, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.35-7.22 (5H, m, H-8, H-9, H-10), 6.37 (1H, d, J 
7.2, N-H), 5.11 (1H, quintet, J 7.0, H-5), 1.44 (3H, d, J 7.0, H-6), 1.38-1.24 (1H, 
m, H-2), 0.97-0.86 (2H, m, H-3/H-4), 0.74-0.61 (2H, m, H-3/H-4). 
 
13C (75 MHz, CDCl3) δC /ppm 172.7 (C-1), 143.5 (C-7), 128.5 (C-8), 127.1 
(C-10), 126.1 (C-9), 48.7 (C-5), 21.8 (C-2), 14.6 (C-6), 7.1 (C-3, C-4). 
 
νmax. / cm-1: 3330 (s, N-H), 3033 (w, C-H), 2972 (m, C-H), 2932 (m, C-H), 1636 
(s, NC=O), 1525 (s), 1495 (s), 1395 (m), 1236 (s), 1133 (w), 958 (s), 764 (s). 
 
m/z: 189 (17%, M), 174 (20), 160 (14), 145 (35), 130 (8), 120 (84), 106 (100). 
Found 189.11452, C12H15ON requires 189.11536. 
 
7.2.5 Thionation reactions 
7.2.5.1 t-Butyl (3R)-3-(2-thioxo-1-pyrrolidinyl)nonanoate (278) 
Method A 
First, t-butyl (3R)-3-(2-oxo-1-pyrrolidinyl)nonanoate (277) (480 mg,  
1.61 mmol) was dissolved, and then Lawesson’s reagent (366 mg, 0.90 mmol) 
suspended in freshly distilled CH2Cl2 (10 mL) in an oven-dried RBF under a 
nitrogen atmosphere. The solution was left stirring at ambient temperature for 
72 hours. The reaction was quenched by the addition of saturated sodium 
bicarbonate solution (10 mL) and then extracted into CH2Cl2 (3 × 20 mL). The 
combined organic fractions were dried with sodium sulfate, the solvent removed 
in vacuo, and the crude material purified by column chromatography (20% 
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EtOAc/hexane). The desired product, t-butyl (3R)-3-(2-thioxo-1-
pyrrolidinyl)nonanoate (278) was obtained as a pale yellow, odoriferous oil 




Rf 0.51 (20% EtOAc/hexane), [α]D20 +7.4 (c 0.88, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 5.36 (1H, quintet, J 7.5, H-3), 3.71 (1H, dt, J 
10.7, 7.5, H-13A), 3.56 (1H, dt, J 10.7, 7.5, H-13B), 3.00 (2H, t, J 7.5, H-11), 
2.55 (1H, dd, J 14.4, 6.0, H-2A), 2.43 (1H, dd, J 14.4, 9.0, H-2B), 2.03 (2H, 
quintet, J 7.5, H-12), 1.64-1.55 (2H, m, H-4), 1.43 (9H, s, H-15), 1.38-1.20 (8H, 
m, H-5, H-6, H-7, H-8), 0.87 (3H, t, J 6.6, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 201.7 (C-10), 169.5 (C-1), 81.0 (C-14), 53.3 
(C-3), 49.0 (C-13), 45.1 (C-11), 38.8 (C-2), 32.2 (C-4), 31.5 (C-5), 28.9 (C-6), 
27.8 (C-15), 25.7 (C-7), 22.4 (C-8), 20.0 (C-12), 13.9 (C-9). 
 
νmax. / cm-1: 2926 (m, C-H), 2856 (m, C-H), 1722 (s, C=O), 1491 (m), 1446 (s), 
1310 (s, C=S), 1220 (s), 953 (w), 842 (w). 
 
m/z: 313 (18%, M), 280 (34), 256 (94), 224 (100), 212 (8), 173 (27), 154 (5), 
128 (17), 102 (55). Found 313.2070, C17H31O2N32S requires 313.2076. 
 
Method B 
First, t-butyl (3R)-3-(2-oxo-1-pyrrolidinyl)nonanoate (277) (0.20 g,  
0.67 mmol) was dissolved, and then phosphorus pentasulfide (90 mg, 
0.20 mmol) suspended in dry CHCl3 (3 mL) in an oven-dried RBF under a 
nitrogen atmosphere. The heterogeneous mixture was stirred at ambient 
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temperature for 72 hours. The reaction was quenched by the addition of 
saturated sodium bicarbonate solution (10 mL) and then extracted into CH2Cl2 
(3 × 10 mL). The organic fractions were combined and dried with sodium 
sulfate. The solvent was removed in vacuo and the crude material was purified 
by column chromatography (20% EtOAc/hexane) to give t-butyl (3R)-3-(2-
thioxo-1-pyrrolidinyl)nonanoate (278) (109 mg, 52% yield) was obtained as a 
pale yellow, odoriferous oil.  
 
7.2.6 Formation of the vinylogous sulfonamide  
7.2.6.1 Preparation of 1-[(4-methylphenyl)sulfonyl]acetone (279)190 
Sodium-p-toluenesulfinate (10.00 g, 56.0 mmol) was dissolved in DMSO (25 
mL), together with chloroacetone (4.47 mL, 57.6 mmol) and the resulting 
mixture was heated to 90ºC under nitrogen and stirred for 4 hours. During this 
period, the clear solution turned dark brown. The solution was cooled and 
washed with distilled H2O (50 mL) before extracting into CH2Cl2 (6 × 50 mL). 
The organic fractions were combined and then rinsed with distilled H2O to 
remove residual DMSO. The organic fractions were dried with magnesium 
sulfate and the solvent was removed in vacuo to give a crude brown oil which 
was further purified by silica column chromatography (40% EtOAc/hexane). The 
resulting product, 1-[(4-methylphenyl)sulfonyl]acetone (279), was a 
odoriferous, brown, low melting solid (11.41 g, 96% yield). Full characterization 














Mp. 49-51ºC (lit. ref. 50-51ºC)190 
 
Rf 0.53 (40 % EtOAc/hexane) 
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1H (300 MHz, CDCl3) δΗ /ppm 7.76 (2H, d, J 8.2, H-4), 7.37 (2H, d, J 8.2, H-3), 
4.15 (2H, s, H-6), 2.45 (3H, s, H-1), 2.39 (3H, s, H-8). 
 
13C (75 MHz, CDCl3) δC /ppm 196.6 (C-7), 145.9 (C-5), 136.2 (C-2), 130.4 
(C-4), 128.6 (C-3), 68.2 (C-6), 31.8 (C-8), 22.0 (C-1). 
 
νmax. / cm-1: 2924 (m, C-H), 2360 (m, C-H), 1712 (s, C=O), 1597 (m), 1462 (m), 
1359 (s, SO2), 1317 (s), 1147 (s, SO2), 1083 (m), 812 (m), 746 (m). 
 
m/z: 212 (15%, M), 170 (26), 155 (45), 148 (29), 105 (18), 91 (100), 77 (5), 65 
(24), 43 (30). Found 212.0521, C10H12O332S requires 212.0507.   
 
7.2.6.2 t-Butyl (3R)-3-{2-[(E)-(p-toluenesulfonyl)methylene-1-pyrrolidinyl} 
nonanoate (280) 
Method A 
In an oven-dried RBF, under a nitrogen atmosphere, the α-thioiminium salt was 
prepared by reacting t-butyl (3R)-3-(2-thioxo-1-pyrrolidinyl)nonanoate (278) 
(500 mg, 1.59 mmol) with freshly distilled methyl iodide (0.15 mL, 2.4 mmol) in 
THF (5 mL). After 72 hours at ambient temperature the starting material was no 
longer visible by TLC. The solvent was removed in vacuo and a premixed 
solution of 1-[(4-methylphenyl)sulfonyl]acetone (279) (675 mg, 3.18 mmol) 
and triethylamine (0.66 mL, 4.8 mmol) in CH2Cl2 (5 mL) was carefully added to 
the α-thioiminium salt. The reaction was left stirring at ambient temperature for 
an additional 96 hours and was quenched with distilled H2O (3 mL), extracted 
into CH2Cl2 (3 × 10 mL) and dried with sodium sulfate. The solvent was 
removed in vacuo and the crude material was purified by column 
chromatography (20% EtOAc/hexane). t-Butyl (3R)-3-(2-oxo-1-
pyrrolidinyl)nonanoate (277) (120 mg, 25% recovery) t-butyl (3R)-3-{2-[(E)-
(p-toluenesulfonyl)methylene-1-pyrrolidinyl}nonanoate (280) (200 mg, 28% 
yield), and the acylated product, t-butyl (3R)-3-{2-[1-(p-toluenesulfonyl)-2-
oxopropylidene]-1-pyrrolidinyl} nonanoate (337), (210 mg, 27% yield) were 
isolated from the column. The desired product (280) was first isolated as a 




Rf 0.47 (30% EtOAc/hexane), [α]D20 +11.6 (c 0.69, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.68 (2H, d, J 8.1, H-16), 7.16 (2H, d, J 8.1, 
H-17), 5.00 (1H, s, H-14), 3.93-3.58 (1H, m, H-3), 3.18 (1H, dt, J 16.1, 7.1, 
H-13A), 3.18 (1H, dt, J 16.1, 8.9, H-13B), 2.90 (2H, t, J 7.7, H-11), 2.32 (3H, s, 
H-19), 1.78 (2H, dt, J 14.7, 5.7, H-2AB), 1.45-1.32 (2H, m, H-12), 1.27 (9H, s, 
H-21), 1.23-1.10 (10H, m, H-4, H-5, H-6, H-7, H-8), 0.80 (3H, t, J 6.6, H-9). 
 
13C (100 MHz, CDCl3) δC /ppm 169.8 (C-1), 161.5 (C-10), 143.0 (C-15), 141.7 
(C-17), 129.2 (C-16), 126.1 (C-18), 87.9 (C-14), 81.2 (C-20), 52.2 (C-3), 47.0 
(C-13), 39.0 (C-11), 32.1 (C-2), 31.6 (C-4), 29.7 (C-5), 29.0 (C-6), 27.9 (C-21), 
26.1 (C-12), 22.5 (C-7), 21.4 (C-8), 20.9 (C-19), 14.0 (C-9). 
 
νmax. / cm-1: 2926 (m, C-H), 2856 (m, C-H), 2360 (w), 2115 (w), 1724 (s, C=O), 
1569 (s, C=C), 1288 (m, SO2), 1132 (s), 1083 (s), 847 (m). 
 
m/z: 449 (2%, M), 429 (9), 376 (6), 355 (12), 294 (23), 238 (79), 196 (94), 179 



































Rf 0.30 (30% EtOAc/hexane), [α]D20 +44.0 (c 1.00, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm  7.74 (2H, d, J 8.1, H-16), 7.25 (2H, d, J 8.1, 
H-17), 3.94 (1H, tt, J 8.7, 4.3, H-3), 3.66-3.49 (2H, m, H-13AB), 3.40 (1H, dt, J 
15.3, 9.1, H-11A), 3.03 (1H, dt, J 15.3, 6.6, H-11B), 2.95 (1H, dd, J 15.2, 4.3, 
H-2A), 2.48-2.40 (1H, m, H-2B), 2.39 (3H, s, H-19), 2.34 (3H, s, H-23), 
2.12-1.83 (2H, m, H-12AB), 1.72-1.51 (2H, m, H-4AB), 1.46 (9H, s, H-21), 
1.42-1.27 (8H, m, H-5, H-6, H-7, H-8), 0.88 (3H, t, J 6.7, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 190.7 (C-22), 174.9 (C-10), 169.7 (C-1), 142.9 
(C-18), 142.1 (C-15), 129.3 (C-17), 125.8 (C-16), 103.7 (C-14), 81.1 (C-20), 
58.5 (C-3), 49.1 (C-13), 37.8 (C-11), 36.9 (C-2), 32.3 (C-4), 31.4 (C-5), 30.4 
(C-23), 28.8 (C-6), 27.9 (C-21), 25.9 (C-7), 22.5 (C-8), 21.3 (C-19), 20.1 (C-12), 
13.9 (C-9). 
 
νmax. / cm-1: 2930 (m, C-H), 2860 (m, C-H), 2363 (w), 1727 (s, OC=O), 1687 (m, 
C=O), 1616 (m, C=C), 1520 (m), 1297 (s, S=O), 1141 (s), 815 (m). 
 
m/z: 492 (1%, M+1), 418 (6), 376 (12), 336 (24), 320 (9), 280 (100), 238 (91), 







In an oven-dried RBF, under a nitrogen atmosphere, the α-thioiminium salt was 
prepared by reacting t-butyl (3R)-3-(2-thioxo-1-pyrrolidinyl)nonanoate (278) 
(320 mg, 1.02 mmol) with freshly distilled methyl iodide (0.10 mL, 1.5 mmol) in 
THF (5 mL). After 48 hours at ambient temperature the solvent was removed in 
vacuo and a premixed solution of 1-[(4-methylphenyl)sulfonyl]acetone (279) 
(435 mg, 2.05 mmol) and DBU (0.46 mL, 3.0 mmol) in CH2Cl2 (5 mL) was 
carefully added to the α-thioiminium salt. The reaction was left stirring at 
ambient temperature for an additional 72 hours and was quenched with distilled 
H2O (3 mL), extracted into CH2Cl2 (3 × 10 mL) and dried with sodium sulfate. 
The solvent was removed in vacuo and the crude material was purified by 
column chromatography (20% EtOAc/hexane). The desired product t-butyl 
(3R)-3-{2-[(E)-(p-toluenesulfonyl)methylene-1-pyrrolidinyl}nonanoate (280) 
(60 mg, 13% yield) and the acylated product, t-butyl (3R)-3-{2-[1-(p-
toluenesulfonyl)-2-oxopropylidene]-1-pyrrolidinyl}nonanoate (337) (190 
mg, 38% yield) were both isolated as yellow oils. 
 
7.2.6.3 Attempted deacetylation reactions 
Method A154 
t-Butyl (3R)-3-{2-[1-(p-toluenesulfonyl)-2-oxopropylidene]-1-pyrrolidinyl} 
nonanoate (337) (200 mg, 0.41 mmols) was dissolved in TFA (3 mL) and 
heated at reflux for 12 hours. The reaction mixture was cooled and then rinsed 
with an ammonia solution (10%, 15 mL). The organic compounds were 
extracted into CH2Cl2 (3 × 20 mL) and dried with sodium sulfate. The solvent 
was removed in vacuo and the crude mixture was purified by column 
chromatography (100% EtOAc). None of the desired product, t-butyl (3R)-3-{2-





nonanoate (337) (190 mg, 0.39 mmols) was dissolved in toluene (3 mL). TFA 
(0.15 mL, 1.9 mmols) was added and the mixture was heated at reflux for 5 
hours, while being monitored by TLC. The mixture was cooled and the reaction 
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was quenched by the addition of an ammonia solution (10%, 15 mL). The 
organic material was extracted in CH2Cl2 (3 × 15 mL) and the combined organic 
fractions were dried with sodium sulfate. The solvent was removed in vacuo 
and the crude mixture was purified by column chromatography (100% EtOAc). 
None of the desired product, t-butyl (3R)-3-{2-[(E)-(p-
toluenesulfonyl)methylene-1-pyrrolidinyl} nonanoate (280), was isolated. 
 
7.2.7 Reduction of the ester 
7.2.7.1 t-Butyl (3R)-3-{2-[(E)-(p-toluenesulfonyl)methylene-1-pyrrolidinyl} 
nonan-1-ol (281) 
In an oven-dried RBF charged with THF (5 mL), t-butyl (3R)-3-{2-[(E)-(p-
toluenesulfonyl)methylene-1-pyrrolidinyl}nonanoate (280) (0.11 g, 0.24 
mmol) was dissolved and lithium aluminium hydride (25 mg, 0.67 mmol) was 
carefully added. The reaction was stirred at ambient temperature for 15 hours 
and quenched by the addition of CH2Cl2 (10 mL), distilled H2O (1 mL) and 
sodium hydroxide solution (2.0 M, 1 mL) sequentially. The mixture was filtered 
through Celite® and the solvent was removed in vacuo. The product, t-butyl 
(3R)-3-{2-[(E)-(p-toluenesulfonyl)methylene-1-pyrrolidinyl}nonan-1-ol (281) 




























Rf 0.14 (50% EtOAc/hexane), [α]D20 -25.0 (c 0.30, CH2Cl2) 
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1H (300 MHz, CDCl3) δΗ /ppm 7.74 (2H, d, J 8.1, H-16), 7.23 (2H, d, J 8.1, 
H-17), 5.09 (1H, s, H-14), 3.75-3.62 (1H, m, H-3), 3.62-3.44 (2H, m, H-13AB), 
3.20 (2H, t, J 6.7, H-1), 3.08-2.96 (1H, m, H-11A), 2.97-2.84 (1H, m, H-11B), 
2.39 (3H, s, H-19), 2.17 (1H, br, O-H), 1.86 (2H, quintet, J 7.4, H-12), 1.71 (2H, 
q, J 6.7, H-2), 1.56-1.39 (2H, m, H-4), 1.29-1.12 (8H, m, H-5, H-6, H-7, H-8), 
0.86 (3H, t, J 6.8, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 162.6 (C-10), 143.4 (C-15), 141.7 (C-18), 129.2 
(C-17), 125.8 (C-16), 86.2 (C-14), 59.0 (C-13), 51.6 (C-3), 45.9 (C-1), 34.7 
(C-2), 32.3 (C-4), 31.7 (C-7), 31.4 (C-11), 29.0 (C-6), 26.2 (C-8), 22.5 (C-5), 
21.4 (C-19), 20.8 (C-12), 14.0 (C-9). 
 
νmax. / cm-1: 3474 (br, O-H), 2927 (m, C-H), 2857 (m, C-H), 1563 (s, C=C), 1272 
(m, S=O), 1126 (s), 1079 (s), 847 (m), 653 (m). 
 
m/z: 355 (9%), 281 (14), 259 (6), 224 (11), 218 (29), 207 (42), 198 (27), 182 
(57), 155 (64), 139 (55), 124 (48), 111 (81), 105 (100).  Found 379.2176, 
C21H33O3N32S requires 379.2181. 
 
7.2.8 Cyclisation reaction 
7.2.8.1 (5R)-5-Hexyl-1,2,3,5,6,7-hexahydro-8-indolizinyl-4-methylphenyl 
sulfone (282) 
Triphenylphosphine (0.17 g, 0.65 mmol), imidazole (18 mg, 0.26 mmol) and 
iodine (66 mg, 0.26 mmol) were sequentially dissolved in toluene (7 mL). The 
alcohol, t-butyl (3R)-3-{2-[(E)-(p-toluenesulfonyl)methylene-1-pyrrolidinyl} 
nonan-1-ol (281) (50 mg, 0.13 mmol) was added and the mixture was heated 
at reflux for 6 hours. The solvent was removed in vacuo and the residue was 
partitioned between distilled H2O (10 mL) and CH2Cl2 (3 × 10 mL). The 
combined organic fractions were dried with sodium sulfate, the solvent removed 
in vacuo, and the crude material purified by column chromatography (30% 
EtOAc/hexane). (5R)-5-Hexyl-1,2,3,5,6,7-hexahydro-8-indolizinyl-4-methyl 
phenylsulfone (282) (45 mg, 96% yield) was isolated as a yellow oil which 




Rf 0.80 (50% EtOAc/hexane), [α]D20 +9.4 (c 0.85, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.69 (2H, d, J 8.1, H-16), 7.26 (2H, d, J 8.1, 
H-17), 3.49 (1H, quintet, J 6.9, H-5), 3.19 (2H, t, J 7.1, H-3), 3.13 (2H, t, J 7.2, 
H-1), 2.39 (3H, s, H-19), 1.91 (2H, quintet, J 7.2, H-2), 1.80-1.51 (4H, m, H-6, 
H-7), 1.38-1.25 (10H, m, H-9, H-10, H-11, H-12, H-13), 0.85 (3H, t, J 6.9, H-14). 
 
13C (75 MHz, CDCl3) δC /ppm 155.1 (C-8a), 141.9 (C-15), 141.7 (C-18), 129.9 
(C-16), 126.1 (C-17), 92.4 (C-8), 53.9 (C-5), 51.2 (C-3), 32.1 (C-1), 31.7 (C-7), 
31.4 (C-6), 29.3 (C-2), 25.6 (C-9), 24.6 (C-10), 22.6 (C-19), 21.4 (C-11), 21.1 
(C-12), 19.4 (C-13), 14.0 (C-14). 
 
νmax. / cm-1: 2928 (m, C-H), 2856 (m, C-H), 1593 (s, C=C), 1291 (s, S=O), 1142 
(s), 1128 (s), 1079 (s), 1077 (m), 813 (m), 665 (m). 
 
m/z: 361 (32%, M), 304 (7), 276 (89), 206 (100), 204 (14), 164 (8), 149 (10), 












EXPERIMENTAL PROCEDURES RELATING TO CHAPTER 4 
 
8.1 The total synthesis of monomorine I and 5-epi-monomorine I  
 
8.1.1 Preparation of ethyl 4-oxooctanoate  
8.1.1.1 Preparation of ethyl 2-acetyl-3-oxoheptanoate (344)192 
Sodium hydride (60% in oil, 7.20 g, 180 mmol) was dissolved in freshly distilled 
THF (400 mL) in an oven-dried 1 litre RBF. The solution was cooled to 0°C and 
ethyl acetoacetate (25.0 mL, 195 mmol) was added dropwise over 45 minutes 
while the solution was vigorously stirred to prevent an emulsion from forming. 
The solution proceeded to turn yellow. Valeroyl chloride (18.1 g, 150 mmol) was 
added dropwise and the solution turned opaque and milky. The reaction mixture 
was allowed to warm to ambient temperature and was left reacting for a further 
12 hours. The reaction was quenched by the careful addition of distilled H2O 
(200 mL). The product was extracted into EtOAc (3 × 200 mL) and dried with 
magnesium sulfate. The solvent was removed in vacuo and the crude oil was 
purified by column chromatography (5% EtOAc/hexane) to give ethyl 2-acetyl-















Rf 0.84 (10% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 17.80 (1H, s, H-2), 4.28 (2H, q, J 7.2, H-8), 2.66 
(2H, t, J 7.5, H-4), 2.34 (3H, s, H-11), 1.75-1.55 (2H, m, H-5), 1.50-1.22 (5H, m, 
H-9, H-6), 0.92 (3H, t, J 7.2, H-7).  
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13C (75 MHz, CDCl3) δC /ppm  198.8 (C-10), 195.6 (C-3), 167.2 (C-1), 108.6 
(C-2), 60.6 (C-8), 37.4 (C-4), 27.8 (C-5), 25.5 (C-11), 22.4 (C-6), 14.1 (C-9), 
13.7 (C-7). 
 
νmax. / cm-1: 2960 (m, C-H), 2934 (m, C-H), 2874 (m, C-H), 1762 (m, C=O), 
1710 (s, C=O), 1670 (m, C=O), 1556 (m), 1415 (m), 1368 (m), 1218 (s), 1075 
(s).  
 
m/z: 214 (6%, M), 199 (38), 192 (3), 185 (10), 172 (38), 157 (100), 153 (35), 
139 (76), 130 (55), 126 (35), 115 (21), 111 (26). Found 214.11920, C11H18O4 
requires 214.12051. 
 
8.1.1.2 Ethyl 3-oxoheptanoate (345)194 
Method A 
Ethyl 2-acetyl-3-oxoheptanoate (344) (13.2 g 62.0 mmol) was dissolved in dry 
Et2O (40 mL) and ammonia gas was bubbled through the solution for 90 
minutes at ambient temperature (approximately 3 equivalents of ammonia were 
added). The solution was rinsed with distilled H2O (2 × 100 mL) and stirred in 
an HCl solution (10% (v/v), 60 mL) for 2 hours. The organic layer was rinsed 
with saturated sodium bicarbonate solution (100 mL), dried with sodium sulfate 
and then the solvent was removed in vacuo. The crude material was purified by 
column chromatography (5% EtOAc/hexane) to give ethyl acetoacetate (339) 
(6.80 g, 84% yield) as the major product and the desired product, ethyl 3-
oxoheptanoate (345), (1.69 g, 16% yield) as the minor product.  
 
 




1H (300 MHz, CDCl3) δΗ /ppm 4.20 (2H, q, J 7.2, H-8), 3.43 (2H, s, H-2), 2.55 
(2H, t, J 7.3,  H-4), 1.63-1.53 (2H, m, H-5), 1.37-1.26 (5H, m, H-6, H-7) 0.91 
(3H, t, J 7.2, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 202.9 (C-3), 167.2 (C-1), 61.2 (C-8), 49.2 (C-2), 
42.6 (C-4), 25.4 (C-5), 22.0 (C-6), 14.0 (C-9), 13.7 (C-7). 
 
νmax. / cm-1: 2960 (m, C-H), 2935 (m, C-H), 2874 (m, C-H), 1741 (s, C=O), 1715 
(s, C=O), 1312 (s), 1234 (s), 1152 (s), 1030 (s). 
 
m/z: 172 (8%, M), 157, (4), 143 (9), 130 (44), 115 (17), 102 (10), 88 (31), 85 
(100), 84 (45), 69 (24), 57 (95).  
 
Method B206 
Sodium hydride (943 mg, 23.6 mmol) was dissolved in dry THF (50 mL) and the 
solution cooled to 0ºC in an ice-bath. Ethyl acetoacetate (2.00 mL, 15.7 mmol) 
was added dropwise and the solution was allowed to stir for 15 minutes. 
n-Butyllithium (1.6 M, 15.0 mL, 23.6 mmol) was slowly added by syringe and 
the solution was stirred for an additional 15 minutes. Finally, chloropropane (2.3 
mL, 25.9 mmol) was added dropwise to the reaction mixture. The reaction was 
monitored by TLC until the ethyl acetoacetate appeared to have reacted 
completely and the reaction was then quenched by the addition of distilled H2O 
(30 mL). The product was extracted into EtOAc (3 × 50 mL), rinsed with distilled 
H2O (2 × 100 mL) and brine (2 × 50 mL) and dried with sodium sulfate.  The 
solvent was removed in vacuo and the crude product was purified by column 
chromatography (5% EtOAc/hexane) to give ethyl 3-oxoheptanoate (345) 
(200 mg, 8% yield) as a clear oil with a pleasant, fruity odour. The low yield was 
likely due to inferior quality of the n-butyllithium. 
 
8.1.1.3  Preparation of 4-oxooctanoic acid (347)198 
n-Butylmagnesium bromide was prepared in situ by reacting bromobutane 
(8.1 mL, 75 mmol) with magnesium turnings (1.95 g, 80.0 mmol) in dry THF 
(100 mL) for 1 hour at 0°C under nitrogen. In a separate RBF succinic 
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anhydride (5.00 g, 50.0 mmol) was dissolved in THF (70 mL) together with a 
catalytic amount of iron (III) acetoacetate, (530 mg, 1.50 mmol). The Grignard 
reagent (0.75 M, 67 mL, 50 mmol) was added dropwise to the succinic 
anhydride solution over 40 minutes. The colour of the solution gradually 
changed from deep red to yellow. The reaction was stirred for an additional 
hour before it was quenched with an HCl solution (10% (v/v), 30 mL). The 
product was extracted into Et2O (3 × 50 mL). The combined organic extracts 
were washed with saturated sodium bicarbonate solution (50 mL) and distilled 
H2O (2 × 50 mL) and dried with sodium sulfate. The Et2O was removed in 
vacuo and the crude product was purified by column chromatography (5% 
EtOAc/hexane) to give the desired product, 4-oxooctanoic acid (347) (2.00 g, 
25% yield), and 5,5-dibutyldihydro-2(3H)-furanone (348) (550 mg, 11% yield) 




M.p. 49-51ºC  
 
Rf 0.15 (10% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 12.00-10.00 (1H, br, O-H), 2.72 (2H, t, J 6.4, 
H-2), 2.63 (2H, t, J 6.4, H-3), 2.45 (2H, t, J 6.7, H-5), 1.63-1.53 (2H, m, H-6), 
1.37-1.24 (2H, m, H-7), 0.91 (3H, t, J 7.3, H-8). 
 
13C (75 MHz, CDCl3) δC /ppm 209.4 (C-4), 179.1 (C-1), 42.8 (C-5), 37.1 (C-3), 
28.2 (C-2), 26.3 (C-6), 22.7 (C-7), 14.2 (C-8). 
 
νmax. / cm-1: 3550-3350 (br, OH), 2958 (m, C-H), 2930 (m, C-H), 2868 (m, C-H), 




 m/z: 158 (1%, M), 141 (8), 116 (62), 111 (9), 101 (75), 98 (79), 85 (92), 73 












Rf 0.32 (10% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 2.57 (2H, t, J 8.4, H-3), 2.02 (2H, t, J 8.5, H-2), 
1.66-1.57 (4H, m, H-5), 1.40-1.26 (8H, m, H-6, H-7), 0.92 (6H, t, J 6.2, H-8). 
 
13C (75 MHz, CDCl3) δC /ppm 177.4 (C-1), 89.5 (C-4), 38.9 (C-5), 31.2 (C-2), 
29.6 (C-3), 26.0 (C-6), 23.4 (C-7), 14.3 (C-8). 
 
νmax. / cm-1: 2959 (m, C-H), 2938 (m, C-H), 2875 (m, C-H), 1772 (s, C=O), 1469 
(m), 1231 (m), 1194 (m), 1160 (m), 935 (m). 
 
m/z: 199 (1%, M), 141 (100), 95 (5), 85 (7), 57 (10), 41 (9). Found 199.1679, 
C12H23O2 (M+1) requires 199.1698.   
 
8.1.1.4 Preparation of ethyl 4-oxooctanoate (292)  
Method A198, 199 
THF (4 mL) and Et2O (12 mL) were distilled and degassed with nitrogen for 30 
minutes. Di-n-butylcopper lithium was prepared in situ by reacting copper iodide 
(762 mg, 4.00 mmol) with n-butyllithium (1.6 M, 5.0 mL, 8.0 mmol) at −90ºC 
under a nitrogen atmosphere for 1 hour (the solution turned black upon addition 
of n-butyllithium). Ethyl 4-chloro-4-oxobutyrate (1.04 mL, 7.30 mmol) was 
added to the cuprate by syringe at −90ºC, and the reaction mixture was allowed 
to warm to ambient temperature and stir for a further 12 hours. The reaction 
was quenched by the addition of saturated aqueous ammonium chloride (20 
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mL) and the biphasic solution was stirred for 40 minutes. Once the pH of the 
solution was neutral the product was extracted into Et2O (4 × 30 mL). The 
combined organic extracts were dried with magnesium sulfate and the solvent 
was removed in vacuo. The crude product was purified by column 
chromatography (5% EtOAc/hexane) to give ethyl 4-oxooctanoate (292) as a 
pale yellow oil (530 mg, 56% yield), with contamination by diethyl succinate 
(346) (305 mg, 24% yield), a by-product from the reaction. When the reaction 
was scaled up (48 mmol) the production of diethyl succinate (346) increased 
to 42% yield and the yield of the ethyl 4-oxooctanoate (292) went down to 2%. 
For all the solvent systems investigated, diethyl succinate (346) and ethyl 4-
oxooctanoate (292) have identical Rf values on silica TLC plates, making 
separation by column chromatography extremely difficult. They do however 
differ in boiling points (at 15 torr. diethyl succinate boils at 105°C and ethyl 
4-oxooctanoate boils at 125°C) and could be separated by distillation if the 
















Rf 0.63 (20% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 4.13 (2H, q, J 7.1, H-9), 2.72 (2H, t, J 7.0, H-3), 
2.62-2.45 (2H, m, H-2), 2.45 (2H, t, J 7.0, H-5), 1.63-1.55 (2H, m, H-6), 
1.34-1.27 (2H, m, H-7), 1.25 (3H, t, J 7.1, H-10), 0.91 (3H, t, J 7.3, H-8). 
 
13C (75 MHz, CDCl3) δC /ppm 209.5 (C-4), 173.2 (C-1), 61.0 (C-9), 42.9 (C-5), 
37.4 (C-3) 28.4 (C-2), 26.3 (C-6), 22.7 (C-7), 14.5 (C-10), 14.3 (C-8). 
 
νmax. / cm-1: 2959 (m, C-H), 2935 (m, C-H), 2874 (m, C-H), 1737 (s, C=O), 1720 
(s, C=O), 1413 (w), 1374 (m), 1350 (w), 1197 (s), 1163 (s), 1021 (m). 
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m/z: 187 (1%, M+1), 144 (55), 141 (65), 129 (47), 111 (8), 101 (100), 85 (57), 











1H (300 MHz, CDCl3) δΗ /ppm 4.15 (4H, q, J 7.2, H-3), 2.62 (4H, s, H-2), 1.26 
(6H, t, J 7.2, H-4). 
 
Method B200 - 202 
Bis-(N,N-dimethylaminoethyl)ether (4.4 mL, 35 mmol) was reacted with  
n-butylmagnesium chloride (2.0 M, 18 mL, 35 mmol) in THF (80 mL), at 0ºC 
under nitrogen, to allow formation of a tridentate ligand. After 20 minutes, this 
solution was added dropwise to a solution of ethyl 4-chloro-4-oxobutanoate (5.0 
mL, 35 mmol) in THF (20 mL) at -90ºC. After 20 minutes, TLC still indicated that 
starting material was present and the reaction mixture was allowed to warm to 
ambient temperature and stir for 2 hours. The reaction was quenched by the 
addition of saturated ammonium chloride solution (75 mL). The THF was 
removed in vacuo and the product was extracted into EtOAc (5 × 70 mL) and 
dried with sodium sulfate. The solvent was removed in vacuo and the product 
was purified by column chromatography (5% EtOAc/hexane) to give ethyl 4-
oxooctanoate (292) (1.35 g, 21%) as a clear oil. 
 
Method C195, 196 
 3-Benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazolium chloride (0.75 g, 
3.0 mmol) was dissolved in dioxane (30 mL) with Et3N (2.5 mL, 18 mmol) and 
ethyl acrylate (3.2 mL, 30 mmol) in a 3-necked RBF. The flask was fitted with a 
condenser which was sealed with a KOH drying tube. It was also fitted with a 
nitrogen leak (1 bubble/second) and a septum. A mixture of valeraldehyde 
(3.2 mL, 30 mmol), a second portion of ethyl acrylate (3.2 mL, 30 mmol) and 
dioxane (5 mL) was added by syringe pump over 10 hours. The reaction was 
left for a further 6 hours at ambient temperature. The dioxane was removed in 
vacuo and the organic residue was redissolved in EtOAc. The organic layer 
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was rinsed with an HCl solution (5% (v/v), 50 mL), saturated sodium 
bicarbonate solution (2 × 50 mL) and distilled H2O (2 × 50 mL). The organic 
layer was dried with magnesium sulfate and the solvent was removed in vacuo. 
The crude material was purified by column chromatography (20% 
EtOAc/hexane) to give ethyl 4-oxooctanoate (292) (901 mg, 16% yield) with 
slight contaminated by diethyl succinate (346).  
   
Method D193 
A flame-dried, nitrogen-flushed 50 mL RBF was charged with dry CH2Cl2 (17 
mL) and neat diethyl zinc (0.60 mL, 5.8 mmol). This was done very carefully by 
means of a nitrogen flushed syringe as the diethyl zinc ignites readily on 
contact with air. Diiodomethane (0.50 mL, 5.8 mmol) was carefully added and 
as soon as exothermic bubbling was initiated the solution was cooled to 0ºC. 
After 10 minutes of stirring, ethyl 3-oxoheptanoate (345) (0.19 g, 1.1 mmol) 
was rapidly added by syringe. The reaction was left at ambient temperature for 
an additional 30 minutes and then quenched by the addition of saturated 
ammonium chloride solution (10 mL). The product was extracted into Et2O (3 × 
25 mL), and the combined organic extracts were rinsed with brine (25 mL) and 
dried with sodium sulfate. The solvent was removed in vacuo and the crude 
product was purified by column chromatography (5% EtOAc/hexane) to give 
ethyl 4-oxooctanoate (292) (125 mg, 62% yield) as a clear oil. 
 
Method E199 
Di-n-butylcopper lithium was prepared in situ by reacting copper iodide 
(720 mg, 4.00 mmol) with n-butyllithium (1.6 M, 5.00 mL, 8.00 mmol) in THF 
(4 mL) at -90 °C under a nitrogen atmosphere for 1 hour. Succinic anhydride 
(727 mg, 7.27 mmol) was carefully added to this solution and the reaction was 
stirred for a further 3 hours at ambient temperature. The reaction was quenched 
by the addition of saturated ammonium chloride solution (10 mL) and the 
biphasic solution was stirred for 30 minutes before being acidified with an HCl 
solution 5% (v/v) and extracted into Et2O (12 mL). The Et2O was removed in 
vacuo and the residue was redissolved in EtOH (10 mL). Approximately 5 drops 
of concentrated H2SO4 were added and the reaction was allowed to stir for 3 
hours. The solvent was then removed in vacuo and the crude material was 
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partitioned between EtOAc (20 mL) and distilled H2O (20 mL). The organic 
fraction was dried with sodium sulfate and the solvent was removed in vacuo. 
Purification by column chromatography (5% EtOAc/hexane) gave ethyl 
4-oxooctanoate (292) (250 mg, 34% yield over the two steps). 
 
Method F203, 204  
Ethyl 4-chloro-4-oxobutanoate (1.0 mL, 7.0 mmol), was dissolved in THF 
(10 mL) in a flame-dried RBF. The solution was cooled to -29°C in a 
xylene/liquid nitrogen bath under a nitrogen atmosphere. Tri-n-butylphosphine 
(1.9 mL, 7.7 mmol) was carefully added and the solution was stirred for 25 
minutes. This was followed by the rapid addition of n-butylmagnesium bromide 
(2.0 M, 4.0 mL, 8.0 mmol) by syringe. The reaction was left stirring for an 
additional 10 minutes and was then quenched with aqueous HCl (1.0 M, 5 mL). 
The reaction mixture was poured into a flask containing additional HCl (1.0 M, 
80 mL) and the product was extracted into EtOAc (3 × 50 mL). The organic 
fractions were combined and rinsed with sodium bicarbonate solution (1% 
(w/w), 50 mL), followed by brine (50 mL) and finally dried with sodium sulfate.  
The EtOAc was evaporated in vacuo and the crude product was purified by 
column chromatography (5% EtOAc/hexane) to give ethyl 4-oxooctanoate 
(292) (1.21 g, 93% yield) as a clear oil.  
 
Method G198 
Ethyl 4-chloro-4-oxobutanoate (5.0 mL, 35 mmol), was dissolved in THF 
(100 mL) together with iron (III) acetoacetate (0.371 g, 1.05 mmol) in an oven-
dried RBF, under a nitrogen atmosphere. The solution was cooled to 0°C and 
n-butylmagnesium bromide (1.75 M, 20 mL, 35 mmol) was added dropwise 
from a dropping funnel. The addition was complete after 10 minutes and the 
reaction was quenched by adding aqueous HCl (10% (v/v), 60 mL). The 
product was extracted into EtOAc (3 × 50 mL), washed with saturated sodium 
bicarbonate solution (60 mL), rinsed with distilled H2O (50 mL) and dried with 
sodium sulfate.  The EtOAc was evaporated in vacuo and the crude product 
was purified by column chromatography (5% EtOAc/hexane) to give ethyl 
4-oxooctanoate (292) (6.51 g, 100% yield).  
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8.1.2 Preparation of ethyl 3-aminobutyrate 
8.1.2.1 (Z)-Ethyl 3-aminobut-2-enoate (349)208 - 210 
Ethyl acetoacetate (15.2 mL, 120 mmol) was dissolved in benzene (150 mL) in 
a 250 mL RBF connected to a Dean-Stark apparatus. AcOH (6 mL) and 
ammonium acetate (18.5 g, 240 mmol) were added and the solution was 
heated at reflux for 4 hours. The solution was then cooled and the benzene and 
AcOH were removed in vacuo. The residual oil was redissolved in EtOAc 
(100 mL) and washed with saturated sodium carbonate solution (100 mL), dried 
with sodium sulfate and evaporated down in vacuo. The product was isolated 
by vacuum distillation to give (Z)-ethyl 3-aminobut-2-enoate (349) (14.0 g 
91% yield) as a clear oil. The 1H-NMR spectrum indicated that the product was 




M.p. 28 -31 °C 
 
Rf 0.71 (50% EtOAc/hexane) 
 
Major Tautomer (349A) 
1H (300 MHz, CDCl3) δΗ /ppm 8.5-7.5 (2H, br, s, N-H2), 4.52 (1H, s, H-2), 4.10 
(2H, q, J 7.1, H-5), 1.90 (3H, s, H-4), 1.25 (3H, t, J 7.1, H-6). 
 
13C (75 MHz, CDCl3) δC /ppm 169.9 (C-1), 159.9 (C-3), 83.1 (C-2), 58.0 (C-5), 
21.6 (C-4), 14.1 (C-6).  
 
Minor Tautomer (349B) 
1H (300 MHz, CDCl3) δΗ /ppm 8.5-7.5 (1H, br, s, N-H), 4.52 (2H, s, H-2), 4.10 
(2H, q, J 7.1, H-5), 1.66 (3H, s, H-4), 1.25 (3H, t, J 7.1, H-6). 
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13C (75 MHz, CDCl3) δC /ppm 200.6 (C-3), 166.8 (C-1), 60.9 (C-5), 49.5 (C-2), 
29.6 (C-4), 13.6 (C-6).   
 
νmax. / cm-1: 3413 (m, N-H), 3320 (m, N-H), 2981 (w, C-H), 2929 (w, C-H), 2896 
(w, C-H), 1655 (m), 1614 (s), 1553 (s), 1476 (w), 1452 (w), 1377 (w), 1291 (s), 
1165 (s), 1113 (m), 1046 (m), 980 (m), 781 (s). 
 
m/z: 129 (53%, M), 119 (29), 105 (100). 
 
8.1.2.2 (Z)-t-Butyl 3-aminobut-2-enoate (353)208 - 210 
t-Butyl acetoacetate (3.32 mL, 20.0 mmol) was dissolved in benzene (75 mL) in 
a 250 mL RBF connected to a Dean-Stark apparatus. AcOH (2 mL) and 
ammonium acetate (3.08 g, 40.0 mmol) were added and the solution was 
heated at reflux for 3 hours. The benzene and the AcOH were removed in 
vacuo and the residual oil was redissolved in EtOAc (100 mL). The organic 
layer was washed with saturated sodium carbonate solution (100 mL) and 
distilled H2O (2 × 100 mL), and then dried with sodium sulfate. The EtOAc was 
removed in vacuo and the product was purified by vacuum distillation to give 
(Z)-t-butyl 3-aminobut-2-enoate (353) (2.79 g, 89% yield) as a low-melting, 












M.p. 35 -37 °C 
 
Rf 0.74 (50% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 8.5-7.5 (2H, br, s, N-H2), 4.46 (1H, s, H-2), 1.87 
(3H, s, H-4), 1.47 (9H, s, H-6). 
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13C (75 MHz, CDCl3) δC /ppm 170.2 (C-1), 158.7 (C-3), 85.9 (C-2), 78.1 (C-5), 
28.6 (C-6), 22.3 (C-4). 
 
νmax. / cm-1: 3411 (s, N-H), 3320 (s, N-H), 2982 (w, C-H), 2929 (w, C-H), 2896 
(w, C-H), 1655 (m), 1614 (s), 1552 (s), 1476 (w), 1453 (w), 1376 (w), 1290 (s), 
1165 (s), 1113 (m), 1047 (m), 980 (m), 781 (s). 
 
8.1.2.3 Preparation of ethyl 3-(dibenzylamino)butanoate (351)158 
Freshly distilled dibenzylamine (4.95 mL, 25.8 mmol) was dissolved in THF 
(100 mL) in oven-dried glassware and cooled to −90ºC under nitrogen. 
n-Butyllithium (1.6 M, 15 mL, 24 mmol) was added by syringe and the reaction 
mixture turned from clear to deep red. The mixture was allowed to stir for 30 
minutes at −90ºC at which point a solution of ethyl crotonate (2.66 mL, 
21.5 mmol) in THF (45 mL) was added from a dropping funnel over 40 minutes. 
The reaction was maintained at −90ºC for a further 2 hours before it was 
quenched with saturated ammonium chloride solution (50 mL) and warmed to 
ambient temperature. The THF was removed in vacuo, distilled H2O (60 mL) 
was added to the aqueous solution and the product was extracted into CH2Cl2 
(6 × 30 mL). The organic fractions were combined and dried with sodium 
sulfate. The CH2Cl2 was evaporated in vacuo and the crude product was 
purified by column chromatography (5% EtOAc/hexane) to give racemic ethyl 
















Rf 0.43 (10% EtOAc/hexane)  
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1H (300 MHz, CDCl3) δΗ /ppm 7.65 (2H, t, J 7.0, H-9), 7.60 (4H, t, J 7.0, H-8), 
7.53 (4H, d, J 7.0, H-7), 4.46 (1H, q, J 7.1, H-10A), 4.33 (1H, q, J 7.1, H-10B), 
3.97 (2H, d, J 13.7, H-5A), 3.78 (2H, d, J 13.7, H-5B), 3.70-3.58 (1H, m, H-3), 
2.96 (1H, dd, J 7.7, 13.9, H-2A), 2.59 (1H, dd,  J 7.0, 13.9, H-2B), 1.50 (3H, t, J 
7.1, H-11), 1.42 (3H, d, J 6.7, H-4). 
 
13C (75 MHz, CDCl3) δC /ppm 172.7 (C-1), 140.4 (C-6), 129.2 (C-7), 128.5 
(C-8), 127.2 (C-9), 60.7 (C-10), 53.8 (C-5), 51.3 (C-3), 39.6 (C-2), 14.5 (C-4, 
C-11). 
 
νmax. / cm-1: 3062 (w, Ar), 3027 (w, Ar), 2975 (m, C-H), 2934 (m, C-H), 2803 
(m), 1734 (s, C=O), 1495 (m), 1454 (m), 1368 (m), 1297 (m), 1190 (s, C-N), 
1095 (m, C-N), 1031 (m), 747 (s), 698 (s). 
 
m/z: 311 (5%, M), 296 (9), 224 (93), 220 (11), 181 (7), 132 (9), 105 (18), 91 
(100), 77 (10). Found 311.1894, C20H25O2N requires 311.1885. 
 
8.1.2.4 Ethyl (3R)-3-{benzyl[(1R)-1-phenylethyl]amino}butanoate (356)158 
Benzyl[(1R)-1-phenylethyl]amine (2.02 mL, 9.67 mmol) was dissolved in THF 
(30 mL) in oven-dried glassware and cooled to −90ºC under nitrogen. 
n-Butyllithium (0.7 M, 12.9 mL, 9.03 mmol) was added by syringe and the 
reaction turned from clear to deep red. The mixture was allowed to stir for 30 
minutes at −90ºC before a solution of ethyl crotonate (1.00 mL, 8.06 mmol) in 
THF (16 mL) was added from a dropping funnel over 35 minutes. The reaction 
was maintained at −90ºC for a further 2 hours before it was quenched with 
saturated aqueous ammonium chloride (50 mL) and warmed to ambient 
temperature. The THF was evaporated in vacuo, distilled H2O (20 mL) was 
added to the aqueous solution and the product was extracted into CH2Cl2 (5 × 
40 mL). The organic fractions were combined and dried with sodium sulfate. 
The CH2Cl2 was evaporated in vacuo and the crude product was purified by 
column chromatography (5% EtOAc/hexane) to give ethyl (3R)-3-{benzyl[(1R)-
1-phenylethyl]amino}butanoate (356) (2.49 g, 95% yield) as a clear and 






















Rf 0.43 (10 % EtOAc/hexane), [α]D20 +7.6 (c 1.06, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.42-7.17 (10H, m, Ar-H), 3.99 (1H, q, J 7.2, 
H-16), 3.92 (2H, q, J 7.0, H-5), 3.71 (1H, d, J 14.7, H-11A), 3.69 (1H, d, J 14.7, 
H-11B), 3.50-3.40 (1H, m, H-3), 2.36 (1H, dd, J 5.9, 14.1, H-2A), 2.10 (1H, dd, J 
8.0, 14.1, H-2B), 1.35 (3H, d, J 7.0, H-6), 1.16 (3H, t, J 7.2, H-17), 1.14 (3H, d, 
J 6.7, H-4). 
 
13C (75 MHz, CDCl3) δC /ppm 172.8 (C-1), 144.7 (C-7), 142.2 (C-12), 128.7, 
128.5, 128.4, 128.1, 127.1, 127.0 (C-8, C-9, C-10, C-13, C-14, C-15), 60.5 
(C-16), 58.2 (C-5), 50.5 (C-3), 50.0 (C-11), 40.2 (C-2), 19.0 (C-17), 18.3 (C-6), 
14.5 (C-4). 
 
νmax. / cm-1: 3062 (w, Ar), 3027 (w, Ar), 2975 (m, C-H), 2934 (m, C-H), 1732 (s, 
C=O), 1494 (m), 1453 (s), 1371 (s), 1296 (s), 1193 (s), 749 (s), 700 (s). 
 
m/z: 325 (8%, M), 310 (30), 248 (4), 238 (71), 220 (20), 134 (54), 120 (5), 105 
(100), 77 (19), 51 (5). Found 325.2067, C12H27O2N requires 325.2042. 
 
8.1.2.5 Ethyl 3-aminobutanoate (291)  
Method A158, 212 
Ethyl 3-(dibenzylamino)butanoate (351) (1.0 g, 3.2 mmol) was dissolved in 
absolute EtOH (15 mL). Activated palladium on carbon (10%, 483 mg, 
0.150 g/mmol) and a catalytic amount of concentrated HCl (1 mL) were added 
and the mixture was stirred in a hydrogenator under 7 atmospheres of 
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hydrogen pressure for 72 hours. The solution was then filtered through Celite® 
to remove the palladium catalyst. The Celite® was thoroughly rinsed with 
CH2Cl2 (300 mL) and the solvent removed in vacuo using toluene as an 
azeotrope to remove the residual AcOH. The organic residue was redissolved 
in CH2Cl2 (30 mL) and stirred with solid sodium bicarbonate (3 spatulas full) for 
5 hours. The sodium bicarbonate was filtered off, thoroughly rinsed and then 
the CH2Cl2 was removed in vacuo to give the partially debenzylated product, 
ethyl 3-(benzylamino)butanoate (355) (540 mg, 71% yield).g 
 
Method B  
Ethyl 3-(dibenzylamino)butanoate (351) (4.00 g, 12.9 mmol) was dissolved in 
glacial AcOH (55 mL). Activated palladium on carbon (10%, 1.93 g, 
0.150 g/mmol) was added and the mixture stirred in a hydrogenator under 
7.5 atmospheres of hydrogen pressure for 72 hours. The solution was then 
filtered through Celite® to remove the palladium catalyst. The Celite® was rinsed 
thoroughly with distilled H2O (100 mL) and CH2Cl2 (100 mL) and the organic 
solvent was removed in vacuo. The aqueous solution was basified with solid 
sodium bicarbonate and the product was back-extracted into CH2Cl2 (6 × 
50 mL). The organic fractions were combined and dried with potassium 
carbonate and the CH2Cl2 was removed in vacuo to give crude ethyl 3-
aminobutanoate (291). A pure sample of ethyl 3-aminobutanoate (291) (400 
mg, 24% yield) was obtained by careful chromatography (100% EtOAc - 10% 
MeOH/EtOAc) for characterization purposes.h  
 
Method C 
Ethyl 3-(dibenzylamino)butanoate (351) (0.20 g, 0.60 mmol) and ceric 
ammonium nitrate (667 mg, 1.20 mmol) were dissolved in a 1:5 mixture of 
                                                 
g The yields for partially and fully debenzylated products were extremely variable. See 
Chapter 4 for the detailed explanation. 
h When the reaction was repeated no water was used in the work up, and low 
temperatures were employed when removing solvent in vacuo. Column 
chromatography was avoided as it resulted in reduced yields, and instead the crude 
amine was used directly in the next reaction. Residual AcOH peaks persisted in the 
crude NMR spectra of these products, but the use of higher temperatures, H2O, or 
column chromatography drastically reduces the yield as the amine is volatile and 
partially soluble in water. 
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MeCN and distilled H2O (10 mL) and the reaction mixture stirred at ambient 
temperature for 12 hours. The reaction was quenched with saturated sodium 
bicarbonate solution (10 mL) and filtered through cotton wool to remove any 
precipitate. The product was extracted into CH2Cl2 (4 × 20 mL) and dried with 
sodium sulfate. The solvent was removed in vacuo and the crude product was 
purified by column chromatography (5% - 50% EtOAc/hexane) to give ethyl 3-




Rf 0.11 (10% MeOH/EtOAc) 
 
1H (300 MHz, CDCl3) δΗ /ppm 4.15 (2H, q, J 7.1, H-5), 3.42-3.34 (1H, m, H-3), 
2.41 (1H, dd, J 4.6, 15.6, H-2A), 2.29 (1H, dd, J 8.4, 15.6, H-2B), 1.71 (2H, s, 
NH2), 1.27 (3H, t, J 7.1, H-6), 1.13 (3H, d, J 6.4, H-4). 
 
13C (75 MHz, CDCl3) δC /ppm 172.4 (C-1), 60.3 (C-5), 44.3 (C-2), 44.1 (C-3), 
23.6 (C-4), 14.3 (C-6). 
 
νmax. / cm-1 3370 -3200 (br, NH2), 2976 (m, C-H), 2932 (m, C-H), 1733 (s, C=O), 
1644 (s), 1552 (s), 1377 (m), 1189 (m). 
 
m/z: 132 (24%, M), 128 (13), 116 (7), 84 (7), 70 (14), 57 (18), 44 (100), 42 (13). 
Found 132.1026, C6H13NO2 requires 132.1025. 
 
                                                 
i Racemic ethyl 3-aminobutyrate is commercially available from Sigma-Aldrich as a 
90% pure, racemic mixture. For all subsequent reactions requiring the racemic amine 




Rf 0.14 (10% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.34-7.17 (5H, m, H-7, H-8, H-9), 4.16-3.98 (2H, 
m, H-10AB), 3.64 (1H, d, J 13.8, H-5A), 3.44 (1H, d, J 13.8, H-5B), 3.31 (1H, 
quintet, J 6.9, H-3), 2.62 (1H, dd, J 13.8, 7.8, H-2A), 2.26 (1H, dd, J 13.8, 6.9, 
H-2B), 1.24 (1H, s, NH), 1.19 (3H, t, J 7.2, H-11), 1.09 (3H, d, J 6.6, H-4). 
 
13C (75 MHz, CDCl3) δC /ppm 172.3 (C-1), 140.0 (C-6), 128.7 (C-7), 128.0 
(C-8), 126.8 (C-9), 60.2 (C-10), 53.3 (C-5), 50.9 (C-3), 37.6 (C-2), 14.1 (C-4), 
14.0 (C-11). 
 
8.1.2.6 Ethyl (3R)-3-aminobutanoate (291) 
Method A158 
Ethyl (3R)-3-{benzyl[(1R)-1-phenylethyl]amino}butanoate (356) (0.570 g, 
1.75 mmol) was dissolved in glacial  AcOH (5 mL). Activated palladium on 
carbon (10%, 262 mg, 0.150 g/mmol) was added and the reaction was left in a 
hydrogenator under 7.5 atmospheres of hydrogen pressure for 72 hours. The 
solution was filtered through Celite® to remove the palladium catalyst. The 
Celite® was thoroughly rinsed with CH2Cl2 (300 mL) and the solvent was 
removed in vacuo, using toluene as an azeotrope to remove the residual AcOH. 
The organic residue was redissolved in CH2Cl2 (30 mL) and stirred with solid 
sodium bicarbonate (3 spatulas full) for 5 hours. The sodium bicarbonate was 
filtered off, rinsed thoroughly and the CH2Cl2 was removed in vacuo. The crude 
material was purified by column chromatography (100% EtOAc - 10% 
MeOH/EtOAc) and two products were identified; ethyl (3R)-aminobutanoate 
(291) (80 mg, 35% yield) and ethyl (3R)-3-{[(1R)-1-













Rf 0.11 (10% MeOH/EtOAc), [α]D20 +37.0 (c 1.20, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 4.15 (2H, q, J 7.1, H-5), 3.41-3.35 (1H, m, H-3), 
2.41 (1H, dd, J 4.6, 15.6, H-2A), 2.29 (1H, dd, J 8.4, 15.6, H-2B), 1.71 (2H, s, 
NH2), 1.27 (3H, t, J 7.1, H-6), 1.13 (3H, d, J 6.4, H-4). 
 
13C (75 MHz, CDCl3) δC /ppm 172.4 (C-1), 60.3 (C-5), 44.3 (C-2), 44.1 (C-3), 
23.6 (C-4), 14.3 (C-6). 
 
νmax. / cm-1: 3370 (br, NH), 2976 (m, C-H), 2932 (m, C-H), 1733 (s, C=O), 1644 
(s), 1552 (s). 
 
m/z: 132 (24%, M), 128 (13), 116 (7), 84 (7), 70 (14), 57 (18), 44 (100), 42 (13). 

















Rf 0.12 (10% EtOAc/hexane), [α]D20 +23.0 (c 1.65, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.39-7.25 (5H, m, H-8, H-9, H-10), 4.12 (2H, q, J 
7.1, H-11), 4.03 (1H, q, J 6.7, H-5), 3.17-3.06 (1H, m, H-3), 2.60 (1H, dd, J 5.2, 
15.4, H-2A), 2.43 (1H, dd, J 7.1, 15.4, H-2B), 2.07 (1H, s, NH), 1.44 (3H, d, J 
6.7, H-6), 1.25 (3H, t, J 7.1, H-12), 1.12 (3H, d, J 6.5, H-4). 
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13C (75 MHz, CDCl3) δC /ppm 177.0 (C-1), 144.7 (C-7), 129.1 (C-8), 128.1 
(C-10), 127.5 (C-9), 61.1 (C-11), 56.2 (C-5), 48.7 (C-3), 40.7 (C-2), 24.3 (C-6), 
21.3 (C-4), 14.95 (C-12). 
 
νmax. / cm-1: 2970 (m, C-H), 1761 (s, C=O), 1455 (m), 1371 (m), 1185 (s), 1080 
(m), 753 (m), 702 (s). 
 
m/z: 235 (2%, M), 220 (100), 185 (8), 174 (6), 158 (9), 148 (77), 132 (88), 120 
(68), 116 (22), 105 (100). APCI Found 235.72, C14H21NO2 requires 235.16. 
 
Method B  
A 100 mL RBF was charged with MeOH (20 mL) and ethyl (3R)-3-
{benzyl[(1R)-1-phenylethyl]amino}butanoate (356) (500 mg, 1.54 mmol). 
Ammonium formate (776 mg, 12.3 mmol) was added and the solution was 
stirred under a nitrogen atmosphere until the solution was homogenous. 
Palladium on carbon (10%, 185 mg, 0.37 eq.) was carefully stirred into the 
mixture (the methanolic vapours readily ignited if the system was not properly 
flushed with nitrogen). The reaction was left at ambient temperature for 3.5 
hours, until TLC indicated that all the starting material was consumed. The 
reaction mixture was filtered through Celite® and rinsed with MeOH (2 × 20 mL) 
to remove the catalyst. The solvent was removed in vacuo and the residue was 
rinsed with NaOH solution (1.0 M, 8 mL) and extracted into CH2Cl2 (2 × 20 mL). 
The combined organic extracts were dried with sodium sulfate and the solvent 
removed in vacuo. Purification of the crude oil by column chromatography (5% - 
100% EtOAc/hexane) gave ethyl (3R)-3-{[(1R)-1-
phenylethyl]amino}butanoate (357) (250 mg, 69% yield) as a clear oil. 
 
Method C  
Ethyl (3R)-3-{[(1R)-1-phenylethyl]amino}butanoate (357) (0.69 g, 2.9 mmol) 
was dissolved in AcOH (5 mL)  with palladium hydroxide (10 - 20%, 70 mg, 
0.10 eq.). The reaction was set up under 7 atmospheres of hydrogen pressure 
in the hydrogenator at ambient temperature for 72 hours. The reaction mixture 
was filtered through Celite® and rinsed with CH2Cl2 (150 mL) to remove the 
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residual catalyst. The solvent was removed in vacuo and the crude product was 
purified by column chromatography (50% - 100% EtOAc/hexane). No products 
were isolated, but starting material was recovered (420 mg, 61% recovery). 
 
8.1.3 Condensation reaction 
8.1.3.1 Ethyl 3-[(4-oxooctanoyl)amino]butanoate (377)128, 221  
4-Oxooctanoic acid (347) (200 mg, 1.26 mmol) was dissolved in dry CH2Cl2 
(7 mL) and cooled to 0ºC. Oxalyl chloride (0.22 mL, 2.5 mmol) was added and 
the reaction was left stirring for 2 hours at ambient temperature. The excess 
oxalyl chloride and CH2Cl2 were removed in vacuo and the crude product was 
placed under high vacuum for 1 hour to remove any residual oxalyl chloride. 
Fresh CH2Cl2 (10 mL) was added to the organic residue, followed by ethyl 3-
aminobutanoate (90%, 0.19 mL, 1.26 mmol) and Et3N (0.17 mL, 1.3 mmol). The 
reaction mixture was stirred at ambient temperature for 14 hours before the 
solvent was removed in vacuo and the crude product was purified by column 
chromatography (40% EtOAc/hexane) to give ethyl 3-[(4-oxooctanoyl) 





M p. 52-53.5 °C 
 
Rf 0.31 (10 % EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 6.18 (1H, d, J 7.6, NH), 4.28-4.21 (1H, m, H-3), 
4.08 (2H, q, J 7.1, H-13),  2.68 (2H, t, J 6.6, H-6), 2.42-2.31 (6H, m, H-2, H-7, 
H-9), 1.55-1.45 (2H, m, H-10), 1.27-1.24 (2H, m, H-11), 1.20 (3H, t, J 7.1, H-
14), 1.14 (3H, d, J 6.8, H-4), 0.83 (3H, t, J 7.3, H-12). 
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13C (75 MHz, CDCl3) δC /ppm 209.1 (C-8), 170.6 (C-1), 170.1 (C-5), 59.5 
(C-13), 41.5 (C-9), 41.1 (C-3), 39.2 (C-7), 36.6 (C-6), 29.0 (C-2), 24.9 (C-10), 
21.3 (C-11), 19.0 (C-14), 13.2 (C-4), 12.8 (C-12). 
 
νmax. / cm-1: 3306 (br, NH), 2960 (m, C-H), 2934 (m, C-H), 2871 (m, C-H), 1731 
(s, OC=O), 1707 (s, C=O), 1640 (s, NC=O), 1546 (m), 1374 (m), 1228 (m). 
 
m/z: Found 271.1767, C14H25O4N requires 271.1784. 
 
8.1.3.2 Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) 
Method A 
Ethyl 3-[(4-oxooctanoyl)amino]butanoate (377) (60 mg, 0.22 mmol) was set 
up to reflux with AcOH (20 mg, 1.11 mmol) in toluene (7 mL) for 72 hours. The 
solution was cooled, the solvent removed in vacuo, and the product purified by 
column chromatography (10% EtOAc/hexane) to give ethyl 3-[(2E)-2-
butylidene-5-oxopyrrolidinyl]butanoate (293) in quantitative yield, 



















Rf 0.27 (20% EtOAc/hexane)  
 
1H (300 MHz, CDCl3) δΗ /ppm 4.77 (1H, t, J 7.4, H-4), 4.45-4.37 (1H, m, H-10), 
4.12 (2H, q, J 7.1, H-13), 3.04 (1H, dd, J 7.4, 15.7, H-11A), 2.81 (1H, dd, J 7.3, 
15.7, H-11B), 2.58 (2H, t, J 8.0, H-6/H-7), 2.42 (2H, t, J 8.0, H-6/H-7), 2.00 (2H, 
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q, J 7.3, H-3), 1.47-1.42 (2H, m, H-2), 1.41 (3H, d, J 6.9, H-9), 1.25 (3H, t, J 7.1, 
H-14), 0.93 (3H, t, J 7.3, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 175.7 (C-8), 171.4 (C-12), 138.7 (C-5), 101.0 
(C-4), 60.4 (C-13), 45.2 (C-10), 37.6 (C-11), 29.2 (C-6/C-7), 29.0 (C-3), 23.2 
(C-2), 21.6 (C-6/C-7), 17.1 (C-9), 14.1 (C-14), 13.7 (C-1). 
 
νmax. / cm-1: 2959 (m, C-H), 2934 (m, C-H), 2872 (m, C-H), 1735 (s, OC=O), 
1669 (s, NC=O), 1408 (m), 1373 (m), 1241 (s), 1186 (s), 1096 (m), 1031 (m). 
 
m/z: 253 (22%, M), 229 (45), 224 (66), 214 (78), 208 (14), 168 (68), 141 (100), 
130 (74). Found 253.1376, C14H23O3N requires 253.1678. 
 
Method B222 
Ethyl 4-oxooctanoate (292) (700 mg, 3.8 mmol) and ethyl 3-aminobutanoate 
(90%, 0.56 mL, 3.8 mmol) were dissolved in toluene (25 mL) and heated at 
reflux for 30 hours using a Dean-Stark apparatus. The toluene was removed in 
vacuo and the residue was purified by column chromatography (20% 
EtOAC/hexane) to give ethyl 3-[(2E)-2-butylidene-5-
oxopyrrolidinyl]butanoate (293) (200 mg, 21% yield) and residual ethyl 4-
oxooctanoate (292) (320 mg, 45% recovery). 
 
Method C 
Ethyl 4-oxooctanoate (292) (2.00 g, 10.7 mmol), ethyl 3-aminobutanoate 
(90%, 1.58 mL, 10.8 mmol) and a catalytic amount of p-toluenesulfonic acid 
(103 mg, 0.54 mmol) were dissolved in toluene (60 mL) and heated at reflux for 
30 hours using a Dean-Stark apparatus with molecular sieves (4Å) in the side-
arm. The toluene was removed in vacuo and the residue was purified by silica 
column chromatography (10% EtOAC/hexane) to give ethyl 3-[(2E)-2-
butylidene-5-oxopyrrolidinyl] butanoate (293) (1.37 g, 50% yield) and ethyl 





Ethyl 4-oxooctanoate (292)  (2.00 g, 10.7 mmol), ethyl 3-aminobutanoate 
(90%, 1.05 mL, 6.44 mmol) and glacial AcOH (2.15 g, 35.8 mmol) were 
dissolved in toluene (18 mL) and heated at reflux for 64 hours using a modified 
Dean-Stark apparatus. The solution was cooled and rinsed with saturated 
sodium bicarbonate solution (20 mL). The product was then extracted into 
EtOAc (3 × 30 mL) and dried with sodium sulfate. The solvent was removed in 
vacuo and the residue purified by column chromatography (10% 
EtOAC/hexane) to give ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl] 
butanoate (293) (1.43 g, 87% yield) as a clear oil. 
  
8.1.3.3 Ethyl (3R)-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate 
Ethyl 4-oxooctanoate (292) (2.04 g, 11.0 mmol), ethyl (3R)-aminobutanoate 
(291) (844 mg, 6.44 mmol) and glacial AcOH (2.15 g, 35.8 mmol) were 
dissolved in toluene (10 mL) and heated at reflux for 72 hours using a modified 
Dean-Stark apparatus. The solution was cooled and then rinsed with saturated 
sodium bicarbonate solution (20 mL). The product was extracted into EtOAc (3 
× 30 mL) and dried with sodium sulfate. The solvent was removed in vacuo and 
the residue was purified by column chromatography (10% EtOAC/hexane) to 
give ethyl (3R)-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) as a 
clear oil (753 mg, 46% yield) and ethyl 4-oxooctanoate (292) (1.02 g, 50% 
recovery).  
 
All characterization was identical to the racemate with the exception of the 
optical rotation.  
 
[α]D20 -10.0 (c 1.20, CH2Cl2) 
 
8.1.3.4 Ethyl (3S)-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate223 - 225 
Ethyl 3-aminobutyrate (90%, 0.45 mL, 3.0 mmol) was mixed together with ethyl 
butyrate (4 mL) and CAL-B (Candida antarctica lipase B)j (50 mg, 17 mg/mmol) 
and the solution was stirred at ambient temperature for 25 hours. The enzyme 
                                                 
j The CAL-B was kindly donated by Dean Brady from the Council for Scientific and 
Industrial Research (CSIR) 
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was filtered off through a sintered glass funnel and the residue was rinsed with 
EtOAc (20 mL). The EtOAc was removed in vacuo and the crude mixture of 
ethyl butyrate, free amine and acylated amine were heated at reflux together 
with ethyl 4-oxooctanoate (292) (700 mg, 3.75 mmol), AcOH (0.45 mL, 
7.5 mmol) and toluene (10 mL). The reaction mixture was allowed to reflux for 
72 hours and the solution was then cooled and the solvent removed in vacuo. 
The crude material was purified by column chromatography (10% 
EtOAc/hexane) to give ethyl (3S)-[(2E)-2-butylidene-5-
oxopyrrolidinyl]butanoate (293) (250 mg, 33% yield based on the racemate).k 
 
All characterization was identical to the racemate with the exception of optical 
rotation.  
 
[α]D20 +1.0 (c 1.00, CH2Cl2). 
 
8.1.4 Stereoselective reduction of the exocyclic alkene 
8.1.4.1 Ethyl 3-(2-butyl-5-oxo-1-pyrrolidinyl)butanoate (294)  
Method A215, 226 
Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) (0.20 g, 
0.79 mmol) was dissolved in freshly distilled CH2Cl2 (10 mL) and cooled to 
−90ºC under nitrogen. Titanium tetrachloride (0.19 mL, 1.7 mmol) was added 
and the reaction mixture was stirred for 5 minutes. Triethylsilane (0.38 mL, 
2.4 mmol) was then added by syringe and the reaction was allowed to warm to 
ambient temperature and react for 48 hours. The reaction was quenched by the 
addition of saturated ammonium chloride solution (10 mL) and the product was 
extracted in CH2Cl2 (4 × 30 mL). The combined organic fractions were dried 
with sodium sulfate and the solvent was evaporated in vacuo. Purification of the 
crude material by column chromatography (50% EtOAc/hexane) gave ethyl 3-
(2-butyl-5-oxo-1-pyrrolidinyl)butanoate (294) (170 mg, 84% yield) as an 
                                                 
k Liljeblad et al. successfully used enzymatic resolution to separate (R)- and (S)-ethyl 
3-aminobutyrate, however, for practical reasons they isolated both the products as 
acetamides by reacting the resolved mixture of the free amine of the (S)-enantiomer 
and the acylated (R)-enantiomer with acetic anhydride. This protocol would not be 




inseparable (1:4) mixture of diastereomers. The minor isomer, (the S,R and R,S 
isomer), has been designated isomer A and the major isomer, (the R,R and S,S 
isomer), has been designated isomer B.l 
 



















Rf 0.15 (20% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 4.12 (2H, q, J 7.2, H-13), 3.94-3.87 (1H, m, 
H-10), 3.68-3.63 (1H, m, H-5), 3.17 (1H, dd, J 16.1, 8.4, H-11A), 2.53 (1H, dd, J 
16.1,  6.0, H-11B), 2.42-2.05 (4H, m, H-6AB, H-7AB), 1.75-1.65 (2H, m, H-4), 
1.39 (3H, d, J 6.9, H-9), 1.40-1.26 (4H, m, H-2, H-3), 1.25 (3H, t, J 7.2, H-14), 
0.93 (3H, t, J 6.9, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 174.7 (C-8), 170.3 (C-12), 60.0 (C-5), 59.9 
(C-13), 46.8 (C-10), 38.3 (C-11), 33.8 (C-4), 30.6 (C-7), 26.8 (C-6), 23.9 (C-3), 
22.4 (C-9), 18.0 (C-2), 13.8 (C-1), 13.7 (C-14). 
 
νmax. / cm-1: 2958 (m, C-H), 2933 (m, C-H), 2873 (m, C-H), 1731 (s, OC=O), 
1679 (s, NC=O), 1444 (m), 1424 (m), 1372 (s), 1291 (s), 1247 (m), 1193 (s), 
1094 (m), 1029 (s), 670 (m). 
 
                                                 
l The diastereomer ratio was determined by the relative integration of the H-5 and H-10 
signals in the 1H-NMR spectra for isomer A and isomer B. 
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m/z: 255 (22%, M), 212 (6), 210 (35), 198 (100), 168 (76), 152 (88), 140 (89), 
110 (82). Found 255.1823, C14H23O3N requires 255.1834. 
 



















Rf 0.15 (20% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 4.20-4.10 (1H, m, H-10), 4.14 (2H, q, J 7.2, 
H-13), 3.62-3.55 (1H, m, H-5), 2.78 (2H, d, J 7.5, H-11), 2.46-2.03 (4H, m, 
H-6AB, H-7AB), 1.77-1.64 (2H, m, H-4), 1.45-1.22 (4H, m, H-2, H-3), 1.31 (3H, 
d, J 6.9, H-9), 1.25 (3H, t, J 7.2, H-14), 0.92 (3H, t, J 7.1, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 174.3 (C-8), 169.6 (C-12), 60.4 (C-13), 58.1 
(C-5), 46.1 (C-10), 38.7 (C-11), 34.3 (C-4), 30.5 (C-7), 27.1 (C-6), 24.3 (C-3), 
22.6 (C-2), 18.6 (C-9), 14.0 (C-1), 13.9 (C-14). 
 
νmax. / cm-1: 2957 (m, C-H), 2933 (m, C-H), 2872 (m, C-H), 1732 (s, OC=O), 
1681 (s, NC=O), 1445 (m), 1420 (m), 1372 (s), 1292 (s), 1248 (s), 1191 (s), 
1091 (m), 1030 (s), 666 (m). 
 
m/z: 255 (7%, M), 207 (18), 198 (84), 168 (38), 152 (100), 140 (35), 110 (84). 




Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) (0.20 g, 
0.79 mmol) was dissolved in freshly distilled CH2Cl2 (10 mL) and cooled to 
−90ºC under nitrogen. TFA (0.14 mL, 1.8 mmol) was added and the reaction 
mixture was stirred for 5 minutes. Triethylsilane (0.38 mL, 2.4 mmol) was then 
added by syringe and the reaction was allowed to warm to ambient temperature 
and react for 60 hours. The reaction was quenched by the addition of saturated 
ammonium chloride solution (10 mL) and the product was extracted in CH2Cl2 
(3 × 30 mL). The combined organic extracts were dried with sodium sulfate and 
the solvent was removed in vacuo. Purification by column chromatography 
(50% EtOAc/hexane) gave ethyl 3-(2-butyl-5-oxo-1-pyrrolidinyl)butanoate 




Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) (0.10 g, 
0.39 mmol) was dissolved in freshly distilled CH2Cl2 (10 mL) and cooled to 
−90ºC under nitrogen. Freshly distilled boron trifluoride etherate (0.11 mL, 
0.87 mmol) was added and the reaction mixture was stirred for 5 minutes. 
Triethylsilane (0.19 mL, 1.2 mmol) was then added by syringe and the reaction 
was allowed to warm to ambient temperature and react for 48 hours. The 
reaction was quenched by the addition of saturated ammonium chloride 
solution (10 mL) and the product was extracted into CH2Cl2 (4 × 30 mL). The 
combined organic extracts were dried with sodium sulfate and the solvent was 
removed in vacuo. Purification by column chromatography (50% 
EtOAc/hexane) gave ethyl 3-(2-butyl-5-oxo-1-pyrrolidinyl)butanoate (294) 




Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) (0.10 g, 
0.39 mmol) was dissolved in freshly distilled CH2Cl2 (10 mL) and cooled to 
−90ºC under nitrogen. Tin (IV) tetrachloride (0.10 mL, 0.87 mmol) was added 
and the reaction mixture was stirred for 5 minutes. Triethylsilane (0.19 mL, 
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1.2 mmol) was added then by syringe and the reaction was allowed to warm to 
ambient temperature and react for a further 30 hours. The reaction was 
quenched by the addition of saturated ammonium chloride solution (10 mL) and 
the product was extracted into CH2Cl2 (4 × 30 mL). The combined organic 
extracts were dried with sodium sulfate and the solvent was removed in vacuo. 
Purification by column chromatography (50% EtOAc/hexane) gave starting 
material, ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293), 
(20 mg, 20% recovery) and ethyl 3-(2-butyl-5-oxo-1-pyrrolidinyl)butanoate 




Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) (0.20 g, 
0.79 mmol) was dissolved in freshly distilled CH2Cl2 (10 mL) and cooled to 
−90ºC under nitrogen. Zirconium tetrachloride (405 mg, 1.74 mmol) was added 
and the reaction mixture was stirred for 5 minutes. Triethylsilane (0.19 mL, 
1.2 mmol) was then added by syringe and the reaction was allowed to warm to 
ambient temperature and react for 48 hours. The reaction was quenched by the 
addition of saturated ammonium chloride solution (20 mL) and the product was 
extracted in CH2Cl2 (4 × 30 mL). The combined organic fractions were dried 
with sodium sulfate and the solvent was removed in vacuo. Purification by 
column chromatography (50% EtOAc/hexane) gave ethyl 3-(2-butyl-5-oxo-1-
pyrrolidinyl)butanoate (294) (160 mg, 79% yield) as a (3:4) mixture of 
diastereomers, favouring diastereomer B. 
 
Method F 
Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) (0.10 g, 
0.39 mmol) was dissolved in freshly distilled CH2Cl2 (7 mL) and cooled to −90ºC 
under nitrogen. Aluminium trichloride (115 mg, 0.860 mmol) was added and the 
reaction mixture was stirred for 5 minutes. Triethylsilane (0.19 mL, 1.2 mmol) 
was then added by syringe and the reaction was allowed to warm to ambient 
temperature and react for 72 hours. The reaction was quenched by the addition 
of saturated ammonium chloride solution (20 mL) and the product was 
extracted in CH2Cl2 (4 × 30 mL). The combined organic extracts were dried with 
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sodium sulfate and the solvent was removed in vacuo. Purification by column 
chromatography (50% EtOAc/hexane) gave ethyl 3-(2-butyl-5-oxo-1-
pyrrolidinyl)butanoate (294) (100 mg, 100% yield) as a (3:4) mixture of 
diastereomers, favouring diastereomer B. 
 
Method G 
Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) (0.10 g, 
0.39 mmol) was dissolved in freshly distilled CH2Cl2 (7 mL) and cooled to −90ºC 
under nitrogen. Titanium isopropoxide (0.23 mL, 0.86 mmol) was added and the 
reaction mixture was stirred for 5 minutes. Triethylsilane (0.19 mL, 1.2 mmol) 
was then added by syringe and the reaction was allowed to warm to ambient 
temperature and react for 48 hours. The reaction was quenched by the addition 
of saturated ammonium chloride solution (20 mL) and the product was 
extracted in CH2Cl2 (4 × 30 mL) – the two layers formed an emulsion and had 
to be filtered through a sintered glass funnel before separation was possible. 
The combined organic extracts were dried with sodium sulfate and the solvent 
was removed in vacuo. Purification by column chromatography (50% 
EtOAc/hexane) gave back the starting material, ethyl 3-[(2E)-2-butylidene-5-
oxopyrrolidinyl]butanoate (293), (70 mg, 70% recovery). 
 
Method H 
Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) (0.10 g, 
0.39 mmol) was dissolved in freshly distilled CH2Cl2 (7 mL) and cooled to −90ºC 
under nitrogen. Lanthanum triflouromethanesulfonate (504 mg, 0.86 mmol) was 
added and the reaction mixture was stirred for 25 minutes. Triethylsilane 
(0.19 mL, 1.2 mmol) was then added by syringe and the reaction was 
maintained at −90ºC for 2 hours before allowing the reaction to warm to 
ambient temperature and react for a further 96 hours. The reaction was 
quenched by the addition of saturated ammonium chloride solution (5 mL) and 
the product was extracted in CH2Cl2 (4 × 30 mL). The combined organic 
fractions were dried with sodium sulfate and the solvent was removed in vacuo. 
Purification by column chromatography (50% EtOAc/hexane) gave the ring-




Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) (0.10 g, 
0.39 mmol) was dissolved in freshly distilled CH2Cl2 (7 mL) and cooled to −90ºC 
under nitrogen. Titanium tetrachloride (0.10 mL, 0.86 mmol) was added and the 
reaction mixture was stirred for 7 minutes. Triphenylsilane (307 mg, 1.18 mmol) 
was then added and the reaction was maintained at −90ºC for 2 hours before it 
was allowed to warm to ambient temperature and react for 96 hours. The 
reaction was quenched by the addition of saturated ammonium chloride 
solution (5 mL) and the product was extracted in CH2Cl2 (3 × 30 mL). The 
combined organic extracts were dried with sodium sulfate and the solvent was 
removed in vacuo. Purification by column chromatography (50% 
EtOAc/hexane) gave ethyl 3-(2-butyl-5-oxo-1-pyrrolidinyl)butanoate (294) 




Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (293) (90 mg, 
0.35 mmol) was dissolved in absolute EtOH (3 mL). Activated palladium on 
carbon (10%, 40 mg, 0.115 g/mmol) was added, and the reaction mixture was 
set-up in a test-tube in the hydrogenator under 7.5 atmospheres of hydrogen 
pressure for 60 hours. The solution was filtered through Celite® and thoroughly 
rinsed with CH2Cl2 (200 mL) to remove the catalyst. The solvent was 
evaporated in vacuo and the resulting crude product was thoroughly dried 
under high vacuum to give ethyl 3-(2-butyl-5-oxo-1-pyrrolidinyl)butanoate 
(294) (90 mg, 100% yield) as a mixture of diastereomers (in a 2:3 ratio), 
favouring diastereomer B. 
 
8.1.5 Thionation reactions 
8.1.5.1 Ethyl 3-(2-butyl-5-thioxo-1-pyrrolidinyl)butanoate (295) 
The diastereomeric mixture of ethyl 3-(2-butyl-5-oxo-1-pyrrolidinyl) 
butanoate (294) (1.53 g, 5.97 mmol) and Lawesson’s reagent (1.33 g, 
3.28 mmol) were mixed in dry CH2Cl2 (40 mL) and stirred at ambient 
temperature under a nitrogen atmosphere for 96 hours. The CH2Cl2 was 
removed in vacuo and the organic residue was purified by column 
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chromatography (15% EtOAc/hexane) to give ethyl 3-(2-butyl-5-thioxo-1-
pyrrolidinyl)butanoate (295) (1.580 g, 98%) as a mixture of diastereomers, in 
the same ratio as the starting material. The diastereomers were partially 
separable by column chromatography (10% EtOAc/hexane).  
 



















Rf 0.25 (10% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 4.80-4.72 (1H, m, H-10), 4.15 (2H, q, J 7.2, 
H-13), 4.11-4.02 (1H, m, H-5), 3.53 (1H, dd, J 6.3, 16.2, H-11A), 3.10-2.85 (2H, 
m, H-7), 2.48 (1H, dd, J 8.0, 16.2, H-11B), 2.25-2.04 (1H, m, H-6A), 1.90-1.60 
(3H, m, H-4, H-6B), 1.52 (3H, d, J 7.1, H-9), 1.40-1.26 (4H, m, H-2, H-3) 1.27 
(3H, t, J 7.1, H-14), 0.93 (3H, t, J 7.0, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 200.9 (C-8), 171.6 (C-12), 67.7 (C-5), 61.0 
(C-13), 51.3 (C-10), 45.1 (C-7), 38.3 (C-11), 33.7 (C-4), 28.0 (C-2), 26.1 (C-6), 
23.0 (C-3), 17.5 (C-9), 14..5 (C-14), 14.4 (C-1). 
 
νmax. / cm-1: 2957 (m, C-H), 2933 (m, C-H), 2872 (m, C-H), 1736 (s, C=O), 1498 
(m), 1456 (s), 1425 (m), 1375 (m), 1312 (s, C=S), 1274 (s), 1180 (s), 1031 (m). 
 
m/z: 271 (100%, M), 242 (57), 238 (50), 226 (29), 198 (72), 184 (13), 158 (26), 
130 (43), 114 (36), 84 (8), 71 (12), 41 (35). Found 271.1606, C14H25O2N32S 
requires 271.1606. 
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Rf 0.22 (10% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 5.30-5.10 (1H, m, H-10), 4.13 (2H, q, J 7.1, 
H-13), 4.11-3.95 (1H, m, H-5), 3.10-2.85 (2H, m, H-7), 2.79 (2H, dq, J 7.5, 15.5, 
H-11AB), 2.20-2.04 (1H, m, H-6A), 1.85-1.68 (2H, m, H-4), 1.58-1.46 (1H, m, 
H-6B), 1.41 (3H, d, J 7.0, H-9), 1.40-1.26 (4H, m, H-2, H-3) 1.25 (3H, t, J 7.1, 
H-14), 0.92 (3H, t, J 6.9, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 201.9 (C-8), 170.9 (C-12), 65.5 (C-5), 61.2 
(C-13), 51.0 (C-10), 44.4 (C-7), 38.8 (C-11), 34.2 (C-4), 28.0 (C-2), 26.4 (C-6), 
23.0 (C-3), 18.9 (C-9), 14.5 (C-14), 14.4 (C-1). 
 
νmax. / cm-1: 2960 (m, C-H), 2935 (m, C-H), 2874 (m, C-H), 1736 (s, C=O), 1497 
(m), 1462 (s), 1427 (m), 1375 (m), 1303 (s, C=S), 1199 (s), 1086 (m), 1033 (m). 
 
m/z: 271 (100%, M) 242 (59), 238 (52), 214 (19), 198 (85), 175 (12), 157 (23), 








8.1.5.3 Ethyl 3-(2-butyl-1H-pyrrol-1-yl)butanoate (381) and ethyl 3-(2-butyl-
5-sulfanyl-1H-pyrrol-1-yl)butanoate (382) 
Ethyl 3-[(2E)-2-butylidene-5-oxopyrrolidinyl]butanoate (294) (0.16 g, 
0.79 mmol) was dissolved in distilled CH2Cl2 (5 mL) at ambient temperature 
under a nitrogen atmosphere. Lawesson’s reagent (0.18 g, 0.44 mmol) was 
added and the reaction was stirred at ambient temperature for 96 hours. The 
solvent was removed in vacuo and the crude residue was purified by column 
chromatography (10% EtOAc/hexane) to give ethyl 3-(2-butyl-1H-pyrrol-1-
yl)butanoate (381) (40 mg, 25% yield) and ethyl 3-(2-butyl-5-sulfanyl-1H-


















Rf 0.66 (50% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ  /ppm 6.62 (1H, d, J 1.8, H-8), 6.10 (1H, dd, J 3.1, 1.8, 
H-7), 5.84 (1H, d, J 3.1, H-6), 4.64-4.57 (1H, m, H-10), 4.10 (2H, q, J 7.1, H-
13), 2.75-2.65 (2H, m, H-11AB), 2.58 (2H, t, J 7.8, H-4), 1.65-1.56 (4H, m, H-2, 
H-3), 1.44 (3H, d, J 6.8, H-9), 1.21 (3H, t, J 7.1, H-14), 0.95 (3H, t, J 7.3, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 170.1 (C-12), 133.0 (C-5), 115.2 (C-8), 107.5 
(C-7), 105.0 (C-6), 60.7 (C-13), 47.5 (C-10), 42.8 (C-4), 31.2 (C-11), 26.0 (C-3), 
22.6 (C-2), 22.0 (C-9), 14.1 (C-14), 13.9 (C-1). 
 
νmax. / cm-1: 2959 (m, C-H), 2934 (m, C-H), 2873 (m, C-H), 1732 (s, C=O), 1532 
(w), 1455 (w), 1378 (m), 1301 (w), 1192 (s), 1095 (m), 1030 (m). 
 


















Rf 0.10 (50% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ  /ppm 6.28 (1H, s, H-7), 5.73 (1H, s, H-6), 4.54-4.47 
(1H, m, H-10), 4.10 (2H, q, J 7.1, H-13), 2.71-2.65 (2H, m, H-11AB), 2.52 (2H, t, 
J 7.7, H-4), 1.62-1.57 (3H, m, H-3, S-H), 1.48-1.37 (2H, m, H-2), 1.40 (3H, d, J 
6.8, H-9), 1.21 (3H, t, J 7.1, H-14), 0.94 (3H, t, J 7.3, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 171.0 (C-12), 134.4 (C-5), 131.9 (C-8), 111.4 
(C-7), 104.1 (C-6), 60.5 (C-13), 47.3 (C-10), 42.9 (C-4), 30.9 (C-11), 26.1 (C-3), 
22.6 (C-2), 21.7 (C-9), 14.1 (C-14), 14.0 (C-1). 
 
νmax. / cm-1: 3366 (br, S-H), 2960 (m, C-H), 2935 (m, C-H), 2873 (m, C-H), 1732 
(s, C=O), 1455 (m), 1373 (s), 1301 (m), 1195 (s), 1096 (m), 1030 (s), 855 (w). 
 
m/z: no parent ion 266 (8), 257 (28), 255 (100), 236 (22), 224 (18), 202 (14), 











8.1.6 Formation of the vinylogous sulfonamide 
8.1.6.1 Ethyl 3-((5E)-2-butyl-5-{[4-methylphenyl)sulfonyl]methylene} 
pyrrolidinyl)butanoate (296)173 
Method A 
 Ethyl 3-(2-butyl-5-thioxo-1-pyrrolidinyl)butanoate (295) (80 mg, 0.29 mmol) 
was dissolved in THF (5 mL) in oven-dried glassware under a nitrogen 
atmosphere. Methyl iodide (0.10 mL, 1.6 mmol) was added by syringe and the 
reaction mixture was stirred at ambient temperature under nitrogen for 24 
hours. At this stage, the starting material had been consumed and the moisture-
sensitive iodine salt could be seen on the baseline of the silica TLC plate (40% 
EtOAc/hexane). The THF and excess methyl iodide were removed under high 
vacuum at 0ºC to give a crude, brown oil. Et3N (0.07 mL, 0.5 mmol) and 
1-[(4-methylphenyl)sulfonyl]acetone (279)m (64 mg,  0.30 mmol) were 
premixed in CH2Cl2 (5 mL) 10 minutes prior to addition to the crude salt. The 
reaction was stirred in an oil bath at 25ºC under a nitrogen atmosphere for 96 
hours before a second portion of Et3N (0.07 mL, 0.5 mmol) was added. After 24 
hours the reaction was quenched with distilled H2O (2 mL), and the organic 
material was extracted into CH2Cl2 (6 × 15 mL). The combined organic fractions 
were dried with sodium sulfate, the solvent was removed in vacuo and the 
crude material was purified by column chromatography (40% EtOAc/hexane). 
Ethyl 3-(2-butyl-5-oxo-1-pyrrolidinyl)butanoate (294) (80 mg, 81% recovery) 
was isolated, indicating that hydrolysis had occurred. None of the desired 
product was obtained. 
 
Method B  
Ethyl 3-(2-butyl-5-thioxo-1-pyrrolidinyl)butanoate (295) (630 mg, 2.33 mmol) 
was dissolved in THF (5 mL) in oven-dried glassware under a nitrogen 
atmosphere. Methyl iodide (0.72 mL, 12 mmol) was added by syringe at 0ºC 
and the flask was protected from light by a covering of tin foil. The reaction 
warmed to ambient temperature and stirred under nitrogen for 48 hours. At this 
stage the starting material had been consumed and the moisture-sensitive 
iodine salt could be seen on the baseline of the TLC plate (40% 
                                                 
m See Chapter 7, section 7.2.6.1 for the synthesis and characterization of 1-[(4-
methylphenyl) sulfonyl]acetone (279). 
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EtOAc/hexane). The THF and excess methyl iodide were removed in vacuo to 
give a brown oil. Et3N (0.65 mL, 4.66 mmol) and 1-[(4-
methylphenyl)sulfonyl]acetone (279) (544 mg,  2.56 mmol) were premixed in 
CH2Cl2 (5 mL) 10 minutes prior to addition to the brown oil. This mixture was 
left stirring at ambient temperature under a nitrogen atmosphere for 96 hours 
before the solvent was removed in vacuo and the organic residue was 
partitioned in distilled H2O (10 mL) and CH2Cl2 (10 mL). The crude product was 
extracted into CH2Cl2 (6 × 15 mL) and dried with sodium sulfate. The solvent 
was removed in vacuo and the crude material was purified by column 
chromatography (30% EtOAc/hexane) to give ethyl 3-(E)-2-butyl-5-(2-oxo-1- 
tosylpropylidene)pyrrolidin-1-yl)butanoate  (384) (450 mg, 45% yield), and 
the desired product, ethyl 3-((5E)-2-butyl-5-{[4-
methylphenyl)sulfonyl]methylene}pyrrolidinyl)butanoate (296), (240 mg, 
25% yield). 
 
This method was repeated with pure diastereomer A (S,R and R,S) (3.03 mmol) 
to give  ethyl 3-(E)-2-butyl-5-(2-oxo-1-tosylpropylidene)pyrrolidin-1-
yl)butanoate  (384A) (500 mg, 37% yield),  and ethyl 3-((5E)-2-butyl-5-{[4-
methylphenyl)sulfonyl]methylene}pyrrolidinyl)butanoate (296A) (450 mg, 
37% yield). 
 
This method was repeated with pure diastereomer B (R,R and S,S)  
(2.75 mmol) to give ethyl 3-(E)-2-butyl-5-(2-oxo-1-tosylpropylidene) 
pyrrolidin-1-yl) butanoate  (384B) (370 mg, 30% yield) and ethyl 3-((5E)-2-
butyl-5-{[4-methylphenyl)sulfonyl]methylene}pyrrolidinyl)butanoate 
(296B) (260 mg, 23% yield). 
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Rf 0.61 (40% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.76 (2H, d, J 8.1, H-17), 7.24 (2H, d, J 8.1 
H-18), 4.99 (1H, s, H-15), 4.12 (2H, q, J 6.9, H-13), 3.98-3.91 (1H, m, H-10), 
3.73-3.68 (1H, m, H-5), 3.11-3.01 (1H, m, H-11A), 2.92-2.80 (2H, m, H-11B, 
H-7A), 2.45-2.31 (1H, m, H-7B), 2.39 (3H, s, H-20), 1.95-1.82 (2H, m, H-4), 
1.70-1.62 (1H, m, 6A), 1.62-1.51 (1H, m, 6B), 1.32 (3H, d, J 6.9, H-9) 1.27-1.15 
(7H, m, H-2, H-3, H-14), 0.89 (3H, t, J 7.1, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 170.7 (C-12), 159.7 (C-8), 143.1 (C-19), 141.6 
(C-16), 129.1 (C-18), 125.9 (C-17), 87.4 (C-15), 62.5 (C-5), 60.7 (C-13), 48.3 
(C-10), 38.2 (C-7), 33.8 (C-11), 29.8 (C-4), 27.6 (C-2), 25.7 (C-6), 22.5 (C-20), 
21.3 (C-3), 17.5 (C-9), 14.0 (C-14), 13.9 (C-1). 
 
νmax. / cm-1: 2932 (m, C-H), 2870 (m, C-H), 2513 (w, C=C), 1713 (s, C=O), 1564 
(s), 1459 (m), 1415 (m), 1372 (m, S=O), 1281 (s), 1132 (s), 1083 (s), 841 (m).   
 
m/z: 407 (5%, M), 378 (2), 343 (3), 322 (19), 255 (10), 252 (57), 236 (10), 210 
(18), 198 (79), 196 (25), 172 (19), 168 (42), 152 (100). Found 407.2126, 
C22H33O4N32S requires 407.2130. 
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Rf 0.61 (40% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.76 (2H, d, J 8.1, H-17), 7.24 (2H, d, J 8.1 
H-18), 4.98 (1H, s, H-15), 4.09 (2H, q, J 7.1, H-13), 4.05-3.90 (1H, m, H-10), 
3.68-3.62 (1H, m, H-5), 3.12-3.02 (1H, m, H-11A), 2.88-2.75 (1H, m, H-11B), 
2.68-2.52 (2H, m, H-7AB), 2.39 (3H, s, H-20), 2.00-1.79 (2H, m, H-4), 1.72-1.65 
(1H, m, 6A), 1.59-1.51 (1H, m, 6B), 1.32 (3H, d, J 6.9, H-9) 1.27-1.15 (7H, m, 
H-2, H-3, H-14), 0.89 (3H, t, J 7.1, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 170.3 (C-12), 160.4 (C-8), 143.2 (C-19), 141.6 
(C-16), 129.1 (C-18), 125.9 (C-17), 87.4 (C-15), 61.4 (C-5), 60.7 (C-13), 48.3 
(C-10), 38.6 (C-7), 34.1 (C-11), 29.6 (C-4), 27.7 (C-2), 26.2 (C-6), 22.5 (C-20), 
21.3 (C-3), 18.0 (C-9), 14.0 (C-14), 13.8 (C-1). 
 
νmax. / cm-1: 2955 (m, C-H), 2933 (m, C-H), 2872 (m, C-H), 2604 (m, C=C), 
2498 (w, C=C), 1731 (s, C=O), 1563 (s), 1457 (m), 1416 (m), 1398 (m, S=O), 
1279 (s), 1131 (s), 1081 (s), 1034 (m), 814 (m), 813 (m). 
 
m/z: 407 (2%, M), 378 (3), 362 (2), 343 (3), 320 (5), 296 (5), 253 (20), 252 
(100), 236 (25), 224 (7), 206 (10), 196 (50), 194 (24), 173 (8), 172 (45). Found 
407.2143, C22H33O4N32S requires 407.2130. 
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Rf 0.43 (30% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.72 (2H, d, J 8.5, H-17), 7.27 (2H, d, J 8.5, 
H-18), 4.25-4.10 (3H, m, H-5, H-13), 4.03 (1H, m, H-10), 3.76 (1H, m, H-7A), 
3.41 (1H, dd, J 15.6, 1.6, H-6A), 2.74 (1H, dt, J 16.4, 7.9, H-7B), 2.55-2.42 (1H, 
m, H-6B), 2.40 (3H, s, H-20), 2.34 (3H, s, H-22), 2.10-1.95 (1H, m, H-11A), 
1.80-1.63 (2H, m, H-11B, H-4A), 1.40-1.23 (8H, m, H-4B, H-2, H-3, H-14), 1.39 
(3H, d, J 7.2, H-9), 0.92 (3H, t, J 6.9, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 189.9 (C-21), 174.4 (C-12), 170.4 (C-8), 142.6 
(C-19), 142.0 (C-16), 129.3 (C-18), 125.6 (C-17), 104.4 (C-15), 62.8 (C-10), 
60.6 (C-13), 55.7 (C-5), 38.0 (C-6), 35.0 (C-7), 33.5 (C-4), 30.0 (C-20), 27.5 
(C-9), 25.4 (C-11), 24.0 (C-3), 22.3 (C-22), 19.5 (C-2), 13.9 (C-14), 13.7 (C-1). 
 
νmax. / cm-1: 2958 (m, C-H), 2933 (m, C-H), 2872 (m, C-H), 1731 (s, OC=O), 
1680 (m, C=O), 1615 (m), 1494 (s), 1396 (s), 1373 (s, S=O), 1297 (s), 1089 (s), 

































Rf 0.36 (30% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.75 (2H, d, J 7.8, H-17), 7.26 (2H, d, J 7.8, 
H-18), 4.38-4.31 (1H, m, H-10), 4.22-4.15 (1H, m, H-5), 4.12 (2H, q, J 7.2, 
H-13) 3.96-3.86 (1H, m, H-7A), 2.78 (1H, d, J 7.2, H-6A), 2.73-2.55 (1H, m, 
H-7B), 2.40 (3H, s, H-20), 2.30 (3H, s, H-22), 2.28-2.10 (1H, m, H-6B), 
2.10-1.95 (1H, m, H-11A). 1.79-1.63 (2H, m, H-11B, H-4A), 1.54 (3H, d, J 6.7, 
H-9), 1.50-1.20 (8H, m, H-4B, H-2, H-3, H-14), 0.92 (3H, t, J 6.9, H-1). 
  
13C (75 MHz, CDCl3) δC /ppm 189.3 (C-21), 174.5 (C-12), 169.5 (C-8), 142.7 
(C-19), 142.0 (C-16), 129.3 (C-18), 125.7 (C-17), 104.9 (C-15), 61.2 (C-13), 
60.3 (C-5), 56.6 (C-10), 40.7 (C-6), 38.6 (C-7), 35.1 (C-4), 30.3 (C-20), 27.0 
(C-3), 24.7 (C-11), 22.5 (C-2), 21.2 (C-22), 18.5 (C-9), 13.8 (C-14), 13.7 (C-1). 
 
νmax. / cm-1: 2958 (m, C-H), 2933 (m, C-H), 2872 (m, C-H), 1731 (s, OC=O), 
1681 (s, C=O), 1616 (w), 1495 (m), 1397 (m, S=O), 1296 (s), 1141 (s), 1053 
(m), 1029 (m).  
 
Method C 
Ethyl 3-(2-butyl-5-thioxo-1-pyrrolidinyl)butanoate (295) (0.17 g, 0.63 mmol) 
was dissolved in THF (10 mL) in oven-dried glassware, under a nitrogen 
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atmosphere. Methyl iodide (0.19 mL, 3.1 mmol) was added by syringe and the 
reaction was stirred at ambient temperature for 24 hours. At this stage the 
starting material had been consumed and the moisture-sensitive iodine salt 
could be seen on the baseline of the TLC plate (40% EtOAc/hexane). The THF 
and excess methyl iodide were removed in vacuo to give a brown oil. K2CO3 
(174 mg, 1.26 mmol) and 1-[(4-methylphenyl)sulfonyl]acetone (279) 
(267 mg, 1.26 mmol) were premixed in DMF (7 mL) 10 minutes prior to addition 
to the crude salt. This mixture was left stirring in an oil bath at 25ºC under a 
nitrogen atmosphere for 96 hours before it was quenched with distilled H2O 
(2 mL), and the organic material was extracted into CH2Cl2 (6 × 15 mL). The 
combined organic extracts were dried with sodium sulfate, the solvent was 
removed in vacuo and the crude material was purified by column 
chromatography (30% EtOAc/hexane) to give ethyl 3-((5E)-2-butyl-5-{[4-
ethylphenyl)sulfonyl]methylene}pyrrolidinyl) butanoate (296) (100 mg, 39% 
yield) as a mixture of diastereomers.  
 
Method D 
Ethyl 3-(2-butyl-5-thioxo-1-pyrrolidinyl)butanoate (295) (626 mg, 2.31 mmol) 
was dissolved in THF (7 mL) in oven-dried glassware under a nitrogen 
atmosphere. Methyl iodide (0.72 mL, 12 mmol) was added by syringe and the 
reaction was stirred at ambient temperature for 48 hours. The THF and excess 
methyl iodide were removed in vacuo to give a brown oil. DBU (0.70 mL, 4.6 
mmol) and 1-[(4-methylphenyl)sulfonyl]acetone (279) (980 mg,  4.62 mmol) 
were premixed in CH2Cl2 (10 mL) 10 minutes prior to addition to the oily 
residue. This mixture was left stirring in an oil bath at 25ºC under a nitrogen 
atmosphere for 72 hours before the reaction was quenched with distilled H2O (2 
mL), and the organic material was extracted into CH2Cl2 (6 × 15 mL). The 
combined organic extracts were dried with sodium sulfate, the solvent was 
removed in vacuo and the crude material was purified by column 
chromatography (30% EtOAc/hexane) to give ethyl 3-((5E)-2-butyl-5-{[4-
methylphenyl)sulfonyl] methylene}pyrrolidinyl)butanoate (296) (458 mg, 




8.1.6.2 Deacylation reactions 
Method A 
Racemic ethyl 3-(E)-2-butyl-5-(2-oxo-1-tosylpropylidene)pyrrolidin-1-
yl)butanoate  (384) (0.32 g, 0.71 mmol) was heated at reflux in AcOH (0.23 
mL, 3.8 mmol) and toluene (5 mL) for 14 hours. The reaction mixture was 
cooled and partitioned with saturated sodium bicarbonate solution (5 mL) and 
extracted into EtOAc (5 × 20 mL). The combined organic fractions were then 
dried with sodium sulfate, the solvent removed in vacuo and the crude material 
purified by column chromatography (30% EtOAc/hexane) to give ethyl 3-((5E)-
2-butyl-5-{[4-methylphenyl)sulfonyl]methylene}pyrrolidinyl)butanoate 
(296) (130 mg, 45% yield). 
 
Method B154 
Diastereomer A (R,S and S,R), ethyl 3-(E)-2-butyl-5-(2-oxo-1-
tosylpropylidene)pyrrolidin-1-yl)butanoate  (384A),  (500 mg, 1.11 mmol) 
was heated at reflux in TFA (5 mL) for 30 minutes. The mixture was cooled, 
rinsed with saturated sodium bicarbonate solution until it was basic and the 
organic material extracted into EtOAc (50 mL). The organic layer was then 
dried with sodium sulfate and the solvent removed in vacuo. The crude product 
was purified by column chromatography (30% EtOAc/hexane) to give ethyl 3-
((5E)-2-butyl-5-{[4-methylphenyl)sulfonyl]methylene}pyrrolidinyl) 
butanoate (296A) (300 mg, 67% yield).  
 
Diastereomer B (R,R and S,S), ethyl 3-(E)-2-butyl-5-(2-oxo-1-
tosylpropylidene)pyrrolidin-1-yl)butanoate  (384B), (0.37 g, 0.82 mmol) was 
heated at reflux in TFA (5 mL) for 30 minutes. The mixture was cooled, rinsed 
with saturated sodium bicarbonate solution until it was basic, and the organic 
material extracted into EtOAc (50 mL). The organic layer was then dried with 
sodium sulfate and the solvent removed in vacuo. The crude product was 
purified by column chromatography (30% EtOAc/hexane) to give ethyl 3-((5E)-
2-butyl-5-{[4-methylphenyl)sulfonyl]methylene}pyrrolidinyl)butanoate 








butanoate (296) (560 mg, 1.37 mmol) was dissolved in THF (20 mL) and 
cooled to 0°C in an ice-bath under a nitrogen atmosphere. Lithium aluminium 
hydride (78 mg, 2.1 mmol) was added and after 20 minutes the ice-bath was 
removed and the reaction mixture was left to stir at ambient temperature for 12 
hours. Monitoring the reaction progress by TLC revealed that the starting 
material had been consumed. The reaction was thus quenched by the addition 
of distilled H2O (5 mL), saturated NaOH solution (5 mL) and more distilled H2O 
(5 mL). The solution was then filtered through Celite® and rinsed thoroughly 
with CH2Cl2 (200 mL) to remove residual lithium aluminium hydride. The solvent 
was removed  in vacuo to give a crude, brown oil which was purified by column 
chromatography (50% EtOAc/hexane) to give 3-((5E)-2-butyl-5-{[(4-
methylphenyl)sulfonyl]methylene}pyrrolidinyl)-1-butanol (297) (460 mg, 
92% yield) as a clear oil.  
 
This method was repeated with pure diastereomer A (S,R and R,S), ethyl 3-
((5E)-2-butyl-5-{[(4-methylphenyl)sulfonyl]methylene}pyrrolidinyl) 
butanoate (296A) (450 mg, 1.10 mmol), to give  3-((5E)-2-butyl-5-{[(4-
methylphenyl)sulfonyl]methylene}pyrrolidinyl)-1-butanol (297A) (350 mg, 
87% yield). 
 
This method was repeated with pure diastereomer B (R,R and S,S), ethyl 3-
((5E)-2-butyl-5-{[(4-methylphenyl)sulfonyl]methylene}pyrrolidinyl) 
butanoate (296B) (660 mg, 1.62 mmol), to give  3-((5E)-2-butyl-5-{[(4-

































Rf 0.27 (50% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.75 (2H, d, J 7.3, H-15), 7.24 (2H, d, J 7.9, 
H-16), 5.07 (1H, s, H-13), 3.74-3.60 (4H, m, H-5, H-10, H-12), 3.04 (1H, ddd, J 
17.4, 9.5, 2.9, H-7A), 2.82 (1H, dt, J 17.4, 8.4, H-7B), 2.39 (3H, s, H-18), 2.02-
1.53 (6H, m, H-4, H-6, H-11), 1.31-1.16 (7H, m, H-2, H-3, H-9), 0.88 (3H, t, J 
7.0, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 160.4 (C-8), 143.3 (C-17), 141.5 (C-14), 129.1 
(C-16), 125.8 (C-15), 86.1 (C-13), 60.3 (C-5), 59.2 (C-12), 48.5 (C-10), 36.6 
(C-11), 33.9 (C-6/7), 29.9 (C-6/7), 27.7 (C-4), 25.8 (C-3), 22.5 (C-18), 21.3 
(C-2), 17.2 (C-9), 14.0 (C-1). 
  
νmax. / cm-1: 3481 (br, O-H), 2933 (m, C-H), 2873 (m, C-H), 1562 (s), 1460 (m), 
1419 (m), 1381 (m, S=O), 1276 (s), 1130 (s), 1083 (s), 846 (m). 
 
m/z: 365 (3%, M), 341 (4), 330 (12), 320 (4), 308 (27), 294 (17), 277 (18), 264 
































Rf 0.30 (50% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.75 (2H, d, J 7.3, H-15), 7.24 (2H, d, J 7.9, 
H-16), 4.95 (1H, s, H-13), 3.72-3.58 (4H, m, H-5, H-10, H-12), 3.15-3.03 (1H, 
m, H-7A), 2.81-2.69 (1H, m, H-7B), 2.39 (3H, s, H-18), 1.96-1.53 (6H, m, H-4, 
H-6, H-11), 1.35-1.08 (7H, m, H-2, H-3, H-9), 0.87 (3H, t, J 7.0, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 160.9 (C-8), 143.2 (C-17), 141.6 (C-14), 129.2 
(C-16), 125.8 (C-15), 86.2 (C-13), 61.3 (C-5), 59.4 (C-12), 48.1 (C-10), 36.1 
(C-11), 34.0 (C-6/7), 29.7 (C-6/7), 27.7 (C-4), 26.0 (C-3), 22.5 (C-18), 21.3 
(C-2), 18.1 (C-9), 13.9 (C-1).  
 
νmax. / cm-1: 3459 (br, O-H), 2928 (m, C-H), 2859 (m, C-H), 1562 (s), 1460 (m), 
1419 (m), 1381 (m, S=O), 1276 (s), 1130 (s), 1083 (s), 846 (m). 
 
m/z: 365 (1%, M), 347 (3), 330 (24), 322 (8), 308 (39), 294 (22), 264 (58), 238 








8.1.8 Cyclisation reaction 
8.1.8.1 3-Butyl-5-methyl-8-[(4-methylphenyl)sulfonyl]-1,2,3,5,6,7-hexa 
hydroindolizine (298)139, 230 
Method A 
3-((5E)-2-butyl-5-{[(4-methylphenyl)sulfonyl]methylene}pyrrolidinyl)-1-
butanol (297) (40 mg, 0.11 mmol) was dissolved in MeCN (8 mL), under 
nitrogen at ambient temperature. Triphenylphosphine (87 mg, 0.33 mmol), 
imidazole (37 mg, 0.55 mmol) and iodine (56 mg, 0.22 mmol) were sequentially 
added to the reaction mixture at 3 minute intervals. The reaction was heated at 
reflux for 5 hours, left for 12 hours at ambient temperature and heated at reflux 
for an additional 2 hours as starting material was still evident by TLC. The 
reaction mixture was then rinsed with saturated sodium bicarbonate solution 
(25 mL) and back-extracted into EtOAc (3 × 30 mL). The combined organic 
fractions were dried with sodium sulfate and the solvent was removed in vacuo. 
The crude product was purified by column chromatography (50% 
EtOAc/hexane) to give back starting material contaminated by 
triphenylphosphine oxide (85 mg). 
 
Method B  
Triphenylphosphine (493 mg, 1.88 mmol), imidazole (128 mg, 1.88 mmol) and 
iodine (319 mg, 1.26 mmol) were mixed in dry toluene (20 mL) in an oven-dried 
flask. 3-((5E)-2-Butyl-5-{[(4-methylphenyl)sulfonyl]methylene}pyrrolidinyl)-
1-butanol (297) (0.23 g, 0.63 mmol) was carefully added to this mixture and the 
reaction was heated at reflux for 3 hours under nitrogen. No more starting 
material was detected by TLC, so the reaction was allowed to cooled and then 
rinsed with saturated sodium bicarbonate solution (25 mL). The organic 
material was extracted into CH2Cl2 (5 × 30 mL) and the combined organic 
fractions were dried with sodium sulfate and the solvent was removed in vacuo. 
The crude product was purified by column chromatography (80% Et2O/hexane) 
to give 3-butyl-5-methyl-8-[(4-methylphenyl)sulfonyl]-1,2,3,5,6,7-hexahydro 
indolizine (298) (185 mg, 85% yield) as a sticky pink oil from which several 
crystals were obtained by slow evaporation in an EtOAc/hexane mixture. 
 
This method was repeated with pure diastereomer A (S,R and R,S), 3-((5E)-2-
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butyl-5-{[(4-methylphenyl)sulfonyl]methylene}pyrrolidinyl)-1-butanol 
(297A) (0.35 g, 0.96 mmol), to give  3-butyl-5-methyl-8-[(4-
methylphenyl)sulfonyl]-1,2,3,5,6,7-hexahydroindolizine (298A) (260 mg, 
78% yield). 
 
This method was repeated with pure diastereomer B (R,R and S,S), 3-((5E)-2-
butyl-5-{[(4-methylphenyl)sulfonyl]methylene}pyrrolidinyl)-1-butanol 
(297B) (0.17 g, 0.47 mmol), to give  3-butyl-5-methyl-8-[(4-
methylphenyl)sulfonyl]-1,2,3,5,6,7-hexahydroindolizine (298B) (110 mg, 
67% yield). 
 






Rf 0.74 (50% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.69 (2H, d, J 7.9, H-15), 7.23 (2H, d, J 8.0, 
H-16), 3.50-3.42 (1H, m, H-5), 3.43-3.34 (1H, m, H-12), 3.27-3.17 (1H, m, 
H-10A), 2.93 (1H, dt, J 17.4, 8.1, 10B), 2.47-2.40 (1H, m, H-7A), 2.39 (3H, s, 
H-18), 2.30-2.19 (1H, m, H-7B), 2.11-2.00 (1H, m, H-6A), 1.85-1.75 (1H, m, 
H-11A), 1.68-1.50 (1H, m, H-6B), 1.47-1.18 (1H, m, H-11B), 1.15-1.08 (6H, m, 
H-2, H-3, H-4), 1.06 (3H, d, J 6.6, H-13), 0.92 (3H, t, J 6.9, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 154.8 (C-8), 141.8 (C-14), 141.4 (C-17), 129.1 
(C-15), 125.8 (C-16), 91.8 (C-9), 64.6 (C-12), 48.0 (C-5), 34.7 (C-11), 29.7 
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(C-10), 27.7 (C-2), 27.5 (C-6), 27.0 (C-4), 22.6 (C-3), 21.2 (C-13), 21.0 (C-18), 
18.5 (C-7), 13.9 (C-1). 
 
νmax. / cm-1: 2930 (m, C-H), 2858 (m, C-H), 1591 (s), 1449 (w), 1375 (w, S=O), 
1279 (s), 1147 (m), 1128 (s), 1089 (s), 670 (s). 
 
m/z: 347 (20%, M), 332 (2), 290 (100), 279 (2), 226 (2), 205 (6), 192 (7), 167 
(8), 162 (11). Found 347.1917, C20H29O2N32S requires 347.1919. 
 






















M.p. 99 -101°C 
 
Rf 0.74 (50% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.69 (2H, d, J 7.9, H-15), 7.23 (2H, d, J 8.0, 
H-16), 3.50-3.45 (2H, m, H-5, H-12), 3.11-3.01 (2H, m, H-10AB), 2.39 (3H, s, 
H-18), 2.36-2.29 (2H, m, H-7AB), 2.04-1.96 (1H, m, H-6A), 1.72-1.53 (4H, m, 
H-6B, H-11AB, H-4A), 1.37-1.21 (5H, m, H-2, H-3, H-4B), 1.05 (3H, d, J 6.6, 
H-13), 0.90 (3H, t, J 6.9, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 155.2 (C-8), 141.8 (C-14), 141.7 (C-17), 129.2 
(C-15), 126.0 (C-16), 91.9 (C-9), 60.1 (C-12), 45.5 (C-5), 31.7 (C-11), 30.1 
(C-10), 27.9 (C-2), 27.3 (C-6), 26.9 (C-4), 22.8 (C-3), 21.4 (C-13), 19.2 (C-18), 
17.1 (C-7), 14.0 (C-1). 
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νmax. / cm-1: 2929 (m, C-H), 2857 (m, C-H), 1590 (s), 1459 (w), 1375 (w, S=O), 
1279 (s), 1128 (s), 1086 (s), 661 (s). 
 
m/z: 347 (18%, M), 319 (2), 298 (3), 290 (100), 277 (9), 261 (1), 226 (1), 207 
(8), 192 (8), 176 (6).  Found 347.1921, C20H29O2N32S requires 347.1919. 
 





indolizine (298) (80 mg, 0.23 mmol) was dissolved in AcOH (4 mL) and 
reacted with platinum dioxide (3 mg, 0.05 eq.) under 7.5 atmospheres of 
hydrogen pressure for 12 hours at ambient temperature. The reaction mixture 
was filtered through Celite® to remove the catalyst and rinsed thoroughly with 
CH2Cl2 (200 mL). The solvent was removed in vacuo and the residue was 
partitioned in distilled H2O (20 mL) and CH2Cl2 (3 × 20 mL). The organic 
fractions were rinsed with saturated sodium hydrogen carbonate solution (20 
mL), dried with sodium sulfate and the solvent was removed in vacuo to give 
the crude product. This was purified by column chromatography (30% 
EtOAc/hexane) to give the product, 3-butyl-5-methyl-8-[(4-
methylphenyl)sulfonyl]octahydroindolizine (299), (67 mg, 84% yield) as a 
clear oil that discolours to pink on standing.  
 
This method was repeated with pure diastereomer A (S,R and R,S), 3-butyl-5-
methyl-8-[(4-methylphenyl)sulfonyl]octahydroindolizine (298A) (0.15 g, 
0.42 mmol), to give 3-butyl-5-methyl-8-[(4-methylphenyl)sulfonyl]octahydro 
indolizine (299A) (130 mg, 88% yield). 
 
This method was repeated with pure diastereomer B (R,R and S,S), 3-butyl-5-
methyl-8-[(4-methylphenyl)sulfonyl]octahydroindolizine (298B) (0.11 g, 
0.32 mmol), to give 3-butyl-5-methyl-8-[(4-methylphenyl)sulfonyl]octahydro 
indolizine (299B) (80 mg, 72% yield). 
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Rf 0.58 (30% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 7.84 (2H, d, J 8.1, H-15), 7.29 (2H, d, J 8.1, 
H-16), 3.33 (1H, m, H-12), 3.03 (1H, t, J 7.5, H-9), 2.62 (1H, m, H-5), 2.58-2.48 
(1H, m, H-8), 2.43 (3H, s, H-18), 2.25-2.13 (4H, m, H-10, H-11AB), 1.82-1.15 
(10H, m, H-2, H-3, H-4, H-6, H-7), 0.91 (3H, d, J 7.5, H-13), 0.88 (3H, t, J 6.3, 
H-1).  
 
13C (75 MHz, CDCl3) δC /ppm 143.9 (C-14), 138.4 (C-17), 129.5 (C-16), 129.2 
(C-15), 67.1 (C-8), 63.4 (C-5), 61.6 (C-12), 59.5 (C-9), 39.2 (C-11), 30.5 (C-10), 
29.0 (C-7), 28.7 (C-6), 27.7 (C-4), 26.1 (C-3), 22.9 (C-2), 22.1 (C-18), 21.6 
(C-13), 14.2 (C-1).  
 
νmax. / cm-1: 2958 (m, C-H), 2928 (m, C-H), 2859 (Bohlmann), 1598 (m), 1454 
(m), 1377 (m, S=O), 1306 (s), 1275 (s), 1140 (s), 1084 (s), 818 (m).  
 
































Rf 0.71 (50% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ  /ppm 7.79 (2H, d, J 7.2, H-15), 7.30 (2H, d, J 7.2, 
H-16), 3.49-3.02 (3H, m, H-12, H-9, H-8), 2.67-2.54 (1H, m, H-5), 2.43 (3H, s, 
H-18), 2.07-1.98 (2H, m, H-10), 1.80-1.65 (2H, m, H-11), 1.52-1.02 (10H, m, 
H-2, H-3, H-4, H-6, H-7), 0.99-0.81 (6H, m, H-13, H-1).  
 
13C (75 MHz, CDCl3) δC /ppm 144.0 (C-14), 137.9 (C-17), 129.4 (C-16), 128.7 
(C-15), 62.9 (C-8), 60.2 (C-5), 56.5 (C-12), 47.0 (C-9), 33.0 (C-11), 29.7 (C-10), 
28.5 (C-7), 28.0 (C-6), 27.8 (C-4), 25.7 (C-3), 23.0 (C-2), 21.5 (C-18), 20.7 
(C-13), 14.1 (C-1).  
 
νmax. / cm-1: 2958 (s, C-H), 2927 (s, C-H), 2857 (Bohlmann), 1597 (m), 1454 
(m), 1378 (m, S=O), 1313 (s), 1301 (s), 1142 (s), 1085 (m), 815 (m). 
 
m/z: 349 (36%, M), 347 (88), 334 (100), 294 (100), 194 (100), 178 (90), 149 




indolizine (298) (0.16 g, 0.46 mmol) and sodium borohydride (26 mg, 
0.69 mmol) were dissolved in MeOH (7 mL) and stirred at ambient temperature 
for 4 hours. TLC showed no significant conversion of starting material. The 
reaction was heated to 60°C and was allowed to react for a further 20 hours. 
The solvent was removed in vacuo and the residue was partitioned in distilled 
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H2O (20 mL) and CH2Cl2 (3 × 20 mL). The organic fractions were combined and 
dried with sodium sulfate and the solvent was removed in vacuo. The crude 
material was purified by column chromatography (40% EtOAc/hexane) to give 
3-butyl-5-methyl-8-[(4-methylphenyl)sulfonyl]-1,2,3,5,6,7-
hexahydroindolizine (298) (80 mg, 50% recovery) and the desired product, 3-
butyl-5-methyl-8-[(4-methylphenyl)sulfonyl]octahydroindolizine (299) 
(15 mg, 13% yield).  
 
8.1.10 Desulfonylation 
8.1.10.1 3-Butyl-5-methyloctahydroindolizine, monomorine I (27), 5-epi-
monomorine I (28) 
Method A234, 236, 254 
A 6% (w/w) sodium amalgam was prepared by placing sodium (1.5 g, 65 mmol) 
freshly rinsed in hexane (to remove traces of paraffin oil) in a dry flask. The 
hexane was removed under high vacuum. A few drops of mercury (25.0 g, 126 
mmol) were slowly added by dropping funnel. The flask was then heated with a 
Bunsen burner until the amalgam ignited, at which point the flame was removed 
and the remaining mercury was slowly added. The flask was heated again to 
melt the amalgam so that it could be poured into a crucible where it was cooled 
under the flow of nitrogen gas. The amalgam was crushed with a mortar and 
pestle and stored in a dessicator. Anhydrous sodium hydrogen phosphate (193 
mg, 1.36 mmol) was pre-dried for 12 hours in a 130°C oven and then dissolved 
in distilled MeOH (7 mL). 3-Butyl-5-methyl-8-[(4-
methylphenyl)sulfonyl]octahydroindolizine (299) (120 mg, 0.34 mmol) and 
the sodium amalgam (515 mg, 1.50 g/mmol) were added to the MeOH solution 
and the reaction stirred at ambient temperature for 14 hours. TLC analysis was 
inconclusive so the reaction was stopped, filtered through Celite® to remove the 
mercury, and rinsed thoroughly with CH2Cl2 (20 mL). The organic layer was 
partitioned with distilled H2O, dried with sodium sulfate and the solvent was 
removed in vacuo. The crude material was purified by column chromatography 
(30% EtOAc/hexane) to give back the starting material, 3-butyl-5-methyl-8-[(4-





Magnesium turnings were pre-activated by washing in an HCl solution (0.5% 
(v/v), 30 mL) rinsing with distilled H2O, EtOH, and Et2O respectively, and then 
drying for several days at 150°C. The activated magnesium turnings (64 mg, 
2.7 mmol) were mixed with MeOH (5 mL) and heated to 50°C until hydrogen 
evolution was constant. 3-Butyl-5-methyl-8-[(4-methylphenyl)sulfonyl] 
octahydroindolizine (299) (58 mg, 0.17 mmol) was added to the methanolic 
mixture. The reaction was maintained at 50°C for 3 hours and during this time 
two further portions of magnesium turnings (64 mg, 2.7 mmol) were added. The 
solution was cooled, filtered through Celite®, and rinsed thoroughly with CH2Cl2 
(100 mL). The solvent was removed in vacuo and the resulting residue was 
redissolved in Et2O (80 mL) and refiltered to remove the solid magnesium 
methoxide. After evaporation in vacuo the oily residue that remained was 
purified by column chromatography (30% EtOAc/hexane) to give 3-butyl-5-
methyloctahydroindolizine (20 mg, 60% yield) as a mixture of monomorine I 
(27), 5-epi-monomorine I (28) and indolizidine 195B (26) (as confirmed by 
13C-NMR spectroscopy only).  
 
RACEMIC MONOMORINE I (27) 
Method C 
Sodium metal (40 mg, 1.8 mmol) was reacted with naphthalene (224 mg, 
1.75 mmol) in THF (10 mL) for 1 hour in an oven-dried flask under inert 
atmosphere, until a dark green solution of sodium naphthalenide had formed. 
Isomer A of 3-butyl-5-methyl-8-[(4-methylphenyl)sulfonyl] 
octahydroindolizine (299A) (44 mg, 0.12 mmol) was added to the sodium 
naphthalenide and the mixture was stirred for 15 minutes at ambient 
temperature whilst constantly monitoring by TLC. The reaction was quenched 
by addition of saturated ammonium chloride solution (20 mL) and the organic 
products were extracted into CH2Cl2 (3 × 30 mL). The combined organic 
fractions were dried with sodium sulfate and the solvent was removed in vacuo. 
The crude material was purified by column chromatography (20% - 50% 








Rf 0.25 (30% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 2.51-2.43 (1H, m, H-3), 2.31-2.15 (1H, m, H-5), 
2.14-2.03 (1H, m, H-8a), 1.88-1.05 (16H, m, H-1, H-2, H-6, H-7, H-8, H-10, 
H-11, H-12), 1.15 (3H, d, J 6.3, H-9), 0.98 (3H, t, J 6.8, H-13). 
 
13C (75 MHz, CDCl3) δC /ppm 67.17 (C-8a), 62.90 (C-3), 60.26 (C-5), 39.73 
(C-9), 35.84 (C-6), 30.91 (C-1), 30.34 (C-8), 29.76 (C-2), 29.40 (C-10), 24.91 
(C-7), 22.90 (C-11), 22.86 (C-13), 14.16 (C-12). 
 
νmax. / cm-1: 2958 (m, C-H), 2930 (m, C-H), 2860 (Bolhmann), 1457 (m), 1380 
(m), 1319 (m), 1304 (m), 1208 (w), 1133 (m), 1089 (w), 816 (w). 
 
m/z:  no molecular ion 193 (6%), 170 (36), 155, 45), 138 (100), 107 (41). APCI 
Found 195.37, C13H25N requires 195.1987. 
 
RACEMIC 5-epi-MONOMORINE I (28) 
Method D 
Sodium metal (40 mg, 1.8 mmol) was reacted with naphthalene (224 mg, 
1.75 mmol) in THF (10 mL) for 30 minutes in an oven-dried flask under inert 
atmosphere until a dark green solution of sodium naphthalenide had formed. 
Isomer B of 3-butyl-5-methyl-8-[(4-methylphenyl)sulfonyl]octahydro 
indolizine (299B) (75 mg, 0.21 mmol) was added to the sodium naphthalenide 
and the mixture was stirred for 15 minutes at ambient temperature whilst 
constantly monitoring by TLC. The reaction was quenched by addition of 
saturated ammonium chloride solution (10 mL) and the organic products were 
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extracted into CH2Cl2 (3 × 30 mL). The combined organic fractions were dried 
with sodium sulfate and the solvent was removed in vacuo. The crude material 
was purified by column chromatography through a Pasteur pipette (0% - 100% 
EtOAc/hexane) to give racemic 5-epi-monomorine I (28) (31 mg, 71% yield) 
as a pale yellow oil that discoloured to turquoise over time. 
 




Rf 0.17 (50% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 3.45-3.30 (1H, m, H-5), 2.51-2.38 (2H, m, H-3, 
H-8a), 1.87-1.07 (16H, m, H-1, H-2, H-6, H-7, H-8, H-10, H-11, H-12), 0.92-0.83 
(6H, m, H-9, H-13). 
 
13C (75 MHz, CDCl3) δC /ppm 59.21 (C-8a), 55.49 (C-3), 47.38 (C-5), 32.34 
(C-1), 32.21 (C-6), 31.46 (C-2), 29.12 (C-8), 28.82 (C-9), 28.12 (C-10), 23.08 
(C-11), 19.26 (C-7), 14.09 (C-12), 7.60 (C-13). 
 
νmax. / cm-1: 2957 (s, C-H), 2927 (s, C-H), 2859 (Bolhmann), 1455 (m), 1375 
(m), 1261 (w), 1201 (w), 1146 (w), 1078 (w), 784 (m), 745 (m). 
 
m/z: 195 (6%, M), 194 (12), 180 (70), 148 (8), 138 (100), 128 (26), 124 (13). 
Found 195.1976, C13H25N requires 195.1987. 
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8.2 Investigation of monobenzylated analogues 
 
8.2.1 (R,E)-5-Butylidene-1-(1-phenylethyl)pyrrolidin-2-one (388) 
Method A 
Ethyl 4-oxooctanoate (292) (6.60 g, 35.4 mmols) was dissolved in toluene 
(30 mL). Crude ethyl (3R)-3-{[(1R)-1-phenylethyl]amino}butanoate (357) 
(29.5 mmols) in AcOH (<5 mL) was added to the toluene and the mixture was 
heated at reflux for 72 hours in a modified Dean Stark apparatus filled with 
molecular sieves. The solvent was removed in vacuo and the crude material 
was purified by column chromatography (10% EtOAc/hexane) to give (R,E)-5-


















Rf  0.11 (10% EtOAc/Hexane), [α]D20 +43.1 (c 1.30, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ  /ppm 7.28-7.24 (5H, m, H-12, H-13, H-14), 5.65 (1H, 
q, J 7.2, H-10), 4.39 (1H, t, J 7.4,  H-4), 2.63-2.51 (4H, m, H-6, H-7), 1.85-1.78 
(2H, m, H-3), 1.71 (3H, d, J 7.2, H-9), 1.19 (2H, s, J 7.4, H-2), 0.72 (3H, t, J 7.4, 
H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 175.7 (C-8), 139.7 (C-11), 136.6 (C-5), 128.4 
(C-12), 126.7 (C-14), 126.3 (C-13), 104.0 (C-4), 48.8 (C-10), 29.0 (C-7), 28.8 
(C-3), 22..9 (C-2), 21.2 (C-6), 15.4 (C-9), 13.3 (C-1). 
 
νmax. / cm-1: 2957 (w, C-H), 2931 (w, C-H), 2871 (w, C-H), 1714 (m), 1666 (s, 
C=O), 1449 (w), 1398 (m), 1372 (m), 1336 (w), 1239 (m), 1201 (w), 689 (m). 
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m/z: 243 (10%, M), 214 (6), 203 (82), 198 (11), 189 (22), 174 (5), 160 (100), 
152 (7), 146 (31), 141 (27),  132 (24), 120 (29), 110 (47), 104 (89).n 
 
Method B 
Ethyl 4-oxooctanoate (292) (0.15 g, 0.90 mmols) was dissolved in toluene 
(10 mL). R-Methylbenzylamine (54 mg, 0.45 mmols) and AcOH (135 mg, 
2.25 mmols) were added to the toluene and the mixture was heated at reflux for 
72 hours in a modified Dean Stark apparatus filled with molecular sieves. The 
solvent was removed in vacuo and the crude material was purified by column 
chromatography (10% EtOAc/hexane) to give (R,E)-5-butylidene-1-(1-
phenylethyl)pyrrolidin-2-one (388) (110 mg, quantitative yield). 
 
8.2.2 (R)-5-Butyl-1-(1-phenylethyl)pyrrolidin-2-one (389) 
Method A 
(R,E)-5-Butylidene-1-(1-phenylethyl)pyrrolidin-2-one (388) (0.30 g, 
1.2 mmols)  was dissolved in CH2Cl2 (10 mL) and cooled to -90°C. Titanium 
tetrachloride (0.30 mL, 2.7 mmols) was carefully added and the reaction 
mixture was left to stir for 10 minutes before triphenylsilane (0.96 g, 3.7 mmols) 
was added and the solution slowly warmed to ambient temperature. The 
reaction was left stirring at ambient temperature for 72 hours and was then 
quenched by adding saturated ammonium chloride solution (10 mL). The 
product was extracted into CH2Cl2 (3 x 50 mL) and the combined organic 
fractions were dried with sodium sulfate. Purification by column 
chromatography (10% - 40% EtOAc/hexane) gave (R)-5-butyl-1-(1-
phenylethyl)pyrrolidin-2-one (389) as a clear oil in quantitative yield as an 
inseparable mixture of diastereomers in a 1:1 ratio. 
 
                                                 

















Rf  0.26 (40% EtOAc/hexane) 
 
ISOMER A [α]D20 +15.7 (c 1.15, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ  /ppm 7.37 (2H, d, J 7.2, H-12), 7.32-7.20 (3H, m, 
H-13, H-14), 5.38 (1H, q, J 7.2, H-10), 3.73-3.67 (1H, m, H-5), 2.54-2.43 (1H, 
m, H-7A), 2.38-2.28 (1H, m, H-7B), 2.19-2.12 (1H, m, H-6A), 1.71-1.67 (1H, m, 
H-6B), 1.63 (3H, d, J 7.2, H-9), 1.26-1.14 (1H, m, H-4A), 1.08-0.80 (5H, m, 
H-4B, H-3, H-2), 0.72 (3H, t, J 6.8, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 175.2 (C-8), 142.0 (C-11), 129.9 (C-14), 128.5 
(C-13), 127.0 (C-12), 56.9 (C-5), 49.2 (C-10), 33.9 (C-4), 30.5 (C-7), 26.7 (C-3), 
24.3 (C-6), 22.3 (C-2), 16.1 (C-9), 13.7 (C-1). 
 
νmax. / cm-1: 2931 (m, C-H), 2861 (m, C-H), 1681 (s, C=O), 1457 (m), 1417 (m), 
1375 (m), 1289 (m), 1212 (m), 1185 (m), 700 (s). 
 
ISOMER B [α]D20 +131.6 (c 0.98, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ  /ppm 7.37 (2H, d, J 7.2, H-12), 7.32-7.20 (3H, m, 
H-13, H-14), 5.38 (1H, q, J 7.2, H-10), 3.26-3.18 (1H, m, H-5), 2.54-2.43 (1H, 
m, H-7A), 2.38-2.28 (1H, m, H-7B), 2.19-2.12 (1H, m, H-6A), 1.71-1.67 (1H, m, 
H-6B), 1.63 (3H, d, J 7.2, H-9), 1.26-1.14 (1H, m, H-4A), 1.08-0.80 (5H, m, 
H-4B, H-3, H-2), 0.72 (3H, t, J 6.8, H-1). 
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13C (75 MHz, CDCl3) δC /ppm 175.0 (C-8), 139.7 (C-11), 128.3 (C-13), 127.4 
(C-14), 127.3 (C-12), 57.2 (C-5), 50.5 (C-10), 34.7 (C-4), 30.4 (C-7), 26.9 (C-3), 
24.2 (C-6), 22.5 (C-2), 18.2 (C-9), 13.8 (C-1). 
 
νmax. / cm-1: 2956 (m, C-H), 2930 (m, C-H), 2871 (w), 1674 (s, C=O), 1456 (m), 
1418 (m), 1375 (w), 1320 (m), 1291 (m), 1216 (m), 1151 (m), 700 (s). 
 
m/z: 245 (14%, M), 198 (7), 188 (19), 174 (6), 160 (18), 146 (10), 120 (8), 110 
(11), 105 (100). Found 245.1765, C16H23ON requires 245.1780. 
 
Method B 
(R,E)-5-Butylidene-1-(1-phenylethyl)pyrrolidin-2-one (388) (0.50 g, 
2.1 mmols) was dissolved in AcOH (7 mL) and 10% palladium on carbon 
(100 mg, 0.20 eq.) was carefully added. The reaction was set up in a 
hydrogenator under 2 atmospheres of hydrogen pressure. The reaction was left 
at ambient temperature for 48 hours before the catalyst was removed by 
filtering the reaction mixture through Celite®. The product was rinsed through 
the Celite® with CH2Cl2 (75 mL) and the crude material was purified by column 
chromatography (10% - 40% EtOAc/Hexane) to give (R)-5-butyl-1-(1-
phenylethyl)pyrrolidin-2-one (389) (450 mg, 89% yield) as a clear oil. The 
diastereomer ratio was 7:1 favouring isomer A. 
 
Method C 
(R,E)-5-Butylidene-1-(1-phenylethyl)pyrrolidin-2-one (388) (1.7 g, 
7.0 mmols)  was dissolved in CH2Cl2 (20 mL) and cooled to -90°C. Titanium 
tetrachloride (1.7 mL, 15 mmols) was carefully added and the reaction mixture 
was left to stir for 10 minutes before triethylsilane (3.3 mL, 21 mmols) was 
added; the solution was then slowly warmed to ambient temperature. The 
reaction was left stirring at ambient temperature for 72 hours and was then 
quenched by adding saturated ammonium chloride solution (10 mL). The 
product was extracted into CH2Cl2 (3 x 50 mL) and the combined organic 
fractions were dried with sodium sulfate. Purification by column 
chromatography (10% - 40% EtOAc/hexane) gave (R)-5-butyl-1-(1-
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phenylethyl)pyrrolidin-2-one (389) (1.15 g, 68% yield) as a clear oil with a 
diastereomer ratio of 3:1, favouring isomer A. 
 
8.2.3 (R)-5-Butyl-1-(1-phenylethyl)pyrrolidine-2-thione (390) 
Method A 
(R)-5-Butyl-1-(1-phenylethyl)pyrrolidin-2-one (389) (0.20 g, 0.81 mmol) was 
dissolved in CH2Cl2 (7 mL) in an oven-dried flask. Phosphorus pentasulfide 
(0.20 g, 0.45 mmols) was added and the heterogeneous mixture was stirred for 
72 hours at ambient temperature, under a nitrogen atmosphere. The reaction 
was quenched by the addition of saturated sodium bicarbonate solution (10 mL) 
and the product was extracted into CH2Cl2 (3 x 20 mL). The combined organic 
fractions were dried with sodium sulfate and the solvent was removed in vacuo. 
Purification by column chromatography (10% - 20% EtOAc/hexane) gave (R)-5-
butyl-1-(1-phenylethyl)pyrrolidine-2-thione (390) (140 mg, 66% yield) as a 


















ISOMER A (minor isomer) 
 
Rf 0.34 (10% EtOAc/hexane), [α]D20 + 226.7 (c 0.75, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ  /ppm 7.38-7.26 (5H, m, H-12, H-13, H-14),  6.30 (1H, 
q, J 7.2, H-10), 3.51-3.47 (1H, m, H-5), 3.12-3.00 (2H, m, H-7AB), 2.02-1.88 
(1H, m, H-6A), 1.70 (3H, d, J 7.2, H-9), 1.67-0.96 (7H, m, H-2, H-3, H-4, H-6B), 
0.89 (3H, t, J 7.2, H-1). 
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13C (75 MHz, CDCl3) δC /ppm 201.8 (C-8), 138.3 (C-11), 128.7 (C-12), 128.0 
(C-14), 127.6 (C-13), 64.4 (C-5), 55.6 (C-10), 43.7 (C-7), 33.5 (C-4), 29.7 (C-6), 
25.8 (C-2), 22.4 (C-3), 16.4 (C-9), 13.9 (C-1). 
 
νmax. / cm-1: 2956 (m, C-H), 2925 (m, C-H), 2856 (m, C-H), 1683 (w), 1447 (s, 
C=S), 1422 (m), 1267 (m), 1095 (m), 1026 (m),  699 (s). 
 
m/z: 261 (12%, M), 245 (14), 228 (8), 205 (6), 188 (19), 176 (7), 160 (9), 146 
(6), 120 (8), 105 (100). Found 261.1547, C16H23N32S requires 261.1551. 
 
ISOMER B (major isomer) 
 
Rf 0.27 (10% EtOAc/hexane), [α]D20 +383.6 (c 1.22, CH2Cl2) 
 
1H (300 MHz, CDCl3) δΗ  /ppm 7.45 (2H, dd, J 7.5, 1.2, H-12), 7.34-7.27 (3H, 
m, H-13, H-14),  6.55 (1H, q, J 7.2, H-10), 4.05-3.99 (1H, m, H-5), 3.16-2.95 
(2H, m, H-7AB), 2.18-2.05 (1H, m, H-6A), 1.78-1.69 (1H, m, H-6B), 1.66 (3H, d, 
J 7.2, H-9), 1.05-0.77 (6H, m, H-2, H-3, H-4), 0.65 (3H, t, J 7.0, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 201.8 (C-8), 140.1 (C-11), 128.3 (C-12), 127.7 
(C-14), 127.1 (C-13), 63.8 (C-5), 53.7 (C-10), 43.6 (C-7), 33.2 (C-4), 27.3 (C-6), 
26.4 (C-3), 22.2 (C-2), 15.1 (C-9), 13.7 (C-1). 
 
νmax. / cm-1: 2955 (m, C-H), 2929 (m, C-H), 2870 (m, C-H), 1681 (w), 1450 (s, 
C=S), 1422 (s) 1314 (s), 1271 (s), 699 (s). 
 
m/z: 261 (100%, M), 245 (42), 228 (67), 205 (33), 188 (59), 176 (50), 162 (51), 
144 (32), 128 (20), 120 (50). Found 261.1539, C16H23N32S requires 261.1551. 
 
Method B 
(R)-5-Butyl-1-(1-phenylethyl)pyrrolidin-2-one (389) (1.05 g, 4.28 mmol) was 
dissolved in CH2Cl2 (50 mL) in an oven-dried flask. Phosphorus pentasulfide 
(476 mg, 1.07 mmols) and hexamethyldisiloxane (1.36 mL, 6.42 mmol) were 
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added and the heterogeneous mixture was stirred for 72 hours at ambient 
temperature under a nitrogen atmosphere. The reaction was quenched by the 
addition of saturated sodium bicarbonate solution (10 mL) and the product was 
extracted into CH2Cl2 (3 x 20 mL). The combined organic fractions were dried 
with sodium sulfate and the solvent was removed in vacuo. Purification by 
column chromatography (10% - 20% EtOAc/hexane) gave (R)-5-butyl-1-(1-
phenylethyl)pyrrolidine-2-thione (390) (1.12 g, 100% yield) as a mixture of 
diastereomers. 
 
8.2.4 (R,E)-2-Butyl-1-(1-phenylethyl)-5-(tosylmethylene)pyrrolidine (391)  
Method A 
(R)-5-Butyl-1-(1-phenylethyl)pyrrolidine-2-thione (390) (0.25 g, 0.96 mmol) 
was dissolved in freshly dried and distilled THF (5 mL) in oven-dried glassware 
under a nitrogen atmosphere. Methyl iodide (0.30 mL, 4.8 mmol) was added 
and the reaction was left stirring under nitrogen for 48 hours. The THF and 
excess methyl iodide were removed in vacuo to give a brown oil. Et3N (0.26 mL, 
1.9 mmol) and 1-[(4-methylphenyl)sulfonyl]acetone (279) (224 mg,  1.06 
mmol) were mixed together in CH2Cl2 (5 mL) 10 minutes prior to addition to the 
brown oil. This mixture was left stirring at ambient temperature under a nitrogen 
atmosphere for 96 hours before the solvent was removed in vacuo and the 
organic residue was partitioned in distilled H2O (10 mL) and CH2Cl2 (10 mL). 
The crude product was extracted into CH2Cl2 (6 × 15 mL), dried with sodium 
sulfate, and the solvent removed in vacuo. The crude material was purified by 
column chromatography (30% EtOAc/hexane) to give the hydrolysis product, 
(R)-5-butyl-1-(1-phenylethyl)pyrrolidin-2-one (389) in 38% yield (90 mg, 0.36 
mmol), and a mixture of (R,E)-2-butyl-1-(1-phenylethyl)-5-(tosylmethylene) 
pyrrolidine (391) and (E)-1-(5-butyl-1-((R)-1-phenylethyl)pyrrolidin-2-


















































ISOMER A (391) 
1H (300 MHz, CDCl3) δΗ  /ppm 7.64 (2H, d, J 8.1, H-17), 7.38-7.20 (5H, m, 
H-12, H-13, H-14), 7.22 (2H, d, J 8.1, H-18), 4.89 (1H, s, H-15), 4.72 (1H, q, J 
7.1, H-10), 3.40-3.32 (1H, m, H-5), 2.89-2.78 (2H, m, H-7AB), 2.07-1.81 (2H, m, 
H-6AB), 1.61 (3H, d, J 7.1, H-9), 1.75-1.04 (6H, m, H-2, H-3, H-4), 0.82 (3H, t, J 
7.1, H-1). 
 
ISOMER B (392) 
1H (300 MHz, CDCl3) δΗ  /ppm 7.38-7.20 (7H, m, H-12, H-13, H-14, H-17), 7.22 
(2H, d, J 8.1, H-18), 6.31 (1H, q, J 7.2, H-10), 3.51 (1H, tt, J 8.9, 2.8, H-5), 
3.16-3.01 (2H, m, H-7AB), 2.40 (3H, s, H-22), 2.07-1.81 (2H, m, H-6AB), 1.70 
(3H, d, J 7.2, H-9), 1.25 (3H, s, H-20), 1.75-1.04 (6H, m, H-2, H-3, H-4), 0.83 
(3H, t, J 7.0, H-1). 
 
ISOMER A and B (391) = A; (392) = B 
13C (75 MHz, CDCl3) δC /ppm 201.4 (C-21B), 160.5 (C-8AB), 143.5, 141.6, 
139.2, 138.4 (C-19AB, C-16AB), 129.9, 129.2 (C-17AB, C-18AB), 128.7, 128.5 
(C-11AB), 128.0 (C-15B), 127.7, 127.6, 127.5, 127.0, 126.0 (C-12AB, C-13AB, 
C-14AB), 88.2 (C-15A), 64.4, 62.2, 55.6, 54.1 (C-5AB, C-10AB), 43.7, 34.0 
(C-7AB), 33.6, 29.8, 29.7, 27.9, 27.4, 26.4, 25.8 (C-2AB, C-3AB, C-4AB, 
C-6AB), 22.5, 22.4 (C-20AB), 21.4, 16.4 (C-9AB), 13.9, 13.8 (C-1AB). 
 
νmax. / cm-1: 2956 (m, C-H), 2929 (m, C-H), 2860 (m, C-H), 1683 (w), 1566 (s), 
1454 (s), 1279 (s), 1132 (s), 1084 (s), 847 (w), 701 (m), 577 (m). 
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8.2.5 Attempted debenzylation reactions 
Method A 
(R)-5-Butyl-1-(1-phenylethyl)pyrrolidin-2-one (389) (0.20 g, 0.81 mmol) was 
dissolved in AcOH (10 mL) and set up in a hydrogenator with palladium 
hydroxide (40 mg, 0.2 eq.) under 5 atmospheres of hydrogen pressure. The 
reaction was left at ambient temperature for 4 days. The residual catalyst was 
removed by filtering the solution through Celite® and rinsing with acetone 
(50 mL). The solvent was removed in vacuo and the crude product was purified 
by column chromatography (40% EtOAc/hexane). Only starting material was 
isolated (170 mg, 85% recovery). 
 
Method B 
(R)-5-Butyl-1-(1-phenylethyl)pyrrolidine-2-thione (390) (80 mg, 0.31 mmol) 
was dissolved in AcOH (5 mL) and set up in a hydrogenator with palladium 
hydroxide (8 mg, 0.1 eq.) under 7 atmospheres of hydrogen pressure. The 
reaction was left at ambient temperature for 3 days. The residual catalyst was 
removed by filtering the solution through Celite® and rinsing with CH2Cl2 
(20 mL). The solvent was removed in vacuo and the crude product was purified 
by column chromatography (10% EtOAc/hexane). Only starting material was 
isolated (80 mg, 100% recovery). 
 
Method C 
(R,E)-5-Butylidene-1-(1-phenylethyl)pyrrolidin-2-one (388) (0.20 g, 
0.82 mmol) was dissolved in methanol (11 mL). Ammonium formate (414 mg, 
6.58 mmol) was added and the solution was stirred under a nitrogen 
atmosphere until the solution was homogenous. 10% Palladium on carbon 
(74 mg, 0.37 eq.) was carefully stirred into the mixture (the methanolic vapours 
readily ignited if the system was not properly flushed with nitrogen). The 
reaction was left at ambient temperature for 3 hours. The mixture was filtered 
through Celite® and rinsed with CH2Cl2 (2 × 20 mL) to remove the catalyst. The 
solvent was removed in vacuo and the crude material was purified by column 





(R)-5-Butyl-1-(1-phenylethyl)pyrrolidin-2-one (389) (0.10 g, 0.41 mmol) and 
ceric ammonium nitrate (894 mg, 1.60 mmol) were dissolved in MeCN/H2O 
(1:5, 6 mL) and stirred at ambient temperature for 12 hours. The reaction 
mixture was filtered through cotton wool and the product extracted into CH2Cl2 
(4 × 20 mL). The organic extracts were combined and rinsed with saturated 
sodium bicarbonate solution (20 mL) and dried with sodium sulfate. The solvent 
was removed in vacuo and the crude product was purified by column 




(R)-5-Butyl-1-(1-phenylethyl)pyrrolidin-2-thione (390) (0.22 g, 0.84 mmol) 
and ceric ammonium nitrate (1.85 g, 3.37 mmol) were dissolved in MeCN/H2O 
(1:5, 60 mL) and stirred at ambient temperature for 12 hours. The reaction was 
quenched with saturated sodium bicarbonate solution (20 mL) and filtered 
through cotton wool. The product was extracted into CH2Cl2 (4 × 20 mL) and 
dried with sodium sulfate. The solvent was removed in vacuo and the crude 
product was purified by column chromatography (20% EtOAc/hexane) to give 
(R)-5-butyl-1-(1-phenylethyl)pyrrolidin-2-one (389) (80 mg, 39% yield), and 
starting material (134 mg, 61% recovery). 
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CHAPTER 9 
EXPERIMENTAL PROCEDURES RELATING TO CHAPTER 5 
 
9.1  Preparation of allylic ketoesters 
 
9.1.1 Ethyl 4-allyl-4-hydroxyhept-6-enoate (394) 
Iron(III) acetoacetate (0.13 g, 0.36 mmol) was dissolved in dry THF (10 mL) in 
an oven-dried RBF. Ethyl 4-chloro-4-oxobutyrate (0.92 mL, 6.1 mmol) was 
added and the mixture was cooled to -10°C. After 10 minutes, allylmagnesium 
bromide (1.0 M, 6.7 mL) was quickly added and the reaction mixture was stirred 
for an additional 7 minutes. The reaction was quenched with HCl (1.0 M, 10 
mL) and extracted into EtOAc (3 × 40 mL). The combined organic fractions 
were rinsed with saturated sodium bicarbonate solution (50 mL) and brine (50 
mL) and dried with sodium sulfate. The solvent was removed in vacuo and the 
crude product was purified by column chromatography (30% - 40% 

















Rf 0.51 (40% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm  5.84 (2H, m, H-6), 5.18-5.07 (4H, m, H-7), 4.16 
(2H, q, J 7.2, H-8), 2.64 (4H, m, H-3, H-4), 2.24 (4H, d, J 7.4, H-5), 1.56 (1H, s, 
OH),1.26 (3H, t, J 7.2, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 172.1 (C-1), 133.5 (C-6), 118.6 (C-7), 73.7 (C-4), 
60.7 (C-8), 43.5 (C-5), 32.1 (C-3), 28.8 (C-2), 14.0 (C-9). 
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νmax. / cm-1: 3090 (w, O-H), 2980 (w, C-H), 2934 (w, C-H), 1716 (s, C=O), 1638 
(w), 1417 (m), 1375 (m), 1163 (s), 1021 (m), 997 (m), 915 (s).  
m/z: 211 (48%, M-1), 191 (31), 183 (25), 173 (8), 155 (16), 147 (7), 129 (100), 
121 (10), 107 (72).  
 
9.1.2 Ethyl 4-oxohept-6-enoate (313) 
Ethyl 4-chloro-4-oxobutyrate (0.50 mL, 2.8 mmol), allyl tri-n-butyl tin (0.95 mL, 
3.1 mmol) and Wilkinson’s catalyst (26 mg, 0.03 mmol) were dissolved in 
CH2Cl2 (3 mL) in a sealed tube and heated to 65°C for 5 hours. The CH2Cl2 
was removed in vacuo and the crude material was purified by column 
chromatography (5% EtOAc/hexane) to give ethyl 4-oxohept-6-enoate (313) 




Rf 0.10 (5% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 5.98-5.88 (1H, m, H-6), 5.20-5.12 (2H, m, H-7), 
4.12 (2H, q, J 7.2, H-8), 3.22 (2H, d, J 6.9, H-5), 2.76 (2H, t, J 6.3, H-3), 2.58 
(2H, t, J 6.3, H-2), 0.92 (3H, t, J 7.2, H-9). 
 
13C (75 MHz, CDCl3) δC /ppm 206.4 (C-4), 172.4 (C-1), 130.2 (C-6), 118.7 
(C-7), 60.4 (C-8), 47.4 (C-5), 36.7 (C-3), 27.8 (C-2), 13.8 (C-9). 
 
m/z: 171 (4%, M+1), 161 (7), 142 (5), 129 (15), 125 (100), 124 (100), 119 (3), 
105 (4). 
 
9.1.3 Ethyl (5E)-4-oxohept-5-enoate (396) 
Ethyl 4-chloro-oxobutyrate (0.50 mL, 2.8 mmol), allyl tri-n-butyl tin (0.95 mL, 
3.1 mmol) and Wilkinson’s catalyst (26 mg, 0.03 mmol) were dissolved in 
CH2Cl2 (3 mL) in a sealed tube and heated to 65°C for 5 hours. The reaction 
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mixture was left stirring at ambient temperature for 12 hours. The CH2Cl2 was 
removed in vacuo and rinsed with MeCN/hexane to remove the residual tin. 
The MeCN fraction was rinsed with hexane (2 × 15 mL) and the solvent was 
removed in vacuo. The crude material was purified by column chromatography 
(5% EtOAc/hexane) to give ethyl (5E)-4-oxohept-5-enoate (396) (310 mg, 




Rf 0.10 (5% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 6.90 (1H, dq, J 15.9, 6.6, H-6), 6.16 (1H, d, J 
15.9, H-5), 4.13 (2H, q, J 7.2, H-8), 2.87 (2H, t, J 6.6, H-3), 2.62 (2H, t, J 6.6, 




13C (75 MHz, CDCl3) δC /ppm 197.9 (C-4), 172.7 (C-1), 142.8 (C-5), 131.5 
(C-6), 60.4 (C-8), 34.2 (C-3), 27.9 (C-2), 18.1 (C-7), 14.0 (C-9). 
 
cis 
13C (75 MHz, CDCl3) δC /ppm 205.2 (C-4), 172.3 (C-1), 142.8 (C-5), 131.5 
(C-6), 60.5 (C-8), 37.7 (C-3), 27.7 (C-2), 17.4 (C-7), 14.0 (C-9). 
 
νmax. / cm-1: 2982 (w, C-H), 2932 (w, C-H), 1732 (s, C=O), 1699 (m, C=O), 1674 
(m), 1635 (m), 1417 (m), 1208 (s), 1163 (s), 1096 (m), 1023 (m), 972 (m). 
 
m/z: 171 (10%, M+1), 161 (19), 129 (43), 125 (76), 124 (59), 119 (18), 107 (5), 




9.2 Attempted condensation reactions 
 
9.2.1  (5E)-1-Allyl-5-butylidenepyrrolidin-2-one (398) 
Ethyl 4-oxooctanoate (292) (1.04 g, 5.60 mmol), allylamine (0.21 mL, 2.8 
mmol) and glacial AcOH (0.84 mL, 14.0 mmol) were dissolved in toluene (10 
mL) and heated at reflux for 72 hours using a modified Dean-Stark apparatus. 
The solution was cooled, the solvent removed in vacuo and the residue purified 
by column chromatography (10% EtOAC/hexane) to give (5E)-1-allyl-5-
butylidenepyrrolidin-2-one (398) (277 mg, 55% yield) as a yellow oil. The 













Rf 0.17 (10% EtOAc/hexane)  
 
1H (300 MHz, CDCl3) δΗ /ppm 5.78-5.65 (1H, m, H-10), 5.17-5.12 (2H, m, 
H-11), 4.66 (1H, t, J 7.2, H-4), 4.09 (2H, d, J 5.1, H-9), 2.74-2.44 (4H, m, H-6, 
H-7), 1.98 (2H, q, J 7.2, H-3), 1.39 (2H, sestet, J 7.2, H-2), 0.90 (3H, t, J 7.2, 
H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 175.1 (C-8), 138.7 (C-5), 131.8 (C-10), 116.7 
(C-11), 101.3 (C-4),42.1 (C-9), 28.7 (C-7), 28.6 (C-3), 23.1 (C-2), 21.2 (C-6), 
13.5 (C-1). 
 
νmax. / cm-1: 2958 (m, C-H), 2930 (m, C-H), 2872 (m, C-H), 1664 (s, C=O), 1412 
(s), 1339 (s), 1229 (m), 1177 (m), 1124 (m), 1077 (m), 991 (w), 955 (w), 921 
(m), 654 (m). 
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m/z: 179 (7%, M), 164 (3), 151 (10), 150 (100), 148 (8), 137 (55), 136 (11), 122 
(29), 108 (10). Found 179.1325, C11H17ON requires 179.1310. 
 
9.2.2 (5E)-1-But-3-enyl-5-butylidenepyrrolidin-2-one (399) 
Ethyl 4-oxooctanoate (292) (342 mg, 1.80 mmol), butenylamine hydrochloride 
(0.10 g, 0.92 mmol) and glacial AcOH (0.28 mL, 4.6 mmol) were dissolved in 
toluene (5 mL) and heated at reflux for 72 hours using a modified Dean-Stark 
apparatus. The solution was cooled, the solvent removed in vacuo and the 
residue purified by column chromatography (10% EtOAC/hexane) to give  (5E)-
1-but-3-enyl-5-butylidenepyrrolidin-2-one (399) (80 mg, 45% yield) as a 













Rf 0.14 (10% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 5.85-5.71 (1H, m, H-11), 5.10-5.02 (2H, m, 
H-12), 4.65 (1H, t, J 7.2, H-4), 3.53 (2H, t, J 7.2, H-9), 2.60 (2H, t, J 7.2, H-6) 
2.50-2.44 (2H, m, H-7), 2.33-2.26 (2H, m, H-10), 2.00 (2H, q, J 7.2, H-3), 1.42 
(2H, sestet, J 7.2, H-2), 0.92 (3H, t, J 7.2, H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 175.4 (C-8), 139.0 (C-5), 134.9 (C-11), 116.8 
(C-12), 100.6 (C-4), 39.0 (C-9), 30.8 (C-10), 28.9 (C-7), 28.7 (C-3), 23.3 (C-2), 
21.3 (C-6), 13.7 (C-1). 
 
νmax. / cm-1: 2958 (m, C-H), 2872 (m, C-H), 1662 (s, C=O), 1414 (m), 1363 (m), 




9.3 Ring-closing metathesis reactions 
 
9.3.1 (E)-5-Butylidene1-(prop-1-enyl)pyrrolidin-2-one (401)242, 176 
(5E)-1-Allyl-5-butylidenepyrrolidin-2-one (389) (200 mg, 1.12 mmol) and 
Grubbs second generation catalyst (47 mg, 0.06 mmol) were dissolved in 
toluene (7 mL) and heated at reflux for 12 hours. The solution was cooled and 
the solvent was removed in vacuo. The crude material was purified by column 
chromatography (10% EtOAc/hexane) to give (E)-5-butylidene1-(prop-1-

















Rf 0.14 (10% EtOAc/hexane) 
 
1H (300 MHz, CDCl3) δΗ /ppm 6.09-5.96 (2H, m, H-9, H-10), 4.91-4.85 (1H, td, 
J 7.2, 2.1, H-4), 2.66-2.60 (2H, m, H-7), 2.55-2.50 (2H, m, H-6), 1.98 (2H, q, J 
7.2, H-3), 1.81 (3H, d, J 5.4, H-11), 1.35-1.29 (2H, m, H-2), 0.90 (3H, t, J 7.2, 
H-1). 
 
13C (75 MHz, CDCl3) δC /ppm 174.8 (C-8), 139.2 (C-5), 122.4 (C-9), 121.3 
(C-4), 102.7 (C-10), 29.4 (C-7), 28.8 (C-3), 23.1 (C-2), 21.3 (C-6), 15.9 (C-1), 
13.7 (C-11).  
 
νmax. / cm-1: 2960 (m, C-H), 2874 (m, C-H), 1699 (s, C=O), 1541 (m), 1457 (m), 
1375 (m), 1188 (m), 1079 (s), 668 (w). 
 
m/z: 179 (28%, M), 166 (18), 150 (85), 148 (20), 139 (24), 124 (32), 122 (19), 




9.3.2 Attempted RCM: (5E)-1-But-3-enyl-5-butylidenepyrrolidin-2-one 
(399)242  
Method A 
(5E)-1-But-3-enyl-5-butylidenepyrrolidin-2-one (399) (20 mg, 0.10 mmol) and 
Grubbs second generation catalyst (6 mg, 0.005 mmol) were dissolved in 
toluene (3 mL) and stirred at ambient temperature for 5 days. The solvent was 
removed in vacuo and the crude material was purified by column 




(5E)-1-But-3-enyl-5-butylidenepyrrolidin-2-one (399) (210 mg, 1.08 mmol) 
and Grubbs second generation catalyst (46 mg, 0.05 mmol) were dissolved in 
toluene (10 mL) and heated at reflux for 12 hours. The solvent was removed in 
vacuo and the crude material was purified by column chromatography. 1H-NMR 
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